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Abstract	Hematopoietic	 stem	 cells	 are	 a	 small	 but	 significant	 population	 of	 cells	 fundamental	 for	 generating	 and	maintaining	the	hematopoietic	system.	These	cells	are	used	in	the	treatment	of	cancer	and	auto-immune	patients.	Studies	in	mammals	suggest	that	inflammation	and	infection	can	modulate	the	biology	of	these	cells,	affecting	their	location,	self-renewal	capacity	and	directing	differentiation.	The	aim	of	this	work	was	to	study	the	effect	of	repeated	stimulation	on	the	hematopoietic	stem	and	progenitor	(HSPCs)	population	in	zebrafish	(Danio	rerio)	to	benefit	from	the	live	imaging	potential	of	this	model	organism.	It	was	hypothesised	that	early	post-transplant	HSPC	behaviour	(e.g.	lodgement	in	the	niche,	self-renewal,	mobilisation	and	differentiation)	could	be	observed	and	would	be	indicative	of	the	success	or	failure	of	HCT.	Double	transgenic	Tg	(cd41:GFP;	lysc:dsRed)	donors,	in	which	 HSPCs	 express	 green	 fluorescent	 protein	 (GFP+)	 and	 myeloid	 cells	 express	 red	 fluorescent	 protein	(dsRed+)	 were	 used.	 HSPCs	 were	 sorted	 from	 donor	 whole	 kidney	 marrow	 (WKM)	 and	 transplanted	 into	irradiated	optically-transparent	recipients,	which	were	then	imaged	using	wide-field	microscopy,	individually	tracked	 for	survival	and	hematopoietic	 reconstitution	was	assessed	after	28	days	by	 flow	cytometry.	 Indeed,	initial	experiments	showed	that	early	observations	of	cells	in	the	WKM	correlated	with	hematopoietic	recovery	and	survival	of	recipients,	although	the	strength	of	the	correlation	was	not	sufficiently	powerful	for	predicting	recipient	outcome.		This	refinement	of	the	HCT	protocol	lead	to	the	potentiality	of	studying	the	behaviour	of	HSPCs	in	the	context	of	inflammation.	 Inflammation	 was	 initiated	 with	 repeated	 intra-peritoneal	 injections	 of	 the	 viral	 mimic	Polyinosinic:polycytidylic	acid	(poly	I:C)	in	either	the	donor	or	recipient	prior	to	transplant.	Poly	I:C	injection	of	donors	prior	to	transplant	causes	HSPCs	to	colonise	the	recipient	WKM	at	a	greater	rate	than	HSPCs	from	sham	(PBS-injected)	donors.	However,	this	did	not	appear	to	affect	recipient	survival	or	WKM	reconstitution	at	28	days.	Poly	I:C	injection	of	recipients	prior	to	transplant	did	not	affect	early	post-transplant	repopulation	of	the	WKM,	myelopoiesis,	recipient	survival,	or	WKM	reconstitution	at	28	days.	Future	work	will	use	competitive	transplants	to	confirm	these	findings	and	will	explore	alternative	inflammation	models.	Furthermore,	the	confounding	factor	of	irradiation-caused	inflammation	will	be	mitigated	by	transplanting	HSPCs	into	optically-transparent	bloodless	recipients.	Overall,	this	thesis	has	demonstrated	that	the	zebrafish	can	provide	valuable	in	vivo	data	for	studying	HSPC	behaviour	in	the	recipient	post-transplant.		 	
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1 Introduction		
1.1 Hematopoietic	stem	cells	Hematopoietic	cell	transplantation	(HCT)	has	been	used	clinically	since	1959	in	the	treatment	of	patients	with	cancers	(leukemias,	lymphomas),	autoimmune	diseases,	or	bone-marrow	syndromes	(such	as	aplastic	anemia	and	 thalassemia	 sickle	 cell	 anemia),	 with	 about	 2,000	 people	 in	 the	 UK	 in	 need	 of	 one	 every	 year	 (1).	Hematopoietic	stem	cells	(HSCs)	are	the	precursor	cells	of	all	mature	blood	cells	throughout	vertebrate	life	and	are	 an	 essential	 component	 of	 the	 transplanted	 population	 as	 they	 ensure	 long	 term	 reconstitution	 of	 the	hematopoietic	 system.	 HSCs	 are	 rare,	 multi-potent,	 and	 self-renewing	 cells	 that	 maintain	 homeostasis	 by	differentiating	to	replace	hematopoietic	cells.	They	were	first	discovered	by	Till	and	McCulloch	in	1961	and	a	comprehensive	stem	cell	theory	was	published	with	Becker	in	1963	(2).	HSCs	are	often	studied	as	part	of	a	larger	population	of	hematopoietic	stem	and	progenitor	cells	(HSPCs).		
1.2 HSC	phenotype	Functionally,	HSCs	are	identified	by	their	ability	to	repopulate	irradiated	recipients.	Their	cell-surface	phenotype	is	determined	by	antibody	binding	and	pre-transplant	 isolation	by	 fluorescence-activated	cell	sorting	(FACS).	Some	markers	are	used	to	positively	select	for	stem	cell	associated	proteins	(see	Table	1.1).	Other	markers	are	used	to	select	against	differentiated	cells,	referred	to	as	lineage	negative	(lin-),	using	a	complex	combination	of	markers,	thereby	by	excluding	mature	populations	(lymphoid,	myeloid	and	erythroid).	Importantly,	the	markers	used	to	isolate	HSCs	will	depend	on	the	organism	(human,	mouse,	zebrafish)	and	the	stage	of	development	(foetal,	adult).			
1.2.1 Purification	of	HSCs	from	mammals		The	most	frequently	used	marker	used	for	isolating	HSCs	from	human	peripheral	blood	in	clinic	is	mucosialin	(hereafter	 referred	 to	as	 cluster	of	differentiation	 (CD)	34),	 a	 transmembrane	protein	whose	 function	 is	 still	unclear	(3).	More	primitive	HSCs	can	be	isolated	by	the	lack	of	expression	of	ADP-ribosyl-cyclase	1	(hereafter	CD38)	 and	 the	 major	 histocompatibility	 class	 II	 antigen	 Human	 Leukocyte	 Antigen	 D	 Related	 (HLA-DR)	expression	(4,	5).	Hénon	et	al.	 reported	better	post-transplant	engraftment	and	hematopoietic	 recovery	with	CD34+	CD38-	cells	than	total	CD34+	cells	(6).	Later	Drake	et	al.	found	even	better	engraftment	and	hematopoietic	reconstitution	with	CD34+	CD38-	HLA-DR-	cells	compared	with	CD34+	CD38-	cells	(7).	About	70%	of	human	CD34+	CD38-	HSCs	express	 the	 thrombopoietin	 receptor	 (also	known	as	 c-mpl,	hereafter	 referred	 to	as	CD110)	and	these	cells	(CD34+CD38-	CD110+)	show	better	engraftment	than	CD34+CD38-	CD110-	(8).					
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Marker	 Mouse	 Human	 Zebrafish	
CD34/Mucosialin	 Negative	 LT-HSCs,	
Positive	ST-HSCs	(9)	
	
Positive	(10)	 	
CD38/ADP-ribosyl-cyclase	1	 Positive	mid-fetal	to	adult	(11)	 Positive	(4)	 	CD105/Endoglin	 Positive	(12)	 Positive	(13)	 	
c-Kit/CD117	 Positive	(14,	15)	 	 	Sca-1	 Positive	(16)	 	 	CD150/SLAM	 Positive	(17)	 	 	
Tie2/CD202	 Positive	(18)	 	 	
Mpl/CD110	 Positive	(8)	 Positive	 mid-fetal	 to	adult	(19)	 	CD90/Thy1	 	 Positive	(20,	21)	 	
Hoescht-SP	 Present	(22)	 Present	(23)	 Present	(24)	
CD133/Prominin-1	 	 Positive	(25)	 	
VEGFR2/FLK1/CD309	 	 Positive	(26)	 	
Flt3/Flk2	 Negative	(27)	 	 	
CD41/alpha	integrin	 Positive	 emerging	 HSCs,	myeloid	 biased	 adult	HSCs	(28)	
	 Positive	 Nascent	 and	adult	 HSCs	 and	thrombocytes	(29)	Runx1	 Positive	 emerging	 HSCs	(30)	 	 Positive	 emerging	 HSCs	(31)	C-myb	 	 	 Positive	 emerging	 HSCs	(32)		
Table	1.1:	A	list	of	HSC	markers	(proteins/genes/dyes)	and	their	expression	in	mouse,	human	and	zebrafish.	Long	term	HSCs	
(LT-HSCs)	refers	to	a	quiescent	population	of	stem	cells	and	Short	term	HSCs	(ST-HSCs)	refers	to	a	population	of	stem	cells	which	
undergoes	cell	cycling	more	frequently	(1.2.4).	
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Other	 proteins	 expressed	 by	 stem	 cells	 and	 immature	 progenitor	 cells	 include	 thymocyte	 antigen	 1	 (thy1,	hereafter	CD90),	a	glycophosphatidylinositol	cell	surface	protein	with	an	 immune-globulin	 like	structure	(20,	21);	 prominin-1	 (CD133),	 a	 transmembrane	 glycoprotein	which	may	 be	 involved	 in	 organization	 of	 the	 cell	membrane	(25);	and	vascular	endothelial	growth	factor	receptor	2	(VEGFR2;	also	known	as	KDR,	Flk1	or	CD309),	involved	in	vascular	endothelial	growth	factor	(VEGF)	signalling	(26,	33).	The	family	of	signal-regulatory	proteins	have	also	been	reported	as	candidate	stem	cell	proteins	expressed	by	CD34+	CD90+	CD133+	cells	(34).			In	contrast	to	human	HSCs,	mouse	HSCs	are	CD34-/low	(Table	1.1).	In	the	mouse,	HSCs	are	typically	isolated	from	the	lineage	negative	(Lin-),	stem	cell	antigen	1	(Sca1)	(16)	positive	and	stem	cell	factor	receptor	(hereafter	c-kit;	also	known	as	CD117)	positive	subset	of	 the	bone	marrow	(BM):	 referred	 to	as	Lin-	Sca1+	Kit+	and	hereafter	abbreviated	to	LSK.	Although	consistently	used	in	isolating	HSCs,	a	study	suggested	that	some	pluripotent	stem	cells	have	low	c-kit	expression	and	are	therefore	omitted	when	using	these	selection	parameters	(15).	In	addition,	the	expression	of	Sca1	(Ly-6	A/E)	varies	between	mouse	strains	(35).	The	LSK	subset	makes	up	between	0.1	and	0.01	%	of	total	BM	cell	population	and	just	10	%	of	LSK	cells	confer	long-term	reconstitution.	In	C57BL/6	mice,	the	CD34-	LSK	subset	makes	up	about	0.005	%	of	total	BM	cells(36).		Subsequently,	the	expression	of	foetal	liver	kinase	2	(also	known	as	fms-like	tyrosine	kinase	3;	hereafter	CD135),	a	tyrosine	kinase	receptor,	was	found	to	distinguish	lymphoid	bias	progenitors	from	multi-potent	HSCs	(27,	37,	38).	 Therefore,	 the	 signature	 LSK	 CD34-	 CD135low/-	 is	 also	 used	 to	 define	 HSCs.	 Just	 like	 in	 the	 human	 HSC	population	(CD34+	CD38-),	 the	thrombopoietin	receptor	CD110	is	expressed	on	70	%	of	mouse	LSK	HSCs	and	used	to	segregate	mouse	HSCs.	These	cells	show	better	engraftment	than	LSK	CD34-	CD110-	(8).		The	most	recent	method	to	purify	mice	HSCs	employ	differential	expression	of	signalling	lymphocytic	activation	molecule	 (SLAM)	receptors	1	and	2,	hereafter	referred	 to	as	CD150	and	CD48	respectively	 (17).	HSCs	highly	express	CD150,	but	not	CD48,	and	are	thus	enriched	in	the	LSK	CD150+	CD48-	population.	This	subset	of	LSK	cells	makes	up	less	than	0.01	%	of	total	BM	cells	but	47	%	of	purified	single-cells	reconstitution	experiments	had	long-term	 reconstitution.	 Most	 LSK	 CD34-	 cells	 are	 CD150+	 and	 CD135-,	 therefore	 these	 populations	 are	 largely	overlapping	 (39).	 One	 in	 105	BM	 cells	 are	 LSK	 CD34-	CD150+	 CD135-,	 and	 a	 third	 (1	 in	 3)	 of	 these	 cells	 are	functionally	able	to	reconstitute	the	immune	system	long-term.		
1.2.2 Studying	HSCs	in	the	zebrafish	Unfortunately,	while	antibodies	are	used	for	the	isolation	of	mammalian	cells,	as	of	yet	there	are	no	antibodies	available	to	isolate	HSCs	from	zebrafish	samples	(40).	However,	this	has	not	prevented	the	use	of	the	zebrafish	model	 to	 study	 the	 regulation	 of	 hematopoiesis	 over	 the	 last	 20	 years.	 Zebrafish,	Danio	 rerio,	 have	 several	advantageous	features,	including	optical	transparency	which	allows	in	vivo	visualisation	of	real	time	events,	and	the	possibility	for	genetic	manipulation	which	allows	control	of	gene	expression	and	the	creation	of	transgenic	lines.	Most	notably,	zebrafish	have	been	instrumental	in	mapping	the	origins	of	HSCs	with	fate	mapping	(41),	real-time	tracking	(42)	as	well	as	for	elucidating	signal	pathways	important	in	HSC	generation	(43,	44).	
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1.2.2.1 Isolating	HSCs	from	teleost	kidney	The	zebrafish	kidney	(referred	to	as	the	whole	kidney	marrow,	WKM)	is	the	primary	site	of	hematopoietic	stem	cell	maintenance	and	thus	the	functional	equivalent	of	the	mammalian	bone	marrow.		Based	on	limiting	dilution	assays,	it	is	estimated	the	WKM	contains	between	1	in	65,	500	and	1	in	38,	140	cells	with	long-term	reconstitution	capacity	(45,	46).	Traver	et	al.	 first	described	HCT	in	zebrafish	and	showed	that	 the	kidney	marrow	contains	repopulating	hematopoietic	cells.	By	separating	the	kidney	marrow	population	by	size	and	granularity	using	flow	cytometry	 forward	 and	 side	 scatter,	 Traver	 et	 al.	 showed	 that	 cells	 with	 reconstitution	 ability	 are	 among	 a	population	of	lymphoid	cells	with	low	forward	and	side	scatter	(47,	48).	However,	less	than	2	%	(2	of	110)	of	recipients	 transplanted	 with	 cells	 of	 the	 lymphoid	 fraction	 had	 long-term	 reconstitution,	 as	 assessed	 by	production	of	donor	derived	erythrocytes	6	months	after	transplantation	(48).			Subsequently,	 transgenic	zebrafish	 lines	were	used	 to	 isolate	HSC	enriched	populations	based	on	 fluorescent	protein	expression,	driven	by	HSC	 related	genes	 (Table	1.1)	 (49,	50).	One	of	 these	 transgenic	 lines	 is	 the	Tg	(cd41:GFP)	line,	in	which	the	green	fluorescent	protein	(GFP)	expressing	population	has	been	shown	to	contain	a	pluripotent	population	capable	of	reconstituting	all	cells	of	the	immune	system	in	irradiated	fish	(51).	In	these	fish,	GFP	expression	is	driven	by	the	thrombocyte	specific	aIIb	integrin	(hereafter	referred	to	as	CD41)	promoter	and	labels	thrombocytes	(GFPhigh)	and	HSPCs	(GFPlow).	CD41	is	expressed	by	definitive	HSCs	in	zebrafish	from	larvae	to	adulthood	(51).	CD41	only	transiently	marks	foetal	HSCs	in	mice	(28,	52).	Images	of	embryonic	mouse	slices	indicate	that	CD41	is	an	important	modulator	of	aortic	generated	HSCs	and	CD41	localises	at	the	point	of	contact	between	cells	 in	 intra-aortic	hematopoietic	clusters	(53,	54).	Ma	et	al.	showed	that	the	reconstituting	potential	 of	 kidney	 cells	was	 primarily	 in	 cd41low	 population.	 These	 cells	make	 up	 0.8%	 of	WKM	 cells,	with	between	5	000	and	10	000	 in	a	6	months	post	 fertilisation	(mpf)	adult.	Limiting	dilution	assays	suggest	HSC	frequency	is	1	in	100	cd41low	cells	(51).	Recently,	the	Zebrabrow	system	was	used	to	induce	a	unique	heritable	colour	to	each	nascent	cd41:GFP+	cells.	Transplantation	of	these	labelled	clones	confirmed	that	the	majority	of	cells	in	this	population	are	progenitors	with	a	balanced	myeloid/lymphoid	output	and	capable	of	contributing	up	to	95	%	of	the	recipient	marrow,	suggesting	this	population	is	multi-potent	(55).	In	this	thesis	a	number	of	fish	 lines	were	exploited	(see	Table	2.1).	 	 Importantly,	 the	Tg	(cd41:GFP)	zebrafish	 line	was	crossed	with	Tg	(lyz:dsRed)	fish	in	which	myeloid	cells	express	dsRed	fluorescent	protein	(56).	This	meant	that	donor	derived	myeloid	cells	could	be	distinguished	from	endogenous	host	myeloid	cells.			More	recently,	Tg	(runx1+23:GFP)	and	Tg	(runx1+23:NLSmCherry)	lines	were	created	by	Tamplin	et	al.	for	the	study	of	HSC	migration	and	seeding	of	HSCs	in	the	endogenous	embryonic	kidney	(42).	Tamplin	et	al.	created	a	transgenic	in	which	fluorescent	protein	expression	was	under	the	control	of	a	regulatory	element	from	the	first	intron	of	 the	mouse	 runt-related	 transcription	 factor	1	 (hereafter	 referred	 to	 as	 runx1;	 also	known	as	 acute	myeloid	leukemia	1	protein	or	core-binding	factor	subunit	apha-2)	locus	(42).	The	enhancer	is	an	important	cis-regulatory	element	which	involves	runx1	and	important	regulators	of	hematopoiesis:	GATA-binding	protein	2	(Gata2),	 E26	 transformation	 specific	 (ETS)	 and	 stem	 cell	 leukemia	 (SCL)	 to	drive	 runx1	 expression	 and	HSC	emergence	(57).	Runx1	is	a	transcription	factor	required	for	definitive	hematopoiesis	and	formation	of	 intra-
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aortic	hematopoietic	clusters	(30).	The	insertion	of	the	mouse	regulatory	element	created	a	transgenic	line	in	which	 the	 fluorescent	 protein	was	 expressed	 in	 adult	 zebrafish	HSPCs.	 This	 regulatory	 element	 is	 a	 531	 bp	sequence	 in	 the	1st	 intron	of	Runx1,	 23	kb	downstream	 from	 the	P1	promoter.	The	enhancer	 regulates	 early	expression	 of	 Runx1	 in	 definitive	 hematopoietic	 cells	 in	 the	 mouse	 embryos	 (57).	 The	 nuclear	 localisation	sequence	 (NLS)	 in	 the	Tg	 (runx1+23:NLSmCherry)	 line	 results	 in	a	 larger	 labelled	population	 than	 in	 the	Tg	(runx1+23:GFP)	 line.	 In	 double	 transgenic	 fish	 Tg	 (runx1+23:NLSmCherry;	 cmyb:GFP),	 the	 population	 of	runx1+23:NLSmCherry+	cells	appears	to	overlap	significantly	with	cmyb:GFP+	cells	(58).	Similarly,	 in	double	transgenic	Tg	(runx1+23:NLSmCherry;	cd41:GFP)	fish,		the	population	of	runx1+23:NLSmCherry+	cells	appears	to	overlap	significantly	with	cd41:GFP+	cells.	However,	 it	 is	not	known	how	the	double	positive	cells	(runx1+	cd41+)	 differ	 from	 single	 positive	 cells	 (runx1+	 cd41-	 and	 runx1-	 cd41+)	 in	 their	 gene	 expression,	 their	engraftment	potential	or	their	reconstitution	potential.	Perhaps	the	expression	of	these	genes	reflect	their	degree	of	 pluripotency	 or	 differentiation	 biases	 of	 these	 cells.	 Runx1:GFP+	 cells	make	 up	 0.4	%	 of	WKM	 cells,	with	between	1,000	and	3,000	in	a	6	mpf	adult.	The	HSC	frequency	is	estimated	at	1	in	35	runx1:GFP+	cells	(42).		Lineage	 tracing	of	HSCs	using	 the	Cre/	 loxP	system	has	also	been	developed	 in	 the	zebrafish.	Bertrand	et	al.	created	the	Tg	(kdrl:Cre;	b-actin2:loxP-STOP-loxP:dsRed)	line	in	which	the	vascular	cells	(kdrl+)	express	Cre.	Cre	recombinase	excises	the	LoxP	sites	which	restrict	dsRed	expression	from	the	b-actin	promoter.	Therefore,	there	is	a	permanent	switch	from	non-fluorescent	to	dsRed+	those	cells	and	in	the	progeny	of	those	cells.	With	this,	they	were	able	to	show	that	almost	all	blood	cells	were	derived	from	hemogenic	endothelium	(41).	Kobayashi	et	
al.	(59)	and	Butko	et	al.	(60)	found	similar	results	with	Tg	(jam1a:CreERT2;	b-actin2:loxP-STOP-loxP:dsRed)	and	Tg	(gata2b:Gal4;	UAS:Cre;	b-actin:LoxP-STOP-LoxP-dsRed)	lines	respectively.	In	the	former,	(jam1a:CreERT2;	b-actin2:loxP-STOP-loxP:dsRed),	HSPC	precursors	express	jam1a	which	drives	expression	of	Cre	to	excise	the	LoxP	sites	preventing	ubiquitous	(b-actin	driven)	expression	of	dsRed.	Thus	enabling	as	before	the	lineage	tracing	of	jam1a+	cells.	Jam1	and	Jam3	are	reliable	markers	of	mouse	HSCs	(61,	62)	and	play	a	role	in	cell	adhesion	to	the	BM	niche.	In	the	latter,	Tg	(gata2b:Gal4;	UAS:Cre;	b-actin:LoxP-STOP-LoxP-dsRed),	gata2b	expression	by	forming	HSPCs,	drives	expression	of	Gal4,	which	 in	 turn	drives	UAS	promoters	 to	express	Cre,	which	excise	 the	LoxP	cassette	 inhibiting	 dsRed	 expression.	 Thus,	 they	 could	 show	 that	 gata2b	 expressing	 cells	 contribute	 to	 adult	hematopoiesis.	Gata2	is	expressed	by	all	mouse	HSCs		and	plays	an	important	role	in	the	emergence	of	these	cells	in	the	embryo	(63).		
1.2.3 Other	selection	parameters	Less	commonly	used	methods	of	HSC	enrichment	include	isolation	of	a	side-population	(SP),	into	which	HSCs	fall	because	 of	 their	 unique	 ability	 to	 efflux	 the	 DNA-binding	 dye	 Hoechst	 33342	 (22).	 The	 efflux	 of	 Hoechst	 is	dependent	on	ABC	transporter	G	family	member	2	(ABCG2).	Transplantation	of	a	single	cell	with	strong	dye	efflux	activity	could	engraft	long	term	in	irradiated	mice	recipients	(64).	However,	Morita	et	al.	have	shown	long-term	repopulating	activity	in	about	50	%	of	non-SP	cells	(65).	In	zebrafish,	the	SP	fraction	of	the	kidney	(24,	66,	67)	was	found	to	highly	express	HSC-related	genes	including	Scl,	LIM	domain	only	2	(lmo2),	and	transcription	factor	c-myb	(24).	Comparative	microarray	analysis	of	zebrafish	lymphoid	SP	fraction	with	mouse	and	human	HSCs	
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found	they	have	a	similar	molecular	signature,	including	expression	of	gata2,	DNA-binding	inhibitor	protein	1	(Id1)	 and	 early	 growth	 response	 protein	 1	 (Egr1)	 transcription	 factors	 (67).	 In	 addition,	 22	 %	 of	 the	 SP	population	 overlapped	with	 zebrafish	HSPCs	 (cd41low).	 This	 suggests	HSCs	 are	 found	 in	 both	 SP	 and	non-SP	populations.			Other	 characteristics	 of	 mouse	 HSCs	 used	 for	 isolation	 include	 low	 staining	 with	 the	 mitochondrial	 dye	Rhodamine	123	(Rho),	expression	of	angiopoietin	receptor	(also	known	as	receptor	tyrosine	kinase	2,	hereafter	referred	to	as	CD202b),	and	expression	of	Transforming	growth	factor	beta	(TGFb)	receptor,	endoglin/CD105	(68-70).	The	Rho	efflux	activity	of	HSCs	is	attributed	to	another	ABC	transporter,	P-glyco-	protein	(71).	Although	the	Rho-SP	has	been	identified	in	ginbuna	carp,	it	has	not	been	studied	in	zebrafish	and	the	population	has	not	been	tested	in	transplantation	assays.		
1.2.4 Long	and	short	term	HSCs	The	mouse	LSK	population	is	functionally	a	heterogeneous	mix	of	HSPCs.	In	the	classic	paradigm	(Figure	1.1),	the	differentiation	potential	of	a	cell	is	restricted	as	it	transitions	from	long	term	(LT-HSC),	to	short	term	(ST-HSC),	to	multi-potent	progenitor	(MPP).	The	LT-HSC	and	ST-HSC	populations	are	both	self-renewing	multipotent	populations	 but	 they	 differ	 in	 cell	 cycle	 dynamics.	 The	 LT-HSC	population	 has	 a	 low	 replication	 cycle	which	reduces	the	risk	of	incorporating	harmful	genetic	mutations	during	DNA	replication.	A	slow	replicative	cycle	is	also	important	for	retaining	self-renewing	potential	as	rapidly	cycling	ST-HSCs	have	lower	reconstitution	ability	(72,	73).	 Similarly,	 LT-HSCs	 can	become	 functionally	 exhausted	by	 increased	 cell	 cycling	activity	or	by	 serial	transplantation	(74).	In	mice,	CD34	is	not	expressed	by	LT-HSCs	but	is	expressed	on	ST-HSCs	(Table	1.1).	MPPs	have	high	cycling	kinetics	and	express	CD34,	CD135(39)	and	CD224,	a	member	of	the	SLAM	family	(17)	(Figure	1.1).		
	
Figure	1.1:	Subsets	of	the	mouse	hematopoietic	stem	and	progenitor	cell	(HSPC)	population.	The	immature	HSPC	population	can	
be	separated	based	on	protein	expression	and	cell	cycle	dynamics,	which	correlate	with	post	 transplantation	reconstitution	
ability.		
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Label-retaining	assays	with	bromodeoxyuridine	(BrdU)	or	Histone	2B-GFP	(H2B-GFP)	dilution	have	been	used	to	 study	 the	 different	 cell	 cycle	 kinetics	 of	 the	 LSK	 population	 (72,	 73).	 BrdU	 is	 a	 thymidine	 analogue	 that	incorporates	into	the	DNA	while	present,	and	then	is	 lost	when	cells	undergo	mitosis	 in	the	absence	of	BrdU.	However,	there	are	doubts	about	the	accuracy	of	the	BrdU	assay.	For	instance,	Kiel	et	al.	found	that	very	few	of	BrdU	 labelled	 cells	 in	 neonatal	 mice	 samples	 expressed	 HSC	 markers	 (75).	 H2B-GFP	 labelling	 is	 done	 by	doxycycline-induced	expression	of	the	histone	protein	2B	gene	fused	with	GFP	in	all	cells.	When	doxycycline	is	removed,	the	transcription	of	the	H2B-GFP	fusion	gene	is	no	longer	induced	and	the	production	of	GFP	is	stopped.	As	histone	2B	is	required	for	DNA	hyperstructure,	the	H2B-GFP	protein	is	gradually	lost	in	replicating	cells	which	produce	H2B	on	demand.	Foudi	et	al.	found	that	transplanted	HSCs	(LSK	CD150+	CD48-)	with	higher	H2B-GFP	expression	had	higher	long-term	reconstitution	potential	(72).		The	ST-HSC	subset	(LSK	CD34+	CD150+	CD48-	CD135-)	is	larger	than	the	LT-HSC	subset	with	about	~85%	of	LSK	CD150+	CD48-	cells	dividing	within	4	weeks	(as	assessed	by	loss	of	BrdU	or	GFP;	(72,	73).	Cells	in	this	population	that	have	divided	more	than	5	times	show	significantly	lower	repopulating	ability	(72,	73).	The	smaller	subset	of	LT-HSC	 (LSK	 CD34-	 CD150+	 CD48-	 CD135-)	 contains	 infrequently	 dividing	 cells,	 also	 known	 as	 dormant	 or	quiescent	HSCs,	and	these	cells	divide	about	every	145	days	(~5%	retain	H2B	label	after	72	weeks	chase(72)).	LT-HSCs	 do	 not	 respond	 to	 irradiation	 but	 can	 be	 activated	 by	 cytokines	 such	 as	 interferon-α	 (IFN-α)	 and	granulocyte	colony-stimulating	factor	(G-CSF;	(73,	76).	Dormant	HSCs	are	also	activated	to	proliferate	following	treatment	with	chemotherapeutic	drug	5-Fluorouracil	(5-FU),	a	drug	used	to	kill	proliferative	cells.		Although	quiescence	seems	to	be	a	stem	cell	requirement,	embryonic	stem	cells	are	highly	proliferative	and	yet	retain	 their	 stemness.	 It	 is	 not	 yet	 known	 if	 the	 cell	 cycling	 dynamics	 of	 an	 individual	 cell	 are	 consistent	throughout	its	life;	does	a	ST-HSC,	characterised	by	its	rapid	loss	of	label	(BrdU	or	GFP)	continue	rapid	cell	cycling,	or	 can	 it	 switch	 to	 a	 quiescent	 state,	 characteristic	 of	 LT-HSCs.	 If	 so,	 the	 cell	 cycle	 behaviour	 could	 simple	distinguish	replicating	clones	from	non-replicating	clones,	rather	than	determine	the	stem	cell	potential	of	that	clone.	Some	evidence	suggest	that	quiescent	HSCs	(Lin-	Sca1+	Thylow)	are	better	at	engrafting	when	transplanted	(77).		Importantly,	 similar	 cell	 cycling	 dynamics	 have	 not	 yet	 been	 demonstrated	 in	 the	 HSPC	 populations	 of	 the	zebrafish.	Perhaps	identifying	infrequently	dividing	cells	in	the	HSPC	population	would	permit	the	identification	of	other	genes	for	isolating	HSCs	in	the	zebrafish	and	progress	the	use	of	zebrafish	in	the	field.	Currently,	the	use	of	zebrafish	is	limited	by	the	lack	of	antibodies	and	imperfect	transgenic	lines	(40).		
1.2.5 HSC	output	bias	In	the	classic	model	of	hematopoietic	differentiation,	mature	blood	cells	are	derived	in	a	step-wise	progression	from	a	pluripotent	stem	cell	through	a	tree-like	hierarchy	to	a	definitive	progenitor	cell	(Figure	1.2).			
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In	the	current	mammalian	model	of	hematopoiesis,	HSCs	differentiate	into	MPPs	and	subsequently	into	oligo-potent	 progenitors,	 common	 myeloid	 progenitors	 (CMPs)	 and	 lymphoid-primed	 multi-potent	 progenitors	(LMPPs).	Recent	mathematical	models	combining	 flow	cytometry,	 transcriptomics	and	 lineage	 fate	data	have	challenged	this	simplistic	binary	model.	For	instance,	Moignard	et	al.	have	used	single	cell	expression	profiling	and	powerful	bioinformatics	to	identify	the	network	of	transcription	factors	controlling	stem	cell	 fate	choices	(78).	As	a	result,	the	hematopoietic	tree	model	with	distinct	branches	has	been	reinterpreted	as	a	developmental	
continuum	 with	 gradual	 separations	 that	 are	 a	 lot	 less	 distinct	 (79,	 80).	 This	 model	 suggests	 a	 greater	heterogeneity	in	the	stem	population	than	the	former	model.	In	addition,	single	cell	sequencing	evidence	suggests	HSCs	can	commit	directly	to	more	definitive	stages	and	cells	bypass	conventional	checkpoints	(81).	This	model	suggests	a	process	by	which	a	rapid	response	to	demand	is	possible.			
	
Figure	1.2:	Hematopoietic	differentiation	progression.	Past	and	present	models	of	hematopoietic	cell	differentiation	 lineage	
hierarchy	based	on	the	human	lineage	hierarchy	proposed	by	Görgens	et	al.	(82).	In	the	binary	model,	there	is	a	linear	sequence	
of	events	from	HSC	to	MPP,	to	common	myeloid	progenitors	(CMP)	and	lymphoid-primed	multi-potent	progenitors	(LMPP),	to	
mature	hematopoietic	cell.	In	the	continuum	model,	the	differentiation	from	HSC	to	mature	hematopoietic	cell	does	not	require	
an	intermediate	cell	type.		Conceptually,	there	are	3	possible	outcomes	when	a	stem	cell	divides	(83):	the	mother	cell	produces	2	daughter	cells	 of	 the	 same	 non-stem	 cell	 identity,	 having	 differentiated	 (Figure	 1.3A);	 the	mother	 cell	 asymmetrically	divides	 into	 a	 daughter	 with	 the	 same	 stem	 cell	 identity	 as	 the	 mother	 cell	 and	 a	 daughter	 cell	 which	 has	
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differentiated	(Figure	1.3B);	or	the	2	daughters	retain	the	same	identity	as	the	mother	cell,	also	known	as	self-renewal	 (Figure	 1.3C).	 Studies	 are	 underway	 to	 decipher	 if,	 when	 and	 why	 these	 outcomes	 happen.	Understanding	the	division	of	these	cells	may	hold	the	key	to	understanding	the	lifespan	of	a	HSC	and	how	the	drive	to	undergo	cell	division,	in	conditions	such	as	inflammation,	can	affect	the	division	of	these	cells.		
	
Figure	1.3:	Symmetrical	and	asymmetrical	division	of	hematopoietic	stem	cells.		There	are	3	conceptual	outcomes	when	stem	
cells	 undergo	 mitosis.	 (A)	 The	 mother	 produces	 2	 non-stem	 cell	 daughters,	 (B)	 the	 mother	 cell	 produces	 1	 non-stem	 cell	
daughter	and	1	daughter	which	retains	stem	cell	qualities,	or	(C)	two	stem-cell	clones	are	produced,	often	referred	to	as	self-
renewal.		Infection	and	immunological	stress	place	a	demand	on	innate	and	immune	cells	which	have	a	limited	lifespan	and	 must	 be	 replenished.	 Hematopoietic	 requirements	 in	 response	 to	 infection	 and	 inflammation	 depend	asymmetrically	 on	 either	 myeloid	 or	 lymphoid	 cells	 and	 both	myeloid	 biased	 and	 lymphoid	 biased	 subsets	appear	to	exist	within	the	MPP	population	(distinguished	by	CD150	and	CD229	expression	in	the	mouse).	There	is	not	much	information	about	the	biases	in	the	HSPC	population	of	the	zebrafish.		
1.3 Immune	homeostasis	Both	zebrafish	and	mammals	share	all	major	blood	cell	types	(48),	making	findings	in	the	zebrafish	translatable	to	mammalian	systems.	Just	as	in	mammals,	the	erythroid	lineage	oxygenates	the	tissues	while	lymphoid	and	myeloid	 lineages	 give	 rise	 to	 adaptive	 and	 innate	 immune	 cells	 respectively	 (Figure	 1.4).	 Recently,	 the	mammalian	hematopoietic	tree	has	been	revised	by	Görgens	et	al.	(78,	82).	They	have	challenged	the	model	of	lineage	restriction	of	MPPs	to	common	myeloid	progenitors	(CMPs)	and	common	lymphoid	progenitors	(CLPs)	by	identifying	a	lymphoid-primed	progenitor	with	partial	myeloid	potential	(LMPP).	This	hierarchy	has	not	yet	been	demonstrated	 in	 the	zebrafish,	but	 in	my	opinion	 is	 likely	 to	be	conserved	and	 therefore	 is	used	 in	 the	schematic	of	hematopoiesis	(Figure	1.4).			
1.3.1 Erythroid	lineage	In	 zebrafish,	 red	 blood	 cells/erythrocytes	 and	 thrombocytes/platelets	 are	 derived	 from	 a	 thrombocyte-erythrocyte	 progenitor	 (TEPs)	 functionally	 equivalent	 to	mammalian	megakaryocyte-erythrocyte	 progenitor	
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(MEPs).	 These	 cells	 are	 supplied	 from	 an	 erythroid-myeloid	 progenitor	 (EMP)	 population	 which	 also	differentiates	into	a	eosinophil	and	basophil	progenitor	(EoBP)	population	(Figure	1.4).	Erythrocyte	production	is	regulated	by	erythropoietin,	and	thrombopoiesis	is	regulated	by	thromobopoietin	(TPO)(84).		Mature	erythrocytes	bind	oxygen	and	transport	it	to	tissues	around	the	body.	Both	mammalian	and	zebrafish	erythrocytes	are	defined	by	the	transcription	factor	GATA-binding	factor	1	(Gata1).	Traver	et	al.	showed	that	populations	of	the	kidney	marrow	could	be	distinguished	by	flow	cytometry	(48).	Zebrafish	erythrocytes	have	an	average	size	of	6.2	μm	and	can	be	separated	from	the	rest	of	the	kidney	marrow	cells	by	selecting,	or	gating,	cells	with	low	forward	scatter	and	high	side	scatter	(FSClow		SSChigh)	(48).	Single	cell	transcriptional	analysis	found	erythroid	cells	of	 the	WKM	expressed	erythroid-specific	genes,	 including	β-A1-globin,	solute-carrier-family-4,	and	spectrin-β-erythrocytic	(85).	Teleost	erythrocytes	resemble	primitive	mammalian	erythrocytes	as	they	are	nucleated.	Zebrafish	also	form	thrombocytes	and	these	have	been	studied	using	the	transgenic	CD41	line	(29).	They	are	smaller	than	erythrocytes	and	have	low	forward	and	side	scatter	(FSClow	SSClow/intermediate)	when	analysed	by	flow	cytometry.		
1.3.2 Myeloid	lineage	In	 the	 revised	 hematopoietic	 tree,	 granulocytes	 (neutrophils,	 eosinophils,	 and	 basophils)	 and	 monocytes	(including	 macrophages	 and	 dendritic	 cells)	 are	 derived	 from	 granulocyte-monocyte	 restricted	 progenitors	(GMPs),	and	EMPs	differentiated	from	CMPs	and	LMPPs	(Figure	1.4).	Myeloid	cells	are	part	of	the	innate	immune	system.	Both	zebrafish	and	mammals	also	have	a	complement	system	that	assists	the	cells	of	the	innate	immune	system.	Traver	et	al.	found	that	the	myeloid	fraction	of	the	WKM	has	high	forward	and	side	scatter	(FSChigh	SSChigh)	in	a	flow	cytometry	plot	and	these	cells	have	an	average	size	of	15.2	μm	(48).			Macrophages,	neutrophils	and	dendritic	cells	all	have	varying	phagocytic	capacity.	They	engulf	pathogens	and	the	debris	of	dead	cells	and	digest	 them	with	enzymes	to	recycle	 their	contents.	Macrophage	phenotypes	are	characterized	as	‘classically	activated	pro-inflammatory	(M1)’	or	‘alternatively	activated	anti-inflammatory	(M2)’	cells.	M1	macrophages	promote	inflammation,	extracellular	matrix	destruction,	and	apoptosis	and	tend	to	lead	to	 chronic	 inflammation.	 M2	macrophages	 promote	 extracellular	 matrix	 construction,	 cell	 proliferation	 and	angiogenesis	which	tend	to	resolve	inflammation	and	facilitate	wound	healing.			Both	macrophages	and	neutrophils	attack	pathogens	by	activating	a	 “respiratory	burst”	which	produces	 free	radicals.	These	cells	also	produce	chemokines	to	recruit	more	cells	to	the	site.	Zebrafish	neutrophils	resemble	human	 neutrophils,	 possessing	 segmented	 nuclei	 and	myeloperoxidase	 (MPO)-positive	 cytoplasmic	 granules	(86).	Transgenic	zebrafish	lines	include	Tg	(pu.1:GFP)	(87)	and	Tg	(lyz:dsRed)	(56)	in	which	the	myeloid	lineage	is	 marked;	 Tg	 (mpx:GFP)(88)	 labels	 neutrophils;	 Tg	 (fms:mCherry)	 and	 Tg	 (mpeg:mCherry)	 (89)	 mark	macrophages	 (Table	 2.1).	 As	 in	 mammals	 (Figure	 1.4),	 leukocyte	 specific	 actin	 binding	 protein	 (l-plastin)	 is	expressed	by	monocytes,	macrophages	and	also	B-cells,	T-cells,	granulocytes	and	NK	cells	(86).		
Introduction	
	26	
	
Figure	 1.4:	 A	 schematic	 comparison	 of	 the	mouse	 and	 zebrafish	 hematopoietic	 tree.	 The	 hematopoietic	 cell	 differentiation	
lineage	hierarchy	is	adapted	from	Bryder	et	al.	(90)	combined	with	the	current	human	hematopoietic	hierarchy	proposed	by	
Görgens	et	al.	(82).	Long-term	(LT-)	and	short-term	(ST-)	HSCs	have	only	been	described	in	mice	(blue).	In	zebrafish	(purple),	a	
more	general	HSPC	population	is	describe	which	may	contain	LT-	and	ST-	populations.	This	HSPC	population	supply	a	population	
of	 MPPs	 which	 respond	 to	 demand	 and	 regulate	myeloid	 and	 lymphoid	 production	 via	 LMPPs	 and	 CMPs.	 LMPPs	 supply	 a	
population	of	granulocyte-monocyte	restricted	progenitors	(GMPs),	producers	of	monocytes/macrophages	and	granulocytes	
and	a	population	of	 common	 lymphoid	progenitors	 (CLPs)	producers	of	B-,	T-	and	natural	killer	 (NK)	 cells.	 LMPPs	can	also	
differentiate	into	dendritic	cells	and	monocytes.	CMPs	also	supply	GMPs	as	well	as	an	erythroid-myeloid	progenitor	population	
(EMPs).	 EMPs	 produce	 erythrocytes	 and,	 in	 the	 mouse	 megakaryocytes,	 via	 the	 megakaryocyte-erythrocyte	 progenitor	
population	(MEP),	or	in	the	zebrafish,	thrombocytes	via	the	thrombocyte-erythrocyte	progenitor	population	(TEP).	EMPs	can	
also	differentiate	into	eosinophils	and	basophils	(putative	in	the	zebrafish)	via	the	eosinophil-basophil	progenitor	(EoBP).	Blue	
labels	indicate	mouse	specific	proteins	used	to	identify	corresponding	cell	population.	Purple	labels	indicate	zebrafish	specific	
gene	promoters/proteins	used	to	identify	corresponding	cell	populations.	
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Eosinophils	and	basophils	are	also	granulocytes,	derived	from	EoBPs,	a	subset	of	EMPs.	They	are	implicated	in	allergic	 responses.	 In	 mammals,	 these	 cells	 degranulate	 in	 response	 to	 activation,	 releasing	 enzymes	 and	cytokines.	Eosinophils	were	isolated	in	a	Tg	(gata2:EGFP)	zebrafish	line	and	shown	to	degranulate	in	response	to	helminth	infection	(91).		It	is	currently	not	known	whether	a	basophil	population	exists	in	the	zebrafish	(86).			
1.3.3 Lymphoid	lineage	With	the	exception	of	natural	killer	(NK)	cells,	lymphoid	cells	(B-	and	T-cells)	form	the	adaptive	component	of	the	immune	system.	Teleost	fish	are	among	the	most	ancient	vertebrates	possessing	an	adaptive	immune	system.	These	cells	have	low	forward	and	side	scatter	(FSClow	SSClow)	in	a	flow	cytometry	plot	of	the	WKM	and	have	an	average	size	of	8.3	μm	(48).	In	the	current	model	of	the	hematopoietic	tree,	myeloid	and	lymphoid	branches	are	much	less	distinct	than	in	the	classical	model	with	CMPs	and	CLPs.	Indeed,	the	monocytic/macrophage	potential	is	retained	by	both	CMPs	and	LMPPs,	leading	some	to	propose	that	the	current	variety	of	immune	cell-types	came	from	the	evolved	specialisations	of	a	macrophage-like	prototype	(82).			NK	 cells	 are	 derived	 from	CLPs	 and	have	 attributes	 of	 both	 the	 innate	 and	 adaptive	 immune	branches	 (92).	Although	zebrafish	NK	cells	are	not	easily	distinguished	using	flow	cytometry	forward	and	side	scatter,	recent	single	cell	transcription	analysis	has	found	a	population	of	NK-lysin	expressing	cells	in	the	WKM	suggesting	a	NK	type	cell	does	exist	(85).	In	mammals,	both	cytotoxic	(CD8	expressing)	T	lymphocytes	and	NK	cells	produce	NK-lysins.	Based	on	the	gene	expression	analysis	of	NK-lysin	expressing	cells	found	in	the	zebrafish	(no	CD4	or	CD8,	but	 lymphocyte-specific-protein-tyrosine-kinase	 (Lck),	 T-cell	 Receptor	 (TCR)	 -a,	 TCR-b	 and	 interleukin-7	receptor	(IL7R,	hereafter	referred	to	as	CD127)	are	expressed),	these	cells	are	a	putative	NK	population	(85).		CLPs	also	differentiate	into	B	cells	and	T	cells,	components	of	the	adaptive	immune	system.	As	in	mammals,	both	of	these	populations	are	produced	in	the	HSC	niche	(BM	of	mammals	or	kidney	marrow	fish),	but	most	T	cell	progenitors	must	migrate	to	mature	in	the	thymus	(93).	The	cells	of	the	adaptive	immune	system	retain	memory	of	 specific	 pathogens	 encountered	 and	 provide	 a	 higher	 affinity	 response	when	 the	 pathogen	 reoccurs.	 The	identification	of	antigens	on	pathogens	relies	on	the	expression	of	immunoglobulin	(Ig)	domain-based	antigen	receptors	that	are	diversified	by	DNA	rearrangement,	somatic	mutation,	and	gene	conversion.	Like	mammals,	fish	B	cells	express	Ig	proteins	and	T	cells	express	TCR	complexes.	Both	these	receptor	types	are	assembled	by	recombination	activating	gene	1	 and	2	 (rag1	and	 rag2)	proteins	 (94).	 In	 the	 zebrafish,	B-	 and	T-cells	 can	be	distinguished	 in	 the	 lymphoid	 fraction	 with	 the	 use	 of	 transgenic	 markers	 of	 Rag2	 and	 Lck	 respectively.	Furthermore,	unsupervised	clustering	of	single	cell	transcriptional	analysis	of	WKM	lymphoid	cells	was	able	to	separate	B-	and	T-cells	based	on	gene	expression	(85).		Ig	receptors	of	B-cells	consist	of	2	heavy	and	2	light	chains.	In	both	mammals	and	zebrafish,	the	variable	antigen	binding	portion	of	the	heavy	chain	is	produced	by	DNA	rearrangement	of	exons.	Also	in	both,	the	constant	portion	of	the	heavy	chain	is	specified	by	µ	and	d	exons	(co-expressed	by	alternative	splicing)	to	produce	IgM	and	IgD	on	naïve	B-cells.	In	mammals,	µ	and	d	exons	get	switched	to	other	istypes	(g,	e	or	a).	However,	these	other	isotypes	
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do	not	exist	in	zebrafish	(or	teleost	fish)	and	switching	is	done	to	another	exon	(z)	to	produce	IgZ	(95,	96).	The	binding	of	an	antigen	to	the	surface	Ig	causes	transmission	of	a	signal	via	CD79	to	induce	B-cell	activation.	Page	
et	 al.	 studied	 different	 stages	 of	 B	 cell	 development	 in	 adult	 zebrafish	 using	 a	 dual	 transgenic	 line	 Tg	(rag2:dsRed;IgM:eGFP)	 line	 (96).	 Single	 cell	 transcriptional	 analysis	 of	 cells	 of	 the	 WKM	 found	 that	 many	mammalian	orthologues	were	expressed	in	zebrafish	B-cells	such	as	paired-box	5	(Pax5),	tetraspanin	membrane	
protein	(CD37),	CD79a,	IgM,	IgD	and	rag2	(85).		In	mammals,	T	lymphocytes	express	cell	surface	TCRs	which	are	constructed	from	variable	chains	(a/b	or	g/d)	and	 constant	 chains	 (CD3-g,	d,	e)(97).	The	variable	domains	on	a-,	b-,	g-	 and	d-chains	have	 complementarity	determining	 regions	 (CDRs)	 that	 determine	 antigen	 specificity.	 The	 variability	 of	 the	 chains	 is	 due	 to	recombination	(by	rag1	and	2),	gene	conversion	(by	cytidine	deaminases,	AID),	and	random	nucleotide	additions.	CDRs	 can	 be	 edited	 by	 recombinases	 in	 a	 process	 termed	 “TCR	 revision”.	 Mammalian	 T-cells	 co-express	glycoproteins	CD4	and	CD8	along-side	the	TCR.	These	enhance	the	specific	recognition	of	class	I	and	class	II	major	histocompatibility	complexes	(MHCs)	constitutively.	Class	I	MHCs	are	expressed	by	most	cells,	while	class	II	are	only	present	on	antigen	presenting	cells	(APC)	including	dendritic	cells,	macrophages	and	B-cells.			While	antibodies	for	discrete	T-cell	populations	(CD4	and	CD8)	have	not	yet	been	studied	in	zebrafish,	single	cell	transcriptional	 profiling	 of	 cells	 of	 the	WKM	 found	 both	 CD4	 and	 CD8	 to	 be	 expressed	within	 the	 lymphoid	fraction	 (85).	 These	 cells	 also	 expressed	 tcrα,	 lck	 and	CD127	 (85).	 Furthermore,	 genetic	 analysis	 found	 that	zebrafish	have	MHC	genes	on	chromosomes	1,	3,	8	and	19	(47).	Chromosome	19	contains	class	I	genes	(98,	99).	Class	II	α	and	β	genes	are	located	on	chromosome	8.	Chromosome	1	contains	an	additional	type	of	class	I	genes	(termed	“ze”	genes)	that	are	most	similar	to	mammalian	non-classical	Class	I	genes	(100).	Finally,	the	“L”	genes,	class	I	genes	unique	to	teleost	fish,	are	located	on	chromosomes	3	and	8.	Antibody	labelling	cannot	be	used	to	determine	cell-surface	expression	and	therefore	the	precise	 function	of	 the	class	 I	and	II	genes	cannot	yet	be	determined	in	zebrafish	(101).		Perhaps	reporter	lines	(in	which	fluorescent	protein	expression	is	driven	by	the	promoter	producing	the	MHC	transcript)	would	help	in	determining	the	function	of	these	genes.		
1.4 Techniques	for	studying	hematopoietic	stem	cells		
1.4.1 Ex	vivo:	Culture	
Ex	vivo	approaches	offer	the	possibility	performing	experiments	in	a	cell-autonomous	manner	to	study	actions	within	or	by	the	single	cell,	independent	of	cells	in	the	environment.	This	complements	in	vivo	experiments	to	study	actions	of	the	cell	in	its	environment.	Mouse	BM	cells	can	be	kept	short-term	in	RPMI	media	supplemented	with	cytokines	but	despite	 three	decades	of	efforts,	 it	has	not	yet	been	possible	expand	or	maintain	 for	 long	periods	 bona	 fide	 HSCs	 ex	 vivo	 for	 regenerative	 medicine	 purposes.	 However,	 HSCs	 have	 been	 cultured	 to	determine	their	long-term	repopulating	activity.	In	vitro	assays	include	colony	forming	cell	(CFC)	assays	and	the	pseudo-emperipolesis	(migration)	of	HSCs	between	stromal	cells	and	the	dish	surface,	also	known	as	the	ability	to	form	cobblestones	(cobblestone	area-forming	cell	assays).	For	CFC	assays,	cells	are	plated	at	a	low	density	in	
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a	semi-solid	medium	in	the	presence	of	cytokines	and	cell	numbers	and	types	of	colonies	formed	are	used	to	quantify	 progenitor	 number	 and	 differentiation	 bias.	 The	 long-term	 culture	 system	 allows	 quantification	 of	precursor	cells	capable	of	initiating	and	sustaining	hematopoietic	cells.	These	cells,	known	as	long-term	culture-initiating	 cells	 (LTC-IC)	 share	 functional	 properties	with	 cells	 capable	 of	 repopulating	 hematopoiesis	 in	 vivo	(102).		Some	 long	 term	hematopoietic	progenitor	 lines	exist,	 including	 the	non-leukemic	Factor	dependent	Paterson	(FDCP)-mix	(103).	These	mouse	cells	were	cloned	and	isolated	from	long	term	bone	marrow	cultures	infected	with	src-MoMuLV	(a	molecular	recombinant	virus	where	Rous	sarcoma	virus	is	under	the	influence	of	murine	amphotrophic	leukaemia	virus).		Although	their	stem-like	properties	only	last	up	to	15	weeks	in	culture,	early	isolates	can	form	spleen	colonies	(CFU-S)	in	irradiated	mice	and	restore	long	term	hematopoiesis	on	irradiated	marrow	 stroma	 in	 vitro.	 FDCP-mix	 is	 used	 instead	 of	 a	 primary	 culture	 of	 BM	 cells	 in	 experiments	where	 a	homogenous	population	or	a	large	number	of	cells	is	required.	Another	cell	line,	recently	developed,	is	the	HoxB8-FL	 cells	 which	 have	 lost	 self-renewal	 capacity	 and	 the	 MEP	 lineage,	 but	 can	 differentiate	 into	 myeloid	 and	lymphoid	lineages	(104).		The	Schroeder	lab	have	been	working	recently	using	microfluidic	devices	to	fluctuate	dosing	of	cytokines	to	BM	derived	 cells	 (105).	 To	 complement	 this	work,	 they	 have	developed	powerful	 software	 for	 high	 through-put	analysis	of	pictures	 (106).	With	 this,	 they	can	continuously	 track	 individual	cells	over	generations,	 recording	position,	cell	divisions,	cell	interactions	and	the	protein	activity	in	live	cells.	This	technology	was	recently	used	to	quantify	the	response	of	HSCs	(LSK	CD135-	CD150+	CD48-	isolated	from	mice)	to	IL-1b	(25	ng	µL-1)	over	6	days	in	liquid	culture	(107).	The	analysis	revealed	that	HSCs	cultured	with	IL-1b	divided	at	a	significantly	higher	rate	because	the	delay	between	cell	divisions	was	significantly	shorter	than	in	HSCs	cultured	without	IL-1b.	Notably,	the	effect	was	specific	to	HSCs	as	IL-1b	did	not	affect	survival	or	proliferation	of	GMPs	and	MPPs.	In	addition,	they	found	that	transcription	factor	PU	box	(Pu.1)	activity	is	significantly	increased	in	HSCs	treated	with	IL-1b,	before	the	first	cell	division	event.	This	type	of	data	cannot	be	obtained	by	any	other	current	method.		Until	recently,	culturing	of	zebrafish	hematopoietic	cells	was	not	possible	because	of	the	divergence	between	mammalian	growth	factors	and	cytokines.	Stachura	et	al.	first	developed	a	method	for	culturing	hematopoietic	cells	 in	 suspension	 over	 isolated	 zebrafish	 kidney	 stromal	 cells	 (108).	 Subsequently,	 Lund	 et	 al.	 isolated	mesenchymal	cells	from	the	caudal	tail	tissue	which	they	called	zebrafish	stromal	cells	and	which	can	maintain	kidney	marrow	cells	 for	up	 to	2	weeks	 (109).	These	 cells	are	 capable	of	migrating	 to	 the	kidney	 in	adoptive	transfer	experiments	(109).	Most	recently,	Campbell	et	al.	have	cultured	a	zebrafish	embryonic	stromal	trunk	cell	from	the	dorsal	aorta	which	supports	the	expansion	and	differentiation	of	zebrafish	HSPCs	(cd41:GFP+)	(110).	These	 culture	 techniques	 can	 be	 used	 to	 study	 terminal	 differentiation	 of	 cells	 but	 do	 not	 provide	 data	 on	differentiation	events	or	self-renewal	events	at	the	single	cell	level.	Svoboda	et	al.	have	subsequently	developed	a	methylcellulose	assay	to	examine	clonal	expansion	and	differentiation	of	HSPCs	and	TEPs	in	real	time	ex	vivo	(84,	111).	Zebrafish	hematopoietic	cells	grow	best	at	32	°C	in	a	humidified	5%	carbon	dioxide	environment	(112).	
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1.4.2 In	vivo:	Transplants	The	gold	standard	for	assaying	HSCs	is	to	test	their	capacity	to	provide	lifelong	reconstitution	of	all	blood-cell	lineages	after	transplantation	into	lethally	irradiated	recipients.	The	most	rigorous	assay	for	assessing	stemness	of	hematopoietic	cells	is	serial	transplantation.	It	requires	that	HSCs	be	serially	re-transplanted	to	show	that	they	retain	self-renewal	and	multi-	potential	differentiation	capacity.	Limiting	dilution	assays	are	used	to	measure	the	stem	cell	frequency	within	a	population	by	transplanting	increasingly	diluted	cell	preparations.		Although	the	order	of	events	is	not	clear,	it	is	thought	that	in	both	mammals	and	zebrafish,	transplanted	HSCs	localise	 to	 hematopoietic	 sites,	 engraft	 in	 the	 tissue,	 self-renew	 and	 differentiate.	 “Homing”	 refers	 to	 the	movement	of	HSCs	through	blood	circulation	from	the	site	of	transplant	into	the	supportive	microenvironment	(either	BM	or	kidney	marrow)	and	is	essential	for	“engraftment”.	Engraftment	is	the	process	in	which	the	HSC	leaves	the	circulation,	transitions	through	the	vascular	wall	and	enters	the	hematopoietic	tissue	(113).	This	latter	behaviour	has	not	yet	been	observed	in	transplant	recipients	(in	any	animal	model)	but	is	thought	to	resemble	the	 endogenous	 process	 that	 occurs	 during	 development	 when	 HSCs	 seed	 the	 hematopoietic	 tissue	 (42).	Engraftment	and	retention	of	HSCs	in	the	correct	microenvironment	is	termed	“lodgement”.	HSC	proliferation	can	be	symmetrical	or	asymmetrical.	Although	the	spleen	and	circulating	blood	contain	low	a	low	frequency	of	HSCs,	ultimately	the	mouse	BM	is	the	only	niche	which	protects	self-renewal	and	quiescence	of	mice	HSCs	(114).	It	is	not	yet	known	whether	the	kidney	marrow	of	zebrafish	is	the	only	site	which	protects	the	stem	properties	of	HSCs,	or	whether	other	sites,	such	as	the	caudal	hematopoietic	tissue	(CHT),	spleen	or	thymus,	could	also	be	involved.				Our	understanding	of	early	post-transplant	events	 is	 limited	because	of	technical	obstacles.	For	 instance,	 it	 is	unclear	whether	transplanted	HSCs	begin	to	differentiate	in	circulation	or	whether	this	occurs	after	engraftment	in	the	hematopoietic	niche.	It	is	also	unclear	whether	early	post-transplant	proliferation	of	HSPCs	is	towards	self-renewal	or	maturation	(Figure	1.3).		
1.4.2.1 Support/carrier	cells	Although	theoretically	a	single	stem	cell	should	be	sufficient	to	initiate	long-term	host	repopulation,	there	is	some	evidence	 that	 a	minimal	 threshold	of	 cells	 is	 required	 for	 engraftment	 (115-117).	 For	 instance,	 human	HSCs	(CD34+	Lin-)	cells	contributed	more	to	the	NOD/SCID	mouse	recipient	hematopoietic	system	when	transplanted	as	an	unfractionated	sample,	even	though	both	recipient	groups	received	equivalent	numbers	of	(CD34+	Lin-)	cells	 (117).	Therefore,	 it	 appears	 to	be	beneficial	 to	 add	 support	 cells	when	 transplanting	 low	 cell	 numbers,	although	the	reason	for	this	is	not	understood.	Bonnet	et	al.	have	hypothesised	that	cytokines	and	proteolytic	enzymes,	such	as	matrix	metalo-proteinase	9	(MMP	9),	could	play	a	role	(116).	Janowsha-Wieczorek	et	al.	have	suggested	a	mechanism	involving	platelet	derived	micro-particles	(118).			
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1.4.2.2 Hematopoietic	cell	transplantation	in	mice	Mouse	hematopoietic	transplantation	experiments	have	been	instrumental	in	our	understanding	the	regulatory	pathways	and	niche	elements	 involved	 in	 the	 regulation	of	hematopoiesis	 and	 the	HSC.	However,	 the	mouse	model	relies	on	monitoring	physiological	factors	such	as	body	weight,	condition	of	hair	and	posture	to	assess	the	initial	 success	 of	 transplantation.	 Later,	 blood	 tests	 are	 used	 to	 assay	 the	 capacity	 for	 self-renewal	 and	engraftment	of	transplanted	cells.	In	a	few	cases,	survival	is	monitored	to	assess	successful	engraftment,	although	most	studies	transplant	sufficient	support	cells	and	do	not	have	this	as	an	end	point.			The	 first	 attempt	 to	 study	 the	 post-transplant	 spatial	 distribution	 of	 progenitor	 cells	 (Lin-	 population;	 Lin-	WGAdim-med	Rh+	population;	and	Lin-	WGAdim-med	Rh-	population)	in	situ	was	by	Nilsson	et	al.	in	2001	when	they	examined	 longitudinal	 femur	 sections	 to	 determine	 the	 proximity	 of	 transplanted	 carboxyfluorescein	succinimidyl	ester	(CFSE)	labelled	cells	to	the	cells	of	the	recipient	BM	(119).	The	first	in	vivo	imaging	of	the	BM	niche	was	in	2003	by	Askenasy	and	Farkas.	They	used	an	imaging	window	over	the	distal	femoral	epiphysis	to	monitor	transplanted	cells,	although	they	did	not	analyse	the	distribution	of	cells	within	the	BM	(120).	Ultimately,	the	most	effective	method	to	image	post-transplant	cell	behaviour	has	been	developed	by	the	Lo	Celso	group	(121).	They	use	intra-vital	microscopy,	scanning	a	4	mm	×	6	mm	window	on	top	of	the	skull,	to	form	a	3D	image	of	the	central	sinus	and	the	surrounding	BM.	They	combine	transgenic	mice	and	dialkylcarbocyanine	dyes	(DiD	or	DiI)	for	cell	tracing	to	obtain	a	dynamic	model	of	the	environment	structure	and	the	behavior	of	the	cells	in	it	over	time.	They	have	documented	cell	mobilization	and	engraftment	in	irradiated	transplant	recipients	and	even	a	cell	dividing.	Their	method	was	used	to	show	that	HSCs	from	Trichinella	spiralis	infected	donors	interact	with	a	more	diverse	set	of	niche	components	than	HSCs	from	non-infected	donors	(122).		Genetically	altered	organisms	have	been	developed	to	study	human	HSCs	in	model	organism.	Humanised	mice	(123),	sheep	(124)	and	zebrafish	(50)	make	it	possible	to	study	human	HSC	function	and	malignancies	such	as	leukaemia.	One	of	the	most	commonly	used	mice	strains	has	a	mutation	in	the	DNA-dependent	protein	kinase	gene	and	is	known	as	severe	combined	immuno-deficient	(NOD/SCID)	mice.	This	mutation	results	in	a	lack	of	T-cells,	B-cells	and	an	altered	cytokine	environment.	Another	useful	model	is	the	Kit	mutant	(125-127).	These	mice	lack	functional	HSCs	and	therefore	do	not	require	radiation	treatment	prior	to	transplant.	Furthermore,	Antonelli	
et	 al.	 have	 generated	mice	with	 a	 human	 BM	 scaffold	 to	 study	 the	 behaviour	 of	 human	 leukemic	 cells	 from	patients	(128).		
1.4.2.3 Hematopoietic	cell	transplantation	in	zebrafish	Due	to	technical	obstacles,	observations	of	hematopoietic	cell	behaviour	in	mammals	is	limited	and	the	animal	burden	is	high	as	testing	multiple	conditions	and	time	points	requires	many	animals.	In	addition,	data	can	be	more	 informative	 if	 it	 is	 obtained	 from	 the	 same	 subject	 over	 time.	 This	makes	 the	 zebrafish	 an	 interesting	alternative	 model.	 Zebrafish	 have	 been	 instrumental	 in	 our	 understanding	 of	 developmental	 hematopoiesis	(129-131).	Naturally,	they	also	lend	themselves	to	studying	HSCT	and	have	been	used	for	this	purpose	since	the	early	2000s	(132).	Original	studies	used	unselected	WKM	cells,	but	gradually	HSPC	enriched	populations	have	
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been	 purified	 for	 transplant	 (Table	 1.2).	 Over	 time	 the	 method	 of	 cell	 delivery	 has	 progressed	 from	 intra-peritoneal	 delivery	 to	 RO	 delivery	 (49).	 Transgenic	 lines	 developed	 for	 the	 dissection	 of	 the	 origins	 of	hematopoietic	cells	have	be	co-opted	as	an	alternative	to	immunohistochemistry	for	identifying	HSCs.		
	
Table	1.2:	List	of	zebrafish	transplant	papers.	PB	indicates	peripheral	blood,	WKM	indicates	kidney	marrow.		The	first	zebrafish	transplant	experiments	were	done	with	embryo	recipients	(in	which	the	thymus	has	not	fully	developed	 and	 does	 not	 produce	 mature	 T-lymphocytes)	 which	 meant	 there	 was	 no	 problem	 of	histocompatibility	between	recipient	and	donor.	This	approach	continues	to	be	used	by	many	researchers	but	limits	 our	 understanding	 of	 HSC	 behaviour	 in	 the	 context	 of	 a	 fully	 developed	 hematopoietic	 system.	Subsequently,	 adult	 recipients	 were	 used	 but	 required	 preconditioning	 to	 deplete	 the	 endogenous	 immune	system.	 	 As	 in	 the	mouse	model,	 recipients	 can	 be	 preconditioned	with	 radiation,	 5-FU	 or	 antibodies	 (133).	Therapeutic	doses	for	humans,	used	in	the	treatment	of	people	with	cancer,	are	typically	between	2	and	4	Gy,	experimental	mice	are	treated	with	9	Gy	(134),	goldfish	are	treated	to	30	Gy	and	zebrafish	with	as	much	as	40	Gy	 (135).	More	 recently,	 in	 order	 to	 reduce	 rejection,	 studies	 use	MHC-	matched	 recipients	 (45)	 or	 immune	deficient	recipients	(46).		Both	 goldfish	 (136)	 and	 zebrafish	 (50)	have	 been	 used	 for	 xenogeneic	 transplantation	 studies.	 In	 the	 latter,	human	CD34+	umbilical	cord	cells	were	labelled	with	fluorescent	dye	PKH26	and	detected	either	by	fluorescent	imaging	of	the	transplanted	zebrafish	embryo	or	by	flow	cytometry.	In	both	goldfish	and	zebrafish,	human	cells	
Donor Recipient Carrier	cells Route Readout Reference
Tg(gata1:eGFP)
102	- 103 adult	WKM	cells
Bloodless	gata1-/- mutant	48	
hpf
embryos
None Sinus	venous Imaging	over	7	days	and	
tracking		recipient	survival	
up	to	6	months
Traver et	al.	(2003)
Tg(βactin:eGFP)
105 adult	WKM	cells
Irradiated	(25	Gy,	day	-2)	adult	
Casper
2x	105 PB Cardiac	puncture Imaged	4	hpt,	sacrificed	for	
flow	cytometry	at	4	wpt
White	et	al.	(2008)
Tg(globin:GFP)
1.5	- 2	x	105	adult	PB	cells
Adult	Casper None Retro-orbital Visualise	circulating	blood	
cells
Pugach et	al.	(2009)
Tg(βactin:eGFP)
100	– 105	adult	WKM	cells
Irradiated	(20- 40	Gy,	day	-2)	
adult	WT
105 PB Cardiac	puncture,	 then	
retro-orbital
Tracking		recipient	survival	
up	to	13-16	weeks,	
engraftment	at	90	days,	
sacrificed	for	flow	cytometry	
at	14-16	wpt
De	Jong	et	al.	(2011)
Tg(cd41:eGFP)
100	– 16000	cd41lo	adult	WKM	
cells
Irradiated	(25-35	Gy,	day	-2	and	
-1)	adult	WT
5x	105 to	8x	105 WT	WKM	
cells
Cardiac	puncture Imaged	at	30	dpt for	
circulating	GFP+	cells
Ma	et	al.	(2011)
WT	or	Tg(ikaros:GFP)
2	– 40	x	104	adult	WKM	cells
Bloodless	cmybt25127 mutant None Retro-orbital Imaging	7	dpt,	sacrificed	for	
flow	cytometry	at	9	wpt
Hess et	al.	(2013)
Tg(ubi:eGFP)
3	x 105	or 5	x	104 adult	WKM	
cells
Immunocompromised,
irradiated	(10	Gy,	day	-2)	adult	
rag2E450fs	mutant
None Intra-peritoneal Imaged	at	30	and	45	dpt for	
circulating	GFP+	cells	or	
sacrificed	for	flow	cytometry
Tang	et	al.	(2014)
Tg (runx1+23:	mCherry; ubi:GFP)	
1	- 50	double	positive	cells	from	
adult	WKM	cells
1,	2	or	4	double	positive	cells	
from	embryo
Irradiated	adult	Casper
2	dpf WT
2x	104 WKM
2x	104 WKM
Retro-orbital
Injected	into	
circulation
Sacrificed for	flow	
cytometry	3	mpt
Survival	to	5	months;	
engraftment	assessed	by	
flow	cytometry
Tamplin et	al.	(2015)
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survived	in	the	kidney	marrow	for	up	to	6	days,	suggesting	that	the	environmental	cues	of	the	teleost	niche	are	sufficiently	conserved	to	sustain	cells	of	diverse	origins,	albeit	for	a	limited	period.		
1.5 Embryonic	origin	of	HSCs	Vertebrates,	including	zebrafish,	are	known	to	undergo	waves	of	hematopoietic	activity	during	which	separate	foetal	and	adult	hematopoietic	populations	form	(Figure	1.5;	(137,	138).	The	first	“primitive”	wave	produces	the	hemangioblast,	a	progenitor	of	both	hematopoietic	and	endothelial	cells.	Primitive	erythroid	and	myeloid	cells	are	produced	at	this	time.	Subsequently,	there	is	a	transition	wave	during	which	erythroid-myeloid	progenitor	(EMP)	cells	emerge	and	produce	definitive	erythroid	and	myeloid	cells.	Both	primitive	and	definitive	erythroid	and	myeloid	cells	are	generated	independently	of	definitive	HSCs.	In	parallel,	there	is	a	“definitive”	wave	during	which	long	term,	self-renewing	pluripotent	hematopoietic	stem	cells	emerge	from	the	dorsal	aorta,	migrate	to	intermediate	sites	of	hematopoiesis	to	proliferate,	and	then	ultimately	settle	in	definitive	hematopoietic	niches.	They	produce	mature	erythroid,	myeloid	and	lymphoid	cells.		
1.5.1 Primitive	wave:	Hemangioblast	derived	hematopoiesis	Hematopoiesis	 in	 the	 embryo	 begins	 with	 the	 emergence	 of	 committed	 progenitors	 followed	 by	 true	 HSCs	(Figure	1.5A).	In	both	mice	and	zebrafish,	the	embryonic	primitive	wave	transiently	produces	hematopoietic	cells	from	the	hemangioblast	(139,	140),	generating	primitive	erythrocytes	(141,	142)	and	primitive	macrophages	(143).	These	primitive	erythrocytes	and	macrophages	are	thought	to	be	important	for	embryonic	development	and	for	immunity	in	the	embryo.			The	 hemangioblast	 emerges	 from	 activation	 of	 VEGFR2	 during	 gastrulation	 of	 the	mouse	 blastula	 (144).	 In	mammals	and	birds,	these	cells	form	in	the	yolk	sac.	In	the	zebrafish,	vascular	endothelial	and	proerythroblasts	are	formed	from	the	hemangioblast	in	the	intermediate	cell	mass	(ICM)	derived	from	posterior	lateral	mesoderm,	while	endothelial	and	primitive	myeloid	cells	are	formed	both	in	the	ICM	and	in	the	rostral	blood	island	(RBI)	derived	from	anterior	lateral	mesoderm	in	the	developing	embryo	(145-147).	Davidson	et	al.	used	cdx4	mutant	fish	 (mutation	 in	 the	 homeobox	 kugelig	 gene)	 to	 show	 that	 patterning	 during	 gastrulation	 is	 important	 for	hematopoiesis	to	occur	in	the	ICM	(148).		Very	 recently,	 somite	 derived	 HSPCs	 have	 been	 discovered	 in	 the	 zebrafish	 that	 do	 not	 originate	 from	 the	posterior	 lateral	mesoderm	 (149).	 These	 cells	 are	 shown	 to	 persist	 to	 adulthood,	 and	when	 transplanted	 in	embryos,	contribute	to	multiple	hematopoietic	lineages	suggesting	pluripotency	(149).			
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Figure	1.5:	A	schematic	of	the	waves	of	hematopoiesis,	adapted	from	Jing	et	al.	(150)	and	Mikkola	et	al.	(151).	Mammals	and	
teleost	fish	undergo	waves	of	hematopoiesis.	(A)	Hematopoietic	cells	originate	from	mesoderm.	The	first	(primitive)	wave	is	
derived	from	the	hemangioblast,	an	endothelial	and	hematopoietic	precursor.	The	hematopoietic	cell	has	 limited	erythroid-
myeloid	 potential,	 Subsequently,	 a	 transitional	 wave	 of	 erythroid-myeloid	 precursors	 (EMPs)	 is	 derived	 from	 hemogenic	
endothelium	in	the	aorta-gonad-mesonephros.	Lymphoid	cells	may	be	produced	by	this	precursor,	or	another	yet	unidentified	
precursor	population.	Definitive	hematopoiesis	is	produced	from	definitive	HSCs,	also	derived	from	the	hemogenic	endothelium.	
These	pluripotent	cells	supply	a	population	of	MPP	which	produce	CMPs	and	CLPs.	The	CMPs	give	rise	to	adult	erythroid	and	
granulocyte	cells.	The	LMPPs	give	rise	to	myeloid	and	lymphoid	cells.	Important	genes	are	listed	along	the	pathway.	(B)	The	
timings	at	which	each	wave	occurs	in	the	zebrafish	(hours	post	fertilization),	mouse	(embryonic	days)	and	human	(embryonic	
days),	ending	when	HSCs	reach	the	kidney/bone	marrow.		Around	6	hours	post	fertilisation	(hpf)	in	the	zebrafish	embryo	(Figure	1.5B),	the	primitive	hematopoietic	and	endothelial	progenitor	known	as	 the	hemangioblast	begins	 to	differentiate	 in	 the	 ICM.	These	cells	have	been	
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imaged	in	vivo	in	zebrafish	embryos	using	single	cell	laser	activation	of	caged	fluorescein	dextran	in	individual	cells	of	 the	ventral	mesoderm	(139).	These	progenitor	cells	express	Scl,	Gata2	and	Lmo2	(60,	140,	152).	The	zebrafish	cloche	mutant	does	not	have	a	primitive	hematopoietic	wave	because	of	a	lack	of	Gata1	and	Gata2	which	have	a	direct	effect	on	 the	differentiation	of	endothelial	and	hematopoietic	 lineages	(153).	 In	addition,	Gata2	expression	 is	 regulated	 by	microRNA	MiR-451	 (154).	 Lmo2	 is	 important	 for	 the	 timing	 of	 c-myb	 and	 runx1	expression	(152).	Transcription	factors	Scl,	Lmo2	and	Gata2	are	all	required	upstream	regulators	of	erythrocyte	transcription	factor	Gata1	and	myeloid	transcription	factor	Pu.1	in	both	zebrafish	and	mammals	(147,	155).	The	balance	of	erythroid	and	myeloid	cells	is	governed	by	the	expression	of	scl	and	lmo2	transcription	factors	(147).			At	about	12	hpf	of	the	zebrafish	embryo,	the	erythrocyte	specific	gene	gata1	 is	observed	in	cells	migrating	to	form	the	ICM	in	transgenic	gata1	reporter	fish	(156).	These	primitive	erythrocytes	enter	circulation	from	24	hpf	and	are	the	only	erythrocytes	for	the	first	4	dpf	(157).	It	is	not	clear	how	long	these	cells	survive,	but	ultimately	they	are	replaced	by	mature	erythrocytes	cells	that	develop	from	the	definitive	hematopoietic	wave	(157).	The	myeloid	 transcription	 factor	Pu.1	 (Spi1	 in	humans)	 is	 expressed	 in	both	 the	 ICM	and	RBI	by	16	hpf	 and	subsequently	only	in	the	RBI	from	20	hpf	(86,	87,	143).	The	leukocyte	specific	actin	binding	protein	(l-plastin)	is	expressed	 in	 the	 RBI	 from	 18	 hpf	 and	 detected	 in	 the	 ICM	 from	 28	 hpf	 (86).	 Mpo,	 an	 enzyme	 produced	 in	granulocytes,	 is	 expressed	 by	 pu.1	 expressing	 cells	 but	 distinct	 from	 l-plastin	 expressing	 cells.	 This	 pattern	suggests	primitive	myeloid	cells	originate	from	both	the	ICM	and	RBI	sites.	Embryonic	myeloid	cells	distribute	around	 the	 zebrafish	 yolk	 sac	 forming	 resident	 macrophages	 (158)	 and	 by	 48	 hpf	 form	 neutrophils	 (159).	Although	early	macrophages	have	phagocytic	activity	(145),	early	neutrophils	do	not	(159).	It	 is	not	yet	clear	whether	these	cells	persist	or	get	replaced	by	cells	differentiating	in	the	definitive	hematopoietic	wave.		Erythroid	and	myeloid	cells	are	also	detected	in	the	mouse	yolk	sac	at	E7.5	(embryonic	day	7.5),	prior	to	the	emergence	 of	 definitive	 HSCs	 (160,	 161)	 (Figure	 1.5B).	 Primitive	 erythrocytes	 emerge	 from	 E7.5	 (162)	 and	macrophages	progenitors	appear	in	the	yolk	sac	at	E8.0.	These	cells	subsequently	migrate	into	the	embryo.	As	in	the	zebrafish,	the	erythroid	and	myeloid	cells	only	exist	transiently,	and	lack	lymphoid	and	self-renewal	potential.	In	the	human	embryo,	the	yolk	sac	generates	early	hematopoietic	cells	from	day	19	(Figure	1.5B)	with	limited	myeloid	potential.		
1.5.2 Transient	definitive	wave:	EMP	derived	hematopoiesis	Definitive	erythrocytes	and	myeloid	cells	initially	differentiate	from	committed	EMPs	(Figure	1.5)	(129).	In	mice,	these	cells	emerge	at	E8.25	from	hemogenic	endothelium	in	the	yolk	sac	and	colonise	the	foetal	liver	by	E10.5	(Figure	1.5B).	The	term	“definitive”	has	been	applied	to	both	yolk	sac-derived	EMPs	that	give	rise	to	adult-type	cells	and	embryo-derived	HSCs.	However,	here	we	make	a	distinction	as,	although	they	engraft	and	transiently	produce	 erythrocytes,	 EMPs	 do	 not	 have	 the	 capacity	 for	 long	 term	 reconstitution	 of	 hematopoiesis	 of	myeloablated	mice	(163).	In	addition,	the	phenotype	and	proliferation	capacity	of	EMP	derived	erythrocytes	is	significantly	different	from	primitive	erythrocytes	derived	from	the	hemangioblast	during	the	primitive	wave	and	definitive	HSC-derived	erythrocytes	 (141),	making	 this	wave	distinct	 from	 the	other	 two.	Both	EMP	and	
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definitive	HSCs	are	runx1	dependent	(30).	However,	Notch	activity	is	required	for	definitive	HSC	specification	(43,	59,	164),	but	not	for	the	specification	of	EMPs	(165).	Downstream	transcriptional	regulators	gata2	(60)	and	
c-myb	(166,	167)	are	required.			EMPs	also	produce	megakaryocytes	and	macrophages,	but	these	are	hard	to	distinguish	from	hemangioblast-derived	and	HSC-derived	myeloid	cells.	This	makes	studying	them	difficult.	It	is	hypothesised	that	their	presence	is	to	support	erythrocytes	and	the	mobilisation	of	definitive	HSCs	arising	from	the	dorsal	aorta	(168).		Interestingly,	 embryos	 with	 persistent	 EMP	 emergence,	 but	 no	 definitive	 hematopoietic	 wave,	 produce	 a	population	of	 lymphoid	cells.	Furthermore,	 lymphoid	cells	have	been	detected	 in	 the	mouse	yolk	sac	at	E9.5,	before	definitive	HSC	activity	and	prior	to	rag1	expression	in	the	embryo	at	E10.5	(169-173).	Current	evidence	suggests	that	the	lymphoid	lineage	is	derived	from	a	progenitor	population,	which	temporally	coincides	with,	but	is	independent	of,	EMPs	(174).		In	 zebrafish,	 the	 adaptive	 immune	 system	develops	over	3	weeks	 and	 it	 is	 not	 clear	whether	 these	 cells	 are	derived	from	EMPs,	specific	lymphoid	progenitors	or	definitive	wave	HSCs.	The	earliest	IgM	expressing	cells	(B-cells)	appear	between	the	dorsal	aorta	and	posterior	cardinal	vein	and	in	the	kidney	about	20	hpf,	prior	to	the	emergence	of	 definitive	HSCs	 at	2	dpf	 (96).	Although	 some	expression	of	Rag1	and	 IgM	was	 reported	 in	 the	pancreas	4	 to	11	dpf	 (175),	 this	 has	not	 been	 subsequently	 confirmed	 (96).	At	 about	3	dpf,	 ikaros,	which	 in	mammals	is	expressed	in	lymphoid	progenitors,	is	expressed	in	the	zebrafish	thymus	(176).	TCRα	is	expressed	from	4	dpf	in	the	thymus,	with	expression	increasing	over	3	weeks	(177).			
1.5.3 Definitive	wave:	HSC	derived	hematopoiesis	The	“definitive”	wave,	which	produces	the	long	term,	self-renewing	pluripotent	hematopoietic	stem	cells	that	are	able	to	generate	into	all	mature	lineages	for	the	lifetime	of	the	organism,	begins	at	2	dpf	in	the	zebrafish	(130)	and	E10.5	 in	 the	mouse	 (178,	179)	 (Figure	1.5B).	Definitive	HSCs	emerge	after	vascular	 remodeling	 from	an	endothelial-hematopoietic	precursor	along	 the	dorsal	 aorta	of	 the	zebrafish	embryo,	 equivalent	 to	 the	aorta-gonad-mesonephros	(AGM)	of	mice.	They	populate	the	liver	at	E14.5	and	the	BM	is	colonised	by	E18.5.		In	humans,	definitive	HSCs	appear	in	hematopoietic	clusters	along	the	aorta	from	day	27	(180,	181).	HSCs	proliferate	in	the	liver	and	the	BM	is	colonised	by	week	10	(180).		In	the	zebrafish,	nascent	HSCs	are	identified	as	kdrl+	runx1+	in	Tg	(kdrlNLS:mCherry;runx1+23:GFP)	embryos.	These	 cells	 migrate	 to	 both	 the	 CHT	 (at	 the	 posterior	 end	 of	 the	 zebrafish,	 close	 to	 the	 cloaca)	 and	 to	 the	pronephric	tissue	(at	the	anterior	end	of	the	zebrafish,	the	area	above	the	heart	and	gut	that	will	develop	into	the	adult	kidney	marrow;	(32,	182).	Similarly,	in	the	mouse,	nascent	HSCs	migrate	from	the	AGM	to	the	foetal	liver,	to	the	spleen,	and	ultimately	to	the	BM	at	the	end	of	gestation	(183).	HSCs	in	the	zebrafish	CHT	or	mammalian	foetal	 liver	proliferate	 to	expand	 the	population.	Time	 lapse	 imaging	of	 the	CHT	 in	zebrafish	has	 shown	 that	
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runx1+	HSCs	are	“cuddled”	by	5	to	6	endothelial	cells	which	control	their	orientation	and	division	(42).	Ex	vivo	imaging	of	mouse	samples	showed	similar	interactions	between	foetal	liver	cells	and	Sca1+	cells	(Ly6a:GFP)	(42).			Hematopoietic	 stem	 cells	 emerge	 from	 the	 aorta	 floor	 through	 a	 process	 termed	 endothelial-hematopoietic	transition	(EHT)	(41,	184).	This	process	requires	runx1	expression	 in	endothelial	cells	but	not	hematopoietic	cells	 (30,	42,	185).	Knocking	out	runx1	 in	mice	 is	 lethal	 to	 the	embryo	(186)	while	knock	down	 in	zebrafish,	inhibits	EHT	(185).	Furthermore,	the	runx1w84x	zebrafish	mutant	embryo	lacks	a	definitive	wave	(185).	Core-binding	factor-beta	(CBFβ)	forms	a	heterodimer	with	Runx1,	and	is	required	for	the	release	of	definitive	HSCs	into	circulation	(187,	188).	However,	unlike	Runx1,	CBFβ	is	not	required	in	transient	hematopoiesis	and	EMP	production	(187,	188).		Another	 marker	 of	 definitive	 HSCs	 is	 the	 proto-oncogene	 c-myb.	 	 Like	 CBFβ	 it	 is	 not	 required	 in	 primitive	hematopoiesis	(189)	but	is	required	for	migration	of	definitive	HSCs	to	the	CHT	at	3	dpf	(166).	In	the	absence	of	
c-myb,	HSCs	numbers	decrease	as	a	result	of	apoptotic	death.	The	zebrafish	c-mybt25127	mutant	lacks	definitive	hematopoiesis.	 This	mutant	 fish	 line	 has	 been	 exploited	 as	 a	 transplant	 recipient	 that	 does	 not	 require	 pre-conditioning	(46,	167).		Many	 more	 genes	 involved	 in	 definitive	 hematopoiesis	 have	 been	 identified	 by	 the	 generation	 of	 mutant	zebrafish	 using	 chemical	 mutagenesis.	 For	 instance,	 in	 grechetto	 mutants	 (mutation	 in	 the	 cleavage	 and	polyadenylation	specificity	factor	1	gene,	cpsf1),	like	in	c-myb	mutant,	HSCs	fail	to	migrate	from	the	aorta	to	the	CHT	(190).	Two	other	mutants	created	this	way,	rumba	(mutated	nuclear	C2H2	zinc-finger	factor)	and	samba	(mutated	human	augmin	complex	subunit	3	gene,	haus3)	produce	HSCs	in	the	aorta	which	migrate	to	the	CHT,	but	expansion	and	maintenance	are	defective	and	the	result	is	a	significantly	reduced	HSC	population	(191).		Scl	 and	 its	partner	Lmo2,	 are	both	 required	 in	primitive	 and	definitive	hematopoiesis.	Morpholino-mediated	knock	 down	 of	 scl	 expression	 in	 embryonic	 zebrafish	 resulted	 in	 a	 loss	 of	 both	 primitive	 and	 definitive	hematopoiesis	 (192).	 Similarly,	 knock	 down	 of	 lmo2	 also	 resulted	 in	 a	 lack	 of	 both	 primitive	 and	 definitive	hematopoiesis	(152).		Finally,	 in	the	zebrafish,	DEAD-box	RNA	helicase	is	expressed	by	HSCs	in	the	CHT	and	required	for	the	multi-lineage	differentiation	of	definitive	HSCs,	possibly	regulating	pu.1	and	gata1	expression	(193).		
1.5.4 Inflammatory	signals	regulate	HSC	emergence	Definitive	HSC	 formation	 and	maintenance	 is	 regulated	 by	 endogenous	 signalling	molecules	 associated	with	inflammation	signalling	(44,	194-197).	Genetic	analysis	of	hematopoietic	cell	clusters	in	mouse	AGM	(195)	and	of	runx1+	HSPCs	in	the	zebrafish	CHT	(198)	show	that	emerging	definitive	HSCs	have	an	immune	profile	(with	high	 expression	 of	 Toll-like	 receptors	 (TLRs)	 and	MHCs)	 and	 inflammatory	 profile	 (with	 expression	 of	 IFN-regulated	 genes).	 As	 described	 earlier,	 erythroid	 and	 myeloid	 cells	 are	 produced	 during	 the	 primitive	
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hematopoietic	wave,	before	the	arrival	of	definitive	HSCs	and	can	therefore	 influence	the	emergence	of	these	cells.	 It	 is	hypothesised	 that	 these	primitive	cells	are	present	both	 for	 immune	protection	and	to	provide	 the	signalling	molecules	required	for	activating	HSC	specification.	Indeed,	there	is	significant	evidence	that	cytokines	such	as	type	I	and	II	IFNs,	tumour	necrosis	factor	(TNF)	and	ILs	secreted	by	neutrophils,	and	to	some	lesser	extent	macrophages,	have	a	direct	impact	on	the	size	of	the	emerging	HSPC	population	(44,	195,	198).	In	both	the	mouse	(199)	 and	 the	 zebrafish	 (41),	 Notch1	 and	 its	 ligand	 Jagged-1	 (Jag1)	 are	 essential	 for	 the	 formation	 of	 the	hemogenic	endothelium	and	successive	EHT	(59,	164,	200).	The	activation	of	cytokine	receptors	often	leads	to	activation	of	the	nuclear	factor	kappa-light-chain-enhancer	of	activated	B	cells	(NfkB)	pathway.	NfkB	is	highly	expressed	in	the	dorsal	aorta	of	Tg	(NfkB:EGFP;kdrl:mCherry)	zebrafish	between	24	and	30	hpf,	prior	to	EHT	(44).	These	cells	also	have	high	levels	of	il-1b	and	NfkB-inhibitor	alpha	(ikbaa)	mRNA.	Loss	of	NfkB	in	endothelial	cells	of	Tg	(fli1a:Gal4;UAS:dn-ikbaa)	resulted	in	a	significant	reduction	in	the	number	of	cmyb+	HSPCs	(44).			Neutrophil	secreted	TNFa	appears	to	drive	endogenous	HSC	emergence.	Espin-Palazon	et	al.	used	titrated	doses	of	morpholinos	to	decrease	mRNA	levels	of	TNFa	and	its	receptors	TNFr1	and	TNFr2.	They	showed	the	number	of	nascent	HSCs	(kdrl+;	runx1+	and	cmyb+)	at	the	dorsal	aorta	was	decreased	in	the	absence	of	TNFa	signalling,	without	effecting	changes	to	the	vasculature	(44).	This	is	supported	by	He	et	al.	who	also	showed	a	reduction	in	of	HSPCs	(runx1+;	cmyb+	kdrl+)	in	tnfr2	morphants	(198).	Furthermore,	conditional	overexpression	of	TNFr2	specifically	in	endothelial	cells	of	the	vasculature	in	Tg	(fli1a:Gal4;	UAS:RFP;	cmyb:GFP;	UAS:tnfr2)	resulted	in	an	increase	in	HSC	(cmyb:GFP+)	numbers	(44).	Altogether	these	results	indicate	that	neutrophils	produce	TNFa	which	binds	to	TNFr2	on	endothelial	cells	and	promotes	EHT	of	the	endothelial	cells.	Moreover,	TNFa	may	also	act	through	the	Notch	and	NfkB	pathway	(44).	Using	Tg	(tp1:eGFP)	in	which	Notch-activated	cells	express	GFP,	Espin-Palazon	et	al.	showed	that	TNFa	signalling	activates	Notch1	in	the	dorsal	aorta.	Endothelial	expression	of	Notch1a	 intracellular	 domain	 (NICD1a),	 the	 transcriptional	 factor	 released	 upon	 Notch1	 activation,	 in	 Tg	(kdrl:Gal4;	 UAS:NICD1a-myc)	 restored	 runx1+	 cells	 in	 TNFr2	 depleted	 zebrafish.	 Treatment	 of	 the	 anaemic	zebrafish	 mutant	 diamond-blackfan,	 caused	 by	 a	 mutation	 in	 ribosomal	 protein	 S19	 which	 alters	 the	 40S	ribosomal	 subunit,	with	 the	 TNFa	 inhibitor	 Etanercept,	 rescues	 erythropoiesis	 and	 indicates	 a	 link	 between	TNFa	the	erythroid	transcription	factor	Gata1	(201).		Recently	the	TLR4	and	Myeloid	differentiation	primary	response	gene	88	(MyD88)	pathway	was	also	associated	with	 EHT	 in	 both	 mice	 and	 zebrafish.	 He	 et	 al.	 found	 that	 reducing	 TLR4	 (in	 tlr4bb	 and	myD88	 zebrafish	morphants	 and	 tlr4	 knock	 out	 mice	 embryos)	 reduced	 the	 number	 of	 definitive	 HSCs	 (runx1+;	 cd41+;	cmyb+kdrl+)	(198).	Notch	target	genes	were	decreased	in	these	morphants,	and	the	number	of	HSCs	could	be	rescued	by	driving	Notch	intracellular	domain	(NCID)	expression.	Furthermore,	vasculature	expression	of	the	dominant	negative	IkBaa,	which	prevents	translocation	of	NfkB	to	the	nucleus,	also	reduced	the	number	of	HSCs,	demonstrating	that	the	effect	is	mediated	by	NfkB.	The	effect	could	be	rescued	by	the	overexpression	of	IL-1b	(198).		
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Another	cytokine	involved	in	early	hematopoiesis	in	zebrafish	is	the	IFNg	homolog	IFNg1.2	(196).	Although	it	does	not	appear	to	drive	EHT,	it	positively	regulates	HSC	proliferation	and	maintenance	during	development.	In	heat	induced	Tg	(hsp:ifng1-2;	cd41:EGFP;	kdrlHRAS:mCherry),	the	number	of	HSCs	(cd41:GFP+)	along	the	dorsal	aorta	 increased	by	30	%(196).	 Furthermore,	 fish	with	 a	mutated	 IFNg1.2	 receptor	 (IFNGR),	 had	 fewer	HSCs	(runx1:GFP+).	Similarly,	morpholino-mediated	knockdown	of	IFNg1.2	and	IFNGR	resulted	in	fewer	HSCs.	They	showed	that	IFNg	acts	downstream	of	Notch	as	HSC	numbers	decreased	in	response	to	Notch-signalling	inhibitor	N-[N-	 (3,5-difluorophenacetyl)-lalanyl]-S-phenylglycine	 t-butyl	 ester	 (DAPT)	 but	 could	 be	 rescued	 by	 over	expression	of	IFNg.	The	application	of	DAPT	was	limited	a	period	of	24	h	begining	24	hpf	so	as	to	not	interfere	with	development	of	 the	vasculature	10-12	hpf.	These	 findings	were	supported	by	Li	et	al.	who	also	showed	morpholino-depletion	of	type	I	interferon	(IFNj)	also	reduced	HSC	(cd41:GFP)	numbers	in	the	AGM	of	zebrafish	(195).	Furthermore,	 they	showed	that	 IFNa	and	 IFNg	knock-out	mouse	embryos	had	 fewer	 functional	HSPCs	(CD45+	Ly6a+)	in	the	AGM	at	E11.5,	although	their	maintenance	was	not	affected.		Furthermore,	Lu	et	al.	have	shown	that	microRNA	(miR)-142-3p	is	specifically	expressed	in	both	zebrafish	and	mouse	 HSCs	 and	 regulates	 the	 expression	 of	 interferon	 regulatory	 factor	 (IRF)	 7	 (irf7)	 and	 G-CSF	 receptor	(Gcsfr)(154).	In	miR-142-3p	morphants,	where	Irf7	expression	is	increased	and	Gcsfr	is	decreased,	there	was	a	decrease	 in	 the	 number	 of	 HSPCs	 (cmyb+;	 runx1+)	 in	 the	 AGM	 and	 CHT.	 Similarly,	 in	 transplants	 of	mouse	hematopoietic	cells	from	the	AGM	at	E11	(CD34+	ckit+),	the	addition	of	an	inhibitor	of	miR-142-3p	reduced	the	number	 of	 CFU-S	 in	 recipient	 mice.	 Thus,	 HSC	 expansion	 and	 differentiation	 is	 regulated	 by	 inflammation	signalling	between	IRF-7	and	G-CSF	receptor.		IL-1	is	a	pro-inflammatory	cytokine	which	has	also	been	implicated	in	the	early	differentiation	of	HSC.	Orelio	et	
al.	 found	that	the	ventral	side	of	the	dorsal	aorta	of	embryonic	mice	express	IL-1,	 its	receptor	(IL1rI)	and	the	signalling	mediators	at	E11(202).	Although	there	was	only	a	minor	increase	of	HSCs	(ckit+	CD34+;	1.2	fold)	in	the	AGM	of	IL1rI	knock	out	mice,	there	was	a	significant	increase	(1.7-2	fold)	in	myeloid	progenitors	(202)	suggesting	that	IL-1	signalling	shifts	the	differentiation	bias	towards	the	lymphoid	lineage.		Runx1	 is	a	previously	mentioned	transcription	 factor	 involved	 in	regulating	HSC	numbers.	This	 transcription	factor	also	drives	IL-3	expression.	Robin	et	al.	showed	that	IL-3	could	increase	the	number	of	HSCs	(c-kit+	CD34+)	in	 haplo-insufficient	 runx1	 (+/-)	 AGM	 explants	 at	 E11.	 Moreover,	 the	 AGM	 of	 il-3	 knock	 out	 embryos	 had	significantly	fewer	HSCs	(ckit+	CD34+).	Thus,	IL-3	signalling	increases	proliferation	and	survival	of	HSCs	during	EHT	(203).		Notably,	recent	 in	vitro	experiments	have	not	been	able	to	use	these	cytokines	(TNFa,	 Il-1b	or	 IFNg)	 to	drive	human	 pluripotent	 progenitor	 cells	 to	 form	 hemogenic	 endothelial	 progenitors	 (CD31+CD34+CD45-	 or	CD34+CD43-CD73-)	 or	 hematopoietic	 cells	 (CD43+CD45+),	 irrespective	 of	 the	 developmental	 window	 (204).	Furthermore,	knockdown	of	endogenous	NfkB	signalling	by	small	molecule	BAY65-5811	inhibitor	did	not	impact	hematopoietic	 differentiation	 (204).	 Despite	 these	 contrary	 findings,	 there	 is	 significant	 evidence	 from	 both	
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mouse	and	zebrafish	models	that	inflammatory	signalling	regulates	HSC	emergence.	These	in	vitro	experiment	results	are	likely	to	reflect	the	limitations	of	current	protocols	and	the	physiological	differences	between	cells	in	
vivo	and	cells	in	culture. 	Finally,	 macrophages	 have	 been	 observed	 in	 association	 with	 emerging	 human	 HSPCs	 (CD34+	 CD45+)	 and	emerging	zebrafish	HSPCs	in	Tg	(cd41:GFP;	mpeg1:mCherry)	(168).	Inhibition	of	MMPs	results	in	accumulation	of	HSPCs	 at	 the	AGM	and	 reduced	 colonisation	of	 subsequent	 hematopoietic	 sites	 (CHT	or	 foetal	 liver).	 This	suggests	that	their	role	may	be	to	secrete	proteolytic	enzymes	to	degrade	the	extracellular	matrix	and	facilitate	HSPC	mobilisation	(168).			
1.6 HSCs	in	the	adult	Definitive	HSCs	are	derived	from	the	aorta,	expanded	in	the	liver,	and	finally	maintained	in	the	BM	of	the	mouse.	An	 analogous	 process	 has	 been	 observed	 in	 the	 zebrafish,	 where	 HSCs	 are	 derived	 from	 the	 dorsal	 aorta,	expanded	in	the	CHT,	and	maintained	in	the	kidney	marrow.	Wright	et	al.	used	genetically	marked	para-biotic	mice	with	shared	circulation	to	show	that	circulating	HSPCs	continuously	enter	and	exit	circulation	as	part	of	normal	hematopoiesis	(205).	Levels	of	progenitors	in	circulation	are	low	in	hematopoietic	homeostasis	as	HSCs	are	maintained	in	quiescence	by	specialised	environments	known	as	the	niche	(206).	Entry	and	exit	from	the	BM	is	regulated	by	intrinsic	and	extrinsic	factors.		The	HSC	niche	was	first	put	forward	by	Schofield	in	1978	where	he	proposed	that	stem	cell	behaviour	could	only	exist	in	association	with	supportive	cells	in	the	microenvironment	(114).	Essentially,	stromal	cells	would	support	a	 stable	HSC	pool	by	 inhibiting	 the	cell's	ability	 to	proliferate,	differentiate	and	exit	 the	niche.	There	 is	 some	debate	over	which	of	the	sub-regions	of	the	BM	(osteoblast	and	perivascular)	are	most	important	for	the	support	of	mammalian	HSCs	(207-210).	Indeed,	perhaps	a	variety	of	cells	is	necessary	to	fulfil	all	the	niche	requirements:	maintenance,	quiescence,	 self-renewal	 and	 inhibition	of	differentiation.	For	 instance,	 a	quiescent	 cell	may	be	maintained	 away	 from	 self-renewing	 cells	 in	 an	 area	 that	 could	 potentially	 signal	 for	 differentiation	 of	 the	daughter	cell	(83).	If	osteoblastic	and	vascular	surfaces	serve	different	support	functions,	this	could	explain	why	studies	have	not	been	able	to	pin	down	a	specific	cellular	niche.		The	BM	is	the	major	mammalian	hematopoietic	niche,	although	HSCs	are	also		found	in	the	spleen	and	circulating	blood.	Mouse	bones	are	smaller	and	more	compact	than	humans	which	have	larger,	less	compact	BM	with	more	adipocytes	 and	 larger	 blood	 volume.	 On	 the	 other	 hand,	 zebrafish	 hematopoiesis	 occurs	 in	 the	 very	 distinct	kidney	which	retains	little	structural	similarity	to	the	BM.	Both	of	these	regions	are	discussed	below.		
1.6.1 The	bone	marrow	is	the	HSC	niche	in	mammals	The	BM	niche	is	typically	split	into	the	anatomically	distinct	regions	of	endosteal	and	perivascular	compartments,	but	 in	 actual	 fact,	 ex	 vivo	 imaging	 of	 femur	 slices	 found	 that	 the	 two	 compartments	 are	 not	 distinct	 (211).	
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Furthermore,	live	imaging	of	the	mouse	calvarium	shows	that	the	majority	of	osteoblasts	(90%)	are	within	20	μm	of	vascular	surfaces	(121).			
1.6.1.1 The	osteoblast	niche	It	was	first	reported	that	functional	pluripotent	hematopoietic	cells	(capable	of	colony	formation)	resided	close	to	the	endosteal	surface	of	bones,	and	not	the	central	marrow	region	(212).	Indeed,	osteoblasts	and	osteoclasts,	responsible	for	depositing	and	reabsorbing	the	lining	of	the	bone	surface	respectively,	provide	important	factors	necessary	to	maintain	HSCs	such	as	G-CSF	(213),	granulocyte-macrophage	colony-stimulating	factor	(GM-CSF)	(213),	stem	cell	factor	(SCF)	(214),	and	IL-6	(215)	which	support	the	maintenance	of	immature	hematopoietic	phenotypes	in	vitro	(216).	Furthermore,	long	term	cultures	of	BM	cells	contain	osteoblasts.		Osteoblasts	and	osteoclasts	(Figure	1.6)	have	been	implicated	in	the	form	and	function	of	the	BM	niche	of	mice	due	to	knock	out	and	conditional	mutants.	For	instance,	mice	lacking	core-binding	factor	alpha1	(CBFa1,	also	known	 as	 runx2)	 have	 defective	 osteoblast	 formation	 resulting	 in	 reduced	BM	hematopoiesis	 and	 increased	extramedullary	hematopoiesis	(217).	In	addition,	Visnijic	et	al.	reported	that	conditional	osteoblast	ablation	in	Col2.3delta-tk	mice	(targeting	thymidine	kinase	expression	with	ganciclovir)	resulted	in	the	destruction	of	the	endosteal	surface	and	a	significant	loss	in	hematopoiesis	(initially	differentiated	cells,	and	over	time	HSPCs)	(218,	219).	It	also	appears	that	osteoclasts	play	an	important	role	by	secreting	proteolytic	enzymes	(such	as	MMP9	and	proteinase	3)	which	degrade	adhesion	molecules	in	the	BM,	thus	releasing	HSCs	from	their	tether	(220).			The	first	functional	evidence	for	the	osteoblast	niche	came	from	2	groups	publishing	the	same	year.	In	2003,	both	Zhang	et	al.	and	Calvi	et	al.	experimentally	 increased	osteoblasts	 to	show	a	direct	role	 for	osteoblasts	 in	HSC	regulation	 (221,	 222).	 Zhang	 et	 al.	 examined	 the	 role	 of	 bone	 morphogenic	 protein	 (BMP)	 on	 HSCs	 using	polyinosinic:polycytidylic	acid	(hereafter	poly	I:C)	inducible	mutant	BMP	receptor	type	1a	mice	(BMPR1A)	(221).	Mice	 lacking	BMPRIA	had	 increased	 long-term	(LSK	BrdU+)	and	short	 term	HSPC	(LSK	BrdU-)	 frequency,	and	these	HSPCs	competitively	reconstituted	irradiated	recipients.	As	this	receptor	is	not	expressed	by	HSPCs,	the	effect	must	be	due	to	the	microenvironment.	Further,	histological	examination	of	the	bone	found	that	BMPRIA	mutant	mice	had	increased	numbers	of	spindle-shaped	N-cadherin	osteoblast	(SNO)	stromal	cells	expressing	N-cadherin	(N-cad+)	and	β-catenin	and	that	these	cells	were	adjacent	to	N-cad+	expressing	HSPCs	(223).		Together	these	data	suggest	that	BMP	regulates	the	number	of	HSPCs	and	links	the	increase	in	SNO	cells	with	increased	HSPC	(LSK)	numbers.	These	findings	are	supported	by	Sugimura	et	al.	who	reported	that	genes	 flamingo	and	
frizzled	are	expressed	by	N-cad+	HSCs	and	permit	non-canonical	Wnt	signalling	with	SNO	cells	that	helps	maintain	the	quiescence	of	HSCs	in	homeostasis	(224).			In	parallel,	Calvi	et	al.	drove	osteoblast	expansion	using	parathyroid	hormone	(PTH)	on	transgenic	mice	with	osteoblast	 specific	 constitutive	expression	of	parathyroid	hormone	receptor	 (PPR)	 (222).	These	mice	had	an	increased	 number	 of	 osteoblasts	 and	 increased	 HSPC	 (LSK)	 frequency	 which	 competitively	 reconstituted	irradiated	 recipients.	Also,	 treating	 recipients	with	PTH	 increased	 transplant	 survival	 from	27	 to	100	%	and	
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substantially	altered	the	histology	of	the	recipient	BM.	Osteoblasts	from	PPR	transgenic	mice	produced	higher	levels	of	CXC	motif	chemokine	ligand	12	(Cxcl12,	also	known	as	Sdf1),	il-6,	Scf	and	Jag1	than	wild	type	(WT)	controls.			Although	 the	 paper	 suggests	 a	 link	 between	 high	 jag1	 expression	 by	 osteoblasts	 and	 the	 increase	 in	 HSPC	frequency,	further	analysis	by	Mancini	et	al.	demonstrated	that	Notch1/Jag1	interactions	were	not	required	for	HSC	maintenance	 (225).	Neither	 the	 reconstitution	ability,	nor	 the	 frequency	of	HSPCs	 (LSK)	was	affected	 in	conditional	knock	out	mutants	of	Jag1	and	Notch1.			Osteoblasts	 lining	 the	 bone	 surface	 provide	 some	of	 the	 requisite	 factors	 to	maintain	HSCs	 (Figure	 1.6).	 For	instance,	Scf	 is	expressed	by	stromal	cells	and	is	a	ligand	for	c-Kit	(CD117),	a	receptor	on	hematopoietic	cells	(although	expression	of	c-Kit	changes	in	certain	conditions	and	therefore	not	always	used	as	a	marker).	Antibody	blocking	of	the	interaction	between	c-KIT	and	SCF	allows	HSCs	to	engraft	without	irradiation	(226).	A	number	of	c-Kit	 mutant	 mice	 have	 been	 exploited	 as	 transplant	 recipients	 that	 do	 not	 require	 preconditioning	 as	 the	endogenous	HSCs	do	not	engage	with	the	niche	(227,	228).		The	role	of	osteoblasts	in	supporting	HSCs,	in	particular	LT-HSCs	was	further	supported	by	the	finding	that	the	angiopoietin	 receptor	 CD202b	 and	 angiopoietin	 1	 (Ang1)	 interaction	was	 shown	 to	 protect	 HSPCs	 from	 the	myelo-ablative	 compound	 5-FU.	 Arai	 et	 al.	 found	 that	 a	 subpopulation	 of	 HSPCs	 (LSK-SP	 CD202b+)	 express	CD202b	and	bind	to	angiopoietin	1	(Ang1)	expressing	osteoblasts	(69).	The	CD202b/Ang1	signalling	increased	N-cadherin	 levels	 and	 reduced	HSC	 cell	 cycling	post-transplant.	 Furthermore,	CD202b	knock	out	mice	 fail	 to	maintain	HSPCs	in	the	BM	(18).			Another	osteoblast	product,	Osteopontin	(OPN),	is	also	implicated	in	conserving	the	HSC	population	(Figure	1.6).	OPN	is	a	phosphorylated	glycoprotein	expressed	specifically	by	osteoblasts	on	the	endosteal	surface	of	the	BM	and	binds	with	alpha4-integrin	and	CD44	expressed	by	HSPCs.	Both	Nilsson	et	al.	and	Stier	et	al.	used	OPN	knock	out	mice	to	show	that	in	the	absence	of	OPN,	the	HSPCs	(LSK	CD34-)	fraction	is	increased,	and	that	therefore	OPN	is	a	negative	regulator	of	HSPC	numbers	(229,	230).	While	Stier	et	al.	reports	only	modest	differences	in	cycling	HSPCs	at	early	time	points	(<10	days),	Nilsson	et	al.	found	a	significant	increase	in	cycling	HSPCs	(LSK)	at	later	time	points	(>	4	weeks)	suggesting	a	delayed	effect.	Transplanting	OPN-/-	HSPCs	had	no	effect	on	reconstitution,	indicating	OPN	is	a	non-cell	autonomous	factor.	OPN-/-	transplant	recipients	were	better	reconstituted	than	WT	counterparts,	 although	 surprisingly,	 the	 HSPCs	 were	 significantly	 further	 from	 endosteal	 surfaces	 in	 these	recipients	(229).		Yet	another	niche	product,	TPO	was	initially	discovered	as	a	regulator	of	platelet	production,	but	subsequently	was	shown	to	preserve	HSPC	quiescence	and	self-renewal	in	vivo	(231).	For	instance,	the	knock-out	of	TPO	or	its	receptor	 CD110	 significantly	 reduces	 functional	 HSPCs	 in	 transplantation.	 TPO	 was	 shown	 to	 enhance	intracellular	expression	of	VEGF-A	in	HSPCs	(LSK)	promoting	cell	survival	and	proliferation	(232).			
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Figure	1.6:	Retention	and	mobilisation	factors	of	the	bone	marrow	niche.	Various	cell	types	are	involved	in	maintaining	and	
trafficking	of	the	HSC	population	from	the	bone	marrow	including:		osteoblasts,	including	spindle-shaped	N-cadherin	osteoblasts	
(SNO),	sinusoidal	endothelial	cells	(SECs),	mesenchymal	stromal	cells	(MSCs),	including	CXCL12-abundant	reticular	(CAR)	cells,	
Leptin	 receptor	 (Lepr+)	 stromal	 cells	 and	 Nestin	 (Nes+)	 expressing	MSCs,	macrophages	 and	 neutrophils.	 Retention	 factors	
(including	CXCL12,	SCF,	VCAM,	Vascular	endothelial	cadherin	(VE-cadherin)	Flamingo	(FML)	and	Frizzled	(Fz8)	involved	in	non-
canonical	 Wnt,	 Angiopoietin	 (ANG1),	 thromobopoietin	 (TPO),	 osteopontin	 (OPN))	 expressed	 by	 niche	 cells	 are	 indicated.	
Mobilisation	requires	down	regulation	of	these	factors,	indicated	by	red	pin	heads,	as	well	as	mobilisation	signals	(including	G-
CSF	and	sphinogosine-1-phosphate	(S1P)).	Sympathetic	nerves	provide	a	circadian	delivery	of	adrenergic	signals.	Macrophage	
egress	signals	for	HSC	proliferation	and	egress.			Finally,	the	osteoblast	specific	expression	of	dickkopf1,	an	inhibitor	of	canonical	Wnt	signalling,	was	shown	to	decrease	Wnt	in	HSCs	(LSK)	which	led	to	increased	cell	cycling	(233).	Furthermore,	exposure	to	the	Wnt	inhibitor	
Dormant	HSC
Osteoclast
RETENTION	and	MAINTENANCE
Blood	vessel	
cavity
SEC
CAR
CXCL12VCAM
SCF
CXCL12
ANG
OSP
CXCL12
VCAM
Nes-
MSC
VEGFR2
VEGFR3
VE-Cadherin
CXCL12
Self	renewing
HSC
CXCL12
SCF
FML
Fz8
CXCL12
SCF	
ANG1
OPN
TPO
Dormant	HSC
Osteoclast
EXPANSION	and	EGRESS
HSC
Macrophage
MSC
CAR
Neutrophil
G-CSF
Elastase
Cathepsin G
G-CSF
S1P
Notch
signalling
Proliferating	HSC
Nes-
MSC
SEC
Introduction	
	44	
reduced	 reconstitution	 ability	 of	 these	 cells,	 even	when	 transplanted	 into	 an	 environment	without	 the	Wnt	inhibitor.	Together,	this	collection	of	data	strongly	supports	the	influence	of	the	niche	on	the	function	of	HSCs.		More	recently,	 intra-vital	 imaging	has	shown	that	contact	with	osteoblasts	 is	also	 important	 for	 transplanted	hematopoietic	cells.		Lo	Celso	et	al.	transplanted	HSCs	(LSK	CD48-	CD135-)	dyed	with	DiD	into	osteoblast	reporter	mice	(Col2.3:GFP)	with	a	c-kit	mutation	(125).	These	recipient	mice	have	GFP	expression	in	osteoblast	to	allow	distance	measurements	to	be	made	and	a	c-Kit	mutation	that	impairs	endogenous	HSPCs	to	engage	with	the	niche,	thus	allowing	transplanted	HSCs	to	engraft	without	chemotherapy	or	radiation	(228).	Using	3-D	 live	 imaging	they	found	that	HSPCs	were	within	16	μm	of	vasculature	and	within	20	μm	of	endosteal	surfaces.	In	contrast,	in	WT	non-conditioned	recipients,	HSPCs	were	always	>	30	μm	from	endosteum	surfaces,	and	none	of	these	cells	ever	engrafted.			Furthermore,	 live	 imaging	 of	 HSPCs	 (LSK	 CD48-	 CD135-)	 transplanted	 into	 transgenic	 PPR	 mice	 (increased	osteoblasts	due	to	constitutive	expression	of	parathyroid	hormone	receptor)	found	that	transplanted	cells	locate	closer	to	the	endosteum	than	in	WT	mice,	even	when	adjustments	were	made	to	allow	for	the	reduced	marrow	cavity	size	(121).	This	is	possibly	due	to	the	high	expression	of	the	anchoring	molecules	expressed	by	osteoblasts.	The	 proximity	 to	 osteoblasts	 suggests	 preservation	 of	 the	 stem	 phenotype	 and	 self-renewal	 rather	 than	differentiation	of	transplanted	cells.		However,	some	data	has	suggested	that	osteoblasts	are	not	required	for	HSC	maintenance.	For	instance,	Kiel	et	
al.	 found	that	neither	(LSK	CD150+	CD48-	CD41-)	or	(LSK	CD135-)	HSC	populations	expressed	N-cadherin	and	that	hematopoietic	cells	that	did	express	N-cadherin	possessed	low	reconstituting	ability	(3	in	30)	(234).	They	argued	that	the	majority	of	HSCs	do	not	depend	on	the	endosteal	surface,	although	a	small	subset	might	(14	%	of	HSPCs	were	localised	near	endosteal	surfaces).			Kiel	et	al.	also	studied	the	effect	of	osteoblasts	on	HSPCs	in	a	biglycan	deficient	mouse	model	(234).	These	mice	have	fewer	osteoblasts	due	to	the	depletion	of	the	extracellular	matrix	proteoglycan.	However,	the	frequency	and	reconstitution	capacity	of	HSPCs	(LSK	CD150+	CD48-	CD41-)	from	these	mice	is	not	significantly	different	to	WT	HSPCs.	 These	 findings	 are	 contrary	 to	 the	 finding	 in	 the	 CBFa1	 mutant	 mouse	 model	 and	 the	 conditional	osteoblast	ablation	 in	Col2.3delta-tk	mice	which	both	resulted	 in	significant	 loss	of	hematopoiesis	(217-219).	These	 contrary	 findings	 may	 be	 due	 to	 the	 severity	 of	 the	 osteoblast	 ablation:	 in	 the	 CBFa1	 mutant	 and	conditional	Col2.3delta-tk	mice,	osteoblasts	are	not	formed	or	severely	impaired,	while	in	the	bigylcan	deficient	mouse	 model	 the	 loss	 of	 osteoblasts	 is	 progressive	 over	 time.	 Together,	 these	 data	 suggest	 that	 the	 HSPC	population	can	be	maintained	by	low	osteoblast	numbers.			In	addition	to	the	results	described	above,	Lo	Celso	et	al.	also	found	that,	post-transplant,	non-committed	HSCs	(LSK	CD48-	CD135-)	located	closest	to	the	osteoblasts,	while	more	mature	MPPs	and	committed	progenitors	were	further	away	(121).	This	supports	previous	findings	by	Nilsson	et	al.	which	also	found	that	the	majority	(60	%)	
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of	non-committed	progenitors	(Lin-	Wga+	Rholow)	 located	closer	 to	endosteum,	while	more	mature	cells	were	found	in	the	central	cavity	(235). 	There	 is	evidence	of	bidirectional	 regulation	of	 the	endosteal	niche.	While	 the	endosteal	niche	regulates	HSC	number	and	function,	there	is	also	evidence	that	HSPCs	(LSK	cells	and	LSK	CD150+	CD48-	CD41-	cells)	can	direct	the	differentiation	of	mesenchymal	cells	into	osteoid	lineages	in	vitro	and	in	vivo	(236).	Jung	et	al.	injected	HSCs	(LSK	 CD150+	 CD48-	 CD41-)	 into	 pre-established	 "vossicles"	 (ectopic	 bone	 formations	 created	 from	 lumbar	vertebrae)	from	CBFa1	(bone	transcription	factor)	reporter	mice	(236).	They	found	that	HSCs	induced	CBFa1	activity	in	the	vossicles,	thus	inducing	differentiation	of	BM	stromal	cells	into	osteoid	lineages.	In	addition,	CBFa1	activity	was	increased	when	vossicles	were	injected	with	HSCs	from	stressed	(phlebotomised)	mice,	compared	to	sham	injected	vossicles	and	vossicles	injected	with	HSCs	from	non-stressed	mice.	Furthermore,	they	found	that	stressed	HSCs	increased	osteogenesis	by	producing	higher	levels	of	BMP2	and	BMP6	(236).				
1.6.1.2 The	perivascular	and	endothelial	niche		Given	that	hematopoietic	cells	arise	from	hemogenic	endothelium	precursor	in	the	dorsal	aorta,	it	is	not	entirely	surprising	 that	HSCs	closely	associate	with	vascular	endothelial	 cells.	While	 the	endosteum	surface	 is	closely	associated	with	the	vascular	surface,	the	central	marrow	cavity	is	made	up	of	vascular	and	extravascular	support	cells	(121,	211).	These	cells	 include	CXCL12-abundant	reticular	cells	(CAR)	(237),	sinusoidal	endothelial	cells	(SECs)	(238),	neural	glial	2	expressing	pericytes	(239)	and	mesenchymal	stem	cells	(MSCs)	(240,	241)	including	Leptin	receptor	(Lepr+)	cells	(242)	and	Nestin	(Nes+)	expressing	cells	(241)	(Figure	1.6).	The	chemokines	CXCL12	and	SCF	are	important	factors	of	the	perivascular	niche.		Although	 initially	 studies	 determined	 the	 endosteal	 niche	 was	 regulating	 HSPCs,	 Kiel	 et	 al.	 argued	 that	 the	perivascular	 structures	 were	 also	 relevant	 to	 HSC	 support.	 They	 used	 the	 expression	 of	 SLAM	 proteins	 to	distinguish	HSCs	in	stained	sections	of	BM	and	found	that	only	14	%	of	HSCs	(LSK	CD150+	CD48-	CD41-)	localised	to	the	endosteal	surface.	On	the	other	hand,	60	%	of	HSCs	were	found	by	sinusoidal	vascular	endothelium	(17).	In	support	of	this,	both	Tokoyoda	et	al.	(243)	and	Sugiyama	et	al.	(237)	found	HSCs	(LSK	CD150+	CD48-	CD41-)	scattered	throughout	the	central	BM	cavity.		SECs	constitute	the	predominant	surface	area	of	the	vascular	niche	(Figure	1.6).	These	cells	express	adhesion	molecules	that	assist	the	migration	and	homing	of	HSPCs	to	the	BM.	SECs	cells	express	VEGFR2,	VEGFR3	and	vascular	 endothelial	 cadherin	 and	 are	 essential	 for	 engraftment	 and	 reconstitution	 of	 hematopoiesis	 (238).	Indeed,	co-culturing	of	hematopoietic	cells	with	SECs	leads	to	incremental	self-renewal	of	HSCs.	SECs	also	play	a	role	 in	 regeneration	 after	BM	 injury	 and	 assist	 in	 hematopoietic	 cell	 differentiation.	However,	 the	molecular	pathways	 that	 modulate	 this	 function	 are	 not	 yet	 understood	 but	 may	 be	 through	 the	 production	 of	 cell	autonomous	factors.	For	instance,	during	recovery,	protein	kinase	B	(hereafter	referred	to	as	Akt)	and	mitogen-activated	protein	kinases	regulate	reconstitution	(244).			
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Imaging	by	both		Lo	Celso	et	al.	(121)	and	Xie	et	al.	(211)	found	that	proliferative	HSPCs	were	mostly	seen	in	the	central	marrow	region.	Xie	et	al.	report	that	HSPCs	in	the	same	field	of	view	had	different	behaviours;	one	stable	and	the	other	actively	dividing	(211).	This	may	be	due	to	cell	autonomous	features,	or	their	position	relative	to	vascular	surfaces	which	would	alter	the	vascular	signals	they	are	receiving.			Histological	 sections	 of	 CXCL12	 reporter	mice	 showed	 CXCL12	 expression	 throughout	 the	 BM	 cavity	 (237),	including	 perivascular	 stromal	 cells,	 endothelial	 cells,	 osteoblasts,	 and	 some	 hematopoietic	 cells	 (245,	 246).	Interestingly,	the	majority	(97	%)	of	HSPCs	(LSK	CD150+	CD48-	CD41-)	cells	were	found	in	contact	with	CAR	cells	(237).	Conditional	deletion	of	CXCL12	receptor	CXCR4	(CXC	receptor	4,	CD184)	reduced	the	fraction	of	HSPCs	(LSK	CD34-	and	SP)	in	the	BM,	but	also	increased	the	MPP	fraction	(LSK	CD34+).	In	support	of	this,	Ding	et	al.	targeted	deletion	of	CXCL12	from	specific	support	cells	(246).	HSPCs	(LSK	CD150+	CD48-)	were	depleted	when	CXCL12	was	deleted	from	endothelial	cells,	and	to	a	greater	extent	when	deleted	from	perivascular	cells	(246).	However,	HSPCs	were	not	depleted	when	CXCL12	was	deleted	from	osteoblasts,	although	HSPCs	became	more	migratory	(240).	This	demonstrates	a	role	for	non-endosteal	surfaces	in	the	quiescence	of	HSCs.	Transplantation	of	HSPCs,	 followed	by	 induced	deletion	of	CXCR4,	showed	that	effects	were	cell	autonomous	and	thus	CXCR4	expression	by	HSPCs	is	important	for	HSPC	quiescence.																		
In	 vivo	 imaging	by	Lo	Celso	et	 al.	 further	noted	 that	 single	 cells	were	 located	 closer	 to	 the	 endosteum	while	clusters	(>3	cells)	were	further	away	(121).	By	combining	DiD	and	DiI	labelling	of	transplanted	cells,	they	also	revealed	that	the	clusters	of	HSPCs	observed	in	the	marrow	are	due	to	the	proliferation	of	single	cells,	and	not	the	clustering	of	cells	transplanted	together.			Although	 distributed	 alongside	 perivascular	 cells	 (Figure	 1.6),	 a	 distinct	 population	 of	 Nes+	 cells	 have	 been	investigated	for	their	role	in	supporting	HSPC	quiescence	because	femoral	sections	from	Nestin	reporter	mice	showed	a	close	association	between	these	cells	and	HSPCs	(LSK	CD150+	CD48-).	Nes+	cells	express	significant	levels	of	ANG1,	CXCL12,	SCF,	IL-7,	vascular	cell	adhesion	molecule	(VCAM)	1,	and	OSP,	genes	implicated	in	HSPC	retention	in	the	BM	(241).	Furthermore,	the	highest	level	of	these	factors	is	found	in	a	subset	of	Nes+	cells	(CD45-	Ter199-	CD31-	PDGFRa+	CD51+)	(247).	Significantly,	conditional	knock	out	of	Nes+	cells	caused	a	50	%	decrease	in	HSPCs	(LSK	CD150+	CD48-)	in	the	BM,	and	an	increase	in	the	spleen.	This	indicates	a	role	for	Nes+	MSCs	in	HSPC	migration.		On	the	other	hand,	ex	vivo	imaging	data	by	Xie	et	al.		that	found	that	HSPCs	(LSK	CD135-)	transplanted	into	non-conditioned	WT	recipients	were	in	direct	contact	with	MSCs	(both	Nes+	and	Nes-)	indicating	that	HSPCs	interact	with	a	diverse	set	of	niche	components	(211).	Both	Nes+	and	Nes-	MSCs	express	important	amounts	of	CXCL12	and	both	have	been	found	to	contribute	to	HSPC	maintenance	in	the	BM	(240,	241).		
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1.6.1.3 Resident	macrophages	Recently,	BM	resident	macrophages	have	emerged	as	 important	regulators	of	HSPCs	(Figure	1.6)	(248).	They	influence	whether	HSPCs	remain	within	the	BM	or	enter	the	circulation	(249,	250).	They	also	regulate	steady	state	erythropoiesis	and	granulopoiesis	(251-254).	Resident	macrophages	are	located	both	in	the	central	cavity	and	 on	 the	 bone	 lining	 where	 they	 support	 osteoblasts	 (250,	 253).	 The	 heterogeneity	 of	 the	 macrophage	populations	 (5	 markers	 currently	 being	 used)	 means	 that	 it	 is	 difficult	 to	 determine	 distinct	 population	contributions.			In	 demand-driven	 hematopoiesis,	 sensors	 of	 cell	 loss	 feedback	 to	 HSPCs	 to	 increase	 cell	 proliferation	 and	differentiation.	 Granulopoiesis	 induced	 by	 the	 loss	 of	 neutrophils	 during	 infection	 requires	 macrophage	phagocytosis	of	dead	cells.	The	exit	of	macrophages	from	the	BM,	needed	to	increase	phagocytic	capacity	in	the	periphery,	results	in	HSPC	proliferation	and	granulopoiesis,	mediated	by	G-CSF,	IL-1	and	TLR4	signalling	(255).	Recently,	 Boettcher	 et	 al.	 found	 that	 endothelial	 cells	 are	 robust	 producers	 of	 G-CSF	 in	 response	 to	lipopolysaccharide	 (LPS)	 (256).	 Endothelial	 expression	 of	 this	 factor	 may	 be	 important	 for	 inducing	macrophages	egress	from	the	BM.			Methods	to	deplete	macrophages	in	mice	(such	as	macrophage	FAS-induced	apoptosis	(MAFIA),	CD169	–DTR	mice	and	clodronate-liposomes	(249,	250))	leads	to	an	increase	in	circulating	HSPCs.	In	these	models,	the	levels	of	retention	factors	including	CXCL12,	ANG1,	Kit	and	VCAM1	are	all	reduced	both	at	the	mRNA	(RT-qPCR	of	total	BM	cells	(249)	and	endosteal	cells	(250))	and	protein	level	(ELISA	of	cultured	MS-5	cells	(249)).	The	depletion	of	macrophages	also	results	in	an	increase	of	both	proliferative	and	dormant	HSPCs	in	the	BM	suggesting	that	macrophages	 limit	HSC	 proliferation	 and	 population	 size	 (257).	 Thus	macrophages	 promote	 quiescence	 and	retention	while	they	are	present,	and	hematopoietic	cell	production	when	they	exit	the	BM.		Granulocyte	 production,	 granulopoiesis,	 is	 stimulated	 by	 G-CSF	 during	 infection	 (258).	 G-CSF	 is	 a	 common	mobilisation	agent	used	for	harvesting	donor	progenitors	today	(259).	It	has	been	shown	to	reduce	the	amount	of	CXCL12	(260)	and	VCAM1	(261)	in	the	BM,	causing	mobilisation	of	the	HSPCs	into	the	circulation	(Figure	1.6).	It	also	reduces	the	number	of	BM	resident	macrophages	(250),	which	may	also	be	the	cause	of	HSPCs	entering	the	circulation.		
1.6.1.4 HSC	mobilisation	and	retention	factors	The	niche	factors	ANG1/CD202b,	SCF/c-Kit,	N-Cadherin,	TPO/CD110	and	OPN/	alpha4-integrin/CD44	described	earlier	all	play	a	role	in	HSC	quiescence	and	retaining	LT-HSCs	in	the	BM	(Figure	1.6).	It	is	worth	noting	that	HSC	mobilisation	 and	 quiescence	 are	 linked.	 Thus,	 although	 listed	 here	 as	 distinct,	 mobilisation	 requires	 the	downregulation	of	these	niche	factors	as	well	as	an	upregulation	of	factors	that	lead	to	HSC	migration	out	of	the	BM.		
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To	begin,	under	normal	physiological	conditions,	HSC	trafficking	to	and	from	the	BM	is	regulated	by	the	circadian	release	of	adrenergic	signals	from	sympathetic	nerves	in	contact	with	Nes+	mesenchymal	cells	(262).	Signalling	through	the	coupling	b3-adrenergic	receptor	Adrb2	leads	to	down	regulation	of	maintenance	genes	(CXCL12	and	Specificity	 protein	 1	 Sp1)	 and	 egress	 of	 HSCs.	 The	 sympathetic	 nervous	 system	 also	 regulates	 HSCs	 though	indirect	influence	on	osteoblast	function	(263).			Migration	 and	 homing	 of	 hematopoietic	 cells,	 in	 response	 to	 injury	 or	 post-transplant,	 involves	 gradients	 of	chemotactic	factors	and	cell	adhesion	molecules	(CAMs).	The	chemotactic	activity	of	the	previously	mentioned	CXCL12,	 as	well	 as	 phosphosphingolipids,	 extracellular	 nucleotides	 and	 calcium	 ions	 also	 appear	 to	 play	 an	important	function	(264-267).	The	lodgement	of	HSPCs	is	then	orchestrated	by	CAMs	which	include	selectins,	integrins	and	CXCL12.	Furthermore,	 the	expression	of	hyaluronic	acid	(HA),	a	component	of	 the	extracellular	matrix,	appears	to	be	a	key	molecule	in	regulating	HSC	distribution.			The	chemokine	CXCL12,	is	an	important	chemo-attractant	of	HSCs	(240,	268,	269)	and	lymphocytes.	This	ligand	is	 constitutively	 expressed	 by	 BM	 stromal	 cells,	 in	 particular	 by	 CXCL12-abundant	 reticular	 (CAR)	 cells	surrounding	 sinusoidal	 endothelial	 cells	 or	 near	 the	 endosteum	 (237),	 and	 by	 endothelial	 cells.	 The	 main	receptor	for	CXCL12	is	CXCR4	which	is	expressed	by	immature	hematopoietic	cells.	CXCL12	binding	to	CXCR4	signals,	through	Gi-protein	messengers,	to	activate	Inositol	triphoshate	IP3,	Protein	kinase	C	PKC	and	the	Janus	kinase	(JAK)	and	Signal	Transducer	and	Activator	of	Transcription	(STAT)	cascade.	The	JAK/STAT	pathway	is	associated	with	HSC	 (LSK	 CD150+	 CD48-)	 proliferation	 (270).	 Transplanted	 human	HSCs	 (CD34+	 CD38-)	 can	engraft	in	mouse	BM,	and	subsequence	proliferate	there,	because	of	this	signalling	(271,	272).	This	pathway	is	also	conserved	in	the	zebrafish	(see	1.6.2.2).		While	CXCL12	is	an	important	ligand	assisting	HSC	retention	in	the	BM,	data	suggests	that	this	protein	pair	is	less	important	for	BM	homing	(273).	In	the	absence	of	CXCL12	and	CXCR4,	homing	and	retention	of	HSPCs	(CD34+)	appears	to	rely	on	very	late	antigen-4	(VLA-4;	part	of	the	b	integrin	family)	and	the	endothelial	expression	of	its	receptor	VCAM1	(273).	Indeed,	a	number	of	b	 integrins	(including	VLA-5	and	lymphocyte	function	associated	antigen-1)	appear	to	be	involved	in	trans-endothelial	migration	and	engraftment.	Using	antibodies	to	block	these	proteins	on	human	CD34+	cells	prior	to	transplant,	partially	or	completely	prevented	engraftment	in	NOD/SCID	mice	(274).		In	support	of	this,	Levesque	et	al.	found	that	elastase	and	cathepsin-G	are	released	by	neutrophils	during	G-CSF	induced	mobilisation	and	these	enzymes	cleave	VCAM1,	preventing	VLA-4	binding	and	thus	contributing	to	cell	mobilisation	(261).	VLA-4	expression	on	hematopoietic	cells	(CD34+)	 	is	regulated	by	cytokines	including	SCF	(275),	GM-CSF	(276),	IL-3	(276)	and	TGFb	(277).	Thus,	quiescence	and	mobilisation	is	regulated	by	cytokines.			In	addition	to	VCAM1,	human	BM	endothelial	cells	also	express	E	and	P-	selectins	important	for	the	homing	of	transplanted	cells	(278).	Mazo	et	al.	took	direct	observations	of	migrating	progenitor	cells	(FDCP-mix)	rolling	
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along	microvessels.	They	showed	reduced	rolling	of	transplanted	cells	in	the	absence	of	E	and	P	selectins	(using	neutralising	antibodies	and	knock	out	mice)	(279).	In	addition,	Rood	et	al.	found	that	blocking	antibodies	against	
b	integrins	did	not	inhibit	adhesion	in	culture	unless	E-selectin	mediated	interaction	was	blocked	(280).		VEGF	and	placental	growth	factor	(PlGF)	are	chemokines	important	for	HSPC	proliferation	and	migration	(33,	281).	Hattori	et	al.	showed	that	VEGF-A	binds	to	VEGFR1	on	human	and	mice	HSPCs	(CD34+	and	LSK	respectively)	increasing	mobilisation	of	these	cells	into	circulation.	Inhibiting	VEGFR1	prevented	hematopoietic	recovery	after	myelo-abalation	with	5-FU	(33).	PIGF	signals	through	VEGFR1	to	promote	migration	of	BM	HSPCs.	This	signalling	is	 dependent	 on	 MMP9	 as	 PIGF	 was	 not	 able	 to	 induce	 proliferation	 in	 MMP9	 knock	 out	 mice	 (33).	 In	corroboration	with	this,	Heissig	et	al.	have	shown	that	myeloablation	by	5-FU	causes	an	increase	in	CXCL12	which	increased	MMP9,	followed	by	the	release	of	soluble	Kit-ligand	and	ultimately	causing	progenitor	cell	recruitment	and	migration	(282).		More	 recently,	 sphinogosine-1-phosphate	 (S1P)	 and	 its	 receptor	 (S1PR)	 have	 been	 found	 to	 be	 strong	chemotactic	signals	for	the	recruitment	of	HSCs	when	vascular	injury	occurs	(Figure	1.6).	S1PRs	are	expressed	by	hematopoietic	progenitors	 (CD34+	CD38-)	 (283)	which	 sense	S1P	 released	by	various	 cell	 types	 including	endothelial	cells	and	activated	platelets	(284).	Indeed,	mice	deficient	in	S1P	or	its	receptor	have	reduced	HSPC	(LSK)	mobilisation	(285).	In	injury,	plasma	levels	of	S1P	increase	during	mobilisation	due	to	activation	of	the	complement	cascade	and	membrane	attack	complex	(286).	Indeed,	it	has	been	proposed	that	a	combination	of	CXCR4	antagonist	and	S1PR	agonist	would	increase	HSPC	mobilisation	when	harvesting	cells	from	donors	which	would	avoid	the	use	of	G-CSF	(287).		HA	is	a	major	component	of	the	extracellular	matrix	and	cell	movement	increases	with	exposure	to	or	expression	of	HA	while	cell	movement	is	inhibited	by	HA	degradation	or	blocking	of	receptors.	HA	is	expressed	by	human	(CD34+	CD38-)	and	mouse	(LSK;	Lin-	Rholow	and	LSK	CD150+	CD48-)	primitive	hematopoietic	cells	(288,	289).	Expression	of	HA	was	higher	on	HSCs	found	at	the	endosteal	surface	than	on	HSCs	or	lineage	committed	cells	found	in	the	central	marrow	(288,	289).	Furthermore,	CT-imaging	of	 the	 femur	from	Has3	knockout	mice	(in	which	HA	 levels	are	 reduced)	 showed	 transplanted	HSPC	 took	 longer	 to	 trans-endothelially	migrate	 into	BM	(290).	These	findings	suggest	that	HA	is	important	for	regulating	cell	distribution	post-transplant.		CD44	 is	expressed	on	primitive	hematopoietic	cells	 (Lin-	CD34+)	and	endothelial	cells.	 It	 	binds	 to	numerous	components	 of	 the	 extracellular	 matrix	 including	 HA	 (291),	 collagen	 (292),	 fibronectin	 (293),	 and	transmembrane	receptors	such	as	E-selectin	(294).	CD44	regulates	homing	and	retention	of	HSCs	in	the	spleen,	foetal	liver	and	BM	(295).	CD44	knock	out	mice,	have	significantly	larger	HSC	(LSK	CD150+	CD48-)	and	progenitor	(LSK	 CD150+	 CD48+)	 populations,	 when	 normalised	 to	 their	 size	 (as	 CD44	 knock	 out	 mice	 are	 significantly	smaller).	Interestingly,	migration	from	the	foetal	liver	to	the	bone	marrow	was	delayed	by	2	days,	correlating	with	 an	 increase	 in	 CXCL12	 over	 this	 period,	 in	 CD44	 knock	 out	mice	 and	may	 be	 the	 reason	 for	 increased	proliferation.	
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Transplantation	studies	found	that	the	absence	of	CD44	in	the	recipient	micro-environment	did	not	affect	homing	and	distribution	of	WT	HSCs.	However,	absence	of	CD44	on	transplanted	HSCs	(both	mouse	LSK	CD150+	CD48-	(289)	and	human	CD34+(295))	reduced	homing	in	WT	recipients.	This	effect	was	accentuated	in	CD44	knock	out	recipients.	Altogether,	 the	data	 indicates	 that	CD44	expression	on	HSCs	 is	critical	 for	 lodgement	and	that	 the	effect	is	worsened	if	CD44	is	absent	in	the	microenvironment.		Finally,	Adams	et	al.	have	argued	that	calcium	sensing	is	important	for	HSC	retention	and	protecting	HSC	function.	Mouse	HSPCs	(LSK)	express	the	calcium	sensing	receptor	(CaR).	The	HSC	population	in	knockout	mice	(CaR-/-)	are	normal	in	number	and	function	but	do	not	retain	close	proximity	to	the	endosteal	surface	of	the	BM	(267).	However,	when	competitively	transplanted,	CaR-/-	HSCs	contribute	only	2.7	%	of	the	hematopoietic	system	after	16	weeks	while	WT	HSCs	 contributed	 to	 84.6	%	of	 BM.	 Furthermore,	HSPCs	 that	 do	 not	 reside	 close	 to	 the	endosteal	surface	are	not	 functionally	competitive	against	WT	HSCs.	These	results	 indicate	a	role	 for	calcium	sensing	or	endosteal	contact	in	maintaining	the	HSPC	population	and	in	post-transplant	reconstitution	of	the	BM.		
1.6.1.5 Cell	autonomous	factors	for	HSC	quiescence	Recently,	Vionnie	et	al.	published	the	results	of	a	set	of	cleverly	designed	experiments	that	strongly	indicated	that	much	of	the	behaviour	of	hematopoietic	cells	is	cell	autonomous.	They	created	a	mouse	strain	they	called	“Hue”	in	which	Cre-induced	recombination	of	20	cassettes	(encoding	fluorescent	genes)	resulted	in	a	range	of	coloured	hematopoietic	 cells.	 Individual	 clones	 in	 transplant	 recipients	 behaved	 as	 they	 had	 in	 the	 endogenous	 hosts	(proliferation	and	lineage	commitment)	and	in	response	to	stress	(LPS	or	total	body	irradiation).	They	found	that	clones	identified	with	the	same	marker	set	(LSK	CD150+	CD48-)	but	which	behaved	differently	(proliferation	rate	and	lineage	bias)	had	distinct	epigenetic	patterning	(296).			A	number	of	transcription	factors	and	proteins	have	been	shown	to	regulate	HSC	cell	cycle	which,	if	absent	will	cause	 unregulated	 cell	 cycling	 and	 stem	 cell	 exhaustion	 (297).	 These	 factors	 include	mammalian	 target	 of	
rapamycin,	a	regulator	of	protein	synthesis	and	metabolism,	and	its	negative	regulators	promyelocytic	leukemia	
protein	and	F-box-and-WD-repeat-domain-containing-7.	Deletion	of	either	of	these	proteins	increased	cell	cycling	and	proliferation	which	led	to	exhaustion	of	the	population	(298,	299).			Similarly,	the	forkhead	box	protein	(FoxO)	family	is	regulated	by	Akt	and	usually	inhibits	cell	cycle	entry.	Loss	of	FOXO3a	in	mice	 increased	cell	cycling	and	apoptosis	of	HSCs	and	this	 is	mediated	by	reactive	oxygen	species	(ROS)	(300).	In	zebrafish,	foxo3b	is	mediated	by	ELL	associated	factor	1.	When	the	transcription	of	ELL	associated	
factor	1	was	knocked	down	by	morpholino,	the	number	of	HSPCs	(runx1+	and	cmyb+)	were	significantly	reduced,	although	knock	down	of	foxo3b	did	not	have	an	effect	on	HSPC	number	(155).	This	suggests	that	related	proteins	might	 compensate	 for	 the	 role	 of	 foxo3b	 in	 the	 zebrafish.	 Together	 this	 data	 suggests	 the	 FOXO	 family	 are	regulators	of	HSPCs.		
Introduction	
	 51	
Activator	protein	(AP-1)	transcription	factor	JunB	is	a	transcriptional	regulator	of	myelopoiesis	that	is	linked	to	chronic	myelogenous	leukemia	(CML).	Interestingly,	Passegue	et	al.	found	that	cell	autonomous	overexpression	of	JunB	in	the	LT-HSC	led	to	a	decrease	in	the	number	of	LT-HSCs	(self-renewal),	while	 inactivation	led	to	an	expansion	of	LT-HSCs	(301)	and	CML.			The	 global	 developmental	 regulator	 pre-B-cell	 leukemia	 transcription	 factor	 PBX1	 has	 also	 been	 shown	 to	regulate	 quiescence.	 In	 a	 conditional	 knockout	 mouse,	 the	 quiescent	 stem	 cell	 pool	 is	 reduced	 and	 their	sensitivity	to	5-FU	as	well	as	their	lower	reconstituting	potential	in	transplantation	suggest	an	increased	cycling	leads	to	exhaustion	(302).	Likewise,	the	conditional	knockout	of	the	all	3	retinoblastoma	genes	(Rb,	p107	and	
p130)	causes	increased	cell	cycling	of	HSPCs	and	exhaustion	(303).	Egr1	is	an	early	transcription	factor,	highly	expressed	in	HSCs	and	significantly	down	regulated	in	differentiated	cells.	Loss	of	Egr1	causes	HSCs	proliferation,	mobilisation	from	the	niche	and	ultimately	shortens	their	lifespan	(304).	Reduced	Egr1	correlates	with	increase	in	polycomb	group	protein	BMI-1	which	increases	HSC	self-renewal	and	restricts	ROS	production	(305).	Bmi-1	targets	are	frequently	mutated	tumour	suppressors.			Lastly,	E3	ubiquitin	 ligase	Casitas	B-lineage	 lymphoma	(c-CBL),	expressed	in	HSCs,	also	restricts	their	cycling	activity	(306).	The	absence	of	this	gene	causes	an	increase	in	the	HSPC	population,	although	HSCs	from	these	knockout	donors	have	increased	repopulating	ability	in	transplant	assays.		
1.6.2 The	kidney	marrow	is	the	HSC	niche	in	zebrafish	In	the	zebrafish,	the	kidney	(and	the	mesonephros)	is	the	primary	site	of	hematopoietic	stem	cell	maintenance.	There	are	some	similarities	between	mammalian	BM	and	zebrafish	kidney	marrow.	Firstly,	both	are	vascularised	so	 hematopoietic	 cells	 can	 distribute	 throughout	 the	 body.	 Secondly,	 both	 are	 populated	 by	 resident	macrophages.	Thirdly,	both	niches	express	retention	factors	such	as	CXCL12	(307).	On	the	other	hand,	a	major	component	of	the	BM	is	the	endosteal	niche	which	retains	quiescent	cells	through	osteoblast	expression	of	factors	(ANG1,	 SCF,	 N-Cadherin,	 TPO	 and	 OPN)	 and	 corresponding	 receptor	 expression	 (CD202b,	 cKit,	 N-Cadherin,	CD110,	 alpha4-integrin	 and	 CD44)	 by	HSCs.	 Although	 zebrafish	 are	 osseous	 (308),	 the	 kidney	 is	 considered	distinct	from	these	cells	and	therefore	the	role	of	bone	cells	has	not	been	investigated.	This	contributes	to	a	lack	of	research	into	the	role	of	these	cells	to	provide	retention	factors.	However,	orthologues	of	Ang1	(Ang2	in	the	zebrafish)	(309),	TPO	(29,	84)	and	OPN	(spp1	in	the	zebrafish)	(310)	have	been	found	to	regulate	ossification	in	the	zebrafish.	Furthermore,	Ang2	was	found	to	be	expressed	in	glomeruli	of	the	developing	embryo	(309).		There	are	a	number	of	reasons	for	using	the	zebrafish	to	study	HSCs.	Firstly,	the	conserved	features	between	teleost	and	mammalian	hematopoietic	systems	(see	1.3).	Secondly,	the	optical	transparency	of	zebrafish	allows	visualization	of	the	cells	in	the	HSC	niche.	Despite	the	obvious	differences	between	the	BM	and	kidney,	human	CD34+	HSCs	have	successfully	homed	to	the	kidney	marrow	of	irradiated	zebrafish	suggesting	that	the	zebrafish	kidney	provides	an	adequate	niche	for	the	recruitment	of	human	HSCs	(50).	Humanised	fish	are	only	just	being	developed	but	 there	 is	 hope	 that	 this	model	 can	be	 used	 to	 study	 in	 vivo	 behaviour	 of	 subsets	 of	 the	CD34+	
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population.	An	analysis	of	these	subsets	could	identify	the	best	cell	population	for	human	therapy.	Furthermore,	comparative	studies	in	mice	and	zebrafish	should	help	identify	key	components/molecules	for	regulating	HSCs.			
1.6.2.1 Structure	of	the	kidney	The	 kidney	 of	 the	 zebrafish	 shares	 many	 features	 (cell	 types	 and	 developmental	 patterning)	 with	 other	vertebrate	 kidneys	 and	 serves	 to	 remove	waste	 from	 the	 blood	 and	 to	maintain	 osmotic	 balance,	 as	well	 as	maintain	hematopoietic	cells	(311).	The	functional	unit	of	the	kidney	is	the	nephros,	made	up	of	the	glomerus	and	 tubular	 epithelium.	Blood	 flows	 through	 the	 glomerus,	 a	 net-like	 structure	 of	 specialised	 epithelial	 cells	connected	by	adheren	junctions,	to	be	filtered	for	 ions	and	small	molecules	(312).	This	filtrate	 is	transported	down	the	lumen	of	proximal	and	distal	kidney	tubules	and	drained	by	collecting	ducts.			The	pronephros	is	the	first	kidney	to	form	during	embryogenesis	and	is	the	functional	kidney	of	larval	zebrafish	(311).	It	consists	of	two	nephros	with	glomeri	fused	at	the	midline	on	the	ventral	side	of	the	dorsal	aorta	(Figure	1.7).	The	tubular	epithelium	extending	from	the	glomeri	to	the	cloaca	is	subdivided	into	2	proximal:	proximal	convoluted	tubule,	PCT	and	proximal	straight	tubule,	PST;	And	2	distal	tubules:	distal	early,	DE	and	distal	late,	DL	(Figure	1.7).	Both	the	PCT	and	PST	express	receptors	that	indicate	a	role	in	the	absorption	of	salts,	sugars	and	protein	that	pass	the	glomeri	filters.	The	DE	and	DL	are	the	diluting	segments	which	help	retention	of	sodium	chloride	 and	 regulation	 osmotic	 balance.	 About	 2	 weeks	 post	 fertilisation	 (wpf),	 progenitor	 mesonephritic	nephrons	migrate	around	and	along	the	length	of	the	pronephros,	and	fuse	with	the	pronephros	forming	the	final	adult	kidney.	The	kidney	continually	generates	mesonephros	throughout	the	life	of	the	fish	(313).		
1.6.2.2 Hematopoietic	function	of	the	kidney	In	teleost	fish,	all	lineages	of	hematopoietic	differentiation	are	observed	in	the	kidney,	and	thus,	in	this	respect	at	least,	the	teleost	kidney	is	thought	to	be	the	primary	hematopoietic	niche,	equivalent	to	the	mammalian	BM	(314).	The	kidney	is	the	primary	site	of	hematopoiesis	and	termed	the	kidney	marrow	(48).	It	is	a	flat	organ	that	adheres	to	the	dorsal	body	wall	via	connective	tissues,	in	close	contact	with	the	osseous	spine	(315).	The	kidney	can	conceptually	be	segmented	into	the	head,	mid	and	tail.	The	head	kidney	has	the	fewest	renal	tubes,	is	the	most	vascularised	section	of	the	kidney	and	the	section	with	the	greatest	hematopoietic	activity	(314).	The	mid	and	tail	kidney	sections	are	less	vascularised	and	have	lower	hematopoietic	activity	(314).			Vascularisation	of	the	glomerulus	occurs	relatively	late,	at	36-40	hpf.	Time-lapse	imaging	shows	HSPCs	(cd41+	and	cmyb+)	migrate	from	the	dorsal	aorta,	along	pronephritic	tubules,	to	the	anterior	glomeruli	from	48-96	hpf	(32)	and	seed	 the	kidney.	When	migrating	cells	reach	 the	glomeruli,	CD41	expression	 is	down	regulated	and	differentiation	marker	CD45	is	upregulated,	suggesting	the	pronephros	signals	for	HSC	maturation	(32).	Blood	filtration	begins	around	48	hpf	and	is	well	established	by	4	dpf	(316).				
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Figure	1.7:	Structure	of	the	embryonic	zebrafish	kidney.	Dorsal	view	of	the	zebrafish.	Blood	flows	through	the	glomeri	(inset,	G)	
of	the	nephros	where	ions,	sugar,	and	proteins	are	reabsorbed	into	the	body.	The	waste	solute	is	transported	down	the	proximal	
convoluted	tubule	(PCT,	red),	into	the	proximal	straight	tubule	(PST,	blue),	then	through	the	distal	early	(DE,	orange)	and	distal	
late	(DL,	green)	structures	to	the	cloaca.	Hematopoietic	stem	cells	migrate	to	and	colonise	the	highly	vascularized	head	kidney.		Not	much	is	known	about	the	signalling	factors	that	retain	HSCs	in	the	kidney	marrow	and	many	of	the	factors	found	 to	 regulate	 HSCs	 in	 the	 mouse	 BM	 has	 not	 yet	 been	 investigated.	 For	 instance,	 zebrafish	 have	 an	angiopoietin	 orthologue	 (Ang2)	 which	 is	 expressed	 in	 the	 developing	 pronephric	 glomeruli	 (309)	 and	thrombopoietin	is	expressed	in	the	zebrafish	but	its	expression	pattern	and	function	in	the	kidney	marrow	has	not	yet	been	studied	(29,	84).		Zebrafish	have	2	copies	of	the	previously	mentioned	CXCL12	(see	1.6.1.4),	with	about	45	%	nucleotide	similarity	with	the	human	gene	(317).	Both	cxcl12a	and	cxcl12b	are	expressed	in	kidney	tubules,	gills,	and	the	skin	(307).	CXCL12a	 is	 the	 predominant	 form	 (317).	 As	 in	 mammals,	 it	 CXCL12a	 is	 a	 ligand	 for	 CXCR4,	 expressed	 by	hematopoietic	cells,	and	this	coupling	is	important	for	regulating	cell	migration/retention	in	the	BM.	Although	homing	in	in	vivo	transplant	experiments	was	not	affected	when	HSCs	were	pretreated	with	AMD3100	to	block	CXCR4,	transplanting	hematopoietic	cells	from	odysseus	mutants	(which	have	a	mutated	form	of	cxcr4b)	resulted	in	fewer	homed	cells	(307).	It	would	be	interesting	to	know	if	CXCR4	could	be	used	as	a	transgenic	marker	to	distinguish	thrombocytes	and	HSCs	in	the	CD41+	population.			
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CXCL12	is	also	a	ligand	for	the	receptor	CXCR7	(318).	This	alternative	receptor	is	expressed	on	the	surfaces	of	activated	endothelial	cells,	on	foetal	liver	cells	and	on	some	tumour	cell	lines	(318).	In	zebrafish,	this	receptor	was	shown	to	regulate	primordial	germ	cells	migration	as	knockdown	of	CXCR7	alters	the	CXCL12a	gradient	and	thus	migration	fails	(319).	This	receptor	has	not	yet	been	associated	with	hematopoietic	migration	but	further	research	is	required.		
1.7 Adult	HSC	response	to	inflammation	The	effect	of	inflammation	signals	on	HSCs	was	previously	addressed	in	relation	to	the	role	of	cytokines	(IFNg,	IFNj,	TNFa,	IL-1b,	G-CSF)	in	regulating	the	size	of	the	HSPC	population	during	EHT	and	embryonic	specification	of	HSCs	(see	1.5.4).	However,	there	is	some	indication	that	inflammatory	cytokines	can	also	profoundly	affect	the	normal	physiological	population	of	HSCs	in	the	adult.	Systemic	inflammatory	insults	such	as	cigarette	smoke	and	diet	have	a	 significant	 impact	on	 immunity	and	 the	 immune	system.	A	 retrospective	cohort	 study	 found	 that	current	smokers	spent	more	days	hospitalized	post	HSCT	and	had	overall	lower	survival	than	previous	smoker	and	non-smokers	 (320).	 In	 vitro,	 human	HSPCs	 exposed	 to	 cigarette	 smoke	 extract	 had	 increased	 intra-and-extracellular	expression	of	TLRs	2,3	and	4	and	produced	IL-8	and	TGFβ	(321).	Transplantation	assays	with	mice	found	 that	 recipients	 of	 BM	 cells	 from	 donor	mice	 exposed	 to	 smoke	 for	 14	 days	 prior	 to	 transplant	 were	normally	reconstituted.	However,	when	recipients	were	exposed	to	smoke	post-transplant	there	was	a	six	fold	decrease	in	CFU	ability	of	BM	cells	12	days	after	transplant	(322).	High	cholesterol	diets	have	been	associated	with	inflammatory	diseases	such	as	diabetes	and	cardio-vascular	disease.	Both	obese	mice	and	human	patients	have	been	found	to	have	an	increased	number	of	circulating	progenitors	(CD34+	or	LSK)	(323,	324)	and	a	pro-inflammatory	 (M1-like)	macrophage	profile.	Both	Singer	et	al.	 and	Feng	et	al.	 have	 reported	 that	 the	dietary	priming	 of	 mouse	 HSCs	 (LSK	 CD150+)	 caused	 a	 myeloid	 bias	 output	 which	 was	 maintained	 in	 transplant	recipients	(324,	325).	Together,	this	information	advocates	for	an	increased	examination	of	how	inflammation	is	affecting	HSCs.		
1.7.1 HSCs	respond	both	directly	and	indirectly	to	infection	Mature	 immune	 cells	 are	 responsible	 for	 resolving	 infection	 and	 injury.	Resident	 immune	 cells	 at	 the	 site	 of	infection	 or	 injury	 use	 pattern	 recognition	 receptors	 (PRRs)	 to	 recognise	 pathogen-associated	 molecular	patterns	 (PAMPs)	and	damage-associated	molecular	pattern	 (DAMPs)	 (326).	 Intracellular	signalling	cascades	within	 these	 immune	cells	 cause	 the	production	of	 type	 I	 IFNs,	pro-inflammatory	cytokines	and	chemokines.	Type	 I	 IFNs	 stimulate	 hundreds	 of	 genes	 in	 infected	 cells	 and	 induce	megakaryopoiesis	 and	 lymphopoiesis.	Together	IFNs	and	cytokines	cause	systemic	inflammation.	The	secretion	of	chemokines	recruits	immune	cells	to	the	site	of	infection.	After	the	wave	of	type	I	IFNs,	stimulated	T-	and	NK	cells	produce	type	II	IFNs.	These	seem	to	bias	progenitor	differentiation	towards	myeloid	production.	Monocytes	and	neutrophils	clear	dead	cells.	Once	the	stimulus	has	been	successfully	cleared,	the	inflammatory	response	is	then	resolved,	and	the	immune	system	returns	to	a	homeostatic	state.	Dysregulation	of	the	inflammatory	response	due	to	chronic	inflammation	has	been	linked	to	autoimmune	diseases	such	as	diabetes	(327)	and	atherosclerosis	(328).	
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Figure	1.8:	Direct	and	indirect	HSC	stimulation.	HSCs	respond	to	direct	and	indirect	stimulation.	Direct	mechanisms	include	
direct	 infection	and	direct	 recognition	of	 a	pathogen.	 Indirect	mechanisms	 include	 cytokine	 stimulation,	 reduction	 in	niche	
retention	factors	and	increase	in	mobilization	factors	or	responding	to	demand	for	mature	cells.		Stimulatory	effects	on	the	mouse	LSK	compartment	have	been	observed	in	viral,	bacterial	and	candida	models	of	infection	 (194,	 329-331).	 In	 addition,	 zebrafish	 hindbrain	 infection	 with	 Salmonella	 interica	 also	 caused	emergency	granulopoiesis	and	 increased	 the	HSPC	population	 (cmyb+	and	kdrl+	 runx1+	cells)	 (332).	There	 is	growing	evidence	that	HSCs	can	respond	to	infection	either	by	direct	or	indirect	mechanisms	(Figure	1.8).	Direct	mechanisms	include	direct	infection	and	direct	recognition	of	a	pathogen.	Indirectly,	HSCs	can	sense	pathogens	either	 by	 responding	 to	 cytokines,	 responding	 to	 niche	 signals	 or	 responding	 to	 demand	 for	 mature	 cells.	Disruption	 to	 HSC	 quiescence	 through	 immune	 activation	 could	 have	 long	 term	 consequences	 for	 the	hematopoietic	 system.	 Indeed,	 several	 studies	 indicate	 chronic	 inflammation	 can	 cause	 self-renewal	 and	functional	defects	in	the	HSC	population	(76,	194,	333,	334).			
1.7.1.1 Direct	stimulation	There	 is	 some	 evidence	 that	 immature	progenitors	 (CD34+)	 can	be	directly	 infected	 (Figure	1.8)	 (335,	 336),	although	it	 is	 likely	that	the	more	primitive	quiescent	LT-HSCs	are	protected	from	direct	 infection	(337).	The	consequence	of	a	direct	infection	is	that	intracellular	pathogens	can	severely	alter	cellular	pathways	which	may	lead	to	malignancies,	either	suppressing	hematopoiesis	or	causing	aberrant	hematopoiesis.			
Di
re
ct Intracellular	 infection
Detecting	PAMPs
Indirect
Detecting	cytokines
Demand	driven
Reduced	retention
Increased	mobilisation
MPP
Mature
Myeloid
Mature	
Lymphoid
ST-HSC
Introduction	
	56	
The	other	mechanism	by	which	HSCs	respond	directly	to	infection	is	through	the	recognition	of	PAMPs	by	PRRs	(Figure	1.8).	PRRs	include	TLRs	and	retinoic	acid-inducible	gene	1	(RIG-I)-like	helicases	(RLHs).	Both	human	and	mouse	HSCs	(CD34+	and	LSK	CD127-	respectively)	express	TLRs	and	the	intracellular	components	necessary	for	transmitting	 the	 signals	 (338-341).	 Different	 TLRs	 have	 distinct	 effects	 on	 HSPC	 differentiation	 (342).	 For	instance,	 TLR4	 and	 TLR9	 stimulated	HSPCs	 differentiated	 into	 dendritic	 cells,	while	 TLR3	 stimulated	HSPCs	increased	neutrophil	production	(343).		Of	note,	 it	has	been	shown	 that	HSCs	 (Lin-	CD34+	CD38low)	express	TLR3,	7	and	8	which	are	anchored	 in	 the	endosomal	 membrane	 meaning	 they	 detect	 PAMPs	 in	 the	 cytosol	 (340,	 344).	 It	 was	 shown	 that	 in	 vitro	stimulation	(TLR	1,	2,	7	and	8)	prompted	cell	cycle	entry	and	myeloid	differentiation	of	both	mouse	and	human	HSCs	(340,	342,	344).	Furthermore,	Megias	et	al.	transplanted	WT	progenitors	(LSK)	into	TLR	knock	out	mice	to	show	that	proliferative	response	to	TLR	agonists	in	vivo	was	due	to	direct	binding	with	progenitor	cells	(345).	It	should	 be	mentioned	 however,	 that	 HSCs	 probably	 proliferate	 and	 differentiate	 quickly	 upon	 arrival	 into	 a	transplant	recipient.	Therefore,	it	may	be	that	the	expansion	of	the	HSC	population	was	a	secondary	feedback	response	from	the	mature	hematopoietic	cells	to	TLR	agonists	rather	than	the	transplanted	progenitor	cells.	To	test	 this,	 the	 proliferation	 of	 WT	 progenitors	 in	 TLR	 knock	 out	 recipients	 should	 be	 compared	 with	 the	proliferation	of	TLR	knock	out	progenitors	(from	conditional	knock	out	mice	in	which	only	LSK	cells	lack	TLRs)	in	TLR	knock	out	recipients.	Moreover,	Takizawa	et	al.	used	prolonged	LPS	exposure	to	show	that	TLR4	activation	of	HSCs	reduces	HSC	fitness	in	transplantations(346).			The	expression	of	TLRs	has	not	yet	been	shown	on	zebrafish	HSPCs.	However,	a	knock	down	of	TLR4	and	MyD88	in	 embryos	 decreased	 HSC	 production	 in	 the	 larvae,	 as	 determined	 by	 runx	 and	 c-myb	 expression	 (198).	Furthermore,	LPS	 stimulation	of	 larval	 zebrafish	 causes	emergency	granulopoiesis	 (347)	mediated	by	G-CSF,	which	expanded	the	HSPC	compartment	(increased	runx	and	c-myb	expression)	(348).	Thus,	TLR	binding	does	affect	hematopoiesis	in	the	zebrafish.		
1.7.1.2 Indirect	stimulation	HSCs	also	respond	to	infection	and	inflammation	through	indirect	mechanisms	(Figure	1.8).	Both	immune	and	non-immune	cells	secrete	cytokines	and	chemokines	in	response	to	PRR	ligation.	For	instance,	LPS	binding	to	TLR4	on	peripheral	hematopoietic	cells	causes	signalling	to	the	nucleus	and	transcription	of	NfkB,	a	transcription	factor	which	regulates	the	production	and	release	of	numerous	pro-inflammatory	cytokines	(IFNg,	IL-6,	IL-1,	TNF)	(349-352).	Cytokines	such	as	 type	 I	and	 II	 IFNs,	TNF	and	some	 interleukins	(IL-1	and	IL-6)	appear	 to	 induce	proliferation	and	differentiation	of	HSCs	both	during	homeostasis	and	under	hematopoietic	stress	(194,	353-355).	HSPCs	(CD34+)	also	express	purigenic	receptors	and	signalling	components.	Inflammation	and	infection	can	alter	the	production	of	adenosine	triphosphate	ATP	and	uridine	triphosphate	UTP	which	bind	to	purigenic	receptors	and	influence	HSC	migration,	proliferation	and	differentiation	(264,	266,	356).		
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Human	HSCs	(CD34+)	express	a	number	of	TNF	receptors	(357).	In	general,	TNF	has	been	shown	to	restrict	HSCs	
in	 vivo	 in	mice	 (358).	 However,	 transplants	 of	 HSCs	 from	 TNF-receptor	 knock	 out	mice	 failed	 to	 engraft	 in	recipients,	suggesting	that	TNF	and	the	2	receptors	may	have	a	role	in	migration	and	homing	(359).		It	remains	to	be	determined	whether	HSCs	express	the	IL-1	receptor.	However,	there	is	evidence	that	the	HSPC	population	responds	to	both	acute	and	chronic	exposure	to	IL-1a	and	IL-1b	both	in	vitro	and	in	vivo	(107).	While	acute	exposure	triggers	myeloid	priming,	chronic	exposure	(0.5	µg	daily	for	70	days)	did	not	appear	to	affect	the	size	 of	 the	 HSC	 (LSK	 CD135-	 CD150+	 CD48-)	 population	 but	 severely	 reduced	 self-renewal	 capacity	 in	transplantation	assays	(107).		Type	I	IFNs	bind	to	IFN-α	receptor	(IFNAR).	Type	II	IFNs	bind	to	the	IFN-g	receptor	(IFNGR).	Both	are	expressed	by	hematopoietic	progenitors	(LSK)	(76,	355).	Indeed,	quantitative	Real-time	Polymerase	Chain	Reaction	(qRT-PCR)	has	found	that	HSCs	(LSK	CD135-	CD34-)	express	more	IFNGR	than	T-,	B-	cells	and	granulocytes	(355).		IFNa	has	been	shown	to	induce	proliferation	of	dormant	HSCs	in	mice	and	exhaustion	of	HSCs	after	4-5	round	of	serial	transplantation	(76).	Interestingly,	HSCs	(CD34-	LSK)	produce	the	highest	levels	of	IFN-2,	a	negative	regulator	of	type	 I	 interferon	 signalling,	 indicating	 that	preventing	 type	 I	 IFN	signalling	 is	 important	 for	maintaining	 this	population	(360).			Interferon	 gamma	 (IFNγ)	 is	 a	 Th1-type	pro-inflammatory	 cytokine	 that	 directs	 innate	 and	 adaptive	 immune	responses.	 Typically,	 IFNγ	 classically	 activates	macrophages	 (cytokine	production,	 phagocytosis,	 and	 antigen	presentation	to	T	cells)	and	drives	the	production	of	monocytes,	monopoiesis.	In	vitro	IFNγ	drives	monopoiesis	bias	by	inhibiting	G-CSF	and	thus	lessening	granulopoiesis.	IFNγ	can	also	impact	the	HSPC	population	by	altering	the	macrophage	population	(334,	361).	HSPC	proliferation	during	M.	avium	infection	is	IFNγ	dependent	(355).	McCabe	et	al.	also	found	that	HSPC	differentiation	was	increased	after	IFNγ	treatment,	which	did	not	occur	in	the	absence	of	macrophages	suggesting	a	role	for	these	cells	in	influencing	HSPC	differentiation	(257).	They	suggest	that	macrophages	produce	inflammatory	factors	in	the	niche	that	drive	differentiation.	Additionally,	it	has	been	suggested	that	the	egress	of	macrophages	recruited	from	the	BM	causes	HSC	proliferation	and	migration.		In	short	term	methycellulose	assays,	cytokines	SCF,	GM-CSF	and	IL-3	all	increased	the	adhesion	of	human	CD34+	cells	to	HA	in	a	CD44	dependent	manner.		This	is	an	important	indicator	that	cytokines	could	control	proliferation	and	differentiation	of	hematopoietic	progenitors,	particularly	in	relation	to	cell	engraftment	(291).		
1.7.2 HSC	response	to	irradiation	The	biological	effects	of	radiation	are	complex	and	affect	both	cells	directly	exposed	to	the	radiation,	as	well	as	cells	not	directly	exposed	to	radiation	(also	called	“non-targeted	effects”	or	“bystander	effect”)	(362).	 In	cells	directly	exposed	to	the	radiation,	the	gamma	rays	energise	the	atoms	of	the	cell	directly	causing	cellular	damage,	and	 they	produce	ROS	which	 indirectly	 cause	damage	 to	non-irradiated	 tissue,	 inducing	a	 systemic	 response	(Figure	1.9).	Although	there	is	a	lot	of	evidence	of	damage	in	non-targeted	cells,	the	mechanism	of	transmission	
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are	 complex	 and	 controversial	 (362).	 It	 is	 likely	 that	multi-factorial	 pathways	 are	 involved	 and	 effects	may	depend	on	the	dose	and	quality	of	exposure.		
		
Figure	1.9:	Ionising	radiation	causes	systemic	inflammation	and	cell	death	by	multiple	mechanisms.	Schematic	adapted	from	
Kim	et	al.	2014.	Arrows	represent	influence	of	one	mechanism	on	another.	Targeted	cells	have	significant	genomic	damage	and	
produce	excessive	reactive	oxygen	species.	Together	these	cause	cell	death	and	apoptosis.	Reactive	oxygen	species	also	induce	
pro-inflammatory	 cytokines	 and	 recruit	 immune	 cells.	 Together	 these	 have	 an	 effect	 on	 non-targeted	 cells,	 resulting	 in	
prolonged	systemic	inflammation.		Ionising	radiation	(IR)	causes	the	most	significant	damage	to	DNA,	causing	single	and	double	strand	breaks	in	enough	places	as	to	make	the	repairs	of	the	breaks	impossible.	The	quantity	of	breaks	(which	induces	apoptosis),	as	well	as	the	high	probability	of	mis-repair	(which	result	in	mutations),	makes	this	damage	the	most	important	for	cell	death	(363).	There	is	evidence	of	genomic	instability	in	both	radiation	targeted	and	non-targeted	cells	(364,	365).	The	damage	done	to	DNA	is	most	significant	during	mitosis,	making	rapidly	dividing	cells	the	most	susceptible	to	radiation	(363).		ROS	are	produced	in	excess	following	radiation	and	cause	DNA	damage	as	well	as	the	oxidation	of	proteins	and	lipids	(366).	ROS	have	paradoxical	roles	in	the	cell.	They	are	produced	by	mitochondria	through	the	cytochrome	C	pathway	and	regulate	genes	that	control	various	process	of	the	cell	(such	as	NFkB	or	hypoxia-inducible	factor	1	 alpha	HIF-1a)	 as	well	 as	 tumour	 suppressors	 (p53	 and	 Phosphatase	 and	 tensin	 homolog,	PTEN).	 ROS	 are	derived	 through	 Nicotinamide-adenine	 dinucleotide	 phosphate	 (NADPH)-oxidase	 at	 the	 cellular	 membrane.	They	are	also	generated	by	the	radio-lysis	of	water	in	the	cell	or	produced	by	leukocytes.				Another	 indirect	 cause	 of	 tissue	 damage	 and	 cell	 death	 is	 the	 induction	 of	 inflammation	 through	 leukocyte	production	of	pro-inflammatory	cytokines	and	other	chemokines	(including	 IL-1,	 IL-6,	TNFa	 and	TGFb	 (367-
Targeted	cell/tissue Non-targeted	cell/tissue
Genomic	instability Reactive	oxygen	species
Oxidative	damage
Pro-inflammatory	cytokines/chemokines
Innate	immune	response
Cell	death/apoptosis
Radiation
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369))	both	immediately,	and	again	later,	post	irradiation	(366,	370).	In	addition	to	their	pro-inflammatory	effects,	both	TNFα	and	IL-1	also	stimulate	the	secretion	of	MPPs.	TNFα	inhibitors	have	been	used	to	mitigate	radiation	induced	skin	injury	in	mice	(371).	TGFβ	is	considered	to	play	a	central	role	in	mediating	radiation-induced	tissue	fibrosis	(372,	373).		Injured	and	dying	 cells	 are	known	 to	 release	pro-inflammatory	DAMPs	 that	 can	also	 stimulate	 inflammatory	response.	These	molecular	signals	can	affect	non-irradiated	cells,	similar	to	a	sterile	inflammatory	response	such	as	wound	healing	(374).	For	instance,	the	clearance	of	radiation	induced	apoptotic	cells	induces	the	activation	of	macrophages	and	infiltration	by	neutrophils,	contributing	to	an	inflammatory	cytokine	storm	(374,	375).	Jaal	et	
al.	 have	 shown	 increased	 activity	 of	macrophages	 (CD105+)	 in	 irradiated	 skin	 tissue	 beginning	 shortly	 after	irradiation	and	persisting	for	several	weeks	(376).	This	is	supported	by	Jenrow	et	al.	who	have	shown	increased	macrophage	activity	in	the	irradiated	skin	beginning	3	days	after	a	single	dose	of	30	Gy	in	mice	and	persisting	for	more	 than	 2	months	 thereafter	 even	 after	 the	 clearance	 of	 apoptotic	 bodies	 (377).	 In	 addition,	macrophage	recruitment	from	the	BM	is	a	factor	that	increases	HSC	migration	and	reduced	homing	and	engraftment.	Thus,	it	has	 been	 suggested	 that	 blocking	 phagocytic	 cell	 infiltration	 could	 mitigate	 irradiation	 injury	 and	 reduce	systemic	inflammation.			Typically,	the	endosteal	region	supports	HSC	quiescence.	However,	when	recipients	were	irradiated	before	being	transplanted	 with	WT	 HSPCs,	 both	 Lo	 Celso	 et	 al.	 and	 Xie	 et	 al.	 saw	 proliferating	 HSPCs	 located	 nearer	 to	endosteal	 regions.	 	 These	 results	 indicate	 that	 radiation	 damage	 of	 the	 microenvironment	 played	 a	 role	 in	stimulating	proliferation	(121,	211).	This	may	be	because	damage	increased	vascular	signalling	and	attenuated	inhibitory	 signalling	 from	 the	 endosteal	 compartment.	 It	 may	 also	 be	 that	 irradiation	 damage	 drove	 cell	autonomous	 factors	 which	 can	 influence	 hematopoietic	 cell	 localisation.	 Indeed,	 Henninger	 et	 al.	 recently	published	that	the	clonal	diversity	of	HSCs	is	significantly	reduced	by	radiation	(55).	They	used	the	Zebrabrow	system	to	induce	a	unique	heritable	colour	to	each	nascent	cd41:GFP+	cell	prior	to	transplantation	into	irradiated	recipients.	 They	 found	 that	 clonal	 diversity	was	 greater	 in	 the	 donor	 (at	 the	 time	 of	 transplant)	 than	 in	 the	recipients	2.5-3	months	post-transplant.	This	indicates	clonal	selection	occurs	in	the	irradiated	environment.		
1.8 Outstanding	questions	and	the	aims	of	this	thesis	HSCs	are	a	small	but	significant	population	of	cells	fundamental	for	hematopoiesis	and	the	immune	system.	There	are	many	outstanding	questions	that	remain	to	be	answered	in	order	to	improve	cell	therapies	for	cancer	and	autoimmune	patients	as	well	as	to	better	understand	the	immune	response	to	inflammation	and	infection.			Firstly,	the	definition	of	a	HSC	is	straight	forward,	but	identifying	and	selecting	these	cells	from	a	heterogeneous	mix	 of	 cells	 is	 difficult.	 How	 do	 cells	within	 the	 sorted	HSC	 (LSK	 CD150+	 CD48-)	 population	 differ?	 Can	 this	population	be	split	 into	further	subsets	and	how	important	are	the	differences	between	these	subsets?	In	the	zebrafish,	 the	 progenitor	 population	 is	 distinguished	 by	 runx1,	 c-myb	 and	 cd41	 expression.	 How	 does	 this	population	compare	with	mammalian	HSPCs?	Does	the	zebrafish	HSPC	population	contain	cells	with	distinct	cell	
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cycle	kinetics?	Does	a	quiescent	population	exist	and	are	these	cells	the	long-term	repopulating	cells	of	the	most	pluripotent	population?	A	primary	objective	of	this	thesis	was	to	determine	if	this	population	exists	using	a	label	retaining	assay.	The	hypothesis	is	that	the	cd41:GFP+	population	can	be	split	into	label	retaining	cells	with	HSC	qualities	and	non-label	retaining	cells	which	are	HSPCs.		Secondly,	there	are	questions	about	how	the	location	of	a	HSC	is	influenced	(the	osteoblast	versus	vasculature	debate),	and	how	the	location	of	HSCs	can	influence	the	environment.	Examining	this	in	homeostatic	conditions	has	 been	 difficult	 because	 HSCs	 are	 extremely	 rare,	 and	 so	 far,	 observations	 have	 been	 contradictory.	 If	osteoblastic	and	vascular	surfaces	serve	different	support	functions,	this	could	explain	why	studies	have	not	been	able	 to	 pin	 down	 a	 specific	 cellular	 niche.	 This	 thesis	will	 use	 observation	 of	 post-transplant	migration	 and	engraftment	 of	 HSCs	 to	 answer	 some	 questions	 such	 as:	Where	 do	 transplanted	 HSCs	migrate	 to	 following	transplantation	 and	 is	 it	 important	 for	 HSCs	 to	 lodge	 into	 the	 niche	 (s)	 within	 a	 particular	 time	 frame	 for	successful	engraftment?	Does	subsequent	expansion	(proliferation	of	HSPCs	and	differentiation	along	myeloid	and	lymphoid	lineages)	depend	on	HSC	biology	prior	to	transplant?	Do	transplanted	cells	prioritise	self-renewal	or	hematopoiesis?	Does	the	recipient	environment	affect	expansion	of	transplanted	HSCs?	Do	HSCs	differentiate	in	the	primary	niche	or	at	secondary	sites	of	hematopoiesis	such	as	the	thymus	or	spleen?	The	second	objective	of	this	thesis	was	to	determine	early	post-transplant	behaviour	of	transplanted	cells	using	live	optical	imaging	of	transgenic	 labelled	donor	HSPCs	 in	optically	 transparent	 recipients.	 In	 addition,	 could	a	method	 such	as	 live	optical	imaging	be	a	good	predictor	of	engraftment	and	successful	transplant,	thus	replacing	survival	as	a	readout	(a	severe	protocol	under	UK	Home	Office	Regulation)	and	significantly	reduce	animal	suffering?	The	hypothesis	is	that	if	HSCs	locate	to	the	WKM	niche	soon	after	transplant	will	increase	hematopoietic	recovery.	Furthermore,	prioritising	hematopoietic	differentiation	over	self-renewal	is	a	sign	of	hematopoietic	stress,	while	prioritising	self-renewal	over	differentiation	is	a	sign	of	hematopoietic	recovery.	Therefore,	HCT	failure	can	be	determined	before	recipient	death.		Finally,	there	are	many	questions	about	how	HSCs	are	affected	by	hematopoietic	stressors	(e.g.	by	infection	or	under	inflammatory	conditions).	The	current	understanding	is	that,	while	HSC	stimulation	for	hematopoiesis	is	considered	beneficial	during	acute	insults,	prolonged	and	chronic	activation	can	result	in	hematopoietic	failure	(in	the	mouse).	It	is	not	known	whether	this	is	true	of	zebrafish	hematopoiesis	but	my	hypothesis	is	that	despite	being	highly	regenerative,	a	similar	failure	in	hematopoiesis	will	be	observed.	The	final	aim	of	this	thesis	is	to	determine	if	repeated	stimulation	can	affect	the	ability	of	HSCs	to	reconstitute	depleted	recipient	WKM.	Recent	research	with	the	Zebrabrow	system	indicates	the	hematopoietic	output	(myeloid	/lymphoid	ratio)	of	cd41+	cells	is	conserved	from	donor	marrow	to	transplant	recipient	marrow	(55).	Thus,	transplant	of	cd41:GFP+	cells	can	be	used	to	determine	if	HSC	stimulation	in	the	donor/recipient	prior	to	transplant	affects	hematopoietic	output	in	transplant	recipients.			
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The	hypothesis	is	that	transplanted	cd41:GFP+	HSCs	will	behave	differently	in	the	WKM,	depending	on	whether	they	were	stimulated	prior	to	transplant	or	transplanted	into	an	inflamed	environment.		In	summary,	the	aims	of	this	thesis	were	to:		 1. Refine	the	zebrafish	HCT	protocol	in	order	to	observe	transplanted	cell	behaviour	in	vivo.	2. Create	an	early	post-transplant	read-out	that	would	predict	HCT	failure	with	the	aim	of	reducing	animal	suffering	with	this	protocol.	3. Examine	 whether	 repeated	 stimulation	 by	 hematopoietic	 stress	 /administration	 of	 inflammatory-inducers	 of	 donor	 hematopoiesis	 affects	 the	 post-transplant	 behaviour	 of	 transplanted	 HSPCs	 in	 the	zebrafish	4. Examine	 whether	 a	 stimulated	 recipient	 environment	 affects	 the	 post-transplant	 behaviour	 of	transplanted	HSPCs	in	the	zebrafish.			 	
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2 Materials	and	Methods		
2.1 Zebrafish	maintenance	Zebrafish	were	bred	and	maintained	according	to	best	practice	and	procedures	conformed	to	UK	Home	Office	Regulation	(ASPA	1986).		Details	of	the	transgenic	fish	lines	outline	in	Table	2.1.		
	
Table	2.1:	Comprehensive	list	of	the	transgenic	fish	lines	and	their	uses	for	the	work	throughout	this	thesis.		Embryos	were	initially	reared	in	50	μL	of	methylene	blue	(3	x10-5%)	(M9140;	Sigma-Aldrich).	At	5	dpf,	larvae	were	transferred	to	3	L	tanks	containing	embryo	growing	medium	(E2;	15	mM	sodium	chloride	(S7653;	Sigma-Aldrich),	0.5	mM	potassium	chloride	(P9333	Sigma-Aldrich),	1	mM	magnesium	sulfate	(M7506,	Sigma-Aldrich),	150	 μM	 potassium	 phosphate	monobasic	 (P5655;	 Sigma-Aldrich),	 50	 μM	 sodium	 phosphate	 dibasic	 (S7907;	Sigma-Aldrich),	 1	mM	 calcium	 chloride	 (C5670;	 Sigma-Aldrich),	 0.7	mM	 sodium	bicarbonate	 (S6297;	 Sigma-Aldrich)	and	10	U/mL	penicillin	streptomycin	(15070-063;	Life	Technologies).	At	12	dpf,	 larvae	were	moved	onto	the	aquarium	system,	supplied	by	a	combination	of	dechlorinated	tap	water	and	reverse	osmosis	water	at	a	ratio	of	1:5.	Room	conditions	were	kept	at	28.5	°C	with	a	cycle	of	14	h	light	and	10	h	dark.	Fish	were	fed	twice	daily	a	combination	of	brine	shrimp	Artemia,	 larval	dry	food	(ZM;	Sytem)	and	adult	dry	food	(Hikari	Tropical	Micro	pellets;	Hikari).			
Mutant/Transgenic Advantage
Tra-Nac- Non-pigmented fish	that	are	optically	translucent.	Ideal	recipients	
as	they	allow	single	cells	to	be	imaged	in	the	live	organism.
Tg(ubi:GFP) All	cells	are	express green	fluorescent	protein.	Used	as a	marker	of	
donor	derived	cells	in	recipient	TraNac.
Tg(cd41:GFP) Marks	HSPCs	(GFPlow) and	thrombocytes	 (GFPhigh).	Used	as	a	marker	
for	sorting	HSPCs	for	transplant	and	used	as	a	marker	of	donor	
derived	cells	in	recipients	post-transplant.
Tg(runx1+23:GFP) Marks	HSPCs. Used	as	a	marker	for	sorting	HSCs	for	transplant	and	
used	as	a	marker	of	donor	derived	cells	in	recipients	post-
transplant.
Tg(lyz:dsRed) Myeloid	cells	express	dsRed. Used	as	a	marker	of	donor	derived	
cells	in	recipients	TraNac.
cmybt12725 Immuno-deficient	fish.	Ideal	recipients	as	they	do	not	require	
harmful	pre-conditioning	prior	 to	transplant.
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2.2 Genotyping	fish	lines	
2.2.1 Obtaining	genomic	DNA	from	tail	clip	tissue		Tail	clips	were	obtained	from	anaethetised	fish	(founders	were	screened	as	adults	>1	mpf;	homozygous	mutant	recipients	were	confirmed	with	a	tail	clip	after	death)	and	DNA	extracted	from	cells	using	“TaqMan	sample	to	SNP”	kit	(Applied	Biosystems).	Genomic	DNA	was	obtained	according	to	manufacturer’s	instructions,	with	the	following	adaptation:	tissue	was	added	to	10	μL	of	lysis	buffer	and	boiled	at	95	°C	for	10	min.	Samples	were	then	cooled	to	room	temperature	and	10	μL	of	DNA	stabiliser	agent	was	added.		
2.2.2 Identification	of	c-mybt25127	mutants	A	mixture	of	fertilised	eggs	from	c-myb	heterozygote	mutants	was	obtained	from	I.	Hess	(46).	Fish	were	raised	and	heterozygote	founders	were	selected	by	PCR.	PCR	reactions	were	set	up	using	1	μL	of	gDNA	(as	described	in	2.2.1)	 with	 10	 μL	 2X	 Taq	 PCR	 master	 mix	 (Qiagen),	 1	 μL	 of	 each	 primer	 (10mM;	 Fwd	(TTTGGAAGAACTTGAGGGTGA)	and	Rev	(GTTCAGGTGCCATTTCCACT))	and	7	μL	of	PCR	grade	water.	Samples	were	run	in	a	thermal	cycler	(Applied	Biosystems)	program:	94	°C	for	4	min,	40	repeats	of	(94	°C	for	30	s,	54	°C	for	30	s,	72	°C	for	1	min),	finally	72	°C	for	5	min.	The	PCR	product	was	purified	from	the	PCR	reaction	with	the	QIAquick	 (Qiagen)	 PCR	 clean-up	 kit	 according	 to	manufacturer’s	 instructions.	 Samples	were	 eluted	 in	 30	 μL	elution	buffer.		The	 t25127	 mutation	 was	 detected	 by	 digesting	 the	 PCR	 product	 with	 restriction	 enzyme	 Hpy188iii	 (New	England	Biolabs).	Purified	samples	(30	μL)	were	incubated	2	h	with	4	μL	of	10X	buffer	and	0.5	μL	of	Hpy188iii	enzyme	in	a	37	°C	water	bath.	Finally,	samples	were	mixed	with	4	μL	orange	loading	dye	(New	England	Biolabs)	and	loaded	into	a	2.5%	agarose	gel	with	ethidium	bromide	(1:1000)	and	run	at	50	V	for	30	min.	This	method	could	distinguish	homozygote	mutants	(2	bands;	260	bp,	184	bp)	from	heterozygotes	(4	bands;	260	bp,	184	bp,	146	bp,	114	bp)	and	homozygous	WT	(3	bands;	184	bp,	146	bp,	114	bp).	For	diagram	see	Figure	3.11.		
2.2.3 Identification	of	transgenic	runx1+23	fish	Fertilised	eggs	from	Tg	(runx1+23:GFP)	and	Tg	(runx1+23:NLSmCherry)	fish	were	obtained	from	O.	Tamplin	and	L.	Zon	(42).	Fish	were	raised	and	founders	were	selected	by	PCR.	This	method	was	also	used	to	identify	runx+	fish	from	crosses	with	Tg	(lyz:GFP),	Tg	(lyz:dsRed)	and	Tg	(ubi:GFP).	PCR	reactions	were	set	up	using	1	μL	of	gDNA	 (as	 described	 above)	with	 10	 μL	 2X	 Taq	 PCR	master	mix	 (Qiagen),	 1	 μL	 of	 each	 primer	 (10mM;	 Fwd	(ACTGATAACGTGGGCAGCTT))	 and	 Rev	 (GCTCTGCACTGCACTAAGGA)	 and	 7	 μL	 of	 PCR	 grade	water.	 Samples	were	run	in	a	thermal	cycler	(Applied	Biosystems)	program:	94	°C	for	5	min,	35	repeats	of	(94	°C	for	30	s,	60	°C	for	1	min,	72	°C	for	30	s),	finally	72	°C	for	7	min.		
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As	the	primers	are	specific	for	the	enhancer	sequence	derived	from	the	mouse	genome,	only	Tg	(runx1+23:GFP)	and	Tg	(runx1+23:NLSmCherry)	fish	would	produce	a	band.	PCR	reactions	(20	μL)	were	mixed	with	4	μL	orange	loading	dye	(New	England	Biolabs)	and	loaded	into	a	1%	agarose	gel	with	ethidium	bromide	(1:1000)	and	run	at	50	V	for	30	min.	This	method	did	not	distinguish	homozygotes	from	heterozygotes.		
2.3 BrdU	labelling	
2.3.1 Labelling	BrdU	 labelling	 requires	 a	 “pulse”	 period	 of	 exposure	 and	 a	 “chase”	 period	without	 exposure.	 The	 pulse	was	achieved	either	by	intra-peritoneal	injections	or	by	dissolving	BrdU	in	system	water	to	make	a	solution	to	swim	fish	in.	Fish	received	8	intra-peritoneal	injections	of	5	μL	every	12	h	(BrdU;	BD	Bioscience;	10	mM	solution	in	Phosphate	Buffered	Saline,	PBS).	Alternatively,	BrdU	(Sigma	Aldrich)	was	dissolved	in	system	water	or	embryo	growing	medium	(E2)	to	make	100	mL	volume	of	0.5	mM,	1	mM,	5	mM,	10	mM,	20	mM	and	40	mM	to	swim	fish	in.		
2.3.2 Staining	and	flow	cytometry	After	the	appropriate	chase	period,	fish	were	humanely	killed	by	anaesthetic	overdose	in	4	mg/mL	tricaine	(4	mg/mL;	MS222;	E10521;	Sigma	Aldrich)	and	brain	concussion	(secondary	confirmation).	The	larvae	body	was	dissociated	in	PBS	containing	0.25%	trypsin	and	5	mg/mL	collagenase	P	(Roche)	at	37	°C	for	30	min.	Adults	were	dissected	to	analyse	the	WKM.	BrdU	was	detected	in	WKM	cells	using	the	BD	Biosciences	APC	BrdU	Flow	kit.	In	brief,	 cells	 were	 fixed	 in	 Cytofix/Cytoperm	 for	 25	 min	 on	 ice.	 Samples	 were	 washed	 with	 1X	Permeablilisation/Wash	buffer	and	permeabilised	in	Permeablilisation	Buffer	Plus	for	10	min	on	ice.	Cells	were	washed	and	fixed	again	for	5	min	at	room	temperature.	Cells	were	washed	again	and	incubated	in	30	μg	DNase	(Invitrogen)	 at	 37	 °C	 for	 1	 h.	 Samples	 were	 washed	 and	 incubated	 with	 5%	 goat	 serum	 in	 1X	Permeablilisation/Wash	buffer	for	20	min,	washed	with	1X	Permeablilisation/Wash	buffer	and	finally	incubated	with	 anti-BrdUantibody	 mouse	 monoclonal	 antibody	 (clone	 MoBU-1)	 Alexa	 Fluorophore	 647	 (1:50;	 Life	technologies)	and	anti-GFP	antibody	conjugated	with	Alexa	Fluorophore	555	(1:400;	Life	technologies).	Stained	cell	samples	were	examined	on	a	BD	Biosciences	LSR	Fortessa	cell	analyser.	Profiles	were	analysed	using	FlowJo	v10.0.7.		
2.4 Flow	cytometry	analysis	of	WKM	populations	Flow	cytometry	analysis	was	done	on	single	cell	suspensions	with	BD	LSR	Fortessa	(BD	Biosciences).	A	minimum	of	 100	 000	 cells	 were	 acquired	 for	WKM	 analysis.	 Data	was	 analysed	with	 FlowJo	 software	 (Treestar).	 Cell	viability	 was	 assessed	 by	 resuspending	 cells	 in	 PBS	 –X	 with	 1	 μg/mL	 4’,6-diamidino-2-phenylindole	dihydrochloride	(DAPI;D9542;	Sigma)	2	min	before	flow	cytometry	analysis.		
Materials	and	Methods	
	 65	
2.5 Transplants	
2.5.1 Irradiation		TraNac,	WT,	Tg	(runx1+23:GFP),	Tg	(runx1+23:NLSmCherry)	and	Tg	(cd41:GFP)	fish	were	pre-conditioned	with	
g-radiation	with	a	137	Cesium	source	irradiator.	Fish	were	contained	in	30	mL	system	water	and	placed	atop	a	7.7cm	spacer	to	place	them	centrally	in	the	container	and	achieve	a	consistent	dose	rate	of	3.65	Gy/min.	Fish	received	two	doses	of	15	Gy	(48	h	and	24	h	before	transplant)	or	a	single	dose	of	30	Gy	(24	h	before	transplant).			
2.5.2 Poly	I:C	treated	recipients	Poly	I:C	treated	recipients	were	anaesthetised	with	0.17	mg/mL	tricaine	(MS222;	E10521;	Sigma	Aldrich)	and	received	 2	 intra-peritoneal	 injections	with	 a	Hamilton	 syringe	 (30	 Gauge)	 of	 1	 μL	 containing	 10	 μg	 poly	 I:C	(P1530;	Sigma	Aldrich)	6	and	4	days	prior	 to	 transplant.	Control	recipients	were	not	 injected.	Both	recipient	groups	were	irradiated	48	h	and	24	h	prior	to	transplant.		
2.5.3 Harvesting	donors	Donors	were	selected	for	their	particular	requirements	(Table	2.1),	and	in	some	cases	donors	were	treated	prior	to	transplant	(described	below).	The	whole	kidney	marrow	was	dissected	from	donors	as	described	by	Gerlach	
et	al.	(315).	In	brief,	fish	were	killed	by	schedule	1	methods;	anesthetic	overdose	in	4	mg/mL	tricaine	(MS222;	Sigma	 Aldrich)	 and	 brain	 concussion	 (secondary	 confirmation).	 The	 thorax	 was	 opened	 ventrally	 using	dissection	scissors	and	the	cavaity	organs	removed.	The	kidney	was	removed	from	the	dorsal	wall	using	fine	forceps	 and	 transferred	 to	 a	 40	 μm	 nylon	 filter	 (Falcon).	 A	 single	 cell	 suspension	was	 obtained	 by	 filtering	through	with	ice	cold	PBS-X	(0.9X	PBS	(Sigma-Aldrich),	2%	fetal	calf	serum	(Gibco)).	Usually	4	donor	cell	samples	were	pooled.		
2.5.4 Sorting	donor	WKM	cells	The	 single	 cell	 suspension	was	 sorted,	 at	 2,000	events/s,	 using	 a	BD	FACSAria	 III	 operated	by	C.	 Simpson,	 J.	Srivatava	or	J.	Rowley	(ICL,	London)	to	obtain	the	population	of	interest.	WKM	cells	were	gated	to	exclude	debris	(using	forward	and	side	scatter,	both	use	488	nm	laser,	480/10	filter).	Cells	were	then	split	by	GFP	(488	nm	laser,	490/20	filter)	and	dsRed	(561	nm	laser,	610/20	filter)	or	mCherry	(561	nm	laser,	480/10	filter)	fluorescence	and	gates	set	to	sort.	Cells	were	sorted	into	PBS-X	at	4	°C.			Carrier	 cells	were	 obtained	 from	WT	 fish.	 Fish	were	 killed	 by	 anaesthetic	 overdose	 in	 0.17	mg/mL	 tricaine	(MS222;	Sigma	Aldrich).	The	heart	was	punctured	with	a	10	μL	pipette	tip	containing	PBS-X	with	heparin	(0.9X	phosphate	buffered	 saline	 (Sigma-Aldrich),	 2%	 fetal	 calf	 serum	 (Gibco),	 1000	U/mL	heparin	 (H3393,	 Sigma-Aldrich)).	The	PBS-X	with	heparin	was	dispensed	into	the	cavity	and	then	the	peripheral	blood	aspirated	from	the	heart	region	while	massaging	the	fish.	The	concentration	of	donor	cells	(sorted	and	carrier)	was	determined	using	a	haemocytometer	(x104	cells/mL).		
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2.5.5 Poly	I:C	donors	Tg	(cd41:GFP;lyz:dsRed)	donors	were	anaesthetised	with	0.17	mg/mL	tricaine	(MS222;	E10521;	Sigma	Aldrich)	and	received	8	intra-peritoneal	injections	of	5	μL	at	48	h	intervals	using	a	Hamilton	syringe	(30	Gauge).	Controls	were	injected	with	0.9%	saline	(9	g	NaCl/L,	Sigma-Aldrich)	and	poly	I:C	donors	were	injected	with	10	μg	poly	I:C	(P1530,	Sigma-Aldrich).				
2.5.6 Retro-orbital	hematopoietic	cell	transplantation		Transplants	were	carried	out	by	retro-orbital	(RO)	injection	as	described	by	Pugach	(49).	In	brief,	the	recipient	is	anaesthetised	with	0.17	mg/mL	tricaine	(MS222;	E10521;	Sigma	Aldrich)	and	placed	laterally	on	a	sponge.	The	needle	is	inserted	at	a	45	angle	between	the	eye	ball	and	socket	and	situated	near	the	heart.	Initially,	adult	fish	were	 transplanted	 with	 4-6	 μL	 of	 Tg	 (ubi:GFP)	 WKM	 suspension	 mixed	 with	 20	 μg	 dextran	 conjugated	 to	tetramethylrhodamine	 (TRITC;	 120kDa),	 using	 a	Hamilton	 syringe	 (30	Gauge,	 5	 μL).	 Subsequent	 transplants	were	carried	out	with	specific	quantities	of	cells	using	an	IM	300	micro-injector	(Narishige,	Japan).	Micro-injector	needles	were	pulled	from	glass	capillaries	and	cut	to	size	to	obtain	an	injection	volume	of	1	to	1.2	μL.		
2.5.7 Survival	Transplants	recipients	were	recovered	from	the	transplant	procedure	in	system	water.	Fish	were	separated	into	individual	tanks,	in	system	water	but	off	the	system,	once	imaging	and	tracking	began	at	4	days	post-transplant	(dpt).	The	water	was	changed	every	2	days	and	individual	fish	were	monitored	for	adverse	signs	until	they	were	harvested	at	28	dpt.	In	order	to	reduce	suffering,	fish	showing	adverse	effects	(lack	of	colour,	oedema,	gasping	for	air)	were	monitored	more	 frequently	and	humanely	killed	with	anaesthetic	overdose	 (4	mg/mL	 tricaine;	MS222;	E10521;	Sigma	Aldrich)	if	the	symptoms	persisted	>	2	h.		Data	from	these	fish	was	stored	and	included	in	the	analysis.		
2.6 Histology	Fish	were	killed	by	overdose	of	tricaine	(4	mg/mL;	E10521;	Sigma-Aldrich)	and	fixed	in	4	%	paraformaldehyde	(PFA;	18814;	Polysciences	Inc)	at	4	°C	overnight.	Fish	were	positioned	in	a	3	%	agar	mount	and	transferred	to	70	 %	 ethanol.	 Samples	 were	 processed	 through	 increasing	 gradients	 of	 ethanol	 and	 paraffin	 and	 finally	embedded	in	paraffin	blocks.	Sections	(4	μm)	were	cut	with	a	Leica	rotary	microtome	RM2235,	mounted	on	slides,	deparraffinised	 in	xylol	and	stained	with	H&E	on	a	Leica	ST5020-CV5030	workstation	by	Lorraine	Lawrence	(Department	of	Medicine,	ICL,	London).		
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2.7 Cytospin	Live	or	fixed	cells	(with	4	%	PFA;	18814;	Polysciences	Inc)	were	sorted	with	a	Fortessa	Aria	and	cytospun	onto	glass	slides	at	300	rpm	for	3	min.	Cells	were	stained	with	Wright	Giemsa.		
2.8 Imaging	
In	vivo	 imaging	of	the	recipients	was	done	using	a	wide	field	Zeiss	Axiovert	200	inverted	microscope.	Optical	depth	was	 not	 calculated;	 only	 “in	 focus”	 fluorescent	 cells	were	 counted.	 Fish	were	 anaesthesised	with	 0.17	mg/mL	 tricaine	 (E10521;	 Sigma-Aldrich)	 and	placed	on	 a	 4	 cm	petri	 dish.	Data	was	 collected	using	 the	20X	objective	(LD	Plan-Neofluar	20x	0.40	KORR).	Fluorescence	was	observed	using	a	filtered	halogen	lamp	(Zeiss	HAL	 100)	 and	 Zeiss	 filter	 cubes:	 GFP	 (excitation	 470/40,	 emission	 525/50)	 and	 dsRed	 (excitation	 562/40,	emission	624/40).	Pictures	were	taken	by	Hamamatsu	ORCA-ER	camera	using	Velocity	software	and	processed	with	FIJI.			
2.9 Gene	expression	by	qRT-PCR	
2.9.1 mRNA	extraction	Gene	expression	was	measured	in	the	whole	organism	or	in	dissected	organs	such	as	the	gill,	spleen	and	WKM.	Samples	were	 collected	 and	mRNA	was	 extracted	 using	 the	RNeasy	mini	 kit	 (Qiagen)	 as	 per	manufacturer’s	instructions.	In	brief,	the	sample	was	homogenised	in	RLT	buffer	with	a	Pestle-Motar	Mixer	(Argos	Technologies)	and	 frozen	overnight.	 Samples	were	 thawed	and	 spun	down	 to	 remove	non-macerated	 tissue.	 Samples	were	mixed	with	an	equal	volume	of	ethanol	and	then	spun	through	a	silica	membrane.	The	membrane	was	washed	with	RW1	and	RPE	solutions.	The	filter	was	then	spun	to	dry	and	the	mRNA	eluted	with	30	uL	of	elution	buffer.	Concentration	was	measured	by	spectrophotometry	(Thermo	Scientific	Nanodrop	1000).		
2.9.2 cDNA	synthesis		mRNA	was	converted	to	cDNA	using	High	Capacity	cDNA	Reverse	Transcription	kit	(ThermoScientific)	according	to	manufacturer’s	 instructions.	In	brief,	125		ng	mRNA	was	mixed	with	dNTPs,	random	primers,	and	TaqMan	master	mix.	Reactions	were	run	in	a	thermal	cycler	(Applied	Biosystems)	program:	25	°C	for	10	min,	37	°C	for	120	min	and	then	95	°C	for	10	min.	cDNA	was	diluted	5	times	(80	μL	added	to	20	μL	reaction).		
2.9.3 Relative	gene	expression		mRNA	levels	were	measured	using	TaqMan®	Probe-Based	Gene	Expression	Assay	(Applied	Biosystems)	or	SYBR	Green	 fast	 Assay	 (Applied	Biosystems).	 Each	Taqman	Probe	 reaction	 takes	 1	 μL	 of	 cDNA,	 0.5	 μL	 of	 Taq	 fast	primer/probe	(Table	2.2),	5	μL	Master	mix	and	3.5	μL	qRT-PCR	grade	water.	Each	SYBR	primer	reaction	takes	1	μL	of	cDNA,	0.5	μL	of	forward	primer,	0.5	μL	of	reverse	primer	(Table	2.2),	5	μL	Master	mix	and	3	μL	qRT-PCR	grade	water.	Expression	of	18S	was	used	as	an	internal	control.	All	reactions	were	run	in	duplicate	and	the	mean	
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value	used	(difference	between	duplicates	<1.2	Ct).	The	qRT-PCR	program	ran	95	°C	for	20	s,	and	then	repeated	[95	°C	for	30	s,	60	°C	for	30	s].		The	DDCT	method	used	to	measure	relative	differences	in	gene	expression.	In	brief,	cycle	threshold	(CT)	values	were	obtained	at	a	threshold	of	0.2.	The	CT	value	of	the	gene-of-interest	was	subtracted	from	the	18S	Ct	value	to	normalise	CT	values	between	samples	(DCT).	Relative	quantification	was	obtained	by	subtracting	the	median	control	sample	DCT	value	from	all	the	experiment’s	DCT	values	(DDCT).	Finally,	the	fold	change	was	calculated	by	2-DDCT.		
2.10 Statistical	analysis	All	statistical	analysis	was	done	using	Graphpad	7.0	software	(Graphpad	software,	CA,	USA).	Normal	distribution	was	tested	with	the	D’Agostino-Pearson	omnibus	test.	The	student	t-test	was	used	to	compare	2	groups	with	Welche’s	correction	if	the	standard	deviation	was	significantly	different.	The	Mann-Whitney	test	was	used	where	data	was	non-parametric.	One-way	Analysis	of	Variance	(ANOVA)	with	Tukey’s	multiple	comparison	test	was	used	to	compare	more	than	2	groups.	Kruskal	–Wallis	test	with	Dunn’s	multiple	comparison	test	was	used	if	the	data	was	non-parametric.	Repeated	Measures	ANOVA	was	used	to	compare	treatments	over	time.	Significance	is	demonstrated	by	right-up-arrow	with	time	(4,	6	and	8	dpt)	on	the	x-axis	and	treatment	groups	(poly	 I:C	and	control)	on	the	y-axis.	 Interaction	 in	 the	angle.	Pearson’s	correlation	coefficient	was	used	to	 test	correlations	between	X	and	Y	factors	(usually	number	of	cd41:GFP+	vs	number	of	lyz:dsRed+).	Mantel-cox	test,	also	known	as	Log	rank	test,	was	used	to	compare	survival.		P	values	less	than	0.5	were	deemed	significant.	Non	significance	was	marked	ns,	p	values	as	*	p<0.5,	**	p<0.01,	***	p<0.001,	****	p<0.0001.	Error	bars	indicate	standard	deviation	(SD).		 	
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Table	2.2:	Comprehensive	list	of	the	Taqman	probe	identification	codes	and	SYBR	primer	sequences	used	for	the	work	in	this	
thesis.		 	
Gene Assay Species Identification	code/	Sequence
18S TaqMan Eukaryote 4319413E
il1β TaqMan Zebrafish Dr03114368_m1
tnf⍺ TaqMan Zebrafish Dr03126850_m1
ifnφ1 TaqMan Zebrafish Dr03100938_m1
Ifnγ1.1 TaqMan Zebrafish Dr03109489_g1	
Ifnγ1.2 TaqMan Zebrafish Dr03081923_m1	
cxcl-c1c TaqMan Zebrafish Dr03436643_m1
cxcl12a TaqMan Zebrafish Dr03119119_m1
l-plastin (lcp) TaqMan Zebrafish Dr03099284_m1
mpx TaqMan Zebrafish Dr03075659_m1
gata1 Taqman Zebrafish Dr03086722_m1
mpeg Taqman Zebrafish Dr03439207_g1
runx1 Taqman	 Zebrafish Dr03074179_m1
c-myb Taqman	 Zebrafish Dr03432766_m1
csf1ra Taqman Zebrafish Dr03125163_m1
mFAP4 Taqman Zebrafish Dr03452550_g1	
il8 SYBR Zebrafish F:	5’	– TGTGTTATTGTTTTCCTGGCATTTC	– 3’
R:	5’	– CTGTAGATCCACGCTGTCGC	- 3’
il6 SYBR Zebrafish F:	5’	– TCAACTTCTCCAGCGTGATG– 3’
R:	5’	– TCTTTCCCTCTTTTCCTCCTG– 3’
lck SYBR Zebrafish F:	5’	–ACGCCGAAGAAGATCTC– 3’
R:	5’	– GCTTGGGGCAGTTACA– 3’
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3 Refinement	of	hematopoietic	cell	transplantation	in	zebrafish		
3.1 Introduction	This	chapter	presents	work	establishing	the	zebrafish	transplant	protocol	which	allows	visualisation	of	kidney	marrow	colonisation	and	engraftment	by	donor	cells.	This	work	builds	on	the	decade	of	zebrafish	 transplant	studies	which	have	been	important	for	the	understanding	of	hematopoiesis	but	have	not	taken	advantage	of	the	
in	vivo	 imaging	potential	 that	 this	model	provides.	This	 chapter	 sets	out	 to	establish	a	 transplant	model	 that	would	allow	early	post-transplant	cell	mobilisation	to	be	quantified	and	to	determine	if	this	can	be	used	to	predict	recipient	survival	and	immune	reconstitution.	Determining	early	markers	of	recipient	recovery	is	an	important	goal	as	it	will	significantly	reduce	the	severity	of	this	protocol.			
3.1.1 In	vivo	monitoring	of	transplanted	hematopoietic	cells	Mammalian	 models	 have	 used	 transplantation	 experiments	 to	 identify	 HSPC	 populations	 and	 mechanisms	regulating	hematopoiesis	 for	 over	50	years	 (2).	HCT	 can	be	used	 to	 test	 the	 self-renewal	 and	differentiation	capacity	of	hematopoietic	cells.	Despite	decades	of	research,	the	early	post-transplant	processes	in	the	irradiated	recipient	are	still	poorly	understood.	It	is	still	unclear	whether	and	how	post-transplant	cell	behaviour	affects	the	success	of	transplants.			Although	the	order	of	events	 is	not	clear,	 it	 is	 thought	 that	 transplanted	HSCs	 localise	 to	hematopoietic	sites,	engraft	in	the	tissue,	self-renew	and	differentiate.	Due	to	technical	obstacles,	most	of	these	events	have	not	been	observed	in	vivo	and	therefore	there	is	a	limited	understanding	of	the	events	after	transplantation.	For	instance,	it	 is	unclear	whether	 transplanted	HSCs	begin	 to	differentiate	 in	 the	 circulation	or	whether	 this	occurs	 after	engraftment	in	the	hematopoietic	niche.			The	first	attempt	to	study	the	post-transplant	spatial	distribution	in	situ	was	by	Nilsson	et	al.	in	2001	(119).	They	labelled	sorted	cell	populations	with	the	cell	fluorescent	dye	CFSE	and	transplanted	them	(0.8	x	105	to	3	x	105	cells,	depending	on	population)	 into	recipient	mice.	Longitudinal	sections	of	 the	recipient	mouse	 femur	were	analysed	to	determine	labelled	cell	proximity	to	the	endosteal	(<12	cells	from	endosteum)	or	central	cavity	(>12	cells	from	endosteum).	They	found	that	both	Lin+	and	Lin-	population	were	evenly	distributed	throughout	the	femur	at	1	hpt.	However,	 significantly	more	(~72%)	of	HSCs	(Lin-	Rhodull)	were	 found	 in	 the	central	marrow	region	at	this	time.	Interestingly,	over	the	following	5	h,	over	half	of	the	HSC	population	was	found	nearer	to	the	endosteal	surface,	while	only	30%	of	the	more	mature	Lin-	population	(Lin-	Rhohigh)	were	in	this	region.	Together	this	 study	 suggests	 that	 transplanted	HSCs	 prefer	 the	 endosteal	 region	while	mature	 populations	 distribute	around	 the	 central	 marrow	 region.	 These	 finding	 are	 supported	 by	 previous	 evidence	 that	 maturing	hematopoietic	cells	consistently	distribute	in	specific	locations.	However,	it	is	important	to	note	that	the	in	situ	results	presented	by	Nilsson	et	 al.	were	done	using	non-ablated	 recipients	 in	order	 to	keep	an	 intact	micro-
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environment.	However,	this	meant	that	none	of	the	transplanted	cells	would	engraft.	It	is	also	important	to	note	that	these	results	could	not	provide	information	about	how	this	distribution	affected	the	success	of	transplants	because	mice	were	humanely	killed	to	obtain	the	data.			In	order	to	correlate	post-transplant	cell	behaviour	with	transplant	success,	real-time	in	vivo	imaging	of	the	bone	marrow	is	required.	In	2003,	Askenasy	and	Farkas	described	a	method	for	tracking	Lin-	PKH-labelled	cells	in	vivo	using	 an	 imaging	 window	 over	 the	 distal	 femoral	 epiphysis	 (120).	 This	 was	 the	 first	 example	 of	 real-time	monitoring	 of	 hematopoietic	 cells	 post-transplant,	 although,	 the	 distribution	 of	 transplanted	 cells	 was	 not	described.	 More	 recently	 in	 2009,	 both	 Xie	 et	 al.	 and	 Lo	 Celso	 et	 al.	 imaged	 post-transplant	 behaviour	 of	hematopoietic	cells	in	mice.			Xie	et	al.	isolated	and	transplanted	2,000	HSCs	(LSK	CD135-)	from	b-actin	promoter	driven	GFP	transgenic	mice	and	transplanted	these	into	irradiated	and	non-irradiated	recipient	mice.	They	used	2	photon	microscopy	(to	image	 cell	 behaviour	 ex	 vivo)	 in	 conjunction	 with	 longitudinal	 sectioning	 (to	 take	 measurements	 of	 cell	distribution).	They	found	that	HSCs	were	more	likely	to	associate	with	the	endosteum	(<16	µm)	in	the	irradiated	recipient	bone	marrow	than	in	non-irradiated	recipients.	By	staining	the	longitudinal	sections,	they	found	GFP	expressing	HSCs	were	in	direct	contact	with	MSCs.	Again,	early	post-transplant	cell	behaviour	was	imaged,	this	time	 in	 irradiated	 recipients.	 However,	 again	 these	 results	 could	 not	 provide	 information	 about	 how	 this	distribution	affected	the	success	of	transplants	because	mice	were	humanely	killed	to	obtain	the	data.		The	first	live	imaging	was	published	by	Lo	Celso	et	al.	in	2009.	Recipient	osteoblast	reporter	mice	(Col2.3:GFP)	were	 transplanted	with	HSCs	 (LSK	 CD48-	CD135-)	 labelled	with	DiD.	 The	 recipient	mice	were	 fitted	with	 an	imaging	window	over	the	calvarium	(top	of	the	skull)	and	imaged	with	a	two-photon	hybrid	microscope	which	rendered	a	3-D	image	of	the	bone	and	vasculature.	They	found	that	 in	non-conditioned	WT	recipients,	HSPCs	were	always	>	30	μm	from	endosteum	surfaces,	and	it	was	known	that	these	cells	would	not	engraft.	However,	in	irradiated	recipients,	they	noted	that	single	cells	were	located	closer	to	the	endosteum,	while	clusters	(>3	cells)	were	further	away.	By	combining	DiD	and	DiI	labelling	of	transplanted	cells,	they	also	revealed	that	the	clusters	of	HSPCs	 observed	 in	 the	marrow	 are	 due	 to	 the	 proliferation	 of	 single	 cells,	 and	 not	 the	 clustering	 of	 cells	transplanted	 together.	 They	 also	 used	 recipient	 osteoblast	 reporter	mice	 (Col2.3:GFP)	with	 a	 c-Kit	mutation	(125).	The	c-Kit	mutation	impairs	endogenous	HSPCs	to	engage	with	the	niche,	thus	allowing	transplanted	HSCs	to	outcompete	and	engraft	in	the	recipient	without	chemotherapy	or	radiation	(228).	They	showed	that,	in	this	intact	micro-environment,	transplanted	cells	were	within	16	μm	of	vasculature	and	within	20	μm	of	endosteal	surfaces.	These	results	provided	significant	data	about	the	early	post-transplant	behaviour	of	transplanted	HSCs	in	 the	 recipient.	 However,	 the	 experimental	 setup	 meant	 that	 this	 behaviour	 could	 not	 be	 correlated	 with	transplant	outcome	in	the	same	recipient.	Firstly,	the	invasiveness	of	the	procedure	means	that	the	mice	would	not	be	recovered	after	imaging.	Secondly,	the	experiments	involved	transplantation	of	a	larger	number	of	HSCs	(5	x	103	to	15	x	103	cells)	in	order	to	consistently	observe	3	to	15	cells	in	the	field	of	view	within	20	minutes	of	
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transplant.	This	guaranteed	the	recipients	were	rescued	and	therefore	there	would	be	no	behavioural	data	for	unsuccessful	transplants.			
3.1.2 Early	post-transplant	behaviour	of	hematopoietic	cells	in	zebrafish	As	mentioned	in	the	introduction	chapter	1.2.2,	the	zebrafish	model	has	made	significant	contributions	to	the	hematopoietic	 field	 (40,	150,	378).	One	of	 the	major	advantages	of	 the	zebrafish	 is	 the	non-invasive	 imaging	potential,	 particularly	 in	 embryos	 and	 juveniles	 (see	 Table	 1.2).	 For	 this	 reason,	 zebrafish	 have	 become	 an	attractive	tool	to	address	the	question	of	early	post-transplant	behaviour	and	its	effect	on	recipient	outcome.			Until	now,	the	visualisation	of	donor	cells	in	the	recipient	fish	has	been	quite	basic.	In	the	first	attempt,	by	White	
et	 al.,	 2	 x105	 WKM	 cells	 from	 Tg	 (b-actin:GFP)	 with	 ubiquitous	 GFP	 expression	 were	 transplanted	 into	transparent	(Casper)	recipients	and	it	was	found	that	it	took	2	weeks	to	visualise	GFP+	cells	in	the	WKM	of	adult	recipients	(379).	Casper	and	TraNac	zebrafish	lines	have	been	used	as	recipients	(Table	1.2)	as	they	are	optically	transparent	 (48,	 379-381).	However,	 as	 they	 grow	 into	 adult	 fish,	 the	 tissues	 and	organs	 scatter	 light	which	interferes	with	image	acquisition	and	therefore	limits	their	use.	Thus,	in	this	thesis,	larvae	are	used	for	image	acquisition	and	adults	are	harvested	for	flow	cytometry.		More	recently,	Li	et	al.	showed	they	could	measure	relative	engraftment	as	a	ratio	of	fluorescence	intensity	from	competing	donor	populations	in	vivo	in	adult	recipients	4	wpt	(381).	They	co-transplanted	WKM	from	ubiquitous	GFP	and	DsRed2	expressing	donors	(Tg	(b-actin:GFP)	and	RedGlow	respectively)	and	calculated	the	“relative	engraftment	capability”	as	the	ratio	of	GFP/DsRed2.	This	method	is	useful	for	comparing	the	relative	fitness	of	2	populations	of	cells,	but	does	not	reveal	when	HSPCs	arrive	in	the	niche	or	the	behaviour	of	single	cells	in	the	recipient.			Some	of	the	best	images	of	transplanted	cells	in	recipients	come	from	embryos	at	48	hpf	which	were	transplanted	with	Tg	(gata1:dsRed;	b-actin:EGFP)	in	which	gata1:dsRed+	erythrocytes	and	non-erythroid	b-actin:GFP+	cells	could	be	seen	circulating	in	the	blood	vessels	1	day	after	transplant	(48).	One	of	the	reported	advantages	of	using	embryo	recipients	is	that	they	have	not	yet	developed	their	adaptive	immune	system	and	therefore	are	not	pre-conditioned	with	irradiation.	However,	studies	suggest	that	lymphoid	progenitors	colonise	the	thymus	from	3	dpf,	even	if	they	are	not	mature	until	3	wpf	(96,	176,	177).	In	this	thesis,	adult	recipients	were	used	in	order	to	study	transplantation	in	a	fully	mature	immune	system	with	the	requirement	of	preconditioning	with	gamma-radiation.			
3.1.3 The	effects	of	irradiation	Radiation	 is	 used	 as	 a	 hematopoietic-ablative	 therapy	 for	 the	 treatment	 of	 certain	 cancers	 and	 autoimmune	diseases	in	order	to	kill	unwanted	malignant	cells.	For	HCT,	immuno-ablation	seems	to	be	important	for	allowing	transplanted	 cells	 to	 be	 in	 contact	 with	 niche	 stroma	 and	 engraft	 (121).	 Indeed,	 CXCL12	 increases	 in	 the	
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irradiated	host	(24	to	48	h),	and	this	contributes	to	cell	homing	and	engraftment	(245).	Furthermore,	Weiss	et	
al.	found	that	recipient	mouse	survival	improved	if	cells	were	transplanted	24	h	or	48	h	after	irradiation	instead	of	straight	away	(382).	The	authors	propose	that	this	delay	allows	the	establishment	of	adequate	niche	space.	However,	 radiation-induced	 toxicity	 is	 an	 import	 factor	 in	 the	 recovery	 of	 recipients.	 Gamma-rays	 of	 energy	cause	irreparable	DNA	breaks	(363-365),	initiate	reactive	oxygen	species	(366),	and	pro-inflammatory	cytokines	and	chemokines	(367-369)	which	result	in	progressive	damage	after	exposure.	The	efficacy	of	gamma-radiation	to	kill	 cells	and	an	 increase	 in	non-target	effects	has	been	associated	with	 temperature	 (383,	384).	This	may	explain	why	mammals	with	 a	 body	 temperature	 of	 37	 °C	 are	 treated	with	 9	 Gy,	 and	 zebrafish	with	 a	 body	temperature	of	28	°C	receive	the	much	higher	dose	of	30	Gy.	The	higher	radiation	dose	in	zebrafish	may	have	an	influence	on	the	non-target	effects	in	the	two	models.		The	effect	of	irradiation	on	zebrafish	have	been	studied	in	regards	to	the	depletion	of	immune	cells	in	the	WKM	and	 the	 survival	 of	 irradiated	 fish	 (135).	 Traver	 et	 al.	 showed	 a	 significant	 decrease	 in	 lymphocytes	 and	precursors	24	h	post	irradiation	(hpIR)	with	20	Gy,	with	populations	beginning	to	recover	8	days	post	ionizing	radiation	(dpIR)	and	recovering	to	pre-irradiation	levels	by	14	dpIR.	The	inflammatory	response	to	irradiation	has	not	been	investigated	in	zebrafish.	Irradiation	induced	inflammation	is	potentially	a	confounding	factor	when	studying	cell	transplantation	and	the	role	of	the	niche	in	the	successful	(engraftment	and	long	term	reconstitution)	transplantation	of	cells	and	therefore	warrants	further	examination.		
3.2 Aims	The	aim	of	this	thesis	is	to	assess	the	response	of	HSCs	under	conditions	of	inflammation.	HSCs	will	be	tested	using	 transplantation	experiments.	The	aim	of	 this	 chapter	 is	 to	 report	 the	 foundation	experiments	 that	will	establish	a	valuable	transplant	and	imaging	procedure	for	the	rest	of	the	thesis.			More	specifically,	the	aims	were	to:	1. Prepare	a	protocol	for	the	preconditioning	of	transplant	recipients	and	examine	the	effect	of	the	protocol	on	cell	depletion	and	production	of	pro-inflammatory	signals.	2. Optimise	a	technique	for	the	visualisation	of	transplanted	cells.	3. Determine	 if	 hematopoietic	 reconstitution	 and	 recipient	 survival	 can	 be	 predicted	 from	 early	 post-transplant	cell	behaviour.	4. Identify	a	LT-HSC	population	in	the	zebrafish	by	labelling	slow	cycling	hematopoietic	cells.		 	
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3.3 Results	
3.3.1 The	effect	of	radiation	on	zebrafish	HSC	“stemness”	and	function	is	assessed	by	its	ability	to	reconstitute	the	immune	system	of	an	hematopoietic-depleted	host.	For	HCT,	recipients	are	treated	with	sub-lethal	doses	of	irradiation	in	order	to	deplete	resident	hematopoietic	 populations	 and	 allow	 donor	 cells	 to	 engraft.	 Previous	 work	 has	 suggested	 that	 the	 dose	 of	irradiation	should	be	assessed	for	specific	zebrafish	lines	as	the	sensitivity	of	lines	varies	greatly	(47).			The	major	blood	populations	of	the	WKM	can	be	distinguished	simply	using	forward	(directly	proportional	to	cell	size)	and	side	scatter	(a	measure	of	cell	granularity)	as	measured	in	flow	cytometry	(48).	This	was	used	to	determine	 the	 proportion	 of	 erythrocytes,	 lymphocytes,	 myelomonocytes,	 and	 precursor	 cells	 in	 the	 WKM	following	 treatment.	 Cells	most	 radio-sensitive	would	 decrease	 in	 percentage	 and	 cells	most	 radio-resistant	would	proportionally	increase	in	percentage.			
3.3.1.1 30	Gy	depletes	populations	in	the	kidney	marrow	Initially,	WT	fish	were	used	to	establish	if	a	single	dose	of	30	Gy	or	a	split	dose	(twice	15	Gy,	24	h	apart)	would	be	most	effective	in	depleting	the	WKM.	Fish	were	irradiated	and	the	WKM	was	harvested	5	dpIR	(would	be	4	days	 after	 transplant)	 for	 flow	 cytometry	 (Figure	 3.1A).	 The	 results	 showed	 that	 both	 protocols	 caused	 a	significant	decrease	in	populations	of	the	WKM	following	exposure	to	30	Gy	irradiation	(Figure	3.1B,	C).	 	The	lymphocyte,	 myelomonocyte,	 and	 precursor	 populations	 decreased	 significantly	 (Figure	 3.1B,	 C).	 and	 are	therefore	the	most	sensitive	to	irradiation.	The	erythrocyte	population	proportionally	increased	relative	to	these	3	populations	(Figure	3.1C).	In	irradiated	samples,	there	is	a	greater	percentage	of	events	that	do	not	fall	within	the	boundaries	(gates)	of	the	4	main	populations,	indicating	that	these	events	are	“debris”	as	they	do	not	have	the	 scatter	properties	of	 the	 cells	 typically	 in	 the	WKM.	 It	 is	unclear	whether	 this	debris	 is	 evidence	of	non-hematopoietic	 kidney	marrow	 cells	 (ie.	 tubular,	 vascular,	 or	 epithelial	 cells)	more	 prominent	 in	 the	 sample	because	the	hematopoietic	cells	of	the	WKM	are	gone;	or	perhaps	the	debris	is	evidence	of	irradiation	damaged	WKM	cells	that	have	changed	shape	as	they	die.	In	addition,	the	erythrocyte	gate	can	be	contaminated	with	debris	that	scatters	in	the	top	left	quadrant.	To	assess	whether	an	increase	in	erythrocytes	is	real,	or	whether	it	reflects	an	 increase	 in	debris,	WKM	cells	were	cytospun	onto	slides	and	stained	with	Wright-Giemsa	(Supplementary	Figure	7.1).		All	4	populations	were	significantly	under	represented	as	seen	in	the	flow	cytometry	profiles,	and	the	majority	of	recovered	events	appeared	to	be	enucleated	and	cytoplasm	rich	cell	structures.	The	number	of	erythrocytes	could	not	be	quantified	accurately,	but	qualitatively	these	cells	were	not	as	abundant	in	irradiated	samples.			
Refinement	of	hematopoietic	cell	transplantation	in	zebrafish	
	 75	
	
Figure	3.1:	Depletion	of	cells	in	the	wild	type	kidney	marrow	by	irradiation.	WT	fish	were	treated	with	2	doses	of	15	Gy	or	1	dose	
of	30	Gy	and	the	WKM	was	harvested	after	5	days.	(A)	Procedure	overview.	This	protocol	does	not	involve	transplantation	but	
(Transplant)	on	day	0	indicates	when	these	irradiated	fish	would	usually	receive	a	transplant.	(B)	Representative	WKM	flow	
cytometry	profile	of	non-irradiated	and	irradiated	WT	5	days	post	irradiation.	SSC	indicates	side	scatter;	FSC	indicates	forward	
scatter	(both	use	488	nm	laser,	488/10	filter).	Percentage	of	(C)	erythrocytes,	myelomonocytes,	lymphocytes	and	precursors	
cells	in	the	WKM.	One	experiment	shown	(n>4).	Experiment	repeated	twice	with	WT,	twice	with	TraNac.	Each	dot	represents	an	
individual	fish.	Statistical	significance	using	one-way	ANOVA	and	Tukey	post-test.		****=p<0.0001,	***=p<0.001,	**=p<0.01,	*=	
p<0.05.	
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Figure	3.2:	Depletion	of	kidney	marrow	cells	in	various	lines	following	2	doses	of	15	Gy	irradiation.	TraNac,	Tg	(runx1+23:GFP),	
Tg	(runx1+23:mCherry)	and	Tg	(cd41:GFP)	fish	were	treated	with	2	doses	of	15	Gy	and	the	WKM	was	harvested	24	h	(24	hpIR)	
and	 5	 days	 (5	 dpIR)	 post	 irradiation.	 One	 experiment	 (n>3).	Work	 in	 collaboration	with	 D.	 Polos.	 Each	 dot	 represents	 an	
individual	fish.	(A)	Procedure	overview.	(B)	Percentage	of	live	cells	as	determined	by	DAPI	staining	in	samples	harvested	24	h	
after	2nd	irradiation	dose.	“Pooled”	indicates	both	TraNac	and	Tg	(cd41:GFP)	fish	are	presented	in	the	same	column.	Statistical	
significance	 using	 student	 t-test.	 (C)	 Percentage	 of	 erythrocytes,	 myelomonocytes,	 lymphocytes	 and	 precursors	 cells	 (as	
determined	by	flow	cytometry	forward/side	scatter)	in	the	WKM	of	non-irradiated	(Non-IR),	24	hours	after	irradiation	(24	hpIR)	
and	5	days	after	irradiation	(5	dpIR)	fish.	One	experiment	shown	(n>4).	Experiment	repeated	twice	with	TraNac,	once	with	the	
other	 lines.	 Statistical	 significance	 using	 one-way	 ANOVA	 and	 Tukey	 post-test.	 	 ****=p<0.0001,	 ***=p<0.001,	 **=p<0.01,	 *=	
p<0.05.	
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Figure	 3.3:	 The	 percentage	 of	 HSPCs	 is	 significantly	 decreased	 post	 irradiation.	 TraNac,	 Tg	 (runx1+23:GFP),	 Tg	
(runx1+23:mCherry)	and	Tg	(cd41:GFP)	fish	were	treated	with	2	doses	of	15	Gy	and	the	WKM	was	harvested	24	h	(24	hpIR)	and	
5	days	(5	dpIR)	post	irradiation.	Same	experiment	as	Figure	3.3.	One	experiment	shown	(n>3).	Experiment	repeated	twice	with	
TraNac,	once	with	the	other	lines.	Each	dot	represents	an	individual	fish.	Work	in	collaboration	with	D.	Polos.	(A)	WKM	flow	
cytometry	profile	of	non-irradiated	and	irradiated	(5	dpIR)	Tg	(runx1+23:GFP),	Tg	(runx1+23:mCherry)	and	Tg	(cd41:GFP)	fish.	
SSC	indicates	side	scatter	(488	nm	laser,	488/10	filter);	GFP	(488	nm	laser,	530/30	filter)	mCherry	(561	nm	laser,	610/20	filter).	
(B)	Percentage	of	GFP+	in	Tg	(runx1+23:GFP)	with	non-irradiated	TraNac	and	Tg	(runx1+23:mCherry)	negative	controls.	(C)	
Percentage	of	mCherry+	in	Tg	(runx1+23:mCherry)	with	non-irradiated	TraNac	and	Tg	(runx1+23:GFP)	negative	controls.	(D)	
Percentage	 of	 GFP+	 in	 Tg	 (cd41:GFP)	with	 non-irradiated	TraNac	 and	Tg	 (runx1+23:mCherry)	 negative	 controls.	 Statistical	
significance	using	one-way	ANOVA	and	Tukey	post-test.		****=p<0.0001,	*=p<0.05	Radiation	 leads	 to	 wide	 spread	 cell	 loss,	 as	 seen	 by	 the	 reduction	 of	 lymphocytes,	 myelomonocytes	 and	precursors.	DAPI,	a	DNA	binding	molecule	which	is	retained	in	live	cells,	was	used	to	compare	percentages	of	dead	cells	(without	a	viable	cell	membrane).	There	was	no	significant	difference	in	the	percentage	of	dead	cells	in	pooled	radiated	and	pooled	non-irradiated	samples,	when	harvested	at	5	dpIR	(Figure	3.2B).		
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Although	the	only	recipients	used	for	transplantation	are	the	translucent	TraNac	mutants,	the	Tg	(cd41:GFP),	Tg	(runx1+23:GFP)and	 Tg	 (runx1+23:mCherry)	 lines	 can	 be	 used	 to	 assess	 if	 the	 HSPC	 populations	 which	 are	labelled	are	radio-sensitive.	The	4	lines	were	treated	with	2	doses	of	15	Gy	and	harvested	at	24	h	(would	be	day	of	 transplant)	and	5	days	(would	be	4	days	after	 transplant)	after	 the	2nd	 irradiation	dose	(Figure	3.2A).	The	results	show	similar	changes	in	the	4	populations	that	were	seen	in	the	WT,	5	days	after	the	2nd	dose	(Figure	3.2C).		Examination	of	the	major	populations	at	24	h	(would	be	day	of	transplant)	shows	that	both	the	lymphocyte	and	precursor	populations	are	severely	decreased	within	24	hpIR	(Figure	3.2C).		Interestingly,	the	myelomonocyte	population,	which	decreased	by	5	dpIR,	is	not	significantly	changed	by	24	hpIR	(Figure	3.2C).	Again,	the	erythroid	population	appears	to	proportionally	increase.		The	results	also	show	a	significant	decrease	in	the	HSPC	population	based	on	GFP+	gating	of	Tg	(cd41:GFP)	and	Tg	 (runx1:23:GFP)	 and	 mCherry+	 gating	 of	 (runx1:23:mCherry)	 fish	 (Figure	 3.3).	 At	 24	 h	 and	 5	 dpIR,	 the	percentage	of	cd41:GFP+	cells	 is	at	half	 the	untreated	 levels.	 	The	runx1:mCherry+	population	 is	significantly	decreased	by	 a	 third	 after	24	h	 and	by	80	%	after	5	days.	 Interestingly,	 the	 runx1:GFP+	population	was	not	affected	after	24	h,	and	appeared	to	be	dropping	at	5	dpIR,	although	to	a	significantly	lower	percentage.			qRT-PCR	was	used	to	confirm	the	flow	cytometry	data	by	measuring	transcript	levels	of	cell	specific	markers	in	the	 whole	 organism.	 As	 before,	 TraNac	 fish	 were	 treated	 with	 2	 doses	 of	 15	 Gy,	 24	 h	 apart,	 and	 then	 the	decapitated	body	was	harvested	24	h	 later	 (at	 time	of	 transplant)	 for	RNA	extraction	 and	qRT-PCR	 analysis	(Figure	 3.4A).	 Interestingly,	 the	 erythroid	 specific	 gene	 gata1	 was	 significantly	 decreased	 (Figure	 3.4B),	supporting	the	possibility	 that	 the	percentage	 increase	determined	 in	 the	 flow	cytometry	data	was	due	to	an	increase	 in	 the	 contaminating	debris	 or	 a	 relative	 increase	due	 to	 the	decrease	of	 the	other	 cell	 populations	(Supplementary	Figure	7.1,	Figure	3.2C).	 	 It	 is	 important	 to	note	that	relative	gene	expression	was	measured	from	the	whole	body	rather	than	the	WKM	and	it	is	not	clear	how	this	would	affect	the	results.		Equally,	 the	 T-cell	 specific	 gene	 lymphocyte	 specific	 protein	 tyrosine	 kinase	 (lck)	was	 significantly	 decreased,	correlating	with	the	significant	decrease	 in	the	 lymphocyte	designated	population	 in	the	 flow	cytometry	data	(Figure	3.2C).		Macrophage	 specific	 genes	microfibrillar-associated	 protein	 4	 (mfap4)	 and	macrophage	 expressed	 1	 (mpeg1)	remain	unchanged,	reflecting	the	flow	cytometry	data	at	24	hpIR	(Figure	3.2C).	On	the	other	hand,	macrophage	and	monocyte	gene	colony	stimulating	factor	1	receptor	a	(csf1ra;	also	known	as	CD115)	increased,	implying	an	increase	in	monocytes	expressing	this	receptor.	The	pan	leukocyte	marker	l-plastin	expressed	by	immune	cells	(385),	remained	unchanged.	Together,	these	data	are	consistent	with	the	flow	cytometry	data	(Figure	3.3).			
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Figure	3.4:	Irradiation	changes	the	prevalence	of	blood	population	markers	in	the	whole	recipient,	at	the	time	of	transplant	(24	
hpIR).	(A)	Procedure	overview.	Fish	were	left	untreated	(Non-IR)	or	irradiated	(IR)	with	2	doses	of	15	Gy,	24	h	apart,	and	were	
killed	24	h	after	 the	2nd	dose.	RNA	was	extracted	 from	 the	decapitated	body	and	qRT-PCR	was	performed	on	 samples.	 (B)	
Expression	levels	of	gata1,	mFAP4,	csf1ra,	lyz,	l-plastin	and	mpeg	were	normalised	to	18S	using	the	DDCT	method.	Fold	change	
relative	to	the	median	control	value.	2	experiments	pooled,	n>7.	Each	dot	represents	an	individual	fish.	Statistical	significance	
using	Mann-Whitney	(non-parametric	t-test).	*	p<0.05,	**	p<0.01,	***	p<0.001.		
3.3.1.2 Irradiation	causes	increased	expression	of	cytokines	in	the	whole	recipient	Irradiation	induces	severe	DNA	damage	in	dividing	cells	throughout	the	organism,	causing	death	in	these	cells	and	 the	 production	 of	 pro-inflammatory	 cytokines.	 In	 order	 to	 assess	 the	 inflammation	 in	 the	 recipient	environment,	the	levels	of	some	previously	mentioned	cytokines	(see	chapter	1.7.2;	il-1β,	tnfα,	il-6	and	tgfb	(367-369))	 were	 measured	 at	 24	 hpIR,	 the	 projected	 time	 of	 transplant	 (Figure	 3.4A).	 Transcript	 levels	 were	
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determined	using	the	DDCT	method	(see	chapter	2.9.3).	Since	transplanted	cells	are	not	delivered	directly	into	the	WKM	(the	RO	injection	technique	is	used,	depositing	cells	near	the	heart),	the	inflammatory	environment	of	the	 recipient	 could	 have	 a	 biological	 impact	 on	 the	 cells,	 perhaps	 influencing	 their	migration	 or	 stimulating	differentiation,	before	they	reach	the	WKM.			The	results	show	that	transcripts	of	many	of	the	classical	cytokines	and	chemokines	(il-1β,	tnfα,	il-6,	ifnγ1.1,	and	
cxcl-c1c)	are	 increased	 in	 irradiated	fish	(Figure	3.5).	Both	 il-1β	and	 ifnγ1.1	were	 increased	»3	fold.	Tnfα	was	increased	»2.5	times.	Il-6	levels	were	approximately	doubled.	 	The	chemokine	cxcl-c1c	was	»4	fold	higher	and	the	most	significantly	upregulated	 transcript.	Neither	 ifnj	nor	 ifnγ1.2	 transcripts	were	 induced,	as	 judged	by	analysis	at	the	whole	body	level,	by	the	irradiation	treatment.			
	
Figure	3.5:	Irradiation	causes	an	increase	in	inflammatory	gene	expression	in	the	whole	recipient,	at	the	time	of	transplant	(24	
hpIR).	Fish	were	left	untreated	(Non-IR)	or	irradiated	(IR)	with	2	doses	of	15	Gy,	24	h	apart,	and	were	killed	24	h	after	the	2nd	
dose.	RNA	was	extracted	from	the	decapitated	body	and	qRT-PCR	was	performed	on	samples.	Expression	levels	of	il-1β,	tnfα,	il-
6,	 cxcl12a,	 ifnφ1,	 ifnγ1.1,	 ifnγ1.2	 and	 cxcl-c1c	were	normalised	 to	18S,	 using	 the	DDCT	method.	 Fold	 change	 relative	 to	 the	
median	control	value.	3	experiments	pooled,	n>10.	Each	dot	represents	an	individual	fish.	Statistical	significance	using	Mann-
Whitney	(non-parametric	t-test).	*	p<0.05,	**	p<0.01,	***	p<0.001.		
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3.3.1.3 Irradiation	causes	inflammation	in	the	WKM	In	order	to	determine	if	the	inflammatory	environment	assessed	in	the	whole	organism	extended	specifically	to	the	kidney	marrow,	TraNac	fish	were	treated	to	2	doses	of	15	Gy,	24	h	apart	and	the	WKM	was	harvested	at	1,	3,	8	and	24	h	after	the	2nd	irradiation	treatment	for	RNA	extraction	and	qRT-PCR	analysis	(Figure	3.6A).	The	time	points	were	chosen	to	determine	when	the	changes	in	expression	occurred	relative	to	the	time	of	exposure	and	to	relate	with	changes	seen	in	at	the	whole	body	level	at	3	hpIR.			
	
Figure	3.6:	Irradiation	causes	an	increase	in	inflammatory	gene	expression	in	the	whole	kidney	marrow.	TraNac	fish	were	left	
untreated	(Non-IR)	or	irradiated	(IR)	with	2	doses	of	15	Gy,	24	h	apart,	and	the	WKM	was	harvested	1,	3,	8,	and	24	h	after	the	
2nd	dose.	RNA	was	extracted	and	qRT-PCR	was	performed	on	samples.	2	experiments	pooled.	Work	done	in	collaboration	with	
D.	Polos.	(A)	Procedure	overview.	(B)	Relative	expression	levels	of	il-1β,	tnf⍺,	cxcl-c1c,	il-6	and	cxcl12a.	(C)	Relative	expression	
of	 lck.	Fold	change	calculated	by	normalising	 to	18S	and	relative	 to	 the	median	control	value.	2	experiments,	n=8.	Each	dot	
represents	WKM	from	an	individual	fish.	Statistical	significance	using	one-way	ANOVA.		Although	 transcript	 levels	 of	 chemokines	 il-1β,	 tnfα	and	 cxcl12a	were	 increased	 in	 the	whole	 irradiated	 fish	(Figure	3.5),	the	levels	in	the	kidney	marrow	did	not	change	significantly	in	the	WKM	over	time	(Figure	3.6B).	Expression	of	cxcl-c1c	 significantly	 increased	over	 the	 time	course,	being	highest	between	1	and	8	hpIR,	and	falling	to	»5	fold	 levels	at	24	hpIR	(Figure	3.6B).	 In	the	whole	organism	the	levels	of	cxcl-c1c	are	also	»5	fold	
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higher	in	irradiated	samples	at	24	hpIR	(Figure	3.5).	Levels	of	il-6	peak	at	1	hpIR,	and	decrease	to	»2	fold	levels	at	24	hpIR	(Figure	3.6B).	In	the	whole	organism	the	levels	of	il-6	are	also	»2	fold	higher	in	irradiated	samples	at	24	hpIR	(Figure	3.5).	Altogether,	the	transcript	levels	of	cytokines	in	the	WKM	somewhat	reflect	the	conditions	in	 the	 entire	 organism.	 Transcript	 levels	 of	 ifnγ1.2	 and	 ifnj1	 were	 also	 measured	 but	 did	 not	 change	(Supplementary	Figure	7.2).		As	the	flow	cytometry	data	shows	the	lymphocyte	population	is	significantly	decreased	in	the	whole	organism	by	24	hpIR	(Figure	3.2C),	the	mRNA	from	this	time	course	was	used	to	look	at	T-cell	specific	lck	expression	to	determine	how	quickly	this	population	is	affected	after	exposure	to	gamma-radiation.	The	level	of	lck	was	»50	%	lower	at	1	hpIR	and	»80	%	lower	by	24	hpIR	(Figure	3.6C)	suggesting	the	death	of	lymphocytes	is	rapid.		
3.3.1.4 Survival	of	irradiated	fish	without	transplant	Of	note,	 the	dose	of	 irradiation	given	 to	TraNac	 recipients	 is	 sub-lethal,	with	 some	 fish	 surviving	 to	28	days	(Figure	3.7).	Half	of	non-transplanted	fish	died	by	11	dpt.	In	order	to	reduce	suffering	of	animals,	fish	showing	adverse	 symptoms	 were	 humanely	 killed	 (see	 chapter	 2.5).	 The	 transplant	 is	 done	 using	 the	 RO	 injection	technique	(49).	Fish	were	injected	this	way	with	PBS	to	assess	whether	the	technique	affected	the	survival	of	fish.	The	method	did	not	significantly	reduce	survival	(Figure	3.7).		
	
Figure	3.7:	Survival	of	TraNac	following	2	doses	of	15	Gy	irradiation,	24	h	apart.	TraNac	fish	were	treated	with	2	doses	of	15	Gy	
or	and	tracked	for	28	days.	Survival	chart	of	IR	fish	and	IR	fish	retro-orbitally	injected	with	5	uL	PBS	at	day	0	(24	h	after	the	2nd	
dose	of	15	Gy).	(Pooled	data	from	2	experiments	with	data	from	“Not	transplanted”	fish	from	8	experiments	presented	in	Figures	
3.9D,	3.15E,	3.19,3.21;	Total	n=	42;	Retro-orbital	injection	of	PBS	in	1	experiment,	n=5).	Mantel-cox	test,	ns.			
3.3.2 Delivery	of	cells	via	retro-orbital	injection	
3.3.2.1 Dextran	confirms	correct	delivery	of	cells	in	hematopoietic	cell	transplantation		In	order	to	investigate	the	effect	of	inflammation	on	HSC	function,	a	baseline	reconstitution	ability	of	WKM	cells	from	healthy	donors	was	established.	Optically	 transparent	TraNac	recipients	were	 irradiated	 (2	x	15	Gy)	 to	deplete	the	resident	hematopoietic	populations.	Cells	from	donor	Tg	(ubi:GFP)	fish	were	harvested	on	the	day	of	
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transplant	and	delivered	using	 the	RO	 injection	 technique	 (Figure	3.8A).	The	ubiquitous	 (ubi)	gene	promoter	allows	expression	of	green	fluorescent	protein	in	>90	%	of	WKM	cells.	These	Tg	(ubi:GFP)	donors	allowed	us	to	determine	 the	 contribution	 of	 donor	 cells	 (ubi:GFP+)	 to	 the	 recipients’	 reconstituted	 immune	 system.	 Single	recipients	received	the	whole	WKM,	from	0.9	to	1.4	x	106	WKM	cells,	from	a	single	donor	(hereafter	referred	to	as	“1:1”)	or	recipients	received	105	or	5	x	104	cells	of	unselected	WKM	from	a	pool	of	donors.			
	
Figure	3.8:	Retro-orbital	injection	successfully	delivers	into	the	vasculature.	(A)	Procedure	overview.	TraNac	or	WT	fish	were	
irradiated	with	2	doses	of	15	Gy	and	either	not	transplanted	or	transplanted	with	105	WKM	cells	from	a	Tg	(ubi:GFP)	donor,	
mixed	with	dextran.	(B)	Fluorescent	imaging	of	recipient	TraNac	injected	with	4	µg	TRITC-conjugated	dextran,	1	hpt.			In	order	 to	establish	and	validate	 the	delivery	 technique,	dextran	was	added	 to	 the	cells.	Dextran	 is	a	glucan	(120kDa)	used	as	a	tracer	because	it	marks	the	vasculature	by	binding	to	the	endothelium	and	erythrocytes.	In	this	case,	 it	 is	conjugated	to	TRITC	so	it	can	be	detected	with	fluorescent	microscopy.	Upon	injection,	the	cell	solution	will	enter	the	blood	stream	and	the	entire	vasculature	will	be	visible.			It	was	 found	 that	when	 these	ubi:GFP+	WKM	cells	were	 injected	 together	with	dextran,	 the	vasculature	was	visible	but	the	ubi:GFP+	cells	were	not	discernible	at	4	or	8	dpt	(Figure	3.8B).	Three	weeks	after	transplant,	single	cells	were	still	not	detectable	but	there	was	a	region	of	fluorescence	in	the	WKM	area.			
3.3.2.2 Transplantation	 of	 heterogeneous	WKM	 cells	 successfully	 reconstitutes	 the	 immune	 system	 of	 TraNac	
recipients	Although	single	cells	were	not	detectable	under	the	fluorescence	widefield	microscope,	a	region	of	fluorescence	in	 the	 WKM	 region	 could	 be	 seen,	 suggesting	 the	 transplants	 had	 been	 successful.	 Survival	 of	 transplant	
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recipients	was	significantly	higher	than	in	non-transplanted	irradiated	fish.	Recipients	of	1:1	transplants	had	a	better	survival	than	recipients	of	lower	doses	(Figure	3.9D).	To	confirm	the	transplanted	cells	had	rescued	these	fish,	and	to	assess	donor	contribution,	surviving	fish	were	harvested	at	28	dpt	and	the	reconstitution	of	the	WKM	was	determined	using	flow	cytometry	(Figure	3.9A).				Donor	contribution	was	assessed	by	gating	ubi:GFP+	cells	within	the	debris	exclusion	gate	(gating	of	around	the	densest	portion	of	the	acquired	data	to	exclude	outliers),	using	donor	WKM	as	a	GFP+	positive	control	and	WT	WKM	as	a	GFP	negative	control	(Figure	3.9B).	The	WKM	of	recipients	contained	on	average	55	%	ubi:GFP+	cells	(ranging	from	30	to	65	%).	As	Tg	(ubi:GFP)	donor	fish	have	75	%	ubi:GFP+	cells,	this	suggests	~20	%	(ranging	from	5	to	40	%)	of	the	cells	in	the	transplant	recipients	were	not	derived	from	Tg	(ubi:GFP)	donor	cells	(Figure	3.9C).	 This	 ~20	 %	 could	 represent	 hematopoietic	 cells	 derived	 from	 the	 recipient,	 or	 these	 cells	 could	 be	contaminating	structural	WKM	cells	derived	from	the	recipient.	It	is	not	clear	whether	the	ubi:GFP+	cells	detected	at	28	dpt	are	the	cells	that	were	originally	delivered	at	the	time	of	transplant	(0	dpt),	and/or	cells	derived	from	transplanted	HSCs	(a	result	of	engraftment	and	hematopoiesis	of	transplanted	HSCs).	To	fully	assess	engraftment	of	HSCs,	fish	would	need	to	be	assessed	after	at	least	6	months.		All	recipients	had	multi-	lineage	reconstitution.	To	confirm	that	titrated	transplant	doses	were	able	to	rescue	all	the	populations	of	the	recipient	WKM,	both	the	GFP	positive	and	negative	populations	of	the	recipients’	WKM	were	gated	for	the	major	blood	populations	(Supplementary	Figure	7.3).	In	general,	the	recipients	had	similar	population	percentages	in	the	ubi:GFP+	fraction	as	the	GFP	negative	fraction	of	WT	WKM	or	the	GFP	positive	fraction	of	Tg	(ubi:GFP)	donor	WKM.			In	Tg	(ubi:GFP)	donors,	the	majority	of	the	GFP	negative	cells	scatter	in	the	erythrocyte	gate,	suggesting	that	this	gate	is	contaminated	by	debris	that	is	not	part	of	the	WKM	cellular	composition	(Figure	3.10A).	The	percentage	of	erythrocytes	in	the	GFP	negative	fraction	of	the	recipient	WKM	(70	%)	was	similar	to	donor	Tg	(ubi:GFP)	WKM	(60	%	to	80	%),	but	higher	than	the	percentage	of	erythrocytes	in	the	GFP	negative	fraction	of	WT	WKM	(40	%).	This	is	because	all	cells	in	the	WT	WKM	are	GFP	negative	and	therefore	the	percentage	is	split	between	the	4	cell	groups.	On	the	other	hand,	the	majority	of	cells	in	recipients	of	Tg	(ubi:GFP)	donor	fish	are	GFP+	and	therefore	there	are	few	GFP-	cells	of	the	4	cell	groups.	This	had	the	effect	of	disproportionally	increasing	the	percentage	of	cells	in	the	erythrocyte	population.			A	significant	proportion	of	recipient	myelomonocyte,	lymphocyte	and	precursor	cells	were	GFP	positive.	The	GFP	positive	 fraction	 was	 25	 %	 myelomonocytes,	 while	 the	 GFP	 negative	 fraction	 had	 <5	 %	 scattering	 in	 the	myelomonocyte	gate.	The	percentage	of	ubi:GFP+	myelomonocytes	in	the	recipient	WKM	was	not	significantly	different	 to	 the	 percentage	 of	 myelomonocytes	 in	 the	 GFP-	 WT	 WKM	 (20	 %)	 or	 the	 percentage	 of	myelomonocytes	in	the	ubi:GFP+	of	Tg	(ubi:GFP)	WKM	(20	%;	Figure	3.10B).	The	same	is	seen	for	lymphocytes,	as	shown	in	(Figure	3.10C).			
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Figure	3.9:	A	transplant	of	heterogeneous	WKM	cells	successfully	populates	the	WKM	and	rescues	irradiated	TraNac	recipients	
at	least	28	dpt.	TraNac	or	WT	fish	were	irradiated	with	2	doses	of	15	Gy	and	retro-orbitally	injected	with	a	whole	Tg	(ubi:GFP)	
donor	WKM	(1:1),	105	WKM	cells	or	5	x	104	cells	from	a	Tg	(ubi:GFP)	donor.	7	experiments	pooled,	not	all	groups	were	present	
in	each	repeat;	3	(1:1)	transplants,	2	(105)	and	2	(5x	104),	n>14.	(A)	Procedure	overview.	(B)	Flow	cytometry	scatter	profile	of	
Tg	(ubi:GFP)	donor,	WT,	transplant	recipient	TraNac	28	dpt	and	non-transplanted	irradiated	TraNac	recipient.	SSC	indicates	
side	 scatter	 (488	 laser,	 488/10	 filter);	GFP	 indicates	 (488	 laser,	 530/30	 filter).	 (C)	Percentage	of	GFP+	 in	 the	WKM	cells	 of	
recipients,	WT	 and	 donor	 Tg	 (ubi:GFP).	 Each	 dot	 represents	 an	 individual	 fish.	 (D)	 Survival.	Mantel-cox	 test	 between	 “not-
transplanted”	and	each	transplanted	group.	****	p<0.0001,	*	p<0.05.	Non-transplanted	recipients	did	not	receive	105	WT	PB	
cells.		
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Interestingly,	 the	 percentage	 of	 ubi:GFP+	 precursors	 in	 the	 recipient	WKM	 (22	%)	was	 twice	 as	 high	 as	 the	percentage	of	precursors		in	the	non-transplant	control	(WT	and	Tg	(ubi:GFP))	WKM	(10	%;	Figure	3.10D).	This	suggests	an	expansion	of	the	precursor	population	following	transplantation.		Taken	together	with	the	dextran	data,	these	results	show	that	the	retro-orbital	method	is	able	to	deliver	cells	into	 the	 recipient	 blood	 stream.	 They	 also	 show	 that	 the	 donor	 cells	were	 successful	 at	 integrating	 into	 the	recipient	WKM	and	to	outcompete	any	remaining	host	derived	cells.		
	
Figure	3.10:	Transplant	 recipients	have	a	 larger	precursor	population	at	28	dpt	 than	non-irradiated,	non-transplanted	 fish.	
TraNac	or	WT	fish	were	irradiated	with	2	doses	of	15	Gy	and	retro-orbitally	transplanted	with	a	whole	Tg	(ubi:GFP)	donor	WKM	
(1:1),	105	WKM	cells	or	5	x	104	cells	from	a	Tg	(ubi:GFP)	donor.	7	experiments	pooled;	3	(1:1)	transplants,	2	(105)	and	2	(5x	104),	
n>11;	Each	dot	represents	an	individual	fish.	(A)	Flow	cytometry	scatter	profile	of	a	standard	Tg	(ubi:GFP)	donor,	standard	WT	
fish,	irradiated	and	transplant	recipient	TraNac	28	dpt	and	irradiated	non-transplanted	TraNac	recipient	28	dpIR.	SSC	indicates	
side	 scatter	 (488	 laser,	 488/10	 filter);	 GFP	 indicates	 (488	 laser,	 530/30	 filter).	 The	 percentage	 of	 (A)	 eyrthrocytes,	 (B)	
myelomonocytes,	(C)	lymphocytes,	and	(D)	precursors	in	the	ubi:GFP+	and	ubi:GFP-	gates	of	cells	in	the	WKM,	as	determined	by	
flow	cytometry.	
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3.3.3 Establishing	the	rescue	of	bloodless	c-mybt25127	mutant	recipients	Conventionally,	 transplant	 recipients	 are	 preconditioned	with	 irradiation	 to	 deplete	 the	 recipient’s	 immune	system.	 This	 is	 often	 necessary,	 for	 instance	 in	 the	 treatment	 of	 leukaemia	 or	 auto-immune	 disease,	 as	 the	purpose	 is	to	remove	malignant	cells	and	replace	them	with	a	healthy	population.	However,	as	shown	by	the	cytokine	data,	this	treatment	causes	general	inflammation	throughout	the	whole	organism.	A	particular	concern	would	be	if	the	supportive	cells	of	the	HSC	niche	are	damaged.	In	order	to	study	hematopoietic	engraftment	in	a	non-inflamed	environment	(see	chapter	5),	we	obtained	a	line	of	c-mybt25127	mutants	that	do	not	undergo	the	definitive	wave	of	hematopoiesis	and	are	therefore	“bloodless”	after	the	cells	from	the	primitive	wave	have	been	exhausted.		Homozygous	 c-mybt25127	 mutants	 do	 not	 live	 long	 enough	 to	 not	 reach	 sexual	 maturity.	 Because	 of	 this,	homozygotes	for	the	mutation	can	only	be	obtained	by	breeding	heterozygotes.	The	homozygote	mutants	(1	in	4)	are	selected	for	transplant	based	on	phenotype	and	then	subsequently	confirmed	as	such	by	genotyping	DNA	from	a	tail	clip	post-transplant	(Figure	3.11A).	In	brief,	genomic	DNA	is	obtained	from	a	tail	clipped	adult,	and	a	polymerase	chain	reaction	with	gene	targeting	primers	amplifies	the	region	of	interest.	In	the	WT,	the	sequence	amplified	has	2	digestion	sites	for	the	Hpy188III	enzyme,	resulting	in	3	products.	However,	in	the	c-myb	mutant,	the	mutation	that	causes	the	bloodless	phenotype	is	a	transversion	mutation	of	thymine	to	adenine	in	the	DNA	binding	domain.	This	point	mutation	removes	the	target	sequence	of	restriction	enzyme	Hpy188III	and	therefore	the	amplified	sequence	just	gets	cut	once,	resulting	in	2	products.	This	PCR	and	restriction	digest	method	can	therefore	 be	 used	 to	 distinguish	 WT	 from	 c-myb	 mutants	 (Figure	 3.11B).	 Unlike	 c-myb	 homozygotes	 and	heterozygotes,	the	WT	will	not	have	the	larger	260	base	pair	(bp)	sequence.	Homozygote	c-myb	mutants	will	present	only	2	bands	(260	bp,	184	bp);	WT	will	present	3	bands	(184	bp,	146	bp,	114	bp);	Heterozygote	c-myb	mutants	will	present	4	bands	(260	bp,	184	bp,	146	bp,	114	bp)	because	they	have	both	a	copy	of	the	gene	with	the	mutation	site	and	a	copy	without.			As	described	by	Hess,	when	transplanted,	the	rescued	c-myb	mutant	is	indistinguishable	from	it	WT	sibling	(46).	Therefore,	the	ability	to	maintain	hematopoietic	cells	is	not	compromised.	To	better	understand	the	phenotype	and	examine	the	physical	structure	of	the	kidney	organ,	histological	sections	of	these	fish	were	prepared.	The	kidney	marrow	was	anatomically	similar	to	WT	but	qualitative	analysis	suggests	there	are	structural	changes	and	fewer	cells	among	the	nephritic	tubules	(Figure	3.11C).		The	c-mybt25127	line	is	difficult	to	maintain	because	it	lacks	a	competent	immune	system.	Fish	were	raised	in	low	antibiotic	embryo	growing	medium	(E2)	but	morbidity	was	high	and	juveniles	did	not	live	past	12	wpf	and	would	not	grow	past	1	cm	 in	 length.	Hess	et	al.	 suggest	 that	size	could	be	restricted	by	 the	requirement	 for	oxygen	exchange	across	the	epithelium	(46).	The	small	size	of	the	fish	meant	it	was	too	difficult	to	inject	with	a	Hamilton	syringe,	as	it	is	typically	done	for	zebrafish	transplants.	Therefore,	the	RO	technique	was	refined	using	a	micro-injector,	typically	used	for	injecting	embryos.	The	ability	to	rescue	these	mutants	at	a	smaller	and	younger	stage	meant	a	greater	proportion	of	rescued	fish.	
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Figure	3.11:	Characterisation	of	the	c-mybt25127	mutant.	Heterozygotes	for	the	c-myb	mutant	gene	were	bred	and	embryo	were	
reared	 with	 low-antibiotic-containing-embryo	 growing	 media	 (E2)	 on	 the	 bench.	 Homozygous	 mutants	 were	 identified	
phenotypically	and	receive	a	transplant	at	5	wpf.	(A)	Genotyping	was	done	on	tail	clip	DNA	by	PCR	amplifying	a	portion	of	the	c-
myb	gene	and	using	restriction	enzyme	Hpy188III	to	cleave	sequence	(indicated	by	arrows);	WT	sequence	cleaved	at	2	sites,	
mutant	sequence	cleaved	at	1	site.	Fragment	sizes	in	base	pair	(bp).	(B)	The	digested	PCR	product	was	run	on	1.5%	agarose	gel.	
Restriction	 digest	 of	WT	produces	 3	 bands,	 c-myb	heterozygotes	 produces	 4	 bands,	 c-myb	homozygotes	 produces	 2	 bands.	
Ladder	 size	on	 the	 left,	 fragment	 sixe	on	 the	 right.	 (C)	Representative	 sagittal	 sections	of	 non-mutant	 (left)	 and	 c-mybt25127	
mutant	(right)	at	4	wpf.	WKM	is	outlined	in	dashed	white	line.	Kidney	tubule	indicated	with	blue	arrow,	hematopoietic	cells	
indicated	with	green	arrow	(Non-mutant	only).		Transplantation	of	7.5	x	104	WKM	cells	from	Tg	(lyz:dsRed)	fish	was	used	to	assess	the	method	of	transplant	in	these	fish	(Figure	3.12A).	Just	like	Tg	(ubi:GFP),	lyz:dsRed+	cells	can	be	used	to	determine	the	contribution	of	donor	cells	in	the	recipient.	The	lysozyme	C	(lyz)	gene	promoter	expresses	red	fluorescent	protein	in	the	myeloid	population	(56).	These	donors	were	also	used	because	red	fluorescent	protein	has	a	higher	fluorescence	intensity	
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which	would	help	visualisation	of	cells	in	the	recipient.	WT	and	c-myb	heterozygote	siblings	from	the	same	batch	were	irradiated	(15	Gy	48	h	and	24	h	prior	to	transplant)	and	transplanted	alongside	the	homozygote	mutants.		Despite	the	pigmentation	of	the	c-myb	mutant	recipients	(as	they	are	not	on	a	translucent	background	such	as	TraNac),	donor	cells	could	be	visualised	in	the	tail	WKM	of	the	recipient	but	could	not	be	accurately	quantified	(Figure	3.12B).			Fish	were	humanely	killed	at	33	dpt	for	flow	cytometry	to	assess	multi-lineage	reconstitution	(Figure	3.13A).	There	 were	 no	 differences	 in	 the	 reconstitution	 of	 the	 WKM	 erythrocyte,	 myelomonocyte,	 lymphocyte	 and	precursor	 populations	 (Figure	 3.13B).	 In	 addition,	 the	 percentage	 of	 lyz:dsRed+	 cells	 in	 the	 WKM	 was	 not	significantly	different	(p=0.4396)	between	c-mybt25127	mutants	and	non-mutant	recipients	(Figure	3.13C).	Finally,	the	survival	of	c-mybt25127	mutants	was	slightly	lower	(although	not	significantly	different)	than	irradiated	non-mutant	recipients.	The	genotype	of	the	recipients	was	verified	by	taking	a	tail	clipping	at	the	time	of	harvest	(33	dpt).		
	
Figure	 3.12:	 Transplanting	 c-mybt25127	mutant	with	 7.5	 x	 104	 unsorted	WKM	 cells	 from	 Tg	 (lyz:dsRed)	 donors.	 C-mybt25127	
mutant	fish	were	raised	in	E2	(embryo	medium)	to	7	wpf	and	then	transplanted	with	75	000	WKM	cells	from	a	pool	of	3	Tg	
(lyz:dsRed)	donors.	Non-mutant	siblings	were	irradiated	twice	with	15	Gy,	24	h	apart	and	transplanted	24	h	later,	alongside	the	
mutants	(A)	Procedure	overview.	(B)	Representative	widefield	image	(Olympus	CKXC41	fluorescent	microscope)	of	c-mybt25127	
mutant	recipient	7	dpt;	the	region	of	interest	is	enlarged.		
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Figure	3.13:	The	WKM	of	c-mybt25127	mutants	transplanted	with	a	heterogeneous	mix	of	WKM	cells	is	populated	with	donor	cells	
33	dpt.	C-mybt25127	mutant	fish	were	raised	in	E2	(embryo	medium)	to	7	wpf	and	then	transplanted	with	75	000	WKM	cells	from	
a	pool	of	3	Tg	(lyz:dsRed)	donors.	Non-mutant	siblings	were	irradiated	twice	with	15	Gy,	24	h	apart	and	transplanted	24	h	later,	
alongside	the	mutants.	Recipients	were	harvested	at	33	dpt	for	flow	cytometry.	1	experiment	(mutant	(c-myb	-/-)	n=	7;	Non-
mutant	 (c-myb	+/-)	 n=	 5).	 (A)	 Scatter	 profile	 of	 Tg	 (lyz:dsRed)	 donor,	 irradiated	 and	 transplanted	non-mutant	 (c-myb	+/-)	
recipient	and	transplanted	c-myb	mutant	(c-myb	-/-)	recipient.	SSC	indicates	side	scatter	(488	laser,	488/10	filter);	dsRed	(561	
nm	 laser,	 610/20	 filter).	 (B)	The	percentage	of	 erythrocytes,	myelomonocytes,	 lymphocytes,	 and	precursors	 in	 the	WKM	of	
recipients.	(C)	The	percentage	of	lyz:dsRed+	cells	in	the	WKM	of	recipients.	(D)	Post-transplant	survival	of	recipients.	Mantel-
cox	test.		Taken	together,	this	experiment	confirms	that	the	c-mybt25127	mutant	can	be	rescued	by	HCT.	Surprisingly,	the	data	 indicates	 that	 immune	 reconstitution	 of	 c-mybt25127	 mutants	 is	 not	 significantly	 different	 from	 their	
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irradiated	non-mutant	heterozygous	or	homozygous	WT	siblings.	The	ability	 to	distinguish	single	cells	 in	 the	recipient	7	dpt	highlighted	 the	possibility	of	using	 juvenile	TraNac	recipients	 to	visualise	 the	post-transplant	establishment	of	donor	cells	in	the	kidney	marrow.		
3.3.4 Early	post-transplant	events	
3.3.4.1 Transplanted	HSPCs	can	be	visualised	migrating	in	smaller	TraNac	recipients	Auxiliary	work	with	c-myb	bloodless	mutants	revealed	it	was	possible	to	image	single	cell	behaviour	in	smaller	fish.	In	order	to	visualise	early	post-transplant	HSPC	lodgment,	mobilisation,	proliferation	and	differentiation,	the	previously	described	micro-injection	technique	above	was	used	to	transplant	irradiated	juvenile	(4-5	wpf)	TraNac	fish.	This	would	minimise	trauma	to	the	recipient	and	optimize	visualization	of	cells	in	the	transplant	recipient	 (a	 combination	 of	 a	 small	 optical	 depth	 with	 the	 fluorescence	 of	 cells	 from	 transgenic	 donors).	 A	preliminary	experiment	in	which	32	recipients	were	injected	with	WKM	cells	mixed	with	dextran	showed	that	the	fluorescence	of	the	dextran	interfered	with	visualisation	of	cells	in	the	recipient.	For	this	reason,	dextran	was	omitted	from	subsequent	experiments.		As	our	interest	lies	in	the	effects	of	inflammation	on	the	behaviour	of	the	HSPC	population	(and	not	the	immune	system	 as	 a	 whole),	 the	 experiment	 relied	 on	 obtaining	 a	 HSPC	 population	 for	 transplantation	 studies.	 As	mentioned	in	the	introduction,	CD41,	integrin	alpha	chain	2b,	is	an	integral	membrane	protein	expressed	on	early	hematopoietic	progenitors	and	thrombocytes	in	the	zebrafish	(28,	29).	Ma	et	al.	showed	that	only	GFPlow	cells	transplanted	into	irradiated	adult	zebrafish	could	reconstitute	the	hematopoietic	system	up	to	68	weeks	after	transplantation	(51).	Tg	(cd41:GFP)	fish	were	crossed	with	Tg	(lyz:dsRed)	fish,	in	which	myeloid	cells	express	dsRed	 fluorescent	 protein	 (56).	 The	 Tg	 (cd41:GFP;lyz:dsRed)	 donors	 allowed	 us	 to	 sort	 a	 HSPC	 enriched	population	for	transplantation,	and	to	determine	the	contribution	of	cd41:GFP+	donor	derived	myeloid	cells	to	the	recipient’s	reconstituted	immune	system.		Firstly,	 the	 reconstitution	 ability	 of	 a	 heterogeneous	 population	 of	WKM	 cells	without	mature	myeloid	 cells	(cd41:GFP+,	lyz:dsRed-)	was	assessed.	This	population	is	richer	in	the	various	cell	types	needed	to	reconstitute	an	 ablated	 immune	 system	 and	 so	 recipient	 rescue	 should	 be	 higher	 than	 when	 cd41:GFP+	 HSPCs	 are	transplanted	alone.	As	HSCs	make	up	<1	%	of	 the	WKM,	 it	was	necessary	 to	 transplant	a	 large	population	 to	improve	the	probability	of	survival	and	long	term	reconstitution.		Juvenile	TraNac	were	irradiated	(2	doses	of	15	Gy,	24	h	apart)	and	transplanted	with	2x	105	lyz:dsRed	negative	cells	(gating	in	Figure	3.14C)	and	105	WT	carrier	peripheral	blood	(PB)	cells.	Recipient	fish	were	imaged	daily	from	3	to	6	dpt	(Figure	3.14A).	The	sorting	of	cells	can	take	up	to	2.5	h,	therefore	DAPI	was	used	to	assess	whether	there	was	a	change	in	cell	viability	over	time.	The	percentage	of	live	cells	at	the	start	of	the	sort	(97.1	%)	was	comparable	to	the	percentage	at	the	end	of	the	sort	(96.6	%),	indicating	that	the	time	taken	for	the	sorting	process	did	not	cause	significant	cell	death	(Figure	3.14B).	
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Figure	3.14:	Transplantation	of	WKM	cells	depleted	of	mature	myeloid	cells	(lyz	negative)	into	irradiated	TraNac	recipients.	
WKM	cells	from	Tg	(cd41:GFP;	lyz:dsRed)	were	sorted	for	lyz	negative	(dsRed-,	GFP+/-)	cells.	(A)	Protocol	overview.	(B)	100	uL	
of	pooled	donor	WKM	was	stained	with	DAPI	pre-	and	post-sort.	Flow	cytometry	scatter	of	donor	WKM	with	DAPI	gating.	SSC	
indicates	side	scatter,		DAPI	(355	nm	laser,	450/20	filter).	(C)	Flow	cytometry	scatter	of	donor	WKM	cells	with	gating	used	to	
obtain	negative/GFP+	donor	population.	SSC	indicates	side	scatter;	FSC	indicates	forward	scatter	(both	use	488	nm	laser,	488/10	
filter).	The	debris	exclusion	gated	population	is	separated	by	dsRed	(561	nm	laser,	610/20	filter)	and	GFP	(488	nm	laser,	530/30	
filter)	scatter	to	obtain	a	lyz-	population.		Recipient	fish	were	kept	in	E2	following	the	transplant,	and	then	imaged	from	3	dpt.	The	number	of	cd41:GFP+	and	lyz:dsRed+	cells	in	the	head,	mid	and	tail	regions	of	the	WKM	were	counted.		
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The	transplanted	cd41:GFP+	population	was	visible	in	the	kidney	marrow	of	most	fish	by	5	dpt	(Figure	3.15Di).	Live	imaging	of	the	fish	revealed	the	cd41:GFP+	cells	behave	in	2	different	ways.	One	population	is	highly	mobile,	and	the	other	is	quite	sedentary.	It	was	not	possible	to	distinguish	high	and	low	expression	of	GFP	because	the	observed	fluorescence	intensity	could	be	affected	by	the	position	of	the	cell	in	the	fish.		The	 lyz:dsRed+	 population	 was	 observable	 in	 the	 fish	 WKM	 from	 4	 dpt	 (Figure	 3.15Dii).	 However,	 some	lyz:dsRed+	could	be	seen	around	the	eye	(the	site	affected	by	the	transplant	needle	insertion)	from	3	dpt.	The	number	of	cells	in	the	WKM	grew	steadily	over	time.	In	order	to	determine	if	the	lyz:dsRed+	cells	have	a	location	bias,	the	distribution	of	cells	was	analysed	across	3	sections	of	the	WKM:	head,	mid	and	tail	(Figure	3.15B,	C).	This	revealed	that	on	day	4,	the	majority	of	cells	are	in	the	head	kidney	and	very	few	are	in	the	mid	or	tail	kidney.	However,	by	day	5,	although	the	number	of	lyz:dsRed+	in	the	head	remained	the	same,	the	cell	numbers	increased	in	the	mid	kidney	and	were	highest	in	the	tail	kidney.	This	suggests	that	the	head	kidney	gets	colonised	before	the	cells	progress	to	the	tail	kidney.	It	is	not	clear	whether	the	spread	to	the	tail	kidney	is	due	to	migrating	mature	cells	or	the	migration	and	subsequent	differentiation	of	precursors	in	these	regions.		Taking	the	lyz:dsRed+	observations	together	with	the	cd41:GFP+	observations,	the	data	suggests	that	precursors	are	present	in	the	fish	before	they	become	observable	by	microscopy	based	on	GFP	expression	and	that	there	may	be	a	limit	to	detection.	To	determine	if	cells	could	be	detected	in	the	WKM	prior	to	when	they	are	observed	at	 day	 4,	 recipients’	 head	 and	 their	WKM	were	 harvested	 at	 3	 dpt	 for	 flow	 cytometry	 analysis.	 No	 distinct	population	of	fluorescent	cells	was	detected	in	the	scatter	of	either	tissue	at	3	dpt	(data	not	shown).	The	cells	were	perhaps	too	few	to	detect,	or	had	lost	fluorescence	as	they	temporarily	stop	expressing	cd41	and	GFP,	or	the	transplanted	cells	have	differentiated	into	a	type	of	multi-potent	progenitor	which	is	not	labelled	by	CD41	or	Lyz	proteins.		Recipients	were	monitored	for	survival	(Figure	3.15E).	Survival	is	shown	for	the	first	28	days.	The	survival	of	irradiated	but	not	transplanted	fish	was	unusually	high	in	this	pool	of	3	experiments,	as	usually	it	is	around	15	%	(Figure	3.7)	and	can	be	as	low	as	0	%	(Figure	3.9D).	This	may	reflect	a	problem	with	the	irradiation	step,	or	is	due	to	variation	in	fish	response	to	the	irradiation	treatment.	The	survival	of	transplanted	fish	was	higher	than	non-transplanted	irradiated	siblings	with	8	out	of	17	fish	receiving	a	transplant	surviving	past	28	dpt.	The	longest	survival	was	55	dpt	for	transplant	recipients,	and	41	days	for	irradiated	but	not	transplanted	fish.			Together	 these	 experiments	 show	 that	 transplanting	 2	 x	 105	 lyz:dsRed	 negative	 cells	 can	 rescue	 irradiated	TraNac	recipients	at	least	4	wpt.	They	also	show	that	single	cells	can	be	observed	in	small	adult	TraNac	recipients.			
Refinement	of	hematopoietic	cell	transplantation	in	zebrafish	
	94	
	
Figure	3:15;	Continued	over	page		
<1
0
10
 - 2
2
>2
2
0
50
100
150
WKM distribution and no. of lyz:dsRed+ 
in recipient of 2 x 105 lyz:dsRed- cells
Survival (dpt)
N
o.
 ly
z:
ds
R
ed
+ 
in
 W
K
M
 
*
<1
0
10
 - 2
2
>2
2
0
50
100
150
Distribution of lyz:dsRed+ in WKM
4 and 5 days post transplant
Survival (dpt)
N
o.
 ly
z:
ds
R
ed
+ 
in
 W
K
M
 
*
A
Tail Tail
Mid Head
B C
cd41:GFP
lyz:dsRed
4 d
pt
5 d
pt
4 d
pt
5 d
pt
4 d
pt
5 d
pt
0
10
20
30
WKM distribution and No. of lyz+ 
in recipients of 2 x 105 lyz- cells
N
o.
 d
sR
ed
+ 
ce
lls
 in
 W
K
M
Head Mid Tail
Sections of the WKM
**
**
ns
He
ad Mi
d
Ta
il
0
5
10
15
20
25
N
o.
 d
sR
ed
+ 
ce
lls
 in
 W
K
M
Distribution of lyz+ cells in the WKM
 4 and 5 days post transplant
4 dpt
5 dpt
Sections of the WKM
**
**
ns
Refinement	of	hematopoietic	cell	transplantation	in	zebrafish	
	 95	
	
Figure	3.15:	Irradiated	TraNac	recipients	of	WKM	cells	depleted	of	mature	myeloid	cells	(lyz:dsRed-)	have	mature	myeloid	cells	
(lyz:dsRed+)	in	the	WKM	from	4	dpt.	TraNac	recipients	were	treated	with	2	doses	of	15	Gy	and	either	did	not	receive	a	transplant,	
or	were	transplanted	with	2	x105	dsRed	negative	WKM	cells	from	Tg	(cd41:GFP;	lyz:dsRed)	donors	and	105	WT	PB	cells.	Non-
transplanted	recipients	did	not	receive	105	WT	PB	cells.	Fish	drawing	reproduced	with	permission	from	E.	Griffith	(A)	Recipients	
were	imaged	3	to	6	dpt	under	a	Zeiss	Axiovert	200	inverted	confocal	microscope	with	488	and	506	nm	lasers.	The	kidney	marrow	
was	divided	into	3	sections	and	dsRed	+	cells	were	counted	in	the	head,	mid	and	tail	segments.	(B)	Bar	graph	shows	mean	number	
of	dsRed+	in	sections	of	the	kidney	marrow	(dots	represent	individual	fish)	at	4	and	5	dpt.	Student’s	t-test	for	each	section	(4	v	
5	 dpt),	 **	 p<0.01.	Data	 from	 a	 single	 experiment.	 (C)	 The	 line	 graph	 shows	 the	mean	number	 (dots)	 of	 dsRed+	 (with	 lines	
connecting	sections)	at	4	and	5	dpt.	(the	same	data	as	in	B).	(D)	The	sum	total	of	dsRed+	and	GFP+	in	the	3	sections	from	3	to	6	
dpt	 was	 plotted;	 each	 dot	 represents	 a	 fish	 (n>9).	 One-way	 ANOVA	 (Kruskal-Wallis)	 with	 Dunn’s	 post	 test,	 **	 p<0.01,	 ****	
p<0.0001	(E)	Survival	chart.	Mantel-cox	test	non-significant.	Experiment	repeated	3	times	and	data	pooled.						
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3.3.4.2 Both	cd41:GFP+	lyz:dsRed-	and	cd41:GFP-	lyz:dsRed-	cells	can	give	rise	to	lyz:dsRed+	cells	in	the	transplant	
recipient	Having	shown	that	transplantation	of	lyz:dsRed	negative	cells	rescues	irradiated	fish	and	allows	differentiation	of	lyz:dsRed+	progeny,	the	next	step	was	to	further	partition	this	population.	The	lyz:dsRed	negative	population	was	 split	 into	 a	 double	negative	 (cd41:GFP-	 lyz:dsRed-)	 population	 and	 a	 cd41:GFP+	population	 (cd41:GFP+	lyz:dsRed-),	as	shown	in	(Figure	3.16B).	As	cd41:GFP+	cells	are	enriched	for	HSCs,	it	was	posited	that	cd41:GFP+	cells	could	produce	lyz:dsRed+	cells,	unless	these	cells	were	lymphoid	biased	HSPCs.	It	was	also	posited	that	the	double	negative	(cd41:GFP-	lyz:dsRed-)	would	produce	lyz:dsRed+	cells	because	this	heterogeneous	mix	of	WKM	cells	would	include	myeloid	precursors.	However,	this	population	may	not	rescue	irradiated	recipients	long-term	because	 it	 does	 not	 contain	 cd41:GFP+	 HSCs.	 It	 may	 also	 generate	 cd41:GFP+	 cells.	 These	 cells	 could	 be	thrombocytes	derived	from	TEPs,	or	precursors	to	a	cd41:GFP+	HSPC	population.			
	
Figure	 3.16:	 Transplantation	 of	 HSPCs	 (cd41:GFP+)	 or	 WKM	 cells	 depleted	 of	 mature	 myeloid	 cells	 and	 HSPCs	 (lyz:dsRed	
negative,	cd41:GFP	negative).	WKM	cells	from	Tg	(cd41:GFP;lyz:dsRed)	were	sorted	for	double	negative	(lyz:dsRed-	cd41:GFP-)	
and	cd41:GFP+	(lyz:dsRed-	cd41:GFP+)		cells.	(A)	Protocol	overview.	(B)	Flow	cytometry	scatter	of	donor	WKM	cells	with	gating	
used	to	obtain	populations	from	donors	for	transplant.	SSC	indicates	side	scatter;	FSC	indicates	forward	scatter	(both	use	488	
nm	laser,	488/10	filter).	The	debris	exclusion	gated	population	is	separated	to	obtain	a	double	negative	(lyz:dsRed-	cd41:GFP-)	
and	cd41:GFP+	(lyz:dsRed-	cd41:GFP+)	population	using	GFP	(488	nm	laser,	530/30	filter)	and	dsRed	(561	nm	laser,	610/20	
filter).			
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As	before,	recipient	TraNac	fish	were	irradiated	(2	doses	of	15	Gy,	24	h	apart)	prior	to	transplant	of	either	2,000	cd41:GFP+	lyz:dsRed-,	or	104	double	negative	WKM	cells	(cd41:GFP-	lyz:dsRed-).	The	number	of	cd41:GFP+	cells	to	be	transplanted	was	reached	by	estimating	the	number	of	cd41:GFP+	cells	that	would	have	been	present	in	the	previous	experiments	with	ubi:GFP	donors	(Figure	3.9).	As	the	typical	WKM	contains	0.5	%	cd41:GFP+	cells,	then	2	x	105	ubi:GFP+	cells	would	contain	approximately	1000	cd:41GFP+	cells.	This	number	was	doubled	to	increase	the	likelihood	of	a	successful	transplant.	The	number	of	double	negative	cells	to	be	transplanted	was	reached	by	reducing	the	number	of	cells	that	would	have	been	present	in	the	previous	experiments	with	ubi:GFP	donors	by	an	order	of	magnitude	and	halving.	This	number	is	approximately	1	%	of	the	WKM,	but	this	population	is	unlikely	to	contain	HSCs.		Cells	of	interest,	either	2,000	cd41:GFP+	lyz:dsRed-,	or	104	double	negative	WKM	cells	(cd41:GFP-	lyz:dsRed-),	were	transplanted	with	support	cells	(Table	1.2)	therefore	all	recipients	also	received	105	support	PB	cells	(45).	Recipients	were	imaged	from	2	to	6	dpt	(Figure	3.16A).	A	transplant	dose	of	2,000	cd41:GFP+	cells	was	chosen	because	 adult	 Tg	 (cd41:GFP)	 fish	 typically	 have	 about	 5,000	 cd41:GFP+	 cells	 and	 also	 based	 on	 previous	experiments	(51).		The	number	of	cd41:GFP+	and	lyz:dsRed+	cells	were	counted	at	non-hematopoietic	sites	such	as	around	the	eye	(the	site	of	transplant),	the	organs,	and	down	the	body	(Figure	3.17A),	as	well	as	in	the	WKM	area	(Figure	3.18A).			In	recipients	of	2,000	cd41:GFP+	cells,	cd41:GFP+	cells	could	be	seen	in	the	WKM	from	3	dpt,	although	numbers	are	constant	initially,	they	increase	significantly	from	5	dpt	(Figure	3.18Ai).	Lyz:dsRed+	cells	are	observed	both	in	the	WKM	(Figure	3.18Bi)	and	around	the	recipient’s	eye	at	the	same	time,	4	dpt	(Figure	3.17Ai).	As	cd41:GFP+	cells	were	 observed	 in	 the	 recipient	WKM	 before	 lyz:dsRed	 cells	were	 present	 in	 the	WKM,	 it	 is	 likely	 that	cd41:GFP+	cells	populate	the	WKM	before	they	differentiate	to	produce	myeloid	cells	(either	directly	or	through	intermediary	precursor	cells).	Importantly,	taken	with	the	previous	experiment,	when	2x	105	lyz:dsRed-	cells	(a	mix	of	cd41:GFP+	and	double	negative	cells)	were	transplanted	into	recipients,	lyz:dsRed+	cells	also	appeared	from	4	dpt	(Figure	3.15).	Furthermore,	cd41:GFP+	cells	were	only	detected	at	5	dpt,	while	in	these	experiments	they	are	visible	2	days	earlier,	at	3	dpt.	Although	this	seems	inconsistent,	it	is	important	to	note	that	the	number	of	cd41:GFP+	cells	does	not	vary	much	between	3	and	5	dpt	 in	 this	set	of	results	(Figure	3.17Ai).	This	might	indicate	that	although	the	cells	were	not	identified	at	3	and	4	dpt	in	the	previous	transplants,	they	were	possibly	already	there.	In	addition,	my	ability	to	distinguish	the	fluorescent	cells	possibly	improved	with	experience.	As	the	increase	in	cd41:GFP+	cells	in	the	WKM	happens	between	5	and	6	dpt	in	both	sets	of	experiments,	and	the	increase	in	lyz:dsRed+	cells	in	the	WKM	happens	between	4	and	5	dpt,	together	these	observations	suggest	that	cd41:GFP+	 colonise	 the	 WKM	 at	 3	 dpt,	 prioritise	 production	 of	 myeloid	 cells	 at	 4	 dpt	 and	 then	 switch	 to	proliferation	at	5	dpt.			
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Figure	3.17:	Both	cd41:GFP+	cells	and	cd41:GFP-	give	rise	to	myeloid	cells	in	the	recipient,	early	post-transplant.	WKM	cells	from	
Tg	 (cd41:GFP;lyz:dsRed)	 were	 sorted	 for	 double	 negative	 (lyz:dsRed-	 cd41:GFP-)	 and	 cd41:GFP+	 (lyz:dsRed-	 cd41:GFP+)	
populations.	Irradiated	TraNac	were	transplanted	with	either	2,000	cd41:GFP+	(lyz:dsRed-	cd41:GFP+)	or	104	double	negative	
(lyz:dsRed-	cd41:GFP-)	WKM	cells	and	105	WT	PB	cells.	Non-transplanted	recipients	did	not	receive	105	WT	PB	cells.	Individual	
fish	were	 imaged	 in	vivo	 (widefield	Zeiss	Axiovert	200	microscope)	daily	 from	2	 to	6	dpt	with	488	and	506	nm	 lasers.	Fish	
reproduced	with	permission	from	E.	Griffith.	(A)	The	number	of	lyz:dsRed+	cells	throughout	the	recipient,	excluding	the	WKM.	
One-way	ANOVA	(Kruskal-Wallis)	with	Dunn’s	post-test.	Each	dot	represents	an	individual	fish.	(B)	The	proportion	of	recipients	
with	mobile	cd41:GFP+	throughout	the	recipient.	3	experiments	pooled	(n=12).		In	recipients	of	104	double	negative	cells,	a	maximum	of	15	cd41:GFP+	cells	were	observed	in	the	recipient	for	the	first	6	dpt	(Figure	3.18Aii)	and	only	half	as	many	had	mobile	cd41:GFP+	cells	(23	%	and	50	%	respectively;	Figure	3.17B).	On	the	other	hand,	lyz:dsRed+	cells	were	seen	in	recipients	of	double	negative	cells	from	3	dpt,	a	day	earlier	than	fish	transplanted	with	2,000	cd41:GFP+	cells	(Figure	3.17A).	They	appear	in	the	recipient	WKM	at	5	dpt,	similar	to	fish	transplanted	with	2,000	cd41:GFP+	cells	(Figure	3.18B).		
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Finally,	 survival	 of	 transplant	 recipients	 suggest	 that	 the	 transplant	 of	 double	negative	 cells	 does	not	 rescue	irradiated	 fish	 (p=0.931;	 Figure	 3.19A).	 However,	 transplanting	 2,000	 cd41:GFP+	 did	 improve	 survival	(p=0.0576;	 Figure	 3.19B).	 The	 same	 experiment	 was	 also	 carried	 out	 using	 bloodless	 c-mybt25127	 mutant	recipients	(Figure	3.19C).	Due	to	the	pigmentation	of	these	fish,	cell	number	could	not	be	accurately	assessed	using	 imaging.	 However,	 survival	 of	 these	 fish	 shows	 that	 a	 transplant	 of	 either	 double	 negative	 cells	 or	cd41:GFP+	cells	can	rescue	the	mutant	to	42	dpt	(Figure	3.19D).	Almost	half	(47	%)	of	recipients	transplanted	with	2,000	cd41:GFP+	cells	survive	past	28	dpt,	significantly	more	than	non-transplanted	mutants	(Figure	3.19E).	The	 longest	 survival	 was	 73	 dpt;	 significantly	 more	 than	 non-transplanted	 siblings,	 but	 not	 as	 good	 as	 the	reported	55	%	survival	to	12	wpt	(84	dpt)	following	transplantation	of	4	x	105	WT	WKM	cells	(46).				
	
Figure	3.18:	Both	cd41:GFP+	cells	and	double	negative	cell	transplantation	gives	rise	to	myeloid	cells	in	the	WKM	of	irradiated	
TraNac	transplant	recipients.	WKM	cells	from	Tg	(cd41:GFP;lyz:dsRed)	were	sorted	for	double	negative	(lyz:dsRed-	cd41:GFP-)	
and	cd41:GFP+	(lyz:dsRed-	cd41:GFP+)	populations.	Irradiated	TraNac	were	transplanted	with	either	2,000	cd41:GFP+	or	104	
double	negative	(lyz:dsRed-	cd41:GFP-)	WKM	cells	and	105	WT	PB	cells.	Non-transplanted	recipients	did	not	receive	105	WT	PB	
cells.	Individual	fish	were	repeatedly	imaged	in	vivo	under	a	Zeiss	Axiovert	200	microscope	daily	from	2	to	6	dpt	with	488	and	
506	nm	lasers.	Fish	reproduced	with	permission	from	E.	Griffith.	(A)	The	number	of	cd41:GFP+	cells	in	the	WKM	of	the	recipients.	
(B)	 The	 number	 of	 lyz:dsRed+	 cells	 in	 the	WKM	 of	 the	 recipients.	 Each	 dot	 represents	 an	 individual	 fish.	 One-way	 ANOVA	
(Kruskal-Wallis)	with	Dunn’s	post-test.	3	experiments	pooled	(n=12).	
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Together	 these	 data	 show	 that	 2,000	 cd41:GFP+	 cells	 have	 the	 potential	 to	 rescue	 irradiated	 recipients	 and	produce	 both	 cd41:GFP+	 and	 lyz:dsRed+	 cells	 (in	 all	 12/12	 fish).	 Fish	 injected	 with	 double	 negative	 cells	produced	very	few	cd41:GFP+	cells,	but	lyz:dsRed+	cells	were	visible	in	these	recipients.	The	lower	survival	rate	of	these	recipients	suggests	that	cd41:GFP+	cells	are	required	for	HCT	rescue.			
		
Figure	 3.19:	 Survival	 of	 irradiated	 TraNac	 recipients	 of	 2,000	 cd41:GFP+	 or	 104	 double	 negative	 WKM	 cells	 (lyz:dsRed-	
cd41:GFP-).	WKM	cells	from	Tg	(cd41:GFP;lyz:dsRed)	were	sorted	for	double	negative	(lyz-	cd41-)	and	GFP+	(cd41+)	populations.	
Irradiated	TraNac	and	c-myb	bloodless	mutants	were	transplanted	with	either	2,000	cd41:GFP+	or	104	double	negative	(lyz-	
cd41-)	WKM	cells	and	105	WT	PB	cells.	Non-transplanted	recipients	did	not	receive	105	WT	PB	cells.	(A)	Survival	chart	of	TraNac	
recipients	of	104	double	negative	(lyz-	cd41-)	WKM	cells.	3	experiments	pooled,	n	=24.	(B)	Survival	chart	of	TraNac	recipients	
of	2,000	cd41:GFP+	WKM	cells.	3	experiments	pooled,	n	=19.	 (C)	Overview	of	protocol	of	experiments	with	c-myb	bloodless	
mutants.	(D)	Survival	of	c-myb	mutant	recipients	of	104	double	negative	(lyz-	cd41-)	WKM	cells	or	2,000	cd41:GFP+	WKM	cells;	
2	experiments	(transplanted	2,000	cd41:GFP+	n=8,	104	double	negative	n=8).	 (E)	Survival	of	c-myb	 fish,	with	and	without	a	
transplant	of	2,000	cd41:GFP+	WKM	cells	(3	experiments,	transplanted	n=21,	non-transplanted	n=10).	
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Interestingly,	there	was	no	difference	in	the	survival	of	c-myb	mutant	recipients	of	double	negative	cells	and	c-myb	mutant	recipients	of	cd41:GFP+	cells.	Perhaps	tracking	these	recipients	for	longer	than	40	days,	perhaps	6	months,	would	determine	if	the	long	term	reconstitution	is	restricted	to	the	cd41:GFP+	transplanted	individuals.			
3.3.4.3 Reducing	cell	dose	reduces	the	rate	of	early	post-transplant	WKM	repopulation	rates	but	does	not	affect	
long	term	reconstitution		For	 this	 thesis,	 there	was	 a	 need	 to	 establish	 a	 dose	 at	 which	 HSCs	would	 be	 pushed	 to	 their	 limit	 so	 that	reconstituting	ability	between	HSCs	from	immune-challenged	donors	and	healthy	donors	can	be	assessed.	As	shown	above,	2,000	donor	cd41:GFP+	cells	can	rescue	irradiated	TraNac	recipients.	In	subsequent	experiments,	irradiated	TraNac	recipients	received	a	transplant	of	200,	50	or	20	cd41:GFP+	cells	from	Tg	(cd41:GFP;lyz:dsRed)	along	with	105	PB	cells	(Figure	3.20A,	B).	Recipients	were	imaged	6	dpt	as	previous	experiments	had	shown	that	recipients	had	visible	cells	in	the	WKM	at	this	time	point	(Figure	3.18).			
	
Figure	3.20:	Titrating	the	number	of	transplanted	cd41:GFP+	cells.	WKM	cells	from	Tg	(cd41:GFP;lyz:dsRed)	were	sorted	for	
GFP+	cells.	(A)	Procedure	overview.	(B)	Flow	cytometry	scatter	of	donor	WKM	cells	with	gating	used	to	obtain	populations	from	
donors	for	transplant.	SSC	indicates	side	scatter;	FSC	indicates	forward	scatter	(both	use	488	nm	laser,	488/10	filter).	The	debris	
exclusion	gated	population	is	separated	to	obtain	a	lyz:dsRed-	cd41:GFP+	population	using	GFP	(488	nm	laser,	530/30	filter),	
dsRed	(561	nm	laser,	610/20	filter).	Far	right	scatter	is	a	density	plot	of	the	sorted	population	(large	dots).			The	counts	at	6	dpt	show	that	the	more	cells	that	get	transplanted,	the	more	cells	are	visible	in	the	WKM	at	this	early	time	point	post-transplant	(Figure	3.21A,	B).	Fish	receiving	a	transplant	of	200	cells	had	on	average	12	cd41:GFP+	cells	(2	of	22	had	none)	and	26	lyz:dsRed+	cells	(1	of	22	had	none)	at	6	dpt.	However,	fish	receiving	
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only	20	cd41:GFP+	cells	had	on	average	3	cd41:GFP+	cells	(5	of	13	had	none)	and	an	average	of	3	lyz:dsRed+	cells	(9	of	13	had	none)	at	6	dpt	(Figure	3.21A,	B).		Fish	were	imaged	again	at	12	dpt	and	10	of	16	fish	that	received	a	transplant	of	20	cd41:GFP+	cells	had	at	least	1	fluorescent	cell	in	the	WKM.	Most	(29	of	32)	surviving	recipients	of	a	transplant	of	200	cd41:GFP+	cells	had	cells	in	the	WKM	by	12	dpt.				
	
Figure	3.21:	The	presence	of	fluorescent	cells	in	the	WKM	at	6	dpt	is	dependent	on	the	number	of	transplanted	cd41:GFP+	cells.	
WKM	cells	from	Tg	(cd41:GFP;lysC:dsRed)	donors	were	sorted	for	cd41:GFP+	cells.	Irradiated	TraNac	were	transplanted	with	
200,	50	or	20	cd41:GFP+	cells	and	105	WT	PB	cells.	Non-transplanted	recipients	did	not	receive	105	WT	PB	cells.	The	number	of	
(A)	 cd41:GFP+	and	 (B)	 lyz:dsRed+	were	 counted	 in	 the	WKM	of	 the	 recipients.	 Each	dot	 represents	 an	 individual	 recipient.	
Individual	recipients	were	monitored	for	28	days.	(C)	Survival	of	irradiated	TraNac	recipients	transplanted	with	200,	50	or	20	
cd41:GFP+	cells.	Four	experiments	pooled,	Logrank	test	(*=	p<0.05,	**=	p<0.01,	***=	p<0.001).		Survival	 to	 28	 dpt	 was	 similar	 among	 the	 3	 groups	 (Figure	 3.21C).	 Just	 4	 out	 of	 20	 of	 the	 recipients	 of	 20	cd41:GFP+	 cells	 survived	 to	 28	 dpt	 and	 their	 WKM	 was	 harvested	 for	 flow	 cytometry.	 They	 had	 too	 few	cd41:GFP+	 or	 lyz:dsRed+	 cells	 to	 be	 detected	 by	 flow	 cytometry.	 A	 quarter	 (2	 out	 of	 8)	 of	 recipients	 of	 50	cd41:GFP+	survived	to	28	dpt.	Both	had	lyz:dsRed+	cells	but	neither	had	cd41:GFP+.	Surviving	recipients	of	200	cd41:GFP	had	both	lyz:dsRed+	and	cd41:GFP+	cells	in	the	WKM	at	28	dpt.	Together,	this	suggests	that	the	survival	of	the	4	recipients	of	20	cd41:GFP+	cells	was	possibly	due	to	the	sub-lethal	irradiation	dose,	and	moreover,	the	PB	carrier	cells	transplanted	with	the	20	cd41:GFP+	cells	helped	with	their	survival.	A	transplant	of	20	or	50	cells	did	not	yield	adequate	imaging	data	or	survival	for	further	studies.	In	order	to	ensure	a	robust	imaging	data	and	survival,	a	dose	of	200	cells	was	chosen	for	future	experiments.	
0 10 20 30
0
50
100
Days post transplant
Pe
rc
en
t s
ur
vi
va
l
Survival of Irradiated TraNac recipients
with titrated doses of cd41:GFP+ WKM cells
50 cd41:GFP+ (n= 8)
200 cd41:GFP+ (n= 28)
20 cd41:GFP+ (n= 20)
Non-transplanted (n= 8)
**
****
No. cd41:GFP+ in WKM at 6 dpt
200 50 20
0
10
20
30
40
50
60
No. cd41:GFP+ cells transplanted 
N
o.
 c
d4
1+
 c
el
ls
 in
 W
K
M
*
No. lyz:dsRed+ in WKM at 6 dpt
200 50 20
0
20
40
60
80
100
No. GFP+ cells transplanted 
N
o.
 d
sR
ed
+ 
ce
lls
 in
 W
K
M
***
A
C
B No. cd41:GFP+ in WKM at 6 dpt
10
20
30
40
5
60
No. cd41:GFP+ cells transplanted 
No
. c
d4
1+
 c
el
ls
 in
 W
KM
*
<1
0
10
 - 2
2
>2
2
0
50
100
150
lyz:dsRed+ in WKM
of recipient of 2 x 105 lyz: sRed- cells
Survival (dpt)
N
o.
 ly
z:
ds
R
ed
+ 
in
 W
K
M
 
*
Refinement	of	hematopoietic	cell	transplantation	in	zebrafish	
	 103	
	
Figure	 3.22:	 Transplanted	 cell	 behaviour	 in	 irradiation	 recipients	 of	 200	 cd41:GFP+	 cells.	 WKM	 cells	 from	 Tg	
(cd41:GFP;lysC:dsRed)	 donors	 were	 sorted	 for	 cd41:GFP+	 cells.	 Irradiated	 TraNac	 were	 transplanted	 with	 200,	 50	 or	 20	
cd41:GFP+	cells	and	105	WT	PB	cells.	Non-transplanted	recipients	did	not	receive	105	WT	PB	cells.	Individual	recipients	were	
monitored	for	28	days	to	correlate	the	number	of	(A)	cd41:GFP+	and	(B)	lyz:dsRed+	in	the	WKM	at	6	dpt	with	recipient	survival,	
up	to	28	dpt.	At	28	dpt,	recipient	WKM	was	harvested	for	flow	cytometry.	The	number	of	(C)	cd41:GFP+	and	(D)	lyz:dsRed+	cells	
at	6	dpt	was	correlated	with	the	percentage	of	cd41:GFP+	and	lyz:dsRed+	cells	(in	the	WKM,	after	debris	exclusion).	(E)	Fish	
were	split	into	3	survival	groups	(<10	days,	10	to	22	days	and	>	22	dpt)	to	compare	the	total	number	of	cd41:GFP+	and	lyz:dsRed+	
cells	at	6	dpt	with	survival.	Five	experiments	pooled.	Includes	data	from	controls	in	PolyI:C	recipient	experiments.	Recipients	
transplanted	with	200	(n=22),	50	(n=8)	or	20	(n=13)	cd41:GFP+	WKM	cells.	One	of	 the	 aims	of	 this	 thesis	was	 to	determine	whether	 transplant	 recipient	 survival	 could	be	predicted	by	observing	post-transplant	cell	behaviour.	Irradiated	TraNac	fish	were	transplanted	with	200	cd41:GFP+	cells,	imaged	6	dpt	and	tracked	so	that	early	imaging	data	could	be	matched	with	survival	(Figure	3.22A,B).	Neither	the	number	of	 cd41:GFP+	 (R	 square	=	0.1099;	p=0.0912),	nor	 the	number	of	 lyz:dsRed+	 (R	 square	=0.1097;	p=0.0914)	cells	in	the	WKM,	significantly	correlated	with	survival	of	the	fish.		
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A	 third	 (35	%)	 of	 recipients	 died	 in	 the	 first	 10	 dpt	 (Figure	 3.21C).	 	 Remarkably,	 these	 fish	 had	 a	 range	 of	cd41:GFP+	(9	out	of	11	had	<10;	1	recipient	had	50	and	1	had	25)	and	lyz:dsRed+	(7/11	had	<10;	4	recipients	between	37	and	64	cells)	cells	in	the	WKM	at	6	dpt	(Figure	3.22A,B).	After	this	point,	50	%	of	the	remaining	fish	(35	%	of	the	overall)	survived	to	28	dpt	(Figure	3.21C).	Interestingly,	the	fish	that	survive	to	28	dpt	also	had	a	range	of	cd41:GFP+	(7	of	9	recipients	had	between	14	and	39;	2	had	<10	cells)	and	lyz:dsRed+	(8	of	9	recipients	had	between	17	and	88;	1	had	10	cells)	cells	at	6	dpt.	The	30	dpt	survival	of	fish	with	<10	fluorescent	cells	(Figure	3.22A,B)	at	6	dpt	could	reflect	the	low	number	of	fish	that	survive	despite	not	receiving	a	transplant	(Figure	3.7).	It	would	appear	that	deaths	occurring	prior	to	10	dpt	cannot	be	predicted	by	the	number	of	cells	present	at	6	dpt.	However,	the	deaths	after	this	period	can	be	anticipated	(Figure	3.22E).	Recipients	that	died	between	10	and	22	dpt	had	on	average	66	%	fewer	fluorescent	cells	than	recipients	which	survived	beyond	this	point	(Figure	3.22E).	Thus,	 culling	 fish	 with	 fewer	 than	 <25	 cells	 total	 at	 6	 dpt	 would	 reduce	 suffering	 in	 this	 protocol,	 without	impacting	the	amount	of	data	that	could	be	obtained	from	the	experiment	(as	these	fish	would	not	survive	to	28	dpt	anyway).		Flow	cytometry	was	used	to	detect	the	number	of	fluorescent	cells	in	the	surviving	recipients’	WKM	at	28	dpt	(Figure	3.22C,	D).	There	was	no	correlation	between	the	number	of	cd41:GFP	(R	square	=	0.0995;	p=0.4466)	cells,	or	the	number	of	lyz:dsRed+	cells	(R	square	=	0.001;	p=0.9304),	between	6	and	28	dpt.	
	
3.3.5 Identifying	dormant	HSPCs	in	the	zebrafish	
3.3.5.1 BrdU	labelling	could	not	identify	a	dormant	HSC	population	in	the	zebrafish	The	transplantation	experiments	reported	so	far	have	relied	on	HSPC	markers	cd41	and	runx.	Both	have	been	good	markers	for	enrichment	of	the	HSC	population.	However,	in	mice,	the	population	of	HSCs	containing	the	best	long-term	self-renewal	capacity	are	slow	cycling	“dormant”	cells,	also	known	as	LT-HSCs.	These	have	not	yet	been	identified	in	zebrafish.	In	mice,	they	were	discovered	using	BrdU	in	a	“label	retention	assay”.	In	brief,	cells	are	“pulsed”	with	BrdU,	a	thymidine	analog	that	integrates	into	proliferating	cells	by	replacing	the	thymidine	residues.	The	BrdU	is	then	removed	from	the	system	to	start	the	“chase”.	Proliferating	cells	loose	BrdU	as	the	replicated	genome	integrates	thymidines	again	instead	of	BrdU.	Non-proliferating	cells	do	not	lose	the	label	as	the	genome	is	not	being	replicated	(Figure	3.23B).			The	 BrdU	 label	 retention	 assay	was	 used	 in	 order	 to	 identify	 if	 zebrafish	 have	 slower	 cycling	 cells	with	 the	objective	of	using	this	label	in	conjunction	with	cd41+	or	runx1+	populations	in	transplantation	assays.	Firstly,	it	was	established	that	BrdU	labelling	of	WKM	cells	could	be	achieved	by	adding	BrdU	to	tank	water	or	injecting	fish	with	the	BrdU	solution.	WT	and	Tg	(cd41:GFP)	fish	were	either	injected	with	10mM	BrdU	twice	a	day	for	4	days	or	BrdU	was	added	to	the	tank	water	(10mM	BrdU)	for	4	days.	The	fish	were	then	humanely	killed,	the	WKM	harvested,	and	 the	cells	 fixed	and	stained	with	anti-BrdU	antibody.	The	samples	were	 then	analysed	by	 flow	cytometry	(Figure	3.23A).		
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Injecting	fish	with	BrdU	labelled	fewer	WKM	cells	than	swimming	fish	in	a	10	mM	BrdU	solution	(18	%	and	25	%	respectively;	Figure	3.23C).	This	is	probably	because	there	is	a	chase	period	between	injections	when	the	cells	that	have	taken	up	the	BrdU	are	dividing	and	the	thymidine	analogue	is	being	lost.	Also,	the	percentage	of	cells	labelled	was	more	consistent	between	fish	that	bathed	in	the	chemical.			
	
Figure	3.23:	Label	retention	assay	to	isolate	quiescent	stem	cells.	TraNac	and	Tg	
(cd41:GFP)	fish	were	either	injected	or	bathed	in	10mM	BrdU	for	a	pulse	of	4	days	
and	then	transferred	to	system	water	for	a	chase	period.	(A)	Protocol	overview.	
(B)	 Schematic	 representation	 of	 the	 BrdU	 labelling	 process.	 During	 BrdU	
exposure	(pulse)	cells	 incorporate	BrdU	 into	DNA	during	DNA	synthesis.	After	
the	BrdU	 is	removed	(chase)	 the	cells	which	divide	more	will	 lose	BrdU	while	
cells	that	do	not	divide	retain	the	BrdU.	(C)	The	percentage	of	BrdU+	WKM	cells	
after	 a	 4	 day	 pulse	 with	 10mM	 BrdU	 by	 injection	 or	 bathing	 in	 solution.	
Representative	of	3	experiments.	(D)	The	percentage	of	BrdU+	WKM	cells	after	a	
4	day	pulse	with	10mM	BrdU	and	1,	3,	and	26	weeks	chase.	Representative	of	2	
experiments.	(E)	The	percentage	of	BrdU+	cells	in	Tg	(cd41:GFP)	larvae	(4	days	post	fertilisation)	after	a	4	day	pulse	in	1,	5	and	
10mM	BrdU	and	after	56	days	chase.	Representative	of	2	experiments.	Statistical	significance	using	one-way	ANOVA	and	Tukey	
post	test.	**=p<0.01,	***=p<0.001	
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In	subsequent	experiments,	BrdU	was	added	to	the	water	for	a	4	day	“pulse”	period.	Immediately	after	pulsing,	fish	had	25%	of	their	WKM	cells	labelled	with	BrdU.	However,	7	days	later,	only	18	%	of	WKM	cells	were	BrdU+,	and	there	was	a	wide	range	of	labelling	between	fish	(Figure	3.23D).	After	3	weeks,	only	5	%	of	WKM	cells	were	BrdU+,	and	this	population	had	disappeared	completely	(in	3	out	of	4	fish)	by	26	weeks	(6	months).	In	one	of	the	samples,	5	%	of	cells	were	BrdU+	after	26	weeks	chase.	The	experiment	needs	to	be	repeated	with	more	fish	to	determine	if	this	result	is	an	outlier	or	a	true	result.	Due	to	the	time	requirement,	this	was	not	possible	in	the	scope	of	the	thesis.	As	GFP	is	quenched	by	fixation	of	cells,	an	anti-GFP	antibody	was	used	in	conjunction	with	the	 anti-BrdU	 in	 order	 to	 correlate	 cd41	 expression	with	 slow	 cycling	 cells.	 No	 overlap	 between	 these	 two	populations	was	seen	(data	not	shown).		The	 original	 experiments	were	 done	 in	 adult	 fish	 (>3	mpf;	 (Figure	 3.23C,	 D)	 but	 no	 BrdU+	 population	was	successfully	 identified	 in	the	WKM.	It	was	reasoned	that	pulsing	at	4	dpf,	when	HSCs	have	emerged	from	the	aorta	and	are	proliferating	in	the	CHT,	could	help	to	label	cells	destined	to	become	slowly	dividing	at	a	time	when	they	are	still	highly	replicating.	Thus,	4	dpf	larvae	were	pulsed	for	3	days	by	adding	BrdU	to	the	E2	solution	(1,	5	and	10	mM)	used	to	raise	embryos.	At	7	dpf,	these	larvae	are	too	small	to	dissect,	therefore	the	whole	organism	was	mashed,	digested	and	filtered	to	run	through	the	flow	cytometer	and	assess	BrdU	incorporation	after	pulse.	At	the	highest	dose	(10mM),	BrdU	labelled	the	largest	percentage	of	cells	(up	to	9	%	of	the	whole	larvae).	No	BrdU+	cells	were	detected	after	6	week	chase	(Figure	3.23E).		
3.4 Discussion	Although	the	aim	of	this	thesis	is	to	assess	the	effect	of	inflammation	on	HSCs,	it	was	first	necessary	to	established	the	baseline	 reconstitution	 ability	 of	 hematopoietic	 cells	 from	healthy	donors	 into	WT	adult	 recipients	 (pre-treated	 with	 irradiation).	 This	 chapter	 recapitulates	 previously	 described	 research	 and	 then	 builds	 upon	zebrafish	HCT	by	determining	a	method	for	assaying	early	post-transplant	hematopoietic	cell	behaviour.		
3.4.1 Summary	of	results	The	findings	of	this	chapter	were:		 1. Flow	cytometry	analysis	of	fish	conditioned	with	2	doses	of	15	Gy	gamma-radiation	showed	that,	at	the	time	of	transplant,	they	had	a	significantly	decreased	erythrocytes,	lymphocytes	and	HSPCs	in	the	WKM	(although	the	decrease	was	found	in	both	runx1+23:NLSmCherry	and	cd41:GFP+	populations,	but	not	the	runx1+23:GFP+	population	which	was	not	significantly	affected).	Furthermore,	qPCR	data	supported	these	 findings	 as	 the	 cell	 lineage-associated	 transcripts	 for	 erythrocytes	 and	 lymphocytes	 were	 also	decreased.	Flow	cytometry	and	qPCR	data	both	suggest	the	myelomonocytes	were	less	affected	by	the	treatment.	
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2. Transcript	levels	of	cytokines	il-1b,	il-6,	tnfa	and	ifnγ1.1	were	all	increased	(2-4	fold)	in	irradiated	fish	at	the	 time	 of	 transplant.	 Furthermore,	 transcript	 levels	 of	 chemokines	 cxcl-c1c	 and	 cxcl12	were	 also	increased.	3. Previously	 reported	 transplant	 protocols	were	 replicated	 and	 confirmed	 previous	 findings.	 HCT	was	performed	with	106,	105	and	5	x	104	heterogeneous	ubi:GFP+	WKM	cells.		The	reconstitution	of	recipients	was	successful,	as	gauged	by	the	significant	survival	and	the	significant	percentage	of	ubi:GFP+	cells	in	the	WKM	of	these	recipients	at	28	dpt.	There	were	no	differences	between	recipients	of	different	doses,	in	terms	of	the	percentage	of	ubi:GFP+	cells	in	the	recipient	at	28	dpt.	Flow	cytometry	analysis	suggested	that	the	percentage	of	precursors	in	the	WKM	was	greater	at	28	dpt,	compared	with	non-transplant	naïve	fish.	4. Live	 imaging	 of	 small	 optically	 transparent	 recipient	 fish	 revealed	 that	 transplanted	 cd41:GFP+	 cells	behave	in	2	different	ways:	highly	mobile	and	sedentary.	Furthermore,	these	transplanted	cells	appeared	to	colonise	the	head	WKM	first	(4	dpt),	and	subsequently	the	mid	and	tail	WKM	(5	dpt).	5. Donor	 cd41:GFP+	 cells	were	not	 visible	 in	 recipients	of	 transplanted	104	double	negative	 (cd41:GFP-	lyz:dsRed-)	cells	or	20	cd41+GFP+	cells.	Some	cd41:GFP+	cells	were	visible	in	recipients	of	50	cd41:GFP+	cells	but	the	best	conditions	for	visualisation	were	in	recipients	of	200	cd41:GFP+	fish.	6. One	 third	of	 transplant	 recipients	 of	 200	 cd41:GFP+	 cells	 survived	 to	28	dpt.	 The	highest	 number	of	deaths	occurred	between	8	and	12	dpt,	even	when	donor	cells	were	visible	 in	 the	recipient	by	8	dpt,	meaning	 these	 deaths	 cannot	 be	 predicted.	 However,	 in	 successful	 transplants	 (survival	 and	hematopoietic	reconstitution	by	28	dpt),	fluorescent	cells	would	be	visible	in	the	recipient	WKM	by	6	dpt	and	therefore	any	recipients	without	fluorescent	cells	should	be	humanely	killed	at	this	time	point.	In	addition,	survival	was	significantly	lower	(died	before	<22	dpt)	when	fewer	than	25	fluorescent	donor	cells	(sum	of	cd41:GFP	and	lyz:dsRed)	were	visible	in	the	WKM	at	8	dpt	and	therefore	these	fish	should	be	humanely	killed	if	studies	persist	beyond	this	range.	7. A	4	day	chase	with	BrdU	labelled	»30	%	of	WKM	cells.	After	a	3	week	chase	the	BrdU+	population	was	<	5	%	of	WKM	cells	and	by	6	months	there	were	<0	%	BrdU+	(1	or	2	events)	cells	in	the	WKM.	Ultimately,	attempts	at	labelling	a	dormant	hematopoietic	population	in	the	zebrafish	were	unsuccessful.			
3.4.2 Irradiation	causes	inflammation	in	the	zebrafish	For	 HCT,	 recipients	 are	 depleted	 of	 resident	 hematopoietic	 populations	 to	 allow	 donor	 cells	 to	 engraft.	 In	zebrafish	models,	this	can	be	achieved	through	radiation	(135,	386).	The	literature	uses	a	variety	of	radiation	doses	(20-40	Gy).	Traver	et	al.	showed	that	a	dose	of	40	Gy	was	too	high	as	a	HCT	(5	x	105)	could	not	rescue	recipients	(135).	A	dose	of	30	Gy	(split	into	2	doses	of	15	Gy)	was	recommended	as	it	was	shown	to	result	in	good	engraftment	(45,	47).	The	split	dose	of	15	Gy	is	thought	to	be	more	effective	for	2	reasons:	firstly,	it	minimises	the	damage	to	less	radiosensitive	tissues	(47);	secondly	demand	for	hematopoiesis	is	driven	by	the	first	dose,	and	thus	the	second	dose	of	irradiation	will	target	the	activated	cells.	Finally,	as	de	Jong	et	al.	showed	that	the	sensitivity	(survival)	to	irradiation	was	dependent	on	the	line	of	zebrafish	(47),	it	was	decided	that	a	single	dose	of	30	Gy	and	2	doses	of	15	Gy	would	be	tested	on	multiple	WT	and	transgenic	lines.	However,	in	this	study	the	
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sensitivity	 of	 the	 lines	 was	 not	 determined	 by	 survival,	 therefore	 this	 factor	 cannot	 be	 compared.	 The	 Tg	(cd41:GFP),	 Tg	 (runx1+23:GFP)	 and	 Tg	 (runx1+23:NLSmCherry)	 were	 used	 to	 assess	 whether	 HSPCs	 were	depleted	by	the	dose.		The	 effect	 of	 30	 Gy	 irradiation	 on	 hematopoietic	 cells	 of	 the	WKM	was	 assessed	 24	 hours	 and	 5	 days	 after	treatment,	based	on	the	time	course	published	by	Traver	et	al.	in	which	they	show	the	myeloid,	lymphoid	and	precursor	 populations	 are	most	 significantly	 affected	 in	WT	 fish	 after	 exposure	 to	 20	 Gy	 (135).	 Our	 results	showed	a	similar	decrease	following	30	Gy	in	all	3	of	these	blood	populations,	both	24	hpIR	and	5	dpIR	(Figure	3.1C	and	Figure	3.2C).	There	was	no	difference	between	a	single	30	Gy	dose	or	when	this	was	split	into	2	doses	of	15	Gy	24	h	apart	in	WT	fish	(Figure	3.1C).	The	significantly	depletion	of	WKM	at	5	dpIR	may	be	the	reason	why	survival	only	begins	to	decline	from	7	dpIR	(Figure	3.7).		Traver	et	al.	 excluded	 the	erythrocyte	population	because	 they	 found	 too	much	variation	 	 (135),	which	 they	explain	is	due	to	the	limitations	of	dissecting	the	kidney	separate	to	the	dorsal	aorta	(although,	they	do	include	this	population	when	they	examine	the	recipients	post-transplant).	The	flow	cytometry	results	presented	here	showed	an	increase	in	erythrocytes	(Figure	3.1C	and	Figure	3.2C).	However,	subsequent	qRT-PCR	data	showed	a	significant	drop	in	the	erythrocyte	gene	gata1	in	irradiated	samples	at	24	hpIR	(Figure	3.4B).	This	suggests	that	the	 increase	 in	 erythrocytes	 is	 due	 to	 debris	 scatter	 and	 the	 relative	 decreases	 in	 percentages	 of	 myeloid,	lymphoid	and	precursors	populations.	Altogether,	this	data	shows	that	the	hematopoietic	cells	of	the	WKM	are	depleted	 following	 irradiation.	 These	 results	 gave	 cause	 to	 add	 PB	 in	 transplants	 that	 did	 not	 include	 a	heterogeneous	WKM	mix	or	which	contain	a	reduced	number	of	donor	cells.		Traver	et	al.	also	reported	a	slight	increase	in	the	myeloid	population,	which	they	suggest	was	due	to	the	relative	decrease	in	lymphoid	and	precursor	populations	(135).	The	results	of	the	experiments	done	with	a	variety	of	fish	lines	suggest	the	myeloid	population	did	not	change.	These	results	are	supported	by	qRT-PCR	data	from	whole	fish	samples	harvested	at	24	hpIR	(Figure	3.4B),	in	which	transcript	levels	of	l-plastin,	mpeg	and	mfap4	remained	unchanged.	 However,	 the	 increase	 in	myeloid	 cells	 observed	 by	 Traver	 et	 al.	 are	 supported	 by	 a	 significant	increase	in	transcript	levels	of	monocyte	and	macrophage	receptor	csf1ra	(Figure	3.4B).			The	difference	between	Traver	et	al.	findings,	and	the	results	presented	here	could	be	due	to	the	differences	in	irradiation	doses	(30	Gy,	while	Traver	et	al.	used	20	Gy).	It	may	also	be	due	to	the	limited	number	of	fish	examined	in	this	study	(n=3,	while	Traver	et	al.	used	n=21),	or	finally	it	may	be	the	difference	in	zebrafish	lines	as	reported	by	de	 Jong	(47).	 It	did	not	seem	necessary	 to	pursue	 these	results	 further	as	 it	was	clear	 the	 irradiation	was	having	an	effect	on	the	WKM.			In	mice	and	humans,	radiotherapy	is	used	to	kill	leukemic	stem	cells,	and	therefore	HSCs	are	likely	to	be	affected	by	the	treatment.	The	effect	of	irradiation	on	the	zebrafish	HSPC	population	was	assessed	by	irradiating	reporter	lines	 Tg	 (cd41:GFP),	 	 Tg	 (runx1+23:GFP)	 and	 Tg	 (runx1+23:NLSmCherry).	 To	 our	 knowledge,	 the	 effect	 of	
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irradiation	on	HSPCs	 in	 the	 zebrafish	has	not	been	 studied.	The	HSPC	populations	marked	by	 cd41:GFP	and	runx1:mCherry	were	significantly	decreased	after	24	h	(Figure	3.3B,	C,	D).	However,	the	runx1:GFP	population	was	 not.	 This	 might	 be	 due	 to	 the	 difference	 in	 sensitivity	 between	 the	 labelled	 populations.	 For	 instance,	cd41:GFP+	marks	both	thrombocytes	and	HSPCs.	The	significant	decrease	may	be	due	to	the	sensitivity	of	the	thrombocyte	 cells	 rather	 than	 the	 HSPCs.	 Distinguishing	 between	 cd41high	 and	 cd41low	 has	 been	 difficult	(Supplementary	 Figure	 7.4),	 however	 all	 attempts	 at	 splitting	 this	 population	 show	 that	 the	 decrease	 in	cd41:GFP+	cells	is	significant	for	both	cd41high	and	cd41low	populations.	Thus,	the	HSPC	population	is	likely	to	be	affected.			The	difference	between	Tg	(runx1+23:GFP)	and	Tg	(runx1+23:NLSmCherry)	 is	 the	NLS	which	sequesters	 the	fluorescent	protein	in	the	nucleus,	possibly	preventing	the	fluorophore	from	being	degraded,	and	thus,	although	cells	no	longer	express	runx1,	they	still	contain	the	dsRed	fluorophore	(42).	It	may	also	be	the	difference	in	the	half-life	 of	 these	 proteins.	 In	 any	 case,	 the	 runx1:NLSmCherry	 population	 is	 significantly	 bigger	 than	 the	runx1:GFP	population	(possibly	because	the	mCherry	protein	is	retained	in	cells	after	they	have	differentiated).	Runx1+23:NLSmCherry+	 cells	 probably	 include	 a	 multipotent	 progenitor	 population	 as	 well	 as	 HSCs.	 The	significant	decrease	in	the	runx1+23:NLSmCherry	population	following	irradiation	may	be	due	to	the	sensitivity	of	the	MMP	population,	which	likely	makes	up	a	higher	proportion	of	the	runx1+23:NLSmCherry+	population.		Additionally,	both	the	cd41:GFP+	and	runx1+23:NLSmCherry+	populations	were	significantly	decreased	5	dpIR	(Figure	3.3B,	D)	but	 the	 runx1+23:GFP	population	was	not	 (Figure	3.3C).	This	 result	might	 indicate	 that	 the	runx1+23:GFP+	 population	 is	 more	 resistant	 to	 irradiation.	 Together	 these	 results	 indicate	 that	 the	 HSPC	population	is	decreased	after	irradiation.	This	could	be	because	the	population	is	radiosensitive,	or	it	could	be	due	to	hematopoietic	production	(demand	driven	hematopoiesis)	following	the	depletion	of	progeny	myeloid,	lymphoid	and	precursors	cells.	However,	demand	driven	hematopoiesis	is	usually	accompanied	by	HSPC	self-renewal,	which	would	cause	this	population	to	increase.		As	previously	reported	in	the	mouse	(367-369),	the	transcript	 levels	of	cytokines	 il-1b,	 il-6,	and	tnfa	were	all	increased	in	irradiated	fish	24	h	after	two	doses	of	15	Gy	(Figure	3.5).	In	addition,	transcript	levels	of	cxcl-c1c,	a	neutrophil	chemokine,	were	increased.	CXCL-c1c	shares	40-50	%	sequence	similarity	with	many	human	proteins	of	the	CXCL	family,	with	CXCL10	(47.5	%)	and	CXCL8	(47.9	%)	being	the	most	similar	(387).	To	our	knowledge,	high	transcript	levels	of	this	gene	have	not	been	previously	reported	in	associated	with	irradiation.	However,	irradiation	is	known	to	cause	recruitment	of	immune	cells	(388)	and	therefore	it	is	perhaps	not	surprising	that	the	 neutrophil	 chemokine	 should	 be	 increased	 in	 irradiated	 fish.	 An	 ancestral	 genome	 duplication	 in	 the	zebrafish	 lineage	means	 that	many	 zebrafish	 genes	 are	 present	 twice.	 Because	 of	 this,	 the	 duplicated	 genes	sometimes	become	functionally	or	temporally	distinct.	This	could	explain	why	the	cytokine	ifnγ1.1	was	increased,	but	 the	 analogous	 ifnγ1.2	 remained	 unchanged.	 Interestingly,	 with	 view	 of	 this	 work	 involving	 HSCs,	 the	chemokine	cxcl12a	was	 increased	 in	 irradiated	 fish.	 	The	chemokine	CXCL12	 is	a	potent	 ligand	expressed	by	CXCL12-abundant	reticular	(CAR)	cells	in	the	mammalian	HSC	niche	that	is	essential	for	maintaining	HSCs	in	the	
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niche	 through	 binding	 with	 its	 receptor	 CXCR4	 (237).	 Zebrafish	 HSPC	maintenance	 is	 also	 regulated	 by	 an	analogous	CXCL12a-CXCR4	axis	(307).	High	transcript	levels	of	cxcl12a	in	the	irradiated	fish	could	have	a	bearing	on	 the	 behaviour	 of	 transplanted	 HSPCs	 into	 the	 irradiated	 recipient	 environment.	 One	 way	 to	 avoid	 the	confounding	factor	of	a	high	cytokine	milieu	would	be	to	use	bloodless	mutants	(46).	These	fish	could	also	be	used	to	determine	if	HSPC	behaviour	is	affected	by	the	chemokine	levels	in	irradiated	recipients.		Preliminary	work	with	these	bloodless	mutants	is	presented	in	this	chapter	(Figure	3.12).	As	described	by	Hess,	transplanted	c-mybt25127	mutants	were	indistinguishable	from	WT	fish	(46).	Like	Hess	et	al.	(46),	the	histological	sections	 performed	here	 show	 the	 kidney	 qualitatively	 devoid	 of	 blood	 cells	 in	 the	bloodless	mutant	 (Figure	3.11C).	The	post-transplant	reconstitution	of	the	mutant	system	was	compared	to	that	of	the	non-mutant	siblings	(preconditioned	with	irradiation).	It	was	hypothesised	that	c-mybt25127	mutants	would	be	superior	recipients	as	the	entire	hematopoietic	compartment	of	the	would	be	donor	derived.	However,	the	flow	cytometry	results	show	that	these	recipients	do	not	necessarily	reconstitute	a	comparable	hematopoietic	profile	to	that	of	their	donor	(Figure	3.13C).	For	 instance,	1	of	 these	recipients	did	not	have	any	 lyz:dsRed+	cells,	while	another	had	25	%	lyz:dsRed+,	similar	to	the	percentage	in	the	WKM	of	Tg	(lyz:dsRed)	fish.	These	results	are	difficult	to	explain	but	indicate	a	 loss	of	 the	 lyz:dsRed+	subset	of	 the	myeloid	population	 in	 this	recipient.	Perhaps	 the	 transplanted	donor	cells	have	lost	or	silenced	this	gene.	This	work	was	important	as	it	revealed	the	possibility	of	using	juvenile	TraNac	to	visualise	single	cells	in	the	transplant	recipient.		
3.4.3 Optimising	HCT	to	obtain	information	on	early	post-transplant	cell	behaviour		Current	“best-practise”	of	zebrafish	HCT	 is	done	by	RO	 injection.	This	protocol	was	amended	to	use	a	micro-injector	and	the	technique	verified	was	using	dextran,	a	glucan	used	as	a	tracer	because	it	marks	the	vasculature	by	 binding	 to	 the	 endothelium	 and	 erythrocytes.	 Typically,	 researchers	 use	 dextran	 systematically	 when	transplanting	into	zebrafish	recipients	of	HCT.	However,	due	to	the	long	lifetime	of	this	tracer,	it	was	interfering	with	accurate	counting	of	cells	in	the	WKM	at	early	time	points	post-transplant	and	therefore	had	to	be	omitted	from	 the	work	 done	 in	 this	 thesis.	 Because	 of	 this,	 the	 success	 of	 the	method	 could	 not	 be	 verified	 in	 each	transplant	recipient	and	so	it	is	possible	that	some	recipients	in	which	transgenic	cells	cannot	be	observed	post-	transplantation,	could	be	due	to	a	failure	in	transplanting	the	cells	correctly.	On	the	other	hand,	in	a	preliminary	experiment,	dextran	was	added	to	donor	cells	for	transplantation.	All	32	recipients	were	correctly	injected,	as	demonstrated	by	the	spread	of	dextran	throughout	the	recipient,	and	showed	similar	survival	and	reconstitution	to	fish	in	subsequent	experiments,	transplanted	without	dextran	for	verification.			Similar	to	the	experiments	presented	here,	transplanting	TraNac	with	105	WKM	cells	from	Tg	(ubi:GFP)),	White	
et	al.	had	transplanted	optically	transparent	mutant	line	casper	fish	with	105	b-actin:GFP+	WKM	cells	from	Tg	(b-actin:GFP)	(379).	They	found	that	it	took	2	weeks	before	they	could	observe	b-actin:GFP+	cells	in	the	WKM	of	these	fish.	In	the	experiments	presented	here,	individual	ubi:GFP+	cells	were	not	visible	in	the	WKM,	although	the	area	of	the	WKM	was	GFP+	under	a	fluorescent	microscope	at	14	dpt.	Furthermore,	White	et	al.	found	that	
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survival	to	24	dpt	was	50	%.	Similarly,	survival	of	transplant	recipients	of	105	ubi:GFP+	cells	was	45	%	at	24	dpt	(Figure	3.9D).			It	 is	 worth	 noting	 that	 all	 transplants	 presented	 here	 were	 done	 without	 immune	 matching	 (genetically	determining	MHCs).	De	Jong	et	al.	found	that	matching	class	I	MHC	genes	on	chromosome	19	between	donors	and	recipients	increased	engraftment	and	percentage	donor	chimerism	at	14	to	16	wpt	(47.86	%	±	30.9	%	and	10.51	%	±	19.88	%	for	myeloid	and	lymphoid	cells	respectively	compared	with	6.45	%	±	1.77	%	and	1.28	%	±	0.38	%	for	myeloid	and	lymphoid	cells	in	unmatched	fish)	(45).	The	same	group	expanded	these	initial	studies,	matching	class	I	genes	on	chromosome	19	(as	before)	and	chromosome	3,	as	well	as	matching	class	II	genes	on	chromosome	8	(47).	The	matching	of	genes	on	chromosomes	3	and	8	did	not	improve	on	the	donor	chimerism	(52.36	%	±	25.43	%	and	9.51	%	±	12.32	%	for	myeloid	and	lymphoid	cells	respectively	compared	with	11.58	%	±	7.03	%	and	3.47	%	±	4.60	%	for	myeloid	and	lymphoid	cells	in	unmatched	fish)	found	by	just	matching	MHC	genes	on	chromosome	19.	As	the	transplant	experiments	presented	here	were	not	protracted	for	14	to	16	weeks,	and	de	Jong	et	al.	used	50	to	75	000	b-actin:GFP+	WKM,	it	is	not	possible	to	compare	the	results.		Having	established	the	transplantation	technique	with	large	cell	doses	(up	to	106	WKM	cells)	from	Tg	(ubi:GFP)	donors,	 transplants	 were	 done	 using	 cd41:GFP+	 WKM	 cells	 from	 Tg	 (cd41:GFP;lyz:dsRed)	 fish.	 The	 Tg	(cd41:GFP;lyz:dsRed)	 donors	 allowed	 sorting	 of	 a	 HSPC	 enriched	 population	 for	 transplantation,	 and	 to	determine	the	contribution	of	cd41:GFP+	donor	derived	myeloid	cells	to	the	recipient’s	reconstituted	immune	system.			Small	(<1	cm)	recipients	were	used	to	facilitate	imaging.	Preliminary	experiments	found	that	the	lyz	negative	population	 produced	 hematopoietic	 cells	 in	 the	WKM	by	 8	 dpt	 (Figure	 3.15D).	 As	 cd41:GFP+	 cells	make	 up	approximately	0.5	%	of	the	WKM,	this	transplanted	population	contained	approximately	1000	cd41:GFP+	cells	(0.5	%	of	2	x	105	cells).	Subsequently,	irradiated	TraNac	fish	were	transplanted	with	2,000	cd41:GFP+	cells.		Live	 imaging	of	 the	recipient	 fish	revealed	 the	cd41:GFP+	cells	behave	 in	2	different	ways.	One	population	 is	highly	mobile,	(potentially	thrombocytes)	and	the	other	is	quite	sedentary	(potentially	HSPCs	or	TEPs).	These	hypothesises	are	supported	by	morpholino	experiments	by	Lin	et	al.	in	which	knock	down	of	stem	cell	factors	(scl	 and	 c-myb)	 could	 abolish	 the	 non-mobile	 cd41:GFP+	 population	 (29).	 In	 addition,	 morphologically,	cd41:GFPhigh	cells	resemble	mature	thromobocytes	while	cd41:GFPlow	cells	have	an	immature	phenotype	(29).		Ma	et	al.	also	reported	the	circulation	of	cd41:GFP+	cells	in	15	%	of	recipients	surviving	to	30	dpt	(51).	However,	their	observations	were	based	on	visualising	cells	in	the	tail	fin	at	30	dpt,	and	not	throughout	the	organism	at	early	time	points.	In	the	experiments	presented	here,	cd41:GFP+	cells	could	be	visualised	from	3	dpt	in	recipients	of	2,000	cd41:GFP+	cells	(Figure	3.17B).	This	is	particularly	important	as	in	some	cases	mobile	cd41:GFP+	cells	disappeared	in	recipients	that	had	these	cells	at	earlier	time	points.	Thus,	Ma	et	al.	underestimated	the	frequency	of	recipients	with	circulating	cd41:GFP+	cells.		
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While	recipients	of	the	lyz	negative	population	(cd41:GFP+/-	lyz:dsRed-)	of	Tg	(cd41:GFP;lyz:dsRed)	donors	had	both	 cd41:GFP+	 cells	 and	 lyz:dsRed+	 cells	 present	 post-transplant,	 the	 recipients	 of	 the	 double	 negative	population	(cd41:GFP-	lyz:dsRed-)	contained	very	few	cd41:GFP+	cells	post-transplant.	On	the	other	hand,	both	groups	 of	 recipients	 contained	 lyz:dsRed+	 cells.	 This	 suggests	 that	 the	 double	 negative	 population	 contains	myeloid	 precursors,	 that	 can	 differentiate	 from	 cd41:GFP-	 precursors,	 but	 do	 not	 contain	 precursors	 to	 the	cd41:GFP+	 population.	 Although	 the	 cd41:GFP+	 population	 produced	 lyz:dsRed	 cells,	 there	 is	 no	 evidence	whether	these	cells	represent	a	myeloid	bias	population	as	they	do	in	mice	(28).	In	order	to	investigate	bias	in	this	population,	these	fish	would	need	to	be	crossed	with	fish	containing	a	transgenic	marker	for	lymphoid	cells	(possibly	lck	or	rag).		All	fish	in	all	groups	presented	with	lyz:dsRed+	cells	around	the	site	of	transplant	(recipients’	eye).	These	cells	were	observed	earlier	(3	dpt)	in	recipients	of	the	double	negative	population.	This	may	be	because	the	double	negative	population	contains	more	myeloid	progenitors	than	the	cd41:GFP+	population.	The	cd41:GFP+	cell	must	first	differentiate	 into	a	myeloid	progenitor	and	then	a	mature	(lys:dsRed+)	myeloid	cell.	Lastly,	recipients	of	2,000	cd41:GFP+	cells	showed	similar	numbers	of	lyz:dsRed+	to	recipients	of	the	double	negative	population	at	5	dpt	(Figure	3.18A,	B).	This	suggests	that	the	cd41:GFP+	population	can	give	rise	to	myeloid	precursors	and	mature	myeloid	cells.			Finally,	both	irradiated	TraNac	and	c-myb	bloodless	mutants	have	improved	survival	if	they	receive	a	transplant	of	2,000	cd41:GFP+	cells	(Figure	3.19A,	B,	D,	E).	Survival	of	irradiated	TraNac	transplanted	with	double	negative	cells	is	extremely	low,	suggesting	that	ultimately	this	population	does	not	contain	enough	stem	cells	to	rescue	irradiated	recipients.	However,	this	population	can	rescue	bloodless	mutants	at	least	42	dpt	(Figure	3.19E).	The	difference	in	survival	between	the	TraNac	and	bloodless	recipients	transplanted	with	2000	cd41:GFP+	cells	 is	possibly	because	the	latter	do	not	have	irradiation-induced	damage	which	can	contribute	to	morbidity.	It	is	worth	noting	that	previously,	transplants	into	bloodless	recipients	have	used	much	higher	cells	numbers	(2	to	10	x	104)	and	all	recipients	were	rescued	with	these	doses.	These	experiments	using	<	2000	cd41:GFP+	cells	test	the	limits	of	the	cells’	capabilities	to	reconstitute	the	system.	Together,	this	data	shows	that	cd41:GFP+	cells	are	not	the	only	HSPC	containing	population	in	the	zebrafish,	and	that	the	cd41	negative	population	also	contains	cells	with	short	term	reconstitution	potential.		As	no	markers	are	available	to	select	for	cd41	negative	HSPCs,	experiments	continued	using	cd41:GFP+	cells	from	Tg	 (cd41:GFP;lyz:dsRed)	donors.	The	number	of	 cd41:GFP+	 cells	was	 titrated	 to	 establish	 a	minimal	dose	 at	which	HSCs	will	be	pushed	to	their	limit	(in	order	to	challenge	HSC	reconstituting	ability),	but	which	would	also	yield	good	quality	imaging	data.			Recipients	of	20	and	50	cd41:GFP	cells	had	very	low	survival	and	few	observable	cells	in	the	WKM	at	6	dpt	(Figure	3.21A,	B).	Ma	et	 al.	 reported	 that	10	 cd41:GFPlow	 cells	were	 enough	 to	 rescue	21	%	 (20	of	95)	of	 recipients,	although	only	3	%	(3	of	95)	survived	and	contained	donor	WKM	cells	(51).	Similarly,	the	results	presented	here	
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show	that	20	cd41:GFP	cells	(approximately	10	cd41low)	could	rescue	20	%	of	fish	(4	of	20)	to	28	dpt,	although	none	showed	engraftment	 (0	of	4).	Perhaps	 if	 a	greater	number	of	 transplants	were	done,	 the	 results	would	reflect	those	reported	by	Ma	et	al.	(51).	However,	these	transplants	were	not	performed	as	the	purpose	of	this	experiment	was	to	optimising	a	protocol	 in	which	cells	can	be	imaged	colonising	the	WKM	within	6	dpt.	Fish	receiving	a	dose	of	200	cd41:GFP	cells	showed	significant	survival	and	cells	were	visible	by	6	dpt.	Therefore,	this	was	the	set	up	used	for	the	next	2	results	chapters.		
3.4.4 Predicting	transplant	recipient	survival	The	most	novel	aspect	of	this	chapter	is	the	work	correlating	early	post-transplant	observations	with	survival.	Previously,	predicting	transplant	survival	has	been	based	on	animal	posture,	behaviour	and	colouring.	In	these	experiments,	only	a	third	of	irradiated	recipients	receiving	a	transplant	of	200	cd41:GFP+	cells	survived	to	28	dpt,	therefore	real	time	imaging	was	used	to	try	and	predict	reconstitution	outcome	and	reduce	suffering.	It	is	important	 to	note	 that	 imaging	causes	stress	 to	animals,	so	 the	benefits	of	 identifying	survival	markers	must	outweigh	 this	 distress.	 It	 is	 noteworthy	 that	 there	 is	 a	 lot	 of	 variability	 between	 recipients	within	 the	 same	experiment,	but	the	range	of	results	between	experiments	is	consistent.			In	this	work	the	period	from	8	to	12	dpt	was	 identified	as	one	of	high	morbidity	(35	%;	Figure	3.21C)	 in	the	irradiated	transplant	recipient,	regardless	of	the	presence	of	fluorescent	cells	(Figure	3.22A,	B).	It	is	hypothesised	that	the	procedural	steps	(radiation	damage,	injection	and	imaging)	are	possible	causes	for	this	early	morbidity	because	of	the	physical	stresses	as	well	as	the	chances	of	catching	an	infection.	It	is	proposed	that	interventions	to	increase	survival	be	made	in	the	days	(4	to	6	dpt)	prior	to	this	period.		Morbidity	in	the	longer	term	(after	a	couple	of	weeks)	can	be	attributed	to	failure	of	HSCs	to	perform	hematopoiesis	or	due	to	graft	versus	host	(GvH).	De	 Jong	et	al.	 have	 reported	 increased	donor	 contribution	and	 reduced	GvH	by	matching	histo-compatibility	complexes	between	donor	and	recipient	(45,	47).		When	attempting	to	correlate	survival	with	the	number	of	fluorescent	cells	present	in	the	WKM	at	6	dpt,	it	was	found	that	80	%	of	fish	that	die	before	10	dpt	have	fewer	than	10	cd41:GFP+	cells,	while	80	%	of	fish	that	survived	beyond	this	had	between	14	and	39	cd41:GFP+	cells.	Although	survival	and	the	number	of	cd41:GFP+	cells	did	not	correlate,	these	data	suggest	that	surviving	recipients	tend	to	have	more	cd41:GFP+	cells	in	the	WKM	early	post-transplant.	Similarly,	70	%	of	recipients	that	died	before	10	dpt	had	fewer	than	10	lyz:dsRed+	cells	in	the	WKM,	while	88	%	of	those	that	survived	longer	had	>17	fluorescent	cells	in	the	WKM.	The	survival	of	fish	with	fewer	than	10	fluorescent	cells	at	6	dpt	(Figure	3.22E)	could	reflect	the	low	number	of	fish	that	survive	despite	not	receiving	a	transplant	(Figure	3.7).			Together	these	data	suggest	that	there	may	be	a	case	for	humanely	killing	transplant	recipients	that	do	not	have	visible	 cells	 in	 the	WKM	 by	 6	 dpt.	 These	 fish	 may	 survive,	 but	 those	 that	 did	 survive	 did	 not	 show	 donor	hematopoietic	 contribution	at	28	dpt.	 In	 addition,	 recipients	with	 fewer	 than	25	 cells	 (sum	of	 cd41:GFP	and	lyz:dsRed)	can	be	humanely	killed	after	10	dpt	as	they	are	the	least	likely	to	survive	to	22	dpt.	Fish	with	at	least	
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70	fluorescent	cells	are	projected	to	survive	beyond	22	dpt	(Figure	3.22E).	This	indicates	that	early	occupation	of	the	WKM	is	important	for	recipient	survival.	The	reason	this	does	not	always	happen	is	not	yet	clear.	It	may	be	because	the	cd41	marker	isolates	a	population	that	does	not	contain	enough	true	HSCs	so	that	there	are	too	few	of	these	cells	in	a	mix	of	200	cells.		
3.4.5 Cycling	kinetics	in	the	cd41:GFP+	population	Despite	 the	zebrafish	being	an	 important	model	 in	 the	study	of	malignant	hematopoiesis	and	 in	 the	study	of	hematopoietic	stem	cell	generation	at	the	onset	of	definitive	hematopoiesis,	difficulty	remains	in	the	isolation	of	HSCs	from	the	kidney	marrow	of	this	organism.	Previous	studies	have	attempted	to	enrich	the	HSPC	population	by	partitioning	the	cd41:GFP+	population	into	high	and	low,	based	on	GFP	expression.	It	was	found	that	both	cd41high	and	cd41low	could	reconstitute	the	immune	system	(Supplementary	Figure	7.4)	and	therefore	I	chose	to	do	all	experiments	without	splitting	this	population.	In	order	to	improve	upon	the	limited	markers	available,	a	BrdU	 label	 retention	 assay	was	 explored	 to	 determine	 if	 a	 distinction	 could	 be	made	 between	 high	 and	 low	expression	of	cd41:GFP+	cells	based	on	the	cycle	kinetics	of	the	HSPC	population	isolated	by	cd41	expression.	Various	attempts	(injection,	swimming,	timing,	fish	maturity)	were	made	at	labelling	a	dormant	population	in	the	zebrafish.	However,	none	of	the	combinations	tried	were	successful	(Figure	3.23).	The	major	problem	with	the	method	is	that	BrdU	is	cytotoxic	and	causes	cells	to	die.	Labelled	cells	loose	BrdU	during	the	chase	period	due	to	mitotic	divisions.	However,	cells	may	also	be	removed	if	they	are	targeted	for	phagocytosis.	Another	problem	was	 that	 too	 few	cells	were	 labelled	during	 the	pulse.	Kiel	et	al.	have	also	reported	difficulties	using	BrdU	 in	neonatal	mice	(75).	They	found	that	only	0.5	%	of	the	6	%	of	BrdU	labelled	cells	were	expressing	HSC	markers.	Other	methods	for	labelling	slow	cycling	cells	is	using	an	inducible	histone	2B-GFP	method	(72,	73).			
3.5 Conclusion	The	aim	of	this	thesis	is	to	assess	the	response	of	HSCs	under	conditions	of	inflammation.	This	will	be	done	using	side-by-side	 comparisons	 of	 donors	 and	 recipients	 in	 transplantation	 studies.	 HSCs	 will	 be	 exposed	 to	inflammation	 either	 prior	 to	 (in	 donors)	 or	 post	 (in	 recipients)	 transplantation.	 This	 chapter	 outlines	 the	groundwork	necessary	to	address	this	question;	essentially	establishing	a	transplant	and	imaging	procedure	to	obtain	early	post-transplant	information.			The	data	present	here	demonstrates	that	cells	can	be	imaged	in	the	WKM	of	irradiated	recipients	of	200	cd41:GFP	cells	 at	6	dpt.	For	 this	 reason,	 fish	will	be	assessed	4,	6	and	8	dpt	 to	determine	 if	HSC	behaviour	 changes	 in	treatment	conditions.	Through	the	establishment	of	 this	protocol,	 factors	such	as	time	 (for	acquiring	 imaging	data),	space	 (required	to	house	 fish	 individually	over	 the	course	of	 the	experiment),	and	high	morbidity	have	meant	that,	for	future	experiments,	data	should	be	acquired	by	multiple	experimental	repeats	with	low	numbers	of	fish.		
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This	chapter	also	acknowledges	that	post-transplant	deaths	before	10	dpt	are	not	predictable	by	imaging	cells	in	the	WKM	at	6	dpt.	However,	it	seems	that	deaths	that	occur	between	10	and	20	dpt	can	be	reduced	by	culling	fish	that	have	 fewer	 than	a	 total	of	25	 cells	 in	 the	WKM	by	6	dpt.	This	 information	 is	useful	 for	 reducing	animal	suffering	and	the	severity	of	this	protocol	under	UK	Home	Office	regulations.	 	
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4 Post-transplant	behaviour	of	HSCs	from	donors	with	systemic	inflammation		
4.1 Introduction	Previous	studies	have	shown	that	hematopoiesis	is	affected	by	inflammation	and	infection,	and	that	HSCs	sense	and	respond	to	these	signals	directly	and	indirectly	(194,	389,	390).	It	is	necessary	to	understand	the	molecular	mechanisms	that	control	HSC	self-renewal	and	differentiation	in	order	to	fully	understand	the	potential	of	HSCs	in	 clinical	 applications.	 Although	 examining	 HSCs	 in	 the	 endogenous	 host	 provides	 information	 about	 the	systemic	effects	of	poly	I:C,	it	does	not	yield	information	about	the	effect	of	this	stimulation	on	the	self-renewal	capacity	of	the	stimulated	HSCs.	Examining	HSC	behaviour	in	the	transplant	recipient	effectively	separates	the	direct	 effects	on	 this	population	 from	 the	 indirect	 effects	on	 the	niche	and	 the	hematopoietic	 system.	 In	 this	results	chapter,	irradiated	recipients	were	transplanted	with	cd41:GFP+	HSPCs	from	poly	I:C	injected	or	saline	injected	donors.	Transplantation	is	used	as	a	regenerative	challenge	to	assess	HSPCs	taken	from	stimulated	and	non-stimulated	environments.	This	results	chapter	benefits	from	the	imaging	protocol	developed	in	the	previous	chapter	and	reports	on	the	early-post	transplant	hematopoietic	cell	behaviour.			
4.1.1 The	effect	of	inflammation	on	HSCs	As	previously	discussed	in	the	 introduction	chapter,	 immune	cells	are	responsible	 for	resolving	 infection	and	injury	and	cytokines	play	a	major	role	in	the	regulation	of	the	response.	There	is	growing	evidence	that	HSCs	also	respond	to	infection	through	direct	and	indirect	mechanisms	and	this	profoundly	affects	how	they	behave.	Direct	mechanisms	include	direct	infection	and	direct	recognition	of	a	pathogen.	Indirectly,	HSCs	respond	to	cellular	demand,	macrophage	egress	from	the	BM	and	cytokine	detection	(358,	359).			
4.1.2 Choosing	a	model	to	induce	inflammation	in	the	zebrafish	For	this	study	it	was	necessary	to	choose	an	inflammatory	model	to	cause	systemic	inflammation	throughout	the	whole	 hematopoietic	 compartment.	 As	 mentioned	 in	 the	 introduction	 chapter	 1.7,	 many	 lifestyle	 factors	including	smoking	and	diet	 (for	which	 there	are	zebrafish	models	(391,	392)),	appear	 to	detrimentally	affect	hematopoiesis.	 However,	 these	 models	 require	 weeks	 of	 exposure	 to	 develop	 a	 chronic	 inflammation.	Furthermore,	they	require	extensive	time	to	optimise.	For	these	reasons,	a	simpler	model	was	sought.	There	are	a	number	of	publications	which	use	poly	I:C	(76,	333,	393),	a	synthetic	viral	mimic,	to	induce	a	controlled	anti-virus-like	 inflammatory	response	in	the	mouse.	This	viral	mimic	model	was	chosen	as	the	amount	of	poly	I:C	could	easily	be	manipulated	and	the	findings	would	be	supported	by	and	build	on	literature	in	the	field.			
4.1.3 Inflammation	with	Poly	(I:C)	Poly	I:C	is	a	synthetic	double	stranded	structure	of	inosinic	and	cytidylic	polymers	used	to	mimic	viral	RNA	and,	therefore,	viral	infections.	A	variant	of	this	compound	is	the	more	stable	Poly	ICLC.	Viral	components,	such	as	
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double	 stranded	RNA	 (dsRNA)	 are	 recognised	 by	membrane	 bound	TLRs	 or	RLHs	 (394).	 This	 results	 in	 the	production	of	cytokines,	in	particular	type	I	interferons	(76,	333,	393),	which	induce	apoptosis	of	infected	cells,	cellular	resistance	to	infection	and	activation	of	NK	and	T	cells	(394).		TLR3	recognises	both	dsRNA	and	the	synthetic	mimic	poly	I:C	(395).	In	zebrafish,	poly	I:C	is	also	recognised	by	TLR22,	a	TLR	only	in	aquatic	animals	(396).	Phylogenetic	analysis	reveals	the	zebrafish	genome	contains	at	least	one	homolog	of	each	of	the	human	TLRs,	 including	TLR3	(397).	Clustering	of	human,	pufferfish	and	zebrafish	TLR	sequences	showed	a	highly	conserved	TLR3	sequence	across	the	3	species.	Gene	expression	analysis	by	M.	Wane	(Dallman	lab,	personal	communication)	shows,	at	the	transcript	level	at	least,	TLR3	is	expressed	in	the	gill,	heart,	spleen,	liver,	gut	and	WKM	of	the	zebrafish.	
	
Figure	4.1:	Cell	detection	of	double	stranded	RNA	or	poly	I:C	through	TLRs	or	RLHs.	Adapted	from	Takeuchi	et	al.	and	DuFour	et	
al.;	 Acronyms	described	 in	 text.	Membrane	bound	TLR	3	 recognises	 intra	 and	 extra-cellular	double	 stranded	RNA.	Adaptor	
protein	TRIF	transmits	signal	to	kinases	(IKK,	TAK,TBK1)	to	phosphorylate	transcription	regulators	(IRF-3,	NFkB,	AP-1).	TLR	3	
also	dimerises	and	recruits	c-Scr	which	causes	cell	mobility	when	phosphorylated;	Cytosolic	RLHs	(RIG-I	and	MDA5)	also	bind	
dsRNA	and	recruit	IPS-1.	Ubiquitination	and	TRAF3	are	required	for	activation	of	IPS-1	signalling	pathways.	On	one	hand,	TRAF3	
recruits	kinases	(TBK1,	IKK-i)	to	phosphorylate	transcriptional	regulators	(IRF-3	and	IRF-7).	IPS-1	and	TRAF3	also	regulate	a	
FADD	and	caspase-8/caspase-10-dependent	pathway	for	the	activation	of	NFkB.		
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Ligand	binding	 to	TLR3	 causes	 activation	of	 two	pathways	 (Figure	4.1).	One	of	 these	 is	 through	 the	adaptor	protein	TIR-domain-containing	adapter	inducing	interferon	b	(TRIF)	to	signal	to	kinases	TGF-b	activated	kinase	(TAK1),	IkB	kinase	(IKK),	and	TANK-binding	kinase	1	(TBK1).	Together	these	induce	transcription	factors	IRF-3,	NfkB	and	AP-1	which	 induce	transcription	of	many	 inflammatory	genes.	 In	a	second	pathway,	reported	by	Johnsen	et	al.,	TLR3	also	recruits	the	oncogene	c-Src	(398).	C-Src	is	a	non-receptor	tyrosine	kinase	regulated	by	phosphorylation.	Yamashita	et	al.	reported	that	in	vitro	poly	I:C	treatment	of	various	cell	types	(including	bone-marrow	derived	primary	macrophages)	caused	c-Src	activation	which	led	to	biphasic	cell	mobility;	initially	cell	migration	was	increased,	but	following	4	h	exposure	was	significantly	suppressed	(395).	They	showed	that	the	suppressed	migration	was	due	to	the	translocation	of	active	c-Src	from	the	cytoplasm	to	lipid	rafts.	Together	this	suggests	that	poly	I:C	could	have	a	measurable	effect	on	the	early	post-transplant	behaviour	of	HSCs.		Cytosolic	 sensors	 include	 PKRs	 (protein	 kinase	R;	 dsRNA	 activated	 protein	 kinase)	 and	RLHs	 (retinoic	 acid-inducible	gene-I	(RIG-I)	and	melanoma	differentiation-associated	gene	5	(MDA5)),	which	are	also	 involved	in	detecting	viral	infections.	Specifically,	MDA5	recognises	poly	I:C.	RLHs	bind	with	dsRNAs	through	the	helicase	domain	 and	 this	 stimulates	 the	 interaction	 with	 	 IFN-b	 	 promoter	 stimulator	 1	 (IPS-1).	 IPS-1	 signalling	 is	mediated	by	ubiquitination	of	TNF-receptor	associated	factor	3	(TRAF3).	TRAF3	recruits	and	activates	TBK1	and	IKK	to	phosphorylate	IRF-3	and	IRF-7.	Phosphorylated	IRFs	allows	nuclear	translocation	and	transcription	of	type	 I	 interferon	genes.	 IPS-1	signalling	 is	also	mediated	by	FAS-associated	death	domain-containing	protein	(FADD)	and	caspases	8	and	10	which	activate	NfkB	and	its	downstream	targets	(399).	The	endonuclease	RNase	L	is	activated	by	the	virus	to	cleave	self	RNA.	These	small	RNAs	are	recognised	by	the	RLHs	and	responsible	for	interferon	production.	 	Single	 strand	RNA	virus	 infection	models	 support	 a	 role	 for	TLRs,	 and	not	RLHs,	 in	 instructing	 the	 adaptive	immune	system.	For	instance,	production	of	B-	and	CD4+	T-cells	against	the	influenza	virus	is	dependent	on	the	presence	of	MyD88	but	not	IPS-1	(400).	Further	studies	are	required	to	determine	if	this	applies	more	generally	to	all	viruses.				
4.1.4 The	effect	of	interferons	on	HSC	Type	I	IFNs	(predominantly	IFNa	and	b	in	mammals,	IFNφ	in	zebrafish)	can	be	produced	by	most	cells	and	are	responsible	for	inducing	transcription	of	a	large	number	of	genes	which	activate	the	immune	system	by	binding	to	a	specific	cell	surface	receptor	IFNAR.	Type	II	IFNs	(IFNg	in	mammals	and	zebrafish)	are	produced	by	adaptive	immune	cells	(T	and	NK	cells)	and	bind	IFNGR.	IFNg	activates	macrophages	and	induces	class	II	MHC	expression	on	APCs.			
4.1.4.1 Type	I	Interferons	Type	1	 IFNs	paradoxically	 induce	cell	 cycle	arrest	 in	human	HSPCs	 (CD34+)	 in	vitro	 (401)	and	cell	 cycling	of	mouse	HSPCs	(LSK	CD150+	CD48-)	 in	vivo	(76,	333).	HSCs	(CD34-	LSK)	produce	 the	highest	 levels	of	 IFN-2,	a	
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negative	 regulator	 of	 type	 I	 IFN	 signalling,	 indicating	 that	 preventing	 type	 I	 IFN	 signalling	 is	 important	 for	maintaining	this	population	(360).	IFNa	has	been	shown	to	induce	proliferation	of	dormant	HSCs	in	mice	and	exhaustion	of	HSCs	after	4-5	round	of	serial	 transplantation	(76).	Constitutive	 type	 I	 IFN	signalling	(in	 IFN-2	knock	out	mice	 (393)	and	 in	mice	expressing	 IFNα	under	 the	control	of	a	constitutive	promoter	on	a	adeno-associated	viral	vector	(402))	causes	a	significant	loss	in	LT-HSCs	(LK	CD150+	CD48-),	ST-HSCs	(LK	CD150-	CD48-)	and	MPPs	(LK	CD150-	CD48+)	(393,	402).	In	addition,	IFN-2	knock	out	mice	are	more	sensitive	to	the	ablative	effect	 of	 5-FU,	 probably	 because	 IFN	 signalling	 has	 increased	 cell	 cycling	 in	 the	 hematopoietic	 compartment	(393).		Pietras	et	al.	found	that	the	balance	between	proliferative	and	suppressive	effects	came	from	the	magnitude	of	the	exposure	(107).	Acute	IFN	treatment	(induced	by	a	single	injection	of	10	µg	g-1	poly	I:C)	causes	proliferation,	but	with	chronic	exposure	(10	µg	g-1	poly	I:C	daily	up	to	30	days)	HSCs	return	to	a	quiescent	state.	They	showed	that	repeated	treatment	did	not	exhaust	HSCs	unless	these	cells	were	forced	to	replicate	in	regenerative	assays,	for	instance	in	cell	culture	or	transplant	conditions.			Essers	et	al.	(76)	found	using	a	BrDU	label	retaining	assay	that	in	vivo,	poly	I:C	increased	HSC	(LSK	CD150+	CD48-)	cell	cycling	 in	WT	but	not	 in	 IFN-α	receptor	knock	out	mice	(INFAR1-/-).	Work	by	Sato	et	al.	 supported	these	findings.	 Sato	 et	 al.	 transplanted	 irradiated	 recipients	 of	WT	 or	 INFAR1-/-	HSCs.	 They	 subsequently	 injected	recipients	with	poly	I:C	(4	times	300	µg	at	48	h	intervals,	then	2	weeks	recovery)	and	found	cell	cycling	of	WT	HSCs,	but	not	of	INFAR1-/-	HSCs,	indicating	a	direct	effect	on	HSCs	(393).	Furthermore,	in	competitive	transplant	assays,	WT	HSCs	outcompete	 IRF2-/-	 (constitutive	 type	 I	 IFN	signalling)	HSCs,	but	 this	phenotype	 is	 reversed	when	WT	compete	with	IRF2-/-	INFAR1-/-	HSCs	(constitutive	type	I	IFN	signalling	but	no	receptor	for	type	I	IFN)	(393).	Together	this	shows	that	interferon	signalling	causes	HSC	cell	cycling	that	is	detrimental	to	HSC	function.		Essers	et	 al.	 ruled	 out	 a	 stromal	 effect	 by	 showing	 that	 transplanted	WT	HSCs	were	 activated	by	poly	 I:C	 in	INFAR1-/-	knock	out	recipients.	To	show	that	HSCs	were	functionally	affected	by	IFN-α,	the	group	transplanted	3	x	107	bone	marrow	cells	from	WT	or	INFAR1-/-	donors	that	had	previously	been	injected	8	times,	at	48	h	intervals,	with	 10	 μg	 g-1	 poly	 I:C	 into	 lethally	 irradiated	 recipients.	 They	 found	 that	while	 both	 recipient	 groups	were	successfully	 reconstituted,	 donor	 WT	 HSCs	 were	 disadvantaged	 in	 competitive	 assays	 compared	 to	 donor	INFAR1-/-	HSCs.	At	22	dpt,	only	 INFAR1-/-	HSCs	 (LSK	CD150+	CD48-)	were	present	 in	 recipient	bone	marrow.	These	results	indicated	that	poly	I:C	affected	the	biology	of	WT	HSCs	such	that	their	regenerative	capacity	was	inferior	to	the	INFAR1-/-	HSCs	which	were	advantaged	because	they	did	not	respond	to	the	poly	I:C	stimulation.	The	paper	did	not	report	on	how	INFAR1-/-	HSCs	cope	in	the	long	term	to	hematopoietic	challenges.	It	should	be	noted	that	the	transplant	is	of	a	large	heterogeneous	bone	marrow	population	so	the	IFN-α	effect	is	on	more	than	just	HSCs.	This	paper	was	used	as	the	basis	for	establishing	the	inflammatory	model	for	poly	I:C	treated	donors	in	this	thesis.		
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4.1.4.2 Type	II	Interferons	Type	II	IFNs	are	expressed	by	activated	T	and	NK	cells	and	have	also	been	shown	to	affect	HSCs	(334,	355,	403,	404).	Both	in	vitro	and	in	vivo	label	retaining	assays	(CFSE,	BrdU)	showed	that	IFNγ	caused	an	increase	in	HSC	proliferation	(334,	355,	404).	MacNamara	et	al.	have	studied	the	effect	of	Ehrlichia	muris,	an	inducer	of	IFNγ,	in	HSCs	of	mice(257,	404).	During	the	acute	infection	there	is	an	expansion	of	the	progenitor	(LSK)	compartment	and	 HSC	 (LSK	 CD34-	 CD135-)	 population.	 Similarly,	 Balbridge	 et	 al.	 used	 a	 model	 of	Mycobacterium	 avium	infection	to	study	the	effect	of	IFNγ	signalling.	After	4	weeks	of	M.	avium	infection,	LT-HSCs	(LSK	CD34-	CD135-),	ST-HSCs	and	MPP	populations	increased	(355).	In	both	cases,	IFNγ	signalling	is	important	as	the	LSK	and	HSC	populations	do	not	expand	in	infected	IFNγ	receptor	knock	out	mice	(IFNGR-/-).	Together	there	is	evidence	that	IFNγ	causes	cell	cycling	but	not	to	the	same	detrimental	extent	as	type-I	IFNs.		De	Bruin	et	al.	studied	the	effect	of	the	Armstrong	strain	of	lymphocytic	choriomeningitis	virus	(LCMV)	on	HSCs	(LK	CD150+	CD48-)	in	WT	and	IFNGR-/-	HSCs	(334).	Again,	they	showed	IFNγ	signalling	is	important	as	they	found	hematopoiesis	in	IFNGR-/-	mice	recovered	by	8	days	post	infection,	while	hematopoiesis	took	12	days	to	recover	in	infected	WT	mice.	These	results	support	the	notion	that	IFNγ	has	a	temporary	negative	effect	on	hematopoiesis	of	HSCs	in	vivo.			Indeed,	when	these	mixed	chimeras	were	infected	with	LCMV,	the	frequency	of	IFNGR-/-	HSCs	(LSK	CD150+	CD48-)	was	higher	than	WT	HSCs	at	8	and	12	days	(334).	On	the	other	hand,	a	similar	experiment	by	McCabe	et	al.	found	that	when	chimeric	recipients	(60	%	IFNGR-/-	HSCs,	40	%	WT	HSCs)	were	infected	with	E.	muris	6	weeks	after	transplant,	there	was	no	change	in	the	frequency	of	WT	or	IFNGR-/-	HSCs	(LK	CD150+	CD48-)	in	these	recipients	(257).	These	confounding	 results	may	be	due	 to	 the	difference	 in	 the	 levels	of	 IFNγ	 induced	by	 the	different	modelling	approaches.			In	non-competitive	transplant	assays,	WT	donors	contributed	to	60	%	of	recipient	PB	while	in	recipients	of	HSCs	from	E.	muris	infected	donors	at	8	and	16	days	post	infection,	10	%	and	35	%	respectively	were	donor	derived.	Similarly,	Baldridge	et	 al.	 transplanted	HSCs	 from	mice	 injected	with	 recombinant	 IFNγ	 and	 found	a	modest	impairment	in	recipient	reconstitution	compared	with	recipients	of	HSCs	from	non-injected	mice	(355).	Both	of	these	results	indicate	that	WT	HSCs	perform	better	than	IFNγ-treated	HSCs	although	they	were	not	assessed	in	a	competitive	assay.			One	study	has	compared	IFN	treated	HSCs	with	untreated	HSCs	in	a	competitive	transplant	assay.	In	this	study,	HSCs	(LK	CD150+	CD48-)	were	cultured	in	media	with	and	without	IFNγ.	They	found	that	IFNγ	treated	HSCs	could	not	compete	against	untreated	HSCs(334).	These	results	confirm	the	non-competitive	transplant	assays	above	and	are	supported	by	the	finding	that	IFNGR-/-	HSCs	have	a	competitive	advantage	over	WT	HSCs	in	competitive	transplant	 assays	 (334,	 355,	 404).	 Altogether	 this	 suggests	 that	 IFNγ	 is	 detrimental	 to	 HSC	 function	 in	regenerative	assays.		
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4.1.5 Inflammation	in	the	donor	affects	early	post-transplant	behaviour	of	HSPCs	Currently,	 not	much	 is	 known	 about	 the	 early	 post-transplant	 behaviour	 of	 HSPCs	 from	 donors	 affected	 by	infection	and	inflammation.	One	study,	by	Rashidi	et	al.,	examined	the	effect	of	Trichinella	spiralis	 infection	in	mice	in	vivo	(122).	They	found	that	this	natural	pathogen	caused	short	term	changes	to	hematopoiesis	(increasing	lymphoid	and	reducing	myeloid	populations)	but	that	homeostasis	was	re-established	within	28	days.	During	the	infection	cycle,	the	LT-HSC,	ST-HSC	and	MPP	populations	did	not	appear	to	be	affected,	indicating	that	the	effect	of	inflammation	cannot	always	be	determined	by	changes	in	hematopoiesis.	However,	using	competitive	repopulation	assays,	they	found	that	bone	marrow	mononuclear	cells	from	infected	donors	had	a	reconstitution	advantage	over	controls	both	in	the	short	term	and	long	term.	They	used	intra-vital	microscopy	of	the	calvarium	bone	marrow	to	image	the	behaviour	of	DiD-labelled	HSCs	(LSK	CD34-	CD135-)	from	control	and	infected	donors	
in	 vivo.	 They	 found	 that	 HSCs	 from	 uninfected	 mice	 would	 stably	 engage	 with	 niche	 cells.	 However,	 HSCs	harvested	during	acute	infection	were	very	motile	and	would	interact	with	a	more	diverse	population	of	niche	cells.	Most	interestingly,	the	movement	of	control	HSCs	was	restricted	and	circular	while	half	of	the	stimulated	HSCs	migrated	within	the	field	of	view,	as	though	scanning	the	tissue.	Finally,	unlike	the	studies	of	 infections	resulting	 in	 interferon	 production	 (poly	 I:C,	 E.	 muris,	 LCMV,	M.	 avium)	 they	 found	 that	 T.	 spiralis	 infection	improved	HSC	reconstitution	ability	in	the	transplant	recipient.	Altogether,	this	data	suggests	that	early	post-transplant	behaviour	is	linked	to	engraftment	and	transplant	outcome.		
4.2 Aims	The	aim	of	this	chapter	is	to	assess	the	engraftment	of	HSCs	after	extended	exposure	to	poly	I:C.	As	described	above,	 the	 effect	 of	 inflammatory	 stimuli	 cannot	 always	 be	 determined	 by	 the	 abundance	 of	 immature	populations	 (LSK;	 LSK	 CD150+	 CD48-)	 after	 infection	 or	 inflammation.	 Therefore,	 in	 this	 results	 chapter,	transplantation	 was	 used	 as	 a	 regenerative	 stress	 to	 better	 assess	 the	 growth	 of	 the	 cd41:GFP	 precursor	population.	In	these	experiments,	donors	were	injected	8	times,	at	48	h	intervals,	with	poly	I:C	so	that	HSCs	were	exposed	to	an	inflammatory	stimulus	prior	to	transplantation	into	an	irradiated	recipient.	As	in	chapter	4,	the	number	of	transplanted	cells	was	restricted	to	200	cd41:GFP+	cells	to	place	an	additional	regenerative	stress	on	the	 cells.	Mobility,	 self-renewal	 and	 differentiation	were	 assessed	 visually	 at	 early	 post-transplantation	 time	points	(4,	6	and	8	dpt)	throughout	the	organism.		In	addition,	survival	was	assessed	and	flow	cytometry	was	used	to	compare	engraftment	and	reconstitution	at	28	dpt.			More	specifically,	the	aims	were	to:	1. Investigate	the	acute	inflammatory	response	to	poly	I:C	in	the	WKM	of	zebrafish.	2. Examine	the	inflammatory	and	hematopoietic	response	following	repeated	exposure	to	poly	I:C	3. Observe	the	behaviour	of	HSCs	(cd41:GFP+)	in	the	transplant	recipient	and	assess	how	pre-treatment	with	poly	I:C	affects	this	early	behaviour	4. Determine	transplant	success	based	on	hematopoietic	response	and	morbidity	of	recipients		 	
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4.3 Results	
4.3.1 Establishing	systemic	inflammation	in	the	zebrafish	with	poly	I:C	In	order	to	begin	studying	the	effect	of	inflammation	on	HSCs,	it	was	first	necessary	to	establish	a	protocol	that	would	induce	systemic	inflammation	in	the	zebrafish.	There	were	a	number	of	immune-stimulants	available	in	the	lab	(diet,	silica,	cigarette	smoke,	tail	transections).	However,	poly	I:C	was	chosen	as	it	is	commonly	used	in	mouse	studies	and	easily	regulated	(the	dose	and	method	of	delivery	are	easily	adjusted).			Initially,	TraNac	fish	were	used	to	establish	a	dose	which	would	cause	a	systemic	response	and	permit	recurring	treatment.	Fish	received	a	single	intra-peritoneal	injection	of	5	μL	containing	1,	10	or	50	μg	of	poly	I:C,	or	a	5	μL	injection	of	saline.	Fish	were	harvested	3	h	after	the	injection	to	compare	with	results	in	the	literature	(Figure	4.2A).	mRNA	levels	were	measured	in	various	organs	(405),	including	the	WKM.	As	before,	transcript	levels	were	determined	using	the	DDCT	method,	normalised	to	18S	expression	(see	chapter	2.9.3).			The	results	show	that	all	3	doses	of	poly	I:C	induced	a	cytokine	response	in	the	WKM,	and	in	general	the	greatest	response	was	induced	by	the	50	μg	dose,	with	the	exception	of	ifnγ1.1	and	ifnγ1.2	(Figure	4.2B).	Il-1β	was	greater	than	125	fold	upregulated	in	fish	injected	with	50	μg	poly	I:C,	and	20	fold	in	recipients	of	10	μg	poly	I:C.	Tnfα	was	almost	100	fold	upregulated	in	fish	injected	with	50	μg,	and	»15	fold	in	recipients	of	10	μg	poly	I:	C.	The	cytokine	
il-6	was	also	upregulated,	with	transcript	levels	over	150	fold	higher	than	saline	controls	in	response	to	50	μg	(and	almost	50	fold	higher	in	response	to	10	μg),	and	the	chemokine	il8	transcript	level	was	increased	»40	times	in	response	to	50	μg	poly	I:C	(and	»20	times	in	response	to	10	μg).		Poly	I:C	is	also	an	inducer	of	type	I	and	II	IFNs.	In	zebrafish,	the	type	I	interferon	is	ifnφ	and	the	type	II	IFNs	are	
ifnγ1.1	 and	 its	 homologue	 ifnγ1.2.	 The	 results	 show	 that	 ifnφ	 is	 significantly	 upregulated	 (over	 100	 fold	 in	response	to	50	μg	poly	I:C	and	»50	fold	in	response	to	10	μg	poly	I:C).	Type	2	IFNs	ifnγ1.1	and	ifnγ1.2	were	also	slightly	induced	by	the	poly	I:C	stimulation.	In	both	cases,	the	lower	dose	of	10	μg	poly	I:C	(»20	fold,	»50	fold	respectively)	 induced	 a	 similar	 level	 of	 cytokine	 transcription	 to	 the	 50	μg	 poly	 I:C	 dose	 (»10	 fold,	»40	 fold	respectively).		The	HSC	chemokine	cxcl12a	was	also	measured	 in	 the	WKM	as	 it	 is	an	 important	signalling	molecule	 for	 the	mobilisation	of	HSPCs.	The	results	show	that	there	was	no	change	in	the	levels	of	cxcl12a	in	the	WKM	3	h	after	poly	I:C	stimulation	(Figure	4.2C).	The	level	of	runx1	transcript,	used	as	a	marker	for	the	HSPC	population,	also	did	not	change.		
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Figure	4.2:	A	single	injection	of	poly	I:C	causes	
inflammatory	 cytokine	 expression	 in	 the	
WKM	by	3	h.	Tg	 (cd41:GFP)	 fish	were	 injected	
with	either	saline	or	50,	10	or	1	μg	poly	I:C	and	
humanely	killed	3	h	after	injection.	(A)	Protocol	
overview.	 (B)	 RNA	 was	 extracted	 from	
dissociated	WKM	tissue	and	qRT-PCR	was	used	
to	measure	relative	expression	of	cytokines	il-1β,	
tnf⍺,	il-6,	ifnφ,	ifnγ1.1,	ifnγ1.2,	cxcl-c1c	and	cxcl8	
using	the	DDCT	method	(normalized	to	18S	and	
fold	change	relative	to	the	median	PBS	value.)	(C)	
Relative	 expression	 of	 HSC	 chemokine	 cxcl12a	
and	HSC	marker	runx1.	Single	experiment,	n=3.	
Statistical	 significance	 using	 One-way	 ANOVA	
and	 Tukey	 post-test.	 *	 p<0.05,	 **	 p<0.01,	 ***	
p<0.001.			
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4.3.1.1 A	repeated	stimulation	with	10	μg	of	poly	I:C	causes	an	increase	in	erythrocytes	in	the	spleen	but	does	not	
affect	blood	populations	of	the	kidney	marrow	The	subsequent	experiments	were	done	using	a	dose	of	10	μg	poly	I:C	as	it	caused	a	moderate	cytokine	response	so	 that	 repeated	 administration	 would	 not	 likely	 be	 lethal	 but	 still	 cause	 systemic	 inflammation.	 Indeed,	throughout	 the	 course	 of	 these	 experiments,	 there	 were	 no	 unexpected	 deaths	 following	 this	 significant	treatment.	Tg	(cd41:GFP;lyz:DsRed)	donors	received	an	intra-peritoneal	injection	of	either	5	μL	saline	or	5	μL	of	poly	I:C	(10	μg)	eight	times,	at	48	h	intervals,	and	then	left	to	recover	for	a	week	prior	to	isolation	of	the	WKM	for	transplantation	(Figure	4.3A).			Poly	I:C	and	saline	injected	donors	were	humanely	killed	and	WKM	cells	were	sorted	for	transplant	studies.	At	the	same	time,	the	spleen	was	also	harvested	from	these	donors	in	order	to	measure	specific	transcript	levels.	In	separate	experiments,	the	WKM	was	harvested	for	transcript	level	measurements	instead	of	transplantation.	As	the	donors	had	a	week	to	recover,	it	was	not	expected	that	chemokines	and	cytokines	could	still	be	detected	and	therefore	this	was	not	assessed.	Instead,	the	level	of	transcripts	for	lineage-associated	genes	were	quantified	to	assess	relative	abundance	of	blood	populations.		Transcript	levels	of	the	immune	cell	gene	l-plastin	were	not	significantly	changed	in	the	spleen	by	the	repeated	poly	I:C	treatment	(Figure	4.3B).	Neither	were	the	transcript	levels	of	the	progenitor	cell-associated	gene	runx1.	However,	transcript	levels	of	erythrocyte-specific	gene	gata1	were	significantly	increased	(»4	fold;	Figure	4.3B)	indicating	poly	I:C	may	induce	erythropoiesis,	or	reduce	loss	of	erythrocytes.			In	separate	experiments,	fish	treated	repeatedly	with	poly	I:C	were	humanely	killed	and	the	WKM	harvested	for	qRT-PCR	analysis.	There	was	no	significant	difference	in	transcript	levels	of	lymphoid	genes	rag1	and	lck	(Figure	4.3C).	Interestingly,	transcript	levels	of	erythrocyte	gene	gata1	were	not	increased	(Supplementary	Figure	7.5),	despite	a	 significant	 increase	 in	 the	 spleen	 (Figure	4.3B).	Transcript	 levels	of	 immune	cell	 gene	 l-plastin	 and	macrophage	gene	mpeg	were	both	significantly	decreased	(Figure	4.3C).	Transcript	levels	of	the	progenitor	cell	genes	 c-myb	 and	 runx1	 (Supplementary	 Figure	 7.5)	 were	 unchanged	 and	 there	 was	 no	 difference	 in	 HSC	chemokine	cxcl12a	mRNA	levels	(Supplementary	Figure	7.5).		
4.3.1.2 Poly	I:C	injected	donors	have	the	same	percentage	of	cd41:GFP+	cells	but	a	smaller	cd41:GFP+	population	
with	properties	(granularity	and	size)	of	a	progenitor	population	Although	 qRT-PCR	 did	 not	 reveal	 significant	 differences	 in	 transcription	 of	 HSPC-associated	 gene	 runx1	transcription	between	the	saline	injected	and	poly	I:C	injected	donors,	it	was	reasoned	that	the	series	of	poly	I:C	injections	 could	 still	 have	 a	 biological	 impact	 on	 the	 hematopoietic	 cells	 that	 would	 distinguish	 them	 in	transplantation	studies.	Flow	cytometry	data	was	collected	on	individual	donors	as	the	WKM	samples	were	being	sorted	for	cd41:GFP+	cells	for	transplant	(Figure	4.4A).	The	flow	cytometry	profile	of	the	WKM	was	analysed	to	select	the	4	major	blood	populations,	the	GFP+	population	(cd41:GFP)	and	dsRed+	population	(lyz:dsRed;	Figure	4.4B).	
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Figure	4.3:	Sequential	injections	of	poly	I:C	cause	increased	expression	of	gata1	in	the	spleen	and	decreased	expression	of	l-
plastin	and	mpeg	in	the	WKM	at	the	time	of	transplant.	Tg	(cd41:GFP;lyz:dsRed)	fish	were	injected	8	times	with	either	saline	or	
10	μg	poly	I:C.	One	week	post	injection,	fish	were	humanely	killed	and	harvested	of	their	spleen	and	WKM.	The	WKM	and	the	
spleen	were	used	to	transcript	levels	of	cell-specific	genes	by	qRT-PCR.	(A)	Procedure	overview.	Adapted	from	mouse	protocol	
by	Essers	el	al.	(B)	Expression	of	gata1,	l-plastin,	mpx	and	runx1	in	the	spleen.	Three	experiments	pooled	(n>9).		(C)	Expression	
of	 l-plastin,	mpeg,	 lck,	and	rag1	in	the	WKM.	Two	experiments	pooled	(n>5).	Relative	gene	expression	level	calculated	using	
DDCT	 method,	 normalising	 to	 18S	 expression.	 Fold	 change	 normalised	 to	 the	 median	 “Saline”	 control	 value.	 Statistical	
significance	using	student	t-test.	*p<0.05.			Analysis	of	the	flow	cytometry	data	analysis	shows	that,	while	the	percentage	of	myelomonocyte	and	precursor	populations	did	not	change,	the	percentage	of	lymphocytes	in	the	WKM	increased	from	a	mean	of	»22	%	in	saline	injected	fish	to	a	mean	of	»27	%	in	poly	I:C	injected	fish.	This	is	a	relative	increase	(calculated	by	the	difference	
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over	the	control;	27-22	%/22	%)	of	»23	%	(Figure	4.5A).	This	suggests	that	repeated	poly	I:C	treatment	may	cause	a	lymphoid	bias	in	the	hematopoietic	progenitor	cells	of	donors	in	the	short	term	that	is	detectable	1	week	after	 the	 last	 poly	 I:C	 stimulation.	 It	 is	 note-worthy	 that	 stem	 cells	 scatter	 in	 the	 lymphocyte	 gate.	 Thus,	 an	increase	in	the	percentage	of	cells	in	the	lymphocyte	gate	could	be	reflecting	an	increase	in	stem	cells	as	well	as	T	and	B	cells.			
	
Figure	4.4:	Experiment	set	up	for	flow	cytometry	analysis	of	the	WKM	of	saline	injected	and	poly	I:C	-injected	donor	fish,	at	the	
time	 of	 transplant.	 Tg	 (cd41:GFP;lyz:dsRed)	 fish	were	 injected	 8	 times	with	 either	 saline	 or	 10	 μg	 poly	 I:C.	 One	week	 post	
injection,	fish	were	harvested	of	their	WKM	and	sorted	for	cd41:GFP+	cells	for	transplant.	Flow	cytometry	data	was	collected	for	
individual	donors	and	analysed.	Red	line	separate	GFP+	gate	into	CD41high	(right)	and	CD41low	(left).	(A)	Procedure	overview.	
(B)	Flow	cytometry	gating	of	all	WKM	cells	from	saline	injected	Tg	(cd41:GFP;lyz:dsRed)	at	day	0.	Left	graph;	SSC	indicates	side	
scatter,	FFC	indicates	forward	scatter.	(Both	use	488	nm	lazer,	488/10	filter).	Right	graph;	GFP	(488	nm	laser,	530/30	filter);	
dsRed	(561	nm	laser,	610/20	filter).		Interestingly,	the	percentage	of	cd41:GFP+	cells	and	the	number	of	cd41:GFP+	events	in	60	000	events	does	not	differ	 significantly	 between	 poly	 I:C	 and	 saline	 injected	 donors	 (Figure	 4.5C).	 Furthermore,	 there	 was	 no	difference	in	the	percentage	of	GFPlow	cells,	a	gate	which	roughly	determines	an	enriched	HSPC	population	(Figure	4.5C).	As	stem	cells	are	found	in	the	lymphoid	fraction,	the	cd41:GFP+	population	was	back	gated	to	determine	the	percentage	of	cd41:GFP+	cells	 in	 the	 lymphocyte	gate.	This	population	was	significantly	 lower	 in	poly	 I:C	injected	donors	 compared	with	 saline	 injected	donors	 (Figure	4.5C).	This	 could	 suggest	 that	poly	 I:C	 treated	donors	 have	 a	 smaller	 HSPC	 population	 than	 saline	 treated	 donors.	 It	 also	 indicates	 that	 the	 increase	 in	
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lymphocytes	in	poly	I:C	treated	donors	is	most	likely	due	to	an	increase	in	adaptive	immune	cells	and	a	lymphoid	bias.		
		
Figure	4.5:	Poly	I:C	injected	donors	have	an	increased	lymphocyte	population	but	a	smaller	cd41:GFP+	lymphocyte	population	
at	the	time	of	transplant,	as	determined	by	flow	cytometry.	Tg	(cd41:GFP;lyz:dsRed)	fish	were	injected	8	times	with	either	saline	
or	10	μg	poly	I:C.	One	week	post	injection,	WKMs	were	harvested	and	sorted	for	cd41:GFP+	cells	for	transplant.	Flow	cytometry	
data	was	collected	for	individual	donors	and	analysed.	(A)	The	percentage	of	myelomonocytes,	lymphocytes	and	precursors.	(B)	
The	 percentage	 of	 cd41:GFP+	 cells.	 (C)	 The	 number	 of	 GFP+	 events	 in	 60	 000	 events,	 the	 percentage	 of	 cd41low	 and	 the	
percentage	of	cd41:GFP+	cells	that	gated	in	the	lymphocyte	gate	(back	gating).	(D)	The	percentage	of	lyz:dsRed+	cells.	Individual	
dots	 represent	 individual	 donors.	 Four	 experiments	pooled	 (n>12).	 Statistical	 significance	using	 student	 t-test.	 *	 p<0.05,	 **	
p<0.01.		Finally,	poly	I:C	treatment	did	not	affect	the	percentage	of	lyz:dsRed+	myeloid	cells	(Figure	4.5D),	a	result	which	is	consistent	with	the	data	showing	that	poly	I:C	did	not	affect	the	percentage	of		myelomonocytes	(Figure	4.5A).	This	finding	further	supports	a	lymphoid	bias	and	suggests	that	poly	I:C	most	likely	causes	an	increase	in	adaptive	immune	cells	in	zebrafish.		Taken	 together,	 these	 results	 present	 the	 possibility	 that	 repeated	 poly	 I:C	 exposure	 results	 in	 changes	 to	hematopoietic	cell	frequencies	of	the	WKM.	In	particular,	increases	in	the	lymphoid	gate.			
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4.3.2 Transplantation	of	200	cd41:GFP+	cells	from	saline	and	poly	I:C	donors	Having	 established	 a	 poly	 I:C	 model	 of	 inflammation	 with	 repeated	 injections	 of	 poly	 I:C	 into	 donor	 Tg	(cd41:GFP;lyz:dsRed)	fish,	the	next	step	was	to	assess	the	effect	poly	I:C	has	on	the	biology	of	HSCs.	HSC	biology	includes	the	ability	to	migrate,	engraft	and	differentiate.	These	behaviours	can	only	be	studied	in	a	regenerative	assay	such	as	transplantation.	Based	on	imaging	studies	by	Kunisaki	et	al.	(406)	and	Rashidi	et	al.	(122),	it	was	hypothesised	that	early	post-transplant	migration,	engraftment	and/or	differentiation	would	be	affected	by	the	poly	 I:C	priming	of	 cells.	The	 increased	percentage	of	 cells	 in	 the	 lymphoid	gate	 seen	 in	 the	poly	 I:C	 injected	donors	 at	 the	 time	 of	 transplant	 suggests	 that	 the	 differentiation	 of	 the	 cd41:GFP+	 cells	 may	 be	 along	 the	lymphoid	lineage	in	the	transplant	recipient.	However,	as	the	donors	did	not	have	a	transgenic	marker	for	the	lymphoid	 population	 (for	 instance	 rag	 or	 lck),	 it	would	 not	 be	 possible	 to	 assess	 lymphocyte	 differentiation	without	killing	the	recipient.			
	
Figure	4.6:	Schematic	overview	of	the	experiment	to	transplant	200	cd41:GFP+	cells	from	poly	I:C	or	saline	injected	donors	into	
irradiated	TraNac	recipients.	Tg	(cd41:GFP;lyz:dsRed)	fish	were	injected	8	times	with	either	saline	or	10	μg	poly	I:C.	One	week	
post	injection,	WKM	were	harvested	and	sorted	for	cd41:GFP+	cells	for	transplant.	TraNac	recipients	were	irradiated	with	15	
Gy	48	and	24	h	prior	to	RO	injection	of	200	cd41:GFP+	cells	from	these	donors	(and	105	WT	PB	cells;	Non-transplanted	recipients	
did	 not	 receive	 105	 WT	 PB	 cells).	 Recipients	 were	 imaged	 using	 Zeiss	 axiovert	 200	 inverted	 microscope	 (wide	 field)	 and	
fluorescent	cells	were	counted	in	the	WKM	at	4,	6,	and	8	dpt.	Fish	were	housed	individually	and	monitored	for	28	dpt.	Survival	
was	recorded	and	flow	cytometry	was	performed	on	the	WKM	of	surviving	recipients.			
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Figure	4.7:	There	is	a	significant	difference	in	the	rate	of	cd41:GFP+	accumulation	in	the	WKM	of	recipients	of	HSCs	from	saline-
injected	donors	and	HSCs	from	poly	I:C-injected	donors.	Tg	(cd41:GFP;lyz:dsRed)	fish	were	injected	8	times	with	either	saline	or	
10	μg	poly	I:C.	One	week	post	injection,	WKM	were	harvested	and	sorted	for	cd41:GFP+	cells	for	transplant.	TraNac	recipients	
were	irradiated	with	15	Gy	48	and	24	h	prior	to	RO	injection	of	200	cd41:GFP+	cells	from	these	donors	(and	105	WT	PB	cells;	
Non-transplanted	recipients	did	not	receive	105	WT	PB	cells).	Groups	were	blinded	and	recipients	were	 imaged	using	Zeiss	
axiovert	200	inverted	microscope	(wide	field)	and	fluorescent	cells	were	counted	in	the	WKM	at	4,	6,	and	8	dpt.	The	number	of	
(A)	lyz:dsRed+	and	(C)	cd41:GFP+	cells	in	the	WKM	of	recipients	was	counted.	The	data	from	the	same	fish	is	connected	by	a	line	
(4	experiments	pooled;	Recipients	of	HSCs	from	saline-injected	donors	in	blue,	n=	19;	recipients	HSCs	from	poly	I:C-injected	
donors	in	orange,	n=	17).	Statistical	significance	tested	using	Two-way	Repeated	Measures	ANOVA.	Significance	demonstrated	
with	 L-shaped	 arrows:	 significance	 over	 time	 indicated	 by	 the	 horizontal	 arrow,	 significance	 between	 treatment	 groups	
indicated	by	vertical	arrow.	Interaction	indicated	in	the	angle	between	the	arrows.	(B	and	D)	The	same	data	is	represented	as	in	
A	and	C	to	show	data	spread.	Each	dot	represents	a	fish.	Student	t-test	at	each	time	point.		
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	The	 subsequent	 transplant	 experiments	were	designed	 to	obtain	multiple	 readouts	 from	 the	 same	animal	 in	order	 to	 reduce	 animal	 numbers	 and	 improve	 data	 quality	 and	 statistical	 power	 (Figure	 4.6).	 Donor	 Tg	(cd41:GFP;lyz:dsRed)	were	injected	8	times	with	10	μg	of	poly	I:C,	at	48	h	intervals,	and	left	for	1	week	prior	to	humane	killing	and	WKM	cell	harvesting.	Recipient	TraNac	were	 irradiated	with	15	Gy	48	and	24	h	prior	 to	transplant.	On	the	day	of	the	transplant	(day	0)	donor	cells	were	harvested	and	cd41:GFP+	cells	were	sorted	from	the	WKM.	As	demonstrated	in	chapter	3,	transplantation	of	200	cd41:GFP+	cells	from	Tg	(cd41:GFP;lyz:dsRed)	donors	(with	105	PB	from	WT	donors)	was	enough	to	rescue	irradiated	TraNac	recipients	and	reconstitute	their	hematopoietic	system.	Thus,	each	irradiated	TraNac	recipient	was	transplanted	this	way	and	imaged	at	4,	6	and	8	 dpt.	 Experiments	were	 blinded	 and	 individual	 fish	were	monitored	 to	 correlate	 observed	 cell	 counts	with	recipient	survival	to	28	dpt	and	with	donor	contribution	to	the	recipient	hematopoietic	system	at	28	dpt.		
4.3.3 Early	post-transplant	behaviour	of	HSCs	(cd41:GFP+)	from	poly	I:C-injected	donors		Early	post-transplant	behaviour	of	donor	cells	cannot	be	easily	monitored	in	most	transplant	systems.	However,	the	method	devised	and	outlined	in	chapter	1	was	used	to	quantify	the	presence	of	donor	cells	in	these	transplant	recipients.	The	same	recipients	were	tracked	individually	for	28	dpt,	but	imaged	at	4,	6	and	8	dpt.	The	number	of	cd41:GFP+	and	lyz:dsRed+	cells	was	counted	throughout	each	transplant	recipient	and	in	the	WKM	in	particular	(Figure	4.7).			The	results	show	that	the	number	of	lyz:dsRed+	cells	significantly	increased	over	time	(p<0.0001;	Figure	4.7A).	Although	there	was	a	significant	increase	in	the	mean	number	of	lyz:dsRed+	cells	over	time,	interestingly,	the	number	of	lyz:dsRed+	in	the	WKM	of	individual	fish	did	not	always	increase	from	4	to	6	to	8	dpt.	The	number	of	lyz:dsRed+	in	the	WKM	of	recipients	did	not	differ	between	saline-treated	and	poly	I:C	treated	recipient	groups	on	 any	 particular	 day	 (Figure	 4.7B).	 Furthermore,	 there	was	 no	 cumulative	 effect	 (interaction)	 between	 the	donor	treatment	and	over	time	(assessed	using	two-way	repeated	measured	ANOVA).			Recipients	were	simultaneously	studied	for	the	presence	of	cd41:GFP+	cells	in	the	WKM,	including	the	presence	of	mobile	cd41:GFP+	cells.	Again,	the	number	of	cells	in	both	groups	of	recipients	increased	significantly	over	time	 (p<0.0001;	Figure	4.7C).	Also,	 the	number	of	 cd41:GFP+	cells	 in	 the	 two	recipient	groups	did	not	differ	significantly	on	any	particular	day	(Figure	4.7D).	However,	as	the	data	from	the	same	fish	was	coupled,	the	two	way	 repeated	measured	 ANOVA	 revealed	 a	 significant	 interaction	 (p<0.05)	 between	 changes	 over	 time	 and	treatments.	Thus,	while	the	cd41:GFP+	population	in	recipients	of	cells	 from	saline	 injected	donors	remained	stable	over	time,	the	cd41:GFP+	population	in	recipients	of	cells	from	poly	I:C	injected	donors	started	lower	at	4	dpt	and	 increased	more	by	8	dpt	(Figure	4.7C).	These	kind	of	data	cannot	be	obtained	using	other	models	of	transplantation.			The	 data	 was	 also	 analysed	 to	 determine	 if	 a	 relationship	 exists	 between	 the	 number	 of	 cd41:GFP+	 and	lyz:dsRed+	cells	in	the	WKM	at	8	dpt	(Figure	4.8A).	Using	the	same	data	as	before	(Figure	4.7),	the	dependence	
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of	 these	 two	 variables	 was	 tested	 using	 Pearson’s	 product-moment	 correlation.	 There	 was	 no	 correlation	between	the	number	of	cd41:GFP+	and	lyz:dsRed+	in	either	group	of	recipients	at	8	dpt	(recipients	of	HSCs	from	saline-injected	donors	r=	0.3016;	recipients	of	HSCs	from	poly	I:C-injected	donors,	r	=0.2885).			The	analysis	was	also	refined	to	include	only	recipients	which	survived	to	28	dpt	to	determine	if	these	fish	have	a	correlation	between	cd41:GFP+	cells	and	lyz:dsRed+	cells	at	8	dpt	which	would	predict	engraftment	success	(Figure	4.8B).	There	was	no	correlation	in	these	fish	either.	However,	it	is	noteworthy	that	the	recipients	with	the	highest	number	of	cd41:GFP+	in	the	WKM	at	8	dpt	survived	to	28	dpt	(5	of	6	recipients	of	HSCs	from	saline-injected	donors;	4	of	6	recipients	of	HSCs	from	poly	I:C-injected	donors).		
	
Figure	4.8:	There	is	no	relationship	between	the	number	of	cd41:GFP+	cells	and	lyz:dsRed+	cells	in	the	WKM	of	recipients	of		
HSCs	from	saline-injected	donors	and	HSCs	from	poly	I:C-injected	donors.	Tg	(cd41:GFP;lyz:dsRed)	fish	were	injected	8	times	
with	either	saline	or	10	μg	poly	I:C.	One	week	post	injection,	WKM	were	harvested	and	sorted	for	cd41:GFP+	cells	for	transplant.	
TraNac	recipients	were	irradiated	with	15	Gy	48	and	24	h	prior	to	RO	injection	of	200	cd41:GFP+	cells	from	these	donors	(and	
105	WT	PB	cells;	Non-transplanted	recipients	did	not	receive	105	WT	PB	cells).	Groups	were	blinded	and	recipients	were	imaged	
using	Zeiss	axiovert	200	inverted	microscope	(wide	field)	and	fluorescent	cells	were	counted	in	the	WKM	at	4,	6,	and	8	dpt.	Both	
graphs	link	cd41:GFP+	counts	with	lyz:dsRed+	count	in	the	same	recipient,	connected	by	a	line.	(6	experiments	pooled,	n	>27;	
same	data	as	above	plus	2	experiments	imaged	8	dpt	only).	(A)	Includes	all	recipients	which	had	fluorescent	cells	in	the	WKM	at	
8	dpt.	(B)	Only	includes	recipients	that	survived	to	28	dpt	and	had	fluorescent	cells	as	assessed	by	flow	cytometry	(6	experiments	
pooled,	n>9).		
4.3.4 Transplant	recipients	of	poly	I:C	cd41:GFP+	cells	survive	equally	well	as	recipients	of	saline	cd41:GFP+	cells	One	of	the	measures	of	HSC	transplant	success	is	the	survival	of	recipients,	which	is	often	associated	with	donor	cell	engraftment,	differentiation	and	proliferation.	To	determine	if	inflammation	affected	the	ability	of	HSCs	to	engraft,	differentiate	and	proliferate,	recipients	were	monitored	for	28	dpt	and	then	harvested	for	flow	cytometry	analysis	 (Figure	 4.6).	 Altogether,	 26	%	of	 recipients	 of	HSCs	 from	 saline	 injected	 donors	 survived	 to	 28	 dpt	
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(Supplementary	Figure	7.6).	However,	when	this	group	of	recipients	was	split	based	on	the	observable	presence	of	cells	at	8	dpt,	the	survival	to	28	dpt	of	recipients	with	observable	cells	(37	%)	was	significantly	higher	than	those	with	no	observable	cells	at	8	dpt	(4	%;	blue	and	broken	blue	line;	Figure	4.9A).	This	suggests	that	early	cell	behaviour	in	these	recipients	could	predict	survival	of	these	recipients.	Recipients	without	cells	observable	at	8	dpt	had	the	same	morbidity	as	non-transplanted	(irradiated)	recipients.		On	the	other	hand,	the	survival	of	recipients	of	HSCs	from	poly	I:C-injected	donors	was	22	%	(Supplementary	Figure	7.6).	This	did	not	change	significantly	when	the	group	was	split	into	recipients	with	observable	cells	at	8	dpt	(25	%)	and	those	with	no	observable	cells	at	8	dpt	(18	%;	orange	and	broken	orange	line;	Figure	4.9B).	This	shows	 that	 these	early	 cell	 behaviour	observations	were	not	 enough	 to	 separate	 recipients	 into	groups	with	better	or	worse	survival.	The	survival	of	both	groups	was	significantly	higher	than	non-transplanted	(irradiated)	recipients	(0	%;	broken	black	line;	Figure	4.9B).			Altogether,	the	survival	did	not	differ	(p=0.129)	between	recipients	of	saline	injected	or	poly	I:C	injected	donors	(orange	 and	 blue	 lines;Figure	 4.9C).	 Both	 groups	 had	 better	 survival	 than	 irradiated	 recipients	 that	 did	 not	receive	a	transplant	(p<0.001	and	p<0.01).	As	seen	in	chapter	3	(Figure	3.22),	due	to	the	stress	of	the	procedure	and	the	low	number	of	HSCs	used,	morbidity	 is	highest	 in	the	first	10	dpt	 in	both	recipient	groups.	However,	survival	continues	to	decline	after	this,	in	particular	in	recipients	of	HSCs	from	poly	I:C-injected	donors.		Survival	of	recipients	was	compared	with	recipients	of	cd41:GFP+	from	non-injected	(naïve)	donors.	These	data	were	 taken	 from	control	recipients	 in	work	which	will	be	described	 later	 (see	chapter	5.3.4).	 In	all	 cases	 the	recipients	were	irradiated	48	and	24	h	before	transplant.	The	transplanted	cd41:GFP+	cells	came	from	different	donors.	The	results	suggest	that	there	is	no	difference	between	recipients	of	cd41:GFP+	cells	from	non-injected	donor	and	recipients	of	cd41:GFP+	cells	from	saline	injected	donors.	However,	there	is	a	greater,	though	non-significant	 (p=0.0531)	 difference	 in	 survival	 of	 recipients	 of	 cd41:GFP+	 cells	 from	 poly	 I:C	 donors	 and	 non-injected	donors	(Figure	4.9D).	In	order	to	confirm	this	finding,	the	experiment	needs	to	be	repeated	to	include	all	3	groups	in	the	same	study.	This	would	mean	the	recipients	would	come	from	the	same	clutch	of	larvae	to	reduce	variation	in	clutch	survival.		
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Figure	4.9:	Transplanting	200	cd41:GFP+	cells	from	poly	I:C	treated	donors	rescues	irradiated	TraNac	recipients	to	28	dpt.	Tg	
(cd41:GFP;lyz:dsRed)	 fish	were	 injected	 8	 times	with	 either	 saline	 or	 10	 μg	 poly	 I:C.	 One	week	 post	 injection,	WKMs	were	
harvested	and	sorted	for	cd41:GFP+	cells	for	transplant.	TraNac	recipients	were	irradiated	with	15	Gy	48	and	24	h	prior	to	RO	
injection	of	200	cd41:GFP+	cells	from	these	donors	(and	105	WT	PB	cells;	Non-transplanted	recipients	did	not	receive	105	WT	
PB	cells).	Groups	were	blinded	and	recipients	were	imaged	and	then	monitored	for	survival	to	28	dpt.	Recipients	were	split	into	
groups	based	on	the	presence	of	any	fluorescent	cells	in	the	WKM	at	8	dpt.	6	experiments	pooled,	n>24.	(A)	Survival	of	recipients	
of	HSCs	from	saline-injected	donors.	(B)	Survival	of	recipients	of	HSCs	from	poly	I:C-injected	donors.	(C)	Survival	of	recipients	of	
HSCs	from	saline-injected	donors	and	recipients	of	HSCs	from	poly	I:C-injected	donors.	(D)	Survival	of	recipients	of	HSCs	from	
saline-injected	donors,	recipients	of	HSCs	from	poly	I:C-injected	donors	and	recipients	of	HSCs	from	non-injected	donors.	Data	
for	recipients	on-manipulated	donors	taken	from	controls	in	Poly	I:C	treated	recipient	experiments	in	chapter	5.		
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4.3.4.1 The	number	of	 lyz:dsRed+	 cells	 in	 the	WKM	at	8	dpt	 correlates	with	 increased	 survival	 in	 recipients	of	
cd41:GFP+	from	saline	injected	donors	but	not	poly	I:C	injected	donors.	In	order	to	determine	if	survival	can	be	predicted	from	the	observable	presence	of	fluorescent	protein	expressing	cells	(cd41:GFP	and	lys:dsRed)	in	the	WKM,	survival	of	recipients	was	plotted	against	the	number	of	lyz:dsRed+	cells	in	the	WKM	at	8	dpt.	In	both	groups,	the	number	of	lyz:dsRed+	cells	in	the	WKM	varies	enormously	(from	0	to	>300	cells)	at	8	dpt	(Figure	4.7A,	B).	The	results	show	that	there	is	a	good	correlation	between	the	number	of	cells	at	8	dpt	and	survival	(R	squared	=	0.1334;	p=0.0399;	Figure	4.10A)	in	recipients	of	HSCs	from	saline	injected	donors.	This	indicates	that	early	deaths	could	be	reduced	by	selecting	recipients	with	fluorescent	cells	at	8	dpt	in	recipients	of	cd41:GFP	from	saline	 injected	donors.	However,	 it	 is	 important	 to	note	 that	due	to	 the	 low	R	squared	value	(<13	%),	survival	cannot	be	predicted	from	this	model	(a	high	R-squared	is	required	for	precise	predictions).			
		
Figure	4.10:	Survival	of	recipients	of	cd41:GFP+	cells	from	saline	injected	donors	can	be	predicted	by	the	observed	presence	of	
lyz:dsRed+	cells	in	the	WKM	at	8	dpt.	Tg	(cd41:GFP;lyz:dsRed)	fish	were	injected	8	times	with	either	saline	or	10	μg	poly	I:C.	One	
week	post	injection,	donors	were	harvested	of	their	WKM	and	sorted	for	cd41:GFP+	cells	for	transplant.	TraNac	recipients	were	
irradiated	with	15	Gy	48	and	24	h	prior	to	RO	injection	of	200	cd41:GFP+	cells	from	these	donors	(and	105	WT	PB	cells;	Non-
transplanted	recipients	did	not	receive	105	WT	PB	cells).	Recipient	groups	were	blinded	during	imaging	for	cell	counting	and	
then	monitored	for	survival	to	28	dpt.	(A)	Number	of	lyz:dsRed+	cells	at	8	dpt	plotted	against	survival	of	recipient.	6	experiments	
pooled,	n>30.	(B)	Number	of	lyz:dsRed+	cells	at	10	dpt	plotted	against	survival	of	recipient.	(2	experiments	pooled,	n>10).	On	the	other	hand,	there	is	no	correlation	between	survival	and	the	number	of	lyz:dsRed+	cells	in	recipients	of	HSCs	from	poly	I:C-injected	donors	(R	squared	=	0.0253;	p=0.4011)		(Figure	4.10A).	This	suggests	that	successful	transplant	recipients	cannot	be	selected	for	at	8	dpt	in	this	group	of	recipients.	As	longer	survival	of	recipients	of	
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HSCs	from	poly	I:C	injected	donors	did	not	correlate	with	an	increase	in	observable	cell	numbers	at	8	dpt,	the	experiment	was	repeated	to	determine	if	there	was	a	correlate	between	the	number	of	observable	cells	at	later	time	points.	For	this	reason,	recipient	fish	were	imaged	at	10	and	12	dpt.	There	was	no	correlation	found	between	number	of	lyz:dsRed+	cells	and	survival	for	either	group	of	recipients	(recipients	of	HSCs	from	saline-injected	donors	(p=0.8139);	recipients	of	HSCs	from	poly	I:C-injected	donors	(p=0.4689);	Figure	4.10B).			
4.3.4.2 Reconstitution	of	recipients’	WKM	at	28	dpt	In	order	to	determine	if	the	surviving	recipients’	hematopoiesis	was	reconstituted,	the	WKM	was	harvested	at	28	 dpt	 for	 flow	 cytometry	 analysis	 (Figure	 4.11A).	 Not	 unexpectedly,	 recipients	 that	 did	 not	 have	 any	hematopoietic	cells	in	the	WKM	by	8	dpt	(n=	4)	but	nevertheless	survived	to	28	dpt,	did	not	have	lyz:dsRed+	or	cd41:GFP+	cells	in	their	WKM	as	determined	by	flow	cytometry.	They	were	not	included	in	the	analysis	as	they	had	not	successfully	engrafted	and	restored	recipient	hematopoiesis.			The	percentage	of	erythrocyte,	lymphocyte,	myelomonocyte,	and	precursor	populations	were	determined	from	forward	 side	 scatter	 (Figure	4.11B).	 There	was	no	 significant	 difference	 in	 the	 reconstitution	 between	 the	2	groups	of	recipients.			Additionally,	to	assess	donor	contribution	to	the	reconstituted	recipient	WKM,	the	percentage	of	lyz:dsRed+	and	cd41:GFP+	 events	 was	 determined.	 There	 was	 a	 lot	 of	 variation	 between	 recipients	 of	 each	 group	 but	 no	statistically	significant	differences	(Figure	4.12A,	B).	To	determine	if	the	recipients	with	a	lower	percentage	of	cd41:GFP+	also	had	a	 lower	percentage	of	 lyz:dsRed+,	 the	data	 from	 the	same	recipient	were	paired	 (Figure	4.12C).	 There	 was	 no	 correlation	 between	 the	 two	 populations	 (Pearson’s	 product-moment	 correlation:	recipients	 of	 HSCs	 from	 saline-injected	 donors	 (p=	 0.714);	 recipients	 of	 HSCs	 from	 poly	 I:C-injected	 donors	(p=0.985)).			
4.3.5 The	number	of	cd41:GFP+	and	lyz:dsRed+	cells	in	the	WKM	at	8	dpt	does	not	correlate	with	the	percentage	
of	those	cells	in	the	WKM	at	28	dpt	Finally,	although	the	number	of	fluorescent	cells	in	the	WKM	at	8	dpt	is	not	always	an	indicator	of	survival,	it	was	still	 interesting	 to	 test	whether	 the	number	of	 cd41:GFP+	and	 lyz:sRed+	cells	observed	 in	 the	WKM	at	8	dpt	relates	 to	 the	 percentage	 of	 cd41:GFP+	 and	 lyz:dsRed+	 events	 detected	 by	 flow	 cytometry	 at	 28	 dpt.	 As	mentioned	earlier,	recipients	with	no	cells	at	8	dpt,	did	not	have	fluorescent	cells	by	28	dpt.			The	recipients	which	survived	to	28	dpt	had	between	10	and	80	cd41:GFP+	cells	observable	in	the	WKM	at	8	dpt.	However,	in	both	recipient	groups,	the	recipients	with	the	highest	number	of	cd41:GFP+	at	8	dpt	did	not	have	the	highest	percentage	of	 cd41:GFP+	at	28	dpt	 (Figure	4.13A).	 In	 fact,	 there	was	no	 correlation	between	 the	number	of	cd41:GFP+	cells	at	8	dpt	and	the	percentage	at	28	dpt	(recipients	of	HSCs	from	saline-injected	donors	(p=0.242);	recipients	of	HSCs	from	poly	I:C-injected	donors	(p=0.764;	Figure	4.13B).	
Post-transplant	behaviour	of	HSCs	from	donors	with	systemic	inflammation	
	136
The	recipients	which	survived	to	28	dpt	had	between	3	and	300	lyz:dsRed+	cells	observable	in	the	WKM	at	8	dpt.	Unlike	the	cd41:GFP+	counts,	the	number	of	lyz:dsRed+	at	8	dpt	did	correlate	with	the	percentage	of	lyz:dsRed	at	28	dpt	in	recipients	of	HSCs	from	saline-injected	donors	(p=0.0213),	though	not	in	recipients	of	HSCs	from	poly	I:C-injected	donors	(p=0.6077).				
	
Figure	 4.11:	 Reconstitution	 of	 the	 WKM	 in	 recipients	 of	 200	 cd41:GFP+	 cells	 from	 saline	 and	 poly	 I:C	 donors.	 Tg	
(cd41:GFP;lyz:dsRed)	 fish	were	 injected	8	 times	with	 either	 saline	 or	 10	μg	poly	 I:C.	One	week	post	 injection,	 donors	were	
harvested	of	their	WKM	and	sorted	for	cd41:GFP+	cells	for	transplant.	TraNac	recipients	were	irradiated	with	15	Gy	48	and	24	
h	prior	to	RO	injection	of	200	cd41:GFP+	cells	 from	these	donors	(and	105	WT	PB	cells;	Non-transplanted	recipients	did	not	
receive	105	WT	PB	cells).	Recipients	were	humanely	killed	and	their	WKM	harvested	at	28	dpt	for	flow	cytometry	analysis.	(8	
experiments	pooled;	n=11;	each	dot	represents	a	recipient).	SSC	indicates	side	scatter,	FFC	indicates	forward	scatter.	(Both	use	
488	nm	lazer,	488/10	filter).	GFP	(488	nm	laser,	530/30	filter);	dsRed	(561	nm	laser,	610/20	filter).	(A)	Flow	cytometry	scatter	
of	WKM	cells	from	recipients.	(B)	Percentage	of	erythrocytes,	myelomonocytes,	lymphocytes,	and	precursors.				
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Figure	4.12:	Donor	cells	in	the	recipient	WKM	in	recipients	of	200	cd41:GFP+	cells	from	saline-injected	and	poly	I:C-injected	
donors.	Tg	(cd41:GFP;lyz:dsRed)	fish	were	injected	8	times	with	either	saline	or	10	μg	poly	I:C.	One	week	post	injection,	WKM	
was	harvested	from	donors	and	sorted	for	cd41:GFP+	cells	for	transplant.	TraNac	recipients	were	irradiated	with	15	Gy	48	and	
24	h	prior	to	RO	injection	of	200	cd41:GFP+	cells	from	these	donors	(and	105	WT	PB	cells;	Non-transplanted	recipients	did	not	
receive	105	WT	PB	cells).	Recipients	were	harvested	at	28	dpt	for	flow	cytometry	analysis.	8	experiments	pooled;	n=11;	each	dot	
represents	a	recipient.	(A)	Percentage	of	cd41:GFP+	and	(B)	lyz:dsRed+	events	in	the	WKM.	(C)	The	percentage	of	cd41:GFP+	is	
connected	with	the	percentage	of	lyz:dsRed+	in	the	same	recipient.			Altogether,	the	data	indicates	that,	though	the	observable	presence	of	cells	in	the	WKM	early	post-transplant	is	a	good	 indicator	 of	 fluorescent	 cells	 being	 present	 at	 28	 dpt	 (and	 therefore	 donor	 contribution	 to	 recipient	hematopoiesis)	in	recipients	of	cd41:GFP+	cells	from	saline-injected	donors,	the	observation	of	the	cells	in	the	WKM	of	recipients	of	cd41:GFP+	cells	from	poly	I:C-injected	donors	does	not	guarantee	fluorescent	cells	being	present	 at	 28	 dpt.	 In	 these	 recipients,	 the	 data	 collected	 was	 not	 useful	 for	 predicting	 survival	 or	 donor	contribution	to	recipient	reconstitution.				
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Figure	4.13:	The	number	of	lyz:dsRed+	cells	in	the	WKM	at	8	dpt	correlates	with	the	percentage	of	lyz:dsRed	in	the	WKM	of	in	
recipients	from	saline-injected	donors,	at	28	dpt.	Tg	(cd41:GFP;lyz:dsRed)	fish	were	injected	8	times	with	either	saline	or	10	μg	
poly	 I:C.	 One	week	 post	 injection,	WKM	was	 harvested	 from	 donors	 and	 sorted	 for	 cd41:GFP+	 cells	 for	 transplant.	 TraNac	
recipients	were	irradiated	with	15	Gy	48	and	24	h	prior	to	RO	injection	of	200	cd41:GFP+	cells	from	these	donors	(and	105	WT	
PB	 cells;	Non-transplanted	 recipients	did	not	 receive	105	WT	PB	 cells).	Recipients	were	humanely	killed	 at	 28	dpt	 for	 flow	
cytometry	analysis.	8	experiments	pooled;	n=11;	each	dot	represents	a	recipient.	(A)	The	number	of	cd41:GFP+	at	8	dpt	plotted	
against	the	percentage	of	cd41:GFP	at	28	dpt.	Data	from	the	same	recipient	is	connected	by	a	line.	(B)	The	same	data	is	presented	
in	XY	scatter.	(C)	The	number	of	lyz:dsRed	+	at	8	dpt	plotted	against	the	percentage	of	lyz:dsRed+	at	28	dpt.	(D)	The	same	data	
is	presented	in	XY	scatter.		
4.4 Discussion	The	aim	of	this	thesis	is	to	use	zebrafish	to	determine	the	early	post-transplant	effects	of	inflammation	on	the	HSC.	Although	the	effect	of	inflammation	on	HSCs	was	assessed	using	transplantation	models	before,	this	will	be	the	first	instance	of	using	the	zebrafish	model	and	obtaining	in	vivo	data	on	the	early	post-transplant	behaviour	of	HSPCs.			In	this	chapter,	HSCs	are	stimulated	prior	to	transplantation.	In	order	to	control	for	inflammation	in	the	recipient	(induced	by	irradiation,	as	described	in	the	previous	chapter),	in	each	experiment	recipients	came	from	the	same	
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clutch,	 were	 raised	 together	 and	 irradiated	 together.	 Recipients	 were	 randomly	 allocated	 to	 2	 groups	 and	received	a	transplant.	Donor	cells	came	from	adult	Tg	(cd41:GFP;lyz:dsRed),	also	randomly	allocated	to	2	groups,	and	injected	with	either	saline	or	10	µg	poly	I:C.	The	variation	in	individual	response	to	treatment	was	reduced	by	 pooling	 the	 harvested	 WKM	 from	 3-4	 adults	 prior	 to	 sorting.	 Sorted	 WKM	 cells	 were	 counted	 on	 a	haemocytometer	and	200	cd41:GFP+	cells	per	recipient	were	mixed	with	2	x	106	WT	PB	cells.	Both	donor	groups	were	mixed	with	PB	from	the	same	WT	donor	to	reduce	variation.	As	the	donor	sets	were	distinct,	there	may	be	some	variation	in	the	number	of	cells	aliquoted	from	the	individual	stocks.	This	error	was	reduced	by	repeating	the	experiment.	Cells	were	transplanted	using	the	same	glass	needle,	washed	repeatedly	in	deionised	water.	The	order	in	which	the	donor	WKM	was	harvested	and	cells	sorted	was	alternated	each	experiment	so	as	to	alternate	the	order	the	recipient	groups	were	transplanted.		
4.4.1 Summary	of	results	The	findings	of	this	chapter	were:		 1. Flow	cytometry	and	qPCR	data	 indicated	that	poly	I:C	treatment	(50	µg,	10	µg	and	1	µg)	significantly	increased	transcript	levels	of	various	(il-1b,	il-6,	tnfa,	ifnj,		ifnγ1.1,	ifnγ1.1,	cxcl-c1c	and	cxcl8)	cytokines.	Importantly,	the	expected	interferon	response	to	poly	I:C	was	generated.	2. A	protocol	for	inducing	systemic	inflammation	was	devised	(8	successive	poly	I:C	injection	of	10	µg	every	48	h)	and	surprisingly,	flow	cytometry	to	assess	the	cd41:GFP+	population	and	qRT-PCR	analysis	of	runx1	and	 c-myb	 transcript	 levels	 	 indicated	 that	 fish	 treated	with	 this	 protocol	 did	 not	 show	 the	 expected	reduction	 in	HSCs.	 Although	 there	was	 no	 reduction	 in	 the	 cd41:GFP+	 population,	 the	 percentage	 of	cd41:GFP+	 that	 were	 FSClow	 SSClow	 (like	 lymphocytes)	 was	 significantly	 lower.	 	 Furthermore,	 flow	cytometry	analysis	indicated	an	increase	in	the	lymphocyte	scatter	(FSClow	SSClow)	in	poly	I:C	treated	fish,	but	this	increase	was	not	reflected	in	the	relative	levels	of	lck	transcript,	therefore	the	increase	maybe	in	HSCs,	B	or	NK	cells.	3. Analysis	 of	 data	 obtained	 by	 live	 imaging	 of	 recipients	 revealed	 the	 number	 of	 fluorescent	 cells	(cd41:GFP+	 or	 lyz:dsRed+)	 at	 each	 time	 point	 did	 not	 differ	 significantly	 between	 recipient	 groups.	However,	 there	was	 a	 greater	 increase	 in	 the	 number	 of	 cd41:GFP+	 in	 the	WKM	 from	 4	 to	 8	 dpt	 in	recipients	of	cd41:GFP+	from	poly	I:C-injected	donors,	compared	to	recipients	of	cd41:GFP+	from	saline	injected	donors.	4. The	survival	of	recipients	of	cd41:GFP+	cells	from	saline-injected	donors	was	not	significantly	different	from	 recipients	 of	 cd41:GFP+	 cells	 from	 poly	 I:C-injected	 donors	 (25	 %	 and	 22	 %	 respectively).	Interestingly,	 using	 live	 imaging	 data	 for	 each	 fish,	 analysis	 comparing	 recipients	 with	 observable	fluorescent	 cells	 in	 the	WKM	revealed	 there	 is	 a	more	notable,	 though	 still	 not	 significant,	 difference	between	the	recipient	groups	(37	%	and	22	%	respectively;	p=0.129).	This	supports	the	hypothesis	that	the	observable	presence	of	fluorescent	cells	in	the	WKM	is	a	good	indicator	of	survival.	In	addition,	there	is	 an	 almost	 significant	 difference	 (p=0.0531)	 between	 recipients	 of	 cd41:GFP+	 cells	 from	 poly	 I:C-injected	 donors	 and	 cd41:GFP+	 cells	 from	 naïve	 donors.	 There	 is	 no	 significant	 difference	 between	
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survival	 of	 recipients	 of	 cd41:GFP+	 cells	 from	 saline-injected	 donors	 and	 survival	 of	 recipients	 of	cd41:GFP+	cells	 from	poly	 I:C-injected	donors	or	naïve	donors.	This	could	suggest	 that	 the	difference	between	the	naïve	donors	and	poly	I:C-injected	donors	is	a	combination	of	the	effects	of	the	poly	I:C	and	the	intra-peritoneal	injection.		5. The	number	of	observed	 lyz:dsRed+	cells	at	8	dpt	correlated	with	survival	of	recipients	of	cd41:GFP+	cells	from	saline-injected	donors.	However,	there	was	no	correlation	in	recipients	of	cd41:GFP+	cells	from	poly	I:C-injected	donors.		6. There	was	no	significant	difference	in	the	reconstitution	of	the	recipient	immune	system	between	the	two	recipient	groups.	A	similar	number	from	each	group	of	transplant	recipients	survived	to	28	dpt	(11	of	70	recipients	of	HSCs	from	saline-injected	donors	(15.7	%);	10	of	75	recipients	of	HSCs	from	saline-injected	donors	(13.3	%)).	Interestingly,	in	recipients	of	cd41:GFP+	cells	from	saline-injected	donors,	the	number	of	observed	lyz:dsRed+	cells	at	8	dpt	correlated	with	the	percentage	of	lyz:dsRed	in	the	WKM	at	28	dpt.	
4.4.2 Systemic	inflammation	and	its	effect	on	the	donor	prior	to	transplant	The	first	part	of	this	chapter	presents	work	establishing	systemic	inflammation.	Poly	I:C	doses	were	titrated	to	confirm	an	 inflammatory	 response	by	 the	 zebrafish	 immune	 system,	 and	determine	 an	 appropriate	dose	 for	repeated	stimulation	(Figure	4.2).	As	expected,	the	most	significant	response	was	with	the	highest	single	dose	(50	µg	poly	I:C).	A	non-significant	(using	one-way	ANOVA)	response	was	seen	with	the	10	µg	poly	I:C	dose.	It	is	important	to	note	that	one-way	ANOVA	takes	into	consideration	variation	among	the	groups	as	well	as	variation	within	each	group	to	determine	statistical	significance.	Variability	within	a	group	is	based	on	standard	deviation	(quantified	as	the	sum	of	the	squares	of	the	differences	between	each	value	and	its	group	mean),	and	variation	between	 groups	 is	 determined	 using	 this	 and	 the	 overall	mean	 (quantified	 as	 the	 sum	 of	 the	 square	 of	 the	difference	between	the	group	mean	and	the	overall	mean).	This	means	that	one-way	ANOVA	did	not	 indicate	statistically	significant	differences	between	saline	and	10	μg	poly	I:C	because	the	significant	variation	in	the	50	μg	poly	I:C	group.	One	could	argue	that	any	increase	in	transcript	levels	is	significant	in	biological	terms.	Thus,	although	most	 of	 the	 upregulated	 genes	 are	 not	 significant	 according	 to	 the	ANOVA	 test,	 personally	 I	would	consider	anything	above	2.5	fold	(admittedly	an	arbitrary	cut-off)	as	biologically	significant.		All	3	doses	of	poly	I:C	had	high	transcript	levels	of	inflammatory	cytokines.	Further	support	of	the	inflammatory	response	to	a	dose	of	10	μg	was	published	with	Jha	et	al.	(405).	In	this	paper	we	injected	zebrafish	with	10	μg	of	either	poly	I:C,	poly	I:C	LC,	or	TLR	7/8	agonist	R848	(resiquimod).	Fish	injected	with	poly	I:C	had	a	significant	increase	in	transcript	levels	of	tnfa,	il-1b,	ifnj,	ifng1.1	and	ifng1.2	in	both	the	WKM	and	the	gill.	Altogether,	these	data	support	the	conclusion	that	10	μg	poly	I:C	induces	systemic	inflammation	in	the	zebrafish.		A	3	h	post	injection	time	point	was	chosen	for	analysis	because	previously	Varela	et	al.	had	examined	this	time	point	and	shown	a	significant	upregulation	of	inflammatory	genes	in	zebrafish	injected	with	10	μg	poly	I:C	(407).	As	in	this	paper,	tnfa,	il-1b	and	il-6	were	all	upregulated	in	the	kidney,	although	fold	change	was	twice	as	high	as	previously	reported	(Figure	4.2).	To	my	knowledge,	neither	cxcl-c1c	nor	cxcl8	(an	important	chemokine	of	the	
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innate	immune	response)	have	previously	been	associated	with	injection	of	poly	I:C.	Thirdly,	it	is	well	established	that	 poly	 I:C	 is	 an	 inducer	 of	 the	 interferon	 response	 and	 this	 data	 shows	 that	 both	 type	 I	 and	 II	 interferon	responses	(ifnj,	ifng1.1	and	ifng1.2)	were	strongly	induced	in	zebrafish	after	3	h.			Having	established	a	dose	of	poly	I:C	for	further	experiments,	the	protocol	for	these	experiments	was	put	in	place	(Figure	4.6).	Donors	were	treated	8	times	with	poly	I:C	and	then	harvested	for	transplantation.	However,	before	beginning	 transplantation	 experiments,	 donor	 spleen	 and	 WKM	 was	 assayed	 qRT-PCR	 to	 determine	 if	 any	hematopoietic	 changes	 could	 be	 used	 to	 validate	 the	 effect	 of	 the	 treatment.	 qRT-PCR	 could	 not	 be	 used	 to	measure	cytokine	expression	because	of	the	short	half-life	of	these	transcripts	(in	support	of	this,	a	time-course	measuring	relative	transcript	levels	in	nasal	lavage	samples	obtained	from	human	volunteers	challenged	with	TLR7/8	agonist	R848	found	that	mRNA	levels	of	TNF-a,	IL-1a,	and	IFN-a2a	peaked	at	2,	5,	and	4	h	respectively	and	importantly,	all	had	returned	to	basal	levels	within	24	h	(405)).	Analysis	of	the	spleen	revealed	a	significant	increase	in	gata1	expression	in	poly	I:C	injected	donors.	The	spleen	is	the	major	site	for	erythropoiesis.	Increased	erythropoiesis	 has	 not	 been	 reported	 as	 an	 effect	 of	 chronic	 interferon	 stimulus.	 The	 spleen	 also	 contains	lymphocytes	and	myelomonocytes	(408),	although	the	level	of	l-plastin	transcripts	was	not	altered	(Figure	4.3).			The	protocol	for	these	experiments	was	adapted	from	a	paper	by	Essers	et	al.	(76)	in	which	8	successive	poly	I:C	(5	µg	g-1)	injections	caused	a	significant	loss	in	WT	HSCs	(LSK	CD150+)	in	the	bone	marrow	of	chimera	mice	(50	%	WT	HSCs,	50	%	type	I	interferon	receptor	knock	out	HSCs).		Based	on	these	reports,	it	was	hypothesised	that	poly	I:C	 injected	 donors	would	 result	 in	 a	 significant	 loss	 of	HSCs	 in	 the	 zebrafish	 and	 thus	 a	 smaller	 cd41:GFP+	population.	However,	the	results	show	that	there	is	no	change	in	the	cd41:GFP+	population	(Figure	4.5),	although	the	percentage	of	cd41:GFP+	that	were	FSClow	SSClow	(like	lymphocytes)	was	significantly	lower.	As	stem	cells	are	found	in	the	FSClow	SSClow	population,	it	can	be	used	in	conjunction	with	cd41	for	HSC	selection.	This	raises	the	possibility	 that	 fewer	cd41:GFP+	HSPCs	get	 transplanted	 from	poly	 I:C	donors.	Furthermore,	qRT-PCR	of	 the	WKM	found	that	neither	runx1	nor	c-myb	mRNA	levels	were	altered	by	the	poly	I:C	treatment	(Supplementary	Figure	7.5).	Together	this	suggests	that	the	decrease	reported	by	Essers	et	al.	in	mice	was	not	replicated	by	the	same	treatment	in	the	zebrafish.			It	 is	 also	 interesting	 to	 note	 that	 Pietras	 et	 al.	 reported	 an	 increase	 in	 HSCs	 and	 runx1	 expression	 after	 20	consecutive	days	of	il-1b	injections	(107).	Furthermore,	a	number	of	studies	suggest	type	II	interferons	induce	HSC	proliferation	(334,	355,	404).	Perhaps	the	difference	can	be	explained	by	the	timing	and	 intensity	of	 the	protocols	 and	 highlights	 the	 need	 for	 alternative	 HSC	markers	 in	 the	 zebrafish	 as	 CD41	 represents	 a	 large	population	of	progenitor	cells.	It	would	be	interesting	to	apply	this	protocol	to	Tg	(runx:GFP)	fish,	an	alternative	transgenic	line	which	labels	HSPCs	in	the	zebrafish	(42).			Analysis	of	donor	WKM	prior	to	transplantation	also	revealed	a	significant	increase	in	the	lymphocyte	population	(Figure	 4.5).	 This	 is	 supported	 by	 data	 from	 AVV-	 IFNα	mice	 (mice	 expressing	 IFNα	 under	 the	 control	 of	 a	constitutive	promoter	on	a	adeno-associated	viral	vector)	which	had	a	significant	production	of	CD8+	T-cells	in	
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the	bone	marrow	and	increased	differentiation	of	hematopoietic	precursors	(LK	cells)	in	the	thymus	(402).	These	mice	also	had	a	profound	decrease	in	LT-HSCs	(LK	CD150+	CD48-),	ST-HSCs	(LK	CD150-	CD48-)	and	MPPs	(LK	CD150-	CD48+)	(402).	In	transplant	assays,	cells	from	AVV-	IFNα	mice	were	significantly	lymphoid	biased	and	only	differentiated	into	CD4+	and	CD8+	cells.	Gene	expression	analysis	showed	that	B	cell	transcription	factors	were	 significantly	 decreased	 in	 IFNα	 treated	 cells,	 suggesting	 a	mechanism	 for	 the	 bias	 seen	 in	 these	mice.	Furthermore,	the	transplantation	of	IRF2-/-	HSCs	(results	in	constitutive	type	I	IFN	signalling)	into	irradiated	WT	recipients	 produced	 fewer	 granulocytes	 than	 control	 transplants	 (393),	 indicating	 that	 type	 I	 IFNs	 shift	 the	differentiation	bias	away	from	the	myeloid	 lineage.	Thus,	although	 il-1b	expression	which	has	been	shown	to	rapidly	induce	pu.1	expression	and	expansion	of	the	myeloid	population	(107)	was	detected,	the	high	levels	of	ifnj	(Figure	4.2)	appears	to	have	caused	lymphopoiesis	in	these	donors.	This	bias	could	be	tested	by	applying	the	poly	 I:C	protocol	 to	 a	 transgenic	 zebrafish	 line	 in	which	 the	 adaptive	 immune	 system	 is	 labelled	 such	as	transgenic	lck	or	rag	fish	(in	which	the	T	cell	and	B	cell	populations	are	labelled	respectively).			qRT-PCR	of	the	donor	WKM	did	not	reflect	the	flow	cytometry	data.	For	instance,	although	the	percentage	of	cells	in	 the	 lymphocyte	 gate	 were	 significantly	 higher	 in	 poly	 I:C	 injected	 fish,	 transcript	 levels	 of	 lck	 were	 not	significantly	 higher.	 This	might	 be	 because	 lck	 is	 expressed	 by	 T-cells	 and	 the	 increase	 in	 lymphocytes	was	partially	due	to	an	expansion	of	B-cells,	NK	or	HSCs	as	well.	Transcripts	of	HSPC	genes	runx1	and	c-myb	were	not	significantly	higher	indicating	the	increase	in	the	lymphocyte	gate	is	due	to	B	or	NK-cells.	It	would	be	interesting	to	examine	transcript	levels	of	B-cell	specific	rag1	and	NK	specific	levels	of	NK-lysins.	Furthermore,	transcript	levels	of	leukocyte	gene	l-plastin	and	myeloid	gene	mpeg	were	decreased	in	the	WKM	of	poly	I:C	treated	donors	at	the	time	of	transplant	(Figure	4.3C).	However,	flow	cytometry	did	not	show	a	significant	change	in	either	the	myelomonocyte	 gate,	 nor	 the	 dsRed	 (lyz+)	 populations.	 Together	 this	 indicates	 a	 discrepancy	 between	 flow	cytometry	and	qRT-PCR	data.	As	qRT-PCR	data	is	a	single	readout	of	a	specific	parameter	across	a	population	while	flow	cytometry	produces	readouts	for	every	member	of	the	population,	I	would	therefore	suggest	that	in	this	case	the	flow	cytometry	data	is	more	reliable.	Especially	considering	that	gene	fold	change	is	measured	by	normalising	to	constitutive	gene	(in	this	case	18S)	required	for	basic	cell	maintenance	and	it	is	possible	that	poly	I:C	causes	a	change	in	18S	expression	that	would	affect	calculations	of	relative	expression.	However,	I	did	check	that	cycle	threshold	values	for	18S	were	consistent	in	both	saline	and	poly	I:C	injected	fish,	suggesting	that	18S	expression	was	not	affected.	It	would	be	interesting	to	use	a	different	gene	such	as	b-actin	for	normalisation.			As	these	results	indicate	an	increase	in	lymphopoiesis	in	poly	I:C	treated	donors,	it	would	be	interesting	to	use	transgenic	lck	or	rag	line	crossed	with	Tg	(cd41:GFP)	as	donors	for	transplantations.	Due	to	the	absence	of	these	lines	 (labelled	with	an	appropriate	 fluorophore),	 this	strategy	was	not	possible	within	 the	 time	 frame	of	 this	thesis.	Future	work	could	use	Tg	(runx1+23:NLSmCherry;lck:GFP)	fish	for	this	study.		While	the	expression	of	HSC	genes	runx1	and	c-myb	did	not	change	between	donor	groups	in	either	the	spleen	or	the	WKM	(Supplementary	Figure	7.5),	 it	 is	noteworthy	 that	 the	cd41:GFP+	population	with	FSClow	SSClow	was	significantly	reduced	in	Poly	I:C	treated	recipients	at	the	time	of	transplant	(Figure	4.5).		This	suggests	that	there	
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may	be	a	greater	ratio	of	thrombocytes	to	HSPCs	in	the	cd41:GFP+	cell	population	that	gets	sorted	from	poly	I:C	donors.	Future	work	could	clarify	this	by	sorting	these	cells	and	using	single	cell	transcriptome	analysis.			The	expansion	of	the	cd41:GFP+	population	was	greater	in	recipients	of	poly	I:C	stimulated	HSCs	(Figure	4.7).	Although	many	papers	report	an	increase	in	HSC	cycling	in	response	to	il-1	and	type	I	and	II	IFNs,	this	is	the	first	example	of	these	cytokines	affecting	cell	proliferation	after	a	delay.	As	the	cells	are	transplanted	into	an	irradiated	recipient	 in	which	 these	cytokines	are	highly	expressed,	 the	expansion	maybe	due	to	 the	hyper	sensitivity	of	treated	HSCs	over	untreated	HSCs.	In	fact	Pietras	et	al.	have	found	that	the	prior	stimulus	does	weaken	the	self-renewal	capacity	of	HSCs	and	is	responsible	for	the	exhaustion	of	these	cells	in	a	regenerative	assay	(107).		
4.4.3 The	rescue	potential	of	HSCs	from	a	donor	with	systemic	inflammation	Survival	is	an	important	readout	of	the	ability	of	a	cell	to	self-renew	and	differentiate	but	is	not	often	assessed	as	it	requires	death	to	be	the	end	point	of	the	licensed	protocol.	In	previous	studies,	such	as	by	Rashidi	et	al.	(122),	a	higher	number	of	transplanted	cells	(105	BM	mononuclear	cells	in	competitive	repopulation	studies,	1-1.5	x	104	labelled	LT-HSCs	in	imaging	studies)	meant	that	the	transplant	was	always	successful.		By	studying	transplants	which	 fail,	 the	 transplanted	 cells	 are	 under	 an	 extreme	 regenerative	 pressure	 and	 therefore	 any	 potential	differences	are	highlighted.			We	obtained	permission	to	assess	the	survival	of	recipients	in	this	experiment.	The	survival	of	all	recipients	of	cells	from	saline	injected	donors	(n=70)	was	26	%	(Supplementary	Figure	7.6).	However,	when	the	groups	were	split	based	on	whether	there	were	fluorescent	cells	observed	in	the	WKM	by	8	dpt,	the	survival	of	the	recipients	with	 cells	 (47	 recipients	 out	 of	 70)	was	 higher	 (37	%)	 than	 the	 survival	 of	 recipients	where	 cells	were	 not	observable	by	8	dpt	(23	out	of	70;	4	%;	Figure	4.9A).	This	suggests	that	transplanting	200	cells	is	an	appropriate	number	for	studying	HSCs,	as	it	was	possible	to	study	recipients	at	the	boundary	between	hematopoietic	success	and	failure.			Interestingly,	31	out	of	75	recipients	(41	%)	of	HSCs	from	poly	I:C-injected	donors	did	not	have	observable	cells	by	8	dpt,	higher	than	in	recipients	of	HSCs	from	saline	donors	(33	%)	and	may	contribute	to	why	survival	cannot	be	predicted	for	recipients	of	cells	from	poly	I:C-injected	donors.	Furthermore,	the	survival	of	recipients	of	cells	from	poly	I:C-injected	donors	(22	%)	was	not	significantly	different	if	the	population	was	split	based	on	whether	they	had	observable	fluorescent	cells	in	the	WKM	by	8	dpt	(25	%	and	18	%;	Figure	4.9B).	This	could	be	indicative	of	a	less	competitive	population	from	poly	I:C	treated	donors	as	recipients	of	cells	from	saline-injected	donors	which	have	cells	in	the	WKM	by	8	dpt	have	a	higher	probability	of	survival	(p<0.01)	compared	to	those	without,	but	 recipients	 of	 HSCs	 from	 poly	 I:C-injected	 donors	 which	 have	 cells	 in	 the	WKM	 by	 8	 dpt	 do	 not	 have	 a	significantly	 different	 chance	 of	 survival	 compared	 to	 those	 without.	 It	 is	 notable	 that	 without	 these	 early	observations,	the	recipients	could	not	be	split	into	2	groups	and	the	survival	of	the	groups	would	be	much	more	similar.	These	data	support	the	hypothesis	that	early	post-transplant	behaviour	can	be	used	to	forecast	survival.		
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Although	early	post-transplant	data	was	a	good	predictor	of	the	survival	of	recipients	of	cd41:GFP+	cells	from	saline-injected	donors,	it	was	not	a	good	predictor	of	the	survival	of	recipients	of	cd41:GFP+	cells	from	poly	I:C-injected	donors.	In	order	to	determine	if	the	was	a	delay	in	the	colonisation	of	the	WKM	in	these	latter	recipients,	the	 study	 was	 extended	 to	 10	 dpt.	 However,	 because	 of	 a	 number	 of	 early	 deaths	 in	 recipients	 with	 very	populated	 WKMs,	 the	 correlation	 was	 almost	 negative.	 Perhaps	 a	 larger	 sample	 size	 would	 yield	 more	information,	but	these	experiments	were	not	repeated	as	the	preliminary	study	did	not	indicate	a	correlation	(p=0.4689).		Cd41:GFP+	cells	from	poly	I:C	donors	are	exposed	to	interferon	signally	prior	to	transplantation	which	may	cause	a	 lymphoid	 bias	 (Figure	 4.5).	 This	might	 explain	why	 lyz:dsRed+	 cell	 counts	 do	 not	 correlate	with	 survival.	Perhaps	 transplanting	 cd41:GFP+	 from	 a	 transgenic	 donor	 in	 which	 lymphoid	 cells	 are	 also	 marked	 could	produce	data	which	fits	better	for	poly	I:C	donors.	Saline-injected	donors	produce	myeloid	and	lymphoid	cells	equally	and	therefore	either	readout	would	correlate	well	with	survival.		Altogether,	the	data	from	the	recipients	of	cd41:GFP+	cells	from	saline-injected	donors	supports	the	findings	by	Rashidi	et	al.	(122)	and	indicate	that	early	post-transplant	behaviour	 is	 linked	to	engraftment	and	transplant	outcome.	However,	the	behaviour	of	cd41:GFP+	cells	from	poly	I:C-injected	donors	does	not	show	a	link	between	early	post-transplant	behaviour	and	survival	or	hematopoietic	reconstitution.		
4.5 Conclusion	and	future	work	In	conclusion,	this	chapter	began	to	examine	the	effect	of	systemic	inflammation	in	the	donor	on	the	migrating,	engrafting	and	differentiation	ability	of	cd41:GFP+	HSCs.	Essentially,	poly	I:C	treated	HSCs	are	less	predictable	in	the	transplant	recipient.	I	hypothesise	that	the	population	of	cd41:GFP+	cells	from	the	poly	I:C	injected	fish	have	fewer	HSPCs	(based	on	flow	cytometry	evidence	that	relatively	fewer	cd41:GFP+	cells	scatter	in	the	lymphoid	gate;	Figure	4.5C)	and	therefore	fewer	HSPCs	initially	colonise	the	recipient	WKM,	thus	their	expansion	needs	to	be	greater	(based	on	evidence	that	the	increase	in	cd41:GFP+	cell	numbers	is	greater	in	recipients	of	cd41:GFP+	cells	 from	poly	 I:C	 injected	donors;	 Figure	4.7C).	The	early	post-transplant	behaviour	of	HSCs	 from	poly	 I:C-injected	donors	did	not	correlate	with	survival	suggesting	that	there	is	a	deficiency	in	colonisation	of	the	WKM	(either	fewer	cells	or	difficulty	in	migration),	so	there	are	more	failed	transplants	in	this	group.			The	data	presented	here	demonstrates	that	cells	from	saline-injected	donors	behave	in	a	more	consistent	manner.	In	recipients	of	these	cells,	 the	number	of	 lyz:dsRed+	cells	observed	at	8	dpt	correlates	with	survival	and	the	percentage	of	lyz:dsRed+	cells	at	28	dpt.	On	the	other	hand,	the	behaviour	of	cells	in	recipients	of	HSCs	from	poly	I:C-injected	donors	did	not	correlate	with	survival	or	reconstitution	at	28	dpt.	Poly	I:C	stimulated	HSCs	did	not	behave	consistently	in	the	recipient	and	this	in	itself	is	an	indication	that	behaviour	of	these	cells	was	affected	by	the	repeated	donor	stimulation.		
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Altogether	this	data	supports	the	general	consensus	(76,	107)	that	inflammation	has	a	detrimental	effect	on	HSCs.	Furthermore,	it	provides	observational	data	that	show	a	change	in	HSC	behaviour	due	to	prior	exposure	to	poly	I:C.			Like	much	of	the	work	studying	type	II	IFNs	(334,	355,	403,	404),	the	fitness	of	the	poly	I:C	stimulated	HSCs	have	only	been	assessed	 in	non-competitive	 transplant	assay,	measured	by	donor	contribution	 to	 the	WKM	of	 the	recipient.	In	these	experiments,	both	recipient	groups	had	equivalent	percentages	of	donor	derived	cd41:GFP+	and	lyz:dsRed+	in	the	WKM	(Figure	4.11B).	This	suggests	that	they	are	equal	 in	their	ability	to	compete	with	endogenous	HSCs.	Ultimately,	the	best	measure	of	stem	cell	fitness	will	be	by	competitive	transplantation	assay.	The	cells	from	both	donors	are	transplanted	into	the	same	recipient	and	the	population	which	successfully	out	competes	 the	 other	 in	 terms	 of	 populating	 the	 niche	 is	 the	 fittest.	 This	 cannot	 be	 done	 using	 our	 current	transgenic	donor	because	there	are	no	markers	available	to	distinguish	donors	(such	as	CD45.1	and	CD45.2	used	to	identify	donors	in	mice).		Recently,	the	Dallman	lab	started	using	Tg	(runx1+23:GFP;lyz:dsRed)	and	Tg	(runx1+23:NLSmCherry;lyz:GFP)	in	 competitive	 repopulation	 assays.	 However,	 it	 was	 determined	 by	 flow	 cytometry	 that	 the	 number	 of	fluorescent	protein	expressing	cells	in	these	2	transgenic	lines	are	very	different,	indicating	the	populations	will	be	 biologically	 different.	 Furthermore,	 the	 double	 positive	 cells	 in	 both	 lines	 overlap	 in	 the	 flow	 cytometry	analysis.	Therefore,	I	suggest	the	experimental	setup	shown	in	Figure	4.14B.	Tg	(runx1+23:GFP)	donors	would	be	 injected	 with	 either	 poly	 I:C	 or	 saline.	 The	 runx:GFP+	 cells	 from	 these	 donors	 will	 then	 be	 mixed	 with	runx:mCherry+	 from	 untreated	 Tg	 (runx1+23:NLSmCherry)	 donors	 and	 transplanted	 into	 irradiated	 TraNac	recipients	groups	(recipients	of	HSCs	from	saline-injected	donors	and	recipients	of	HSCs	from	poly	I:C	injected	donors).	 In	 this	 way,	 the	 fitness	 of	 the	 runx1:GFP+	 population	 will	 be	 assessed	 against	 a	 consistent	runx1:mCherry+	population	(Figure	4.14A).	
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Figure	4.14:	Schematic	of	suggested	competitive	transplant	experiments.	The	Tg	(runx1+23:GFP)	donors	are	injected	8	times,	at	
48	 h	 intervals,	 with	 either	 5	 	 μL	 saline	 or	 10	 μg	 Poly	 I:C.	 One	week	 post	 injections,	 the	WKM	 is	 harvested	 and	 sorted	 for	
runx1:GFP+	cells.	These	cells	are	mixed	with	runx1:mCherry+	cells	from	non-injected	Tg	(runx1+23:mCherry)		donors	and	105	
PB	cells	from	non-injected	WT.	The	mix	is	retro-orbitally	delivered	into	irradiated	TraNac	recipients.	The	ratio	of	runx1:GFP+	
cell	to	runx1:mCherry+	cells	would	determine	which	of	the	donors	(poly	I:C	or	saline-injected)	were	more	competitive	against	
non-injected	donors.	(A)	Simple	schematic	diagram.	(B)	Procedure	overview.	 	
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5 Post-transplant	behaviour	of	HSCs	in	recipients	with	systemic	inflammation		
5.1 Introduction	The	background	to	this	chapter	is	carried	on	from	previous	chapters.	In	brief,	there	is	mounting	evidence	that	HSCs	 respond	 both	 directly	 and	 indirectly	 to	 infection	 and	 inflammation.	 This	 chapter	mainly	 examines	 the	response	of	HSPCs	to	indirect	stimulation	from	the	recipient	niche.		The	HSC	niche	is	a	complex	milieu	of	different	stromal	cells	that	preserve	the	stem	cell	properties	of	HSCs	while	also	regulating	self-renewal,	differentiation	and	trafficking	to	and	from	the	niche.	The	mechanisms	regulating	HSC	niche	maintenance	during	homeostasis	include	both	cell	intrinsic	and	extrinsic	factors.	However,	the	factors	that	regulate	the	regenerative	process	that	takes	place	after	hematopoietic	injury	are	less	well	understood.	In	fact,	when	this	thesis	began,	the	effect	of	inflammation	in	the	recipient	on	transplanted	HSCs	had	not	yet	been	experimentally	tested	(409).	However,	just	recently,	Ishida	et	al.	published	the	first	study	examining	how	pre-conditioning	of	 the	mouse	recipient,	 and	specifically	 the	effect	of	TNFa,	 could	affect	donor	HSCs	 (410).	They	transplanted	untreated	HSCs	(LSK	CD34-)	 into	irradiated	recipients	at	various	time	points	after	 irradiation	in	order	to	expose	these	cells	to	a	range	of	inflammatory	environments	(there	is	a	peak	in	inflammation	at	3	dpIR).	There	 was	 no	 difference	 in	 chimerism	 between	 primary	 transplant	 recipients	 transplanted	 at	 0	 or	 3	 dpIR.	However,	chimerism	in	secondary	recipients	was	significantly	lower	in	recipients	of	HSCs	from	donors	initially	transplanted	 3	 dpIR	 (when	 inflammation	 was	 at	 its	 peak;	 high	 cytokine	 and	 ROS	 milieu)	 compared	 with	recipients	of	HSCs	from	donors	initially	transplanted	0	dpIR	(when	inflammation	had	not	yet	begun;	low	cytokine	and	ROS	milieu).	Thus,	HSCs	transplanted	during	the	peak	of	inflammation	in	the	primary	transplant	were	less	competitive	 than	 HSCs	 obtained	 from	 a	 time	 point	 with	 lower	 inflammation.	 Subsequently,	 Ishida	 et	 al.	transplanted	irradiated	recipients	at	various	time	points	(0,	1,	2	and	3	dpIR)	with	naïve	HSCs	and	harvested	cells	24	h	after	the	transplant	for	secondary	transplantation;	for	example,	mice	transplanted	at	3	dpIR,	were	humanely	killed	at	4	dpIR	and	HSCs	were	harvested	for	a	secondary	transplant.	Chimerism	in	secondary	recipients	was	decreased,	though	not	significantly,	in	recipients	of	HSCs	from	donors	initially	transplanted	3	dpIR	and	harvested	4	dpIR.	The	difference	in	chimerism	between	recipients	of	HSCs	from	a	lower	inflammatory	milieu	(transplanted	0	 dpIR,	 harvested	 at	 24	 h)	 and	 recipients	 of	 HSCs	 from	 a	 higher	 inflammatory	milieu	 (transplanted	 3	 dpIR,	harvested	at	4	dpIR)	was	most	significant	in	tertiary	transplant	recipients.	Together,	this	data	shows	that	HSC	reconstitution	ability	was	significantly	impaired	after	exposure	to	an	inflammatory	bone	marrow	environment,	even	for	just	24	h.	The	inflammatory	environment	of	the	recipients	in	the	study	were	created	by	changing	the	interval	between	irradiation	and	transplant	so	that	the	difference	between	recipients	was	in	the	levels	of	ROS	and	cytokines	(il-1b,	TNFa	and	IFNg).	Although	irradiation	caused	higher	expression	of	multiple	cytokines	in	the	recipient,	using	single	cell	colony	assays	with	the	various	cytokines	induced,	Ishida	et	al.	showed	that	TNFa	had	the	most	significant	effect	on	colony	formation.	They	then	showed	that	HSCs	reconstituted	better	in	an	irradiated	TNFa-KO	recipient	BM	than	in	an	irradiated	WT	recipient	BM.	Furthermore,	they	showed	that	incubating	HSCs	
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in	 N-Acetyl-L-Cysteine	 to	 inhibit	 TNF-mediated	 ROS	 accumulation	 prior	 to	 transplant	 allowed	 these	 cells	 to	better	reconstitute	irradiated	recipients	than	non-N-Acetyl-L-Cysteine	treated	HSCs.				
5.1.1 The	inflamed	recipient	environment		In	this	chapter,	poly	I:C	stimulation	was	used	to	create	an	inflammatory	environment	in	the	recipients	prior	to	irradiation	and	transplantation.	As	described	in	chapter	4.1.3,	poly	I:C	is	a	ligand	of	TLR3	(and	TLR22	in	zebrafish)	and	induces	pro-inflammatory	cytokines,	especially	interferons.	Acute	interferon	exposure	causes	proliferation	(76,	333,	355)	and	chronic	 interferon	stimulation	 leads	 to	 loss	of	stemness	 and	exhaustion	(334,	393).	These	studies	have	examined	the	effect	of	interferon	stimulation	(through	poly	I:C	injection	or	infection	models)	on	the	endogenous	population	of	HSPCs,	through	both	direct	and	indirect	stimulation.	The	loss	of	stemness	was	assessed	using	competitive	and	non-competitive	transplantation	of	stimulated	HSPCs.		Only	a	few	experiments	have	examined	the	effect	of	inflammation	in	the	recipient,	with	a	view	to	understanding	the	role	of	interferon	in	the	niche.	Essers	et	al.	showed	that	transplanted	WT	HSCs	(LSK	CD150+)	were	activated	by	 poly	 I:C	 in	 IFN-α	 receptor	 knock	 out	 (IFNRA-/-)	 recipients	 (76).	 This	 showed	 that	HSCs	 could	 respond	 to	interferons	directly	but	does	not	exclude	possible	indirect	stimulation	from	the	niche.	In	fact,	recently	the	Essers	group	examined	the	effect	of	poly	I:C	on	the	BM	niche	(411).	They	found	that	treatment	of	WT	mice	with	poly	I:C	or	IFNa	increased	BM	vascularity	(via	VEGF)	but	compromised	vessel	integrity.	The	stimulation	of	endothelial	cells	 (Lin-	 CD45-	 CD31+)	 caused	 an	 increase	 in	 the	 expression	 of	 junction	molecules	 endothelial	 cell-selective	
adhesion	molecule,	 vascular	 endothelial-cadherin	 and	 laminin.	 Interestingly,	 the	 stimulation	was	 transient	 as	continuous	treatment	(at	48	h	intervals,	8	times)	did	not	cause	continuous	inflammatory	effects.	They	showed	that	the	stimulation	of	endothelial	cells	occurs	via	hematopoietic	and	non-hematopoietic	pathways	as	junction	molecules	increased	in	IFNAR-/-	recipients	transplanted	with	WT	HSCs	(thus	hematopoietic	stimulation)	and	in	WT	 recipients	 transplanted	 with	 IFNAR-/-	 HSCs	 (thus	 non-hematopoietic	 stimulation).	 While	 these	 results	indicate	that	poly	I:C	does	in	fact	alter	the	BM	environment,	there	is	no	indication	that	this	had	an	effect	on	the	reconstitution	capacity	of	HSCs.			More	substantially,	Sato	et	al.	found	that	transplantation	of	WT	HSCs	(LSK	CD150+)	into	IRF2-/-	recipients	(which	have	 constitutive	 interferon	 signalling)	 did	 not	 affect	 reconstitution	 (393).	 This	 indicates	 that	 high	 levels	 of	interferon	signalling	in	the	recipient	is	not	important	for	reconstitution	of	the	transplant	recipient.	Unlike	Ishida	
et	al.,	these	results	indicate	that	environmental	interferons	do	not	significantly	alter	HSC	survival(410).		Inflammatory	 stimulation	 of	 the	 recipient	 has	 also	 been	 used	 to	 establish	 a	 pre-conditioning	 regimen	 for	transplantation.	Sato	et	al.	and	Essers	et	al.	used	poly	I:C	and	5-FU	as	a	pre-transplant	conditioning	of	recipient	mice	(76,	412)	as	poly	I:C	induces	proliferation	(406)	and	5-FU	kills	proliferative	cells.	Essers	et	al.	injected	mice	with	poly	I:C	twice	(10	μg	g-1,	48	h	apart)	and	then	twice	with	5-FU	(1	week	apart).	They	found	that	without	poly	I:C	exposure	(injected	PBS),	5-FU	treatment	alone	did	not	affect	survival.	However,	2	injections	of	poly	I:C	prior	to	5-FU	severely	affected	mouse	survival	(none	of	the	mice	survived	past	12	days	post	the	1st	5-FU	treatment/5	
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days	post	the	2nd	5-FU	treatment).	There	were	no	fatalities	when	the	same	treatment	was	applied	to	IFNRA-/-	mice.	These	results	indicate	that	IFN-α	stimulation	of	the	bone	marrow	made	the	hematopoietic	cells	sensitive	to	ablation.	This	supports	findings	by	Ishida	et	al.	who	demonstrated	that	environmental	inflammation	exposure	reduced	HSC	competitiveness	(410).		Similarly,	Sato	et	al.	injected	recipient	mice	with	poly	I:C	twice	(10	μg	g-1,	48	h	apart),	then	injected	with	5-FU	(48	h	later)	before	transplantation	with	HSCs.	They	found	that	type	I	IFN-based	pre-transplant	conditioning	permits	the	engraftment	of	multi-lineage,	long-term	repopulating	donor	HSCs	without	total	body	irradiation	and	reduced	DNA	damage	(gamma-histone	2AX	was	not	induced).	It	is	Sato’s	protocol	that	was	adapted	for	the	studies	in	this	chapter.	5-FU	treatment	was	replaced	with	irradiation	as	the	previous	work	(see	chapters	3.3	and	4.3)	had	been	done	with	irradiated	recipients.			
5.1.2 The	control	recipient	environment		For	this	study,	inflamed	recipients	were	compared	with	“control”	recipients,	treated	like	those	in	the	previous	chapters	(simply	irradiated	48	and	24	h	prior	to	transplant).		Interestingly,	this	is	also	the	inflammatory	stimulus	used	by	Ishida	et	al.	in	the	experiments	described	above	(410).	As	mentioned	in	chapter	3.1.3,	ionising	radiation	(IR)	causes	significant	damage	to	the	environment	that	can	affect	the	dynamics	of	bone	marrow	cell	production,	maturation,	trafficking	and	lifespan	(413).	The	effects	of	irradiation	are	highly	dependent	on	dose	and	biological	characteristics	(microenvironment	and	proliferative	state)		of	the	cell	(414).	Although	stromal	cells	such	as	MSCs	are	relatively	resistant	to	exposure,	mature	mesenchymal	cells	undergo	rapid	cell	death	(415-417).	Global	gene	expression	studies	with	B10	cells	(immortalised	human	MSCs)	show	time	and	dose	dependent	changes	in	>	5000	transcript	levels	(p<0.5),	highlighting	the	complexity	of	the	response	to	irradiation	stress	(418).		Ishida	et	al.	demonstrated	time-dependent	changes	in	conditions	following	radiation	(410).	There	are	mounting	cytokine	levels	from	the	time	of	exposure	to	a	peak	about	3	dpIR	which	gradually	reduces	by	5	dpIR.	Incomplete	or	delayed	engraftment	results	in	longer	periods	of	immune-compromise.	During	this	time,	recipients	are	at	a	high	risk	of	fatal	infection	or	hematopoietic	failure	which	is	why	transplants	at	5	dpIR	were	ultimately	lethal.	However,	 Lo	 Celso	 et	 al.	 found	 that	 radiation	 damage	 of	 the	microenvironment	 played	 a	 role	 in	 stimulating	proliferation	of	HSPCs	(121).	When	non-irradiated	recipients	are	transplanted,	cells	typically	could	not	engage	with	 the	 endosteal	 region,	 which	 typically	 supports	 HSC	 quiescence,	 and	 cell	 engraftment	 was	 significantly	reduced.	However,	when	recipients	were	irradiated	before	being	transplanted	with	WT	HSPCs,	both	Lo	Celso	et	
al.	and	Xie	et	al.	saw	proliferating	HSPCs	located	nearer	to	endosteal	regions	and	donor	cells	could	engraft	(121,	211).		Thus,	despite	the	toxic	effects	of	immune-ablation,	removing	or	lack	of	BM	resident	hematopoietic	cells	is	important	for	survival	and	engraftment	of	donor	cells.		Irradiation	 is	 known	 to	 create	 an	 inflammatory	environment	where	 injured	and	dying	 cells	produce	DAMPs.	Inflammatory	 molecules	 are	 also	 generated	 when	 macrophages	 respond	 to	 TLR	 ligands	 produced	 by	 the	intestinal	 flora,	 released	 when	 the	 gastrointestinal	 lumen	 is	 damaged	 by	 irradiation	 (419).	 Phagocytic	 cells	
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remain	in	irradiated	tissue	for	months	after	exposure,	possibly	due	to	retention	signals.	High	doses	of	radiation	also	cause	the	production	of	ROS	which	oxidate	proteins	and	 lipids	and	exacerbate	DNA	damage	through	the	activation	of	cell	cycle	inhibitors	(420).	The	loss	of	HSC	senescence,	and	thus	of	stemness,	alters	HSC	repopulating	ability	(417,	421).				
5.1.3 A	recipient	environment	that	is	not	inflamed	The	previously	mentioned	bloodless	c-mybt25127	mutant	(see	chapter	3.3.3)	is	used	as	a	recipient	without	induced	inflammation	in	this	chapter.	Due	to	a	transversion	mutation,	these	mutants	lack	a	functional	c-myb	transcription	factor,	thus	affecting	expression	of	downstream	gene	targets	required	for	definitive	haematopoiesis	(46).			
5.1.4 Inflammation	in	the	recipient	affects	early	post-transplant	behaviour	of	HSPCs	Currently,	not	much	is	known	about	the	behaviour	of	HSPCs	in	inflamed	environments.	Previous	studies	have	used	 imaging	 techniques	 to	 understand	 the	 effect	 of	 infection	 on	 endogenous	HSC	behaviour	with	 a	 view	of	understanding	 the	 role	 of	 the	 niche.	 For	 instance,	 Kunisaki	 et	 al.	 used	 ex	 vivo	 whole	 mount	 confocal	immunofluorescence	to	examine	HSC	associations	with	small	arterioles	in	the	sternal	bone	marrow	of	mice	(406).	They	found	that	injecting	mice	with	poly	I:C	(5	μg	g-1,	twice	48	h	apart)	increased	HSC	(LSK	CD150+	CD48-)	cell	cycling	and	reduced	the	percentage	of	HSCs	within	20	µm	of	arterioles,	as	compared	with	saline	injected	mice.	As	they	used	endogenous	models	and	not	transplantation,	it	is	not	possible	to	distinguish	the	direct	effect	of	poly	I:C	on	subset	populations	of	the	hematopoietic	compartment	(LT-HSC	compared	to	ST-HSC	etc.).	It	was	also	not	possible	to	separate	the	direct	effect	on	the	hematopoietic	cells	from	the	indirect	effect	of	poly	I:C	on	the	niche	cells	 (MSC,	 vascular	 etc.).	 However,	 this	 data	 supports	 the	 notion	 that	 HSC	 behaviour	 is	 influenced	 by	inflammatory	signalling.			There	is	currently	no	in	vivo	imaging	data	on	the	post-transplant	behaviour	of	HSPCs	in	inflamed	conditions.	The	only	 studies	 available	 have	 examined	 the	 movement	 of	 the	 transplanted	 hematopoietic	 population	 by	 flow	cytometry	 assessment	 of	 the	 organ	 of	 interest.	 For	 instance,	 Kašėta	 et	 al.	 have	 shown	 that	 transplanted	progenitors	 (Lin-	 cells)	preferably	 relocate	 to	 the	 ischemic	 foot	 in	a	mouse	model	of	 contact	hypersensitivity	(422).	Similarly,	in	a	model	of	ischemic	kidney,	Stroo	et	al.	used	flow	cytometry	to	show	an	increase	of	progenitor	cells	(DiI	labelled	LSK	cells)	in	the	damaged	kidney	24	h	post-transplant	(423).	Stroo	et	al.	did	image	sections	of	the	kidney	ex	vivo,	but	they	did	not	focus	on	the	associations	of	these	cells	with	the	environment.	Although	these	studies	were	done	using	flow	cytometry	and	not	in	vivo	imaging,	they	do	suggest	that	inflammatory	signalling	can	influence	post-transplant	HSPC	localisation.		Finally,	 a	 study	 by	 Bastianutto	 et	 al.	 used	 bioluminescent	 imaging	 to	 track	 transplanted	HSPCs	 (Sca1+	c-Kit+	Thy1.1low)	 following	 right	 leg	 irradiation	 (388).	 They	 found	 that	 HSPCs	would	 preferentially	 relocate	 to	 the	irradiated	 tissue	 following	 transplantation	 (388).	 They	 found	 that	 this	 recruitment	was	 CXCL12,	MMP2	 and	MMP9	dependent.		
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5.2 Aims	The	aim	of	this	chapter	is	to	assess	the	effect	of	inflammation	in	the	niche	on	HSCs.	As	described	in	chapter	4,	a	decrease	in	HSC	stemness	is	most	obvious	under	regenerative	stress,	such	as	transplantation.	In	this	chapter,	WT	HSPCs	(cd41:GFP+)	were	transplanted	into	either	“control	recipients”	(irradiated	with	15	Gy	48	and	24	h	prior	to	 transplant;	 albeit	 these	 recipients	 will	 have	 some	 irradiation	 induced	 inflammation)	 or	 recipients	 with	additional	inflammation	(injected	twice	with	10	µg	poly	I:C,	6	and	4	days	prior	to	transplant,	and	treated	with	15	Gy	irradiation	48	and	24	h	prior	to	transplant).	The	number	of	transplanted	cells	was	restricted	to	200	cd41:GFP+	cells	to	cause	additional	regenerative	stress	on	the	cells.	As	in	the	previous	chapter,	cell	behaviour	(mobility,	self-renewal	and	differentiation)	was	observed	at	early	post-transplantation	time	points	(4,	6	and	8	dpt)	throughout	the	organism.	Survival	of	each	recipient	was	monitored	for	28	days	and	then	flow	cytometry	was	used	to	compare	engraftment	 and	 reconstitution.	 These	 data	 were	 compared	 with	 data	 from	 bloodless	 (c-mybt25127	 mutant)	recipients.	These	fish	are	not	irradiated	and	do	not	have	a	hematopoietic	system,	therefore	it	is	hypothesised	that	these	recipients	would	have	considerably	lower	inflammation	(although	will	need	to	be	determined).	As	they	are	not	optically	transparent,	they	cannot	be	used	to	obtain	early	imaging	data.	However,	they	could	be	used	for	non-imaging	techniques	such	as	survival	and	reconstitution	(as	measured	using	flow	cytometry).		More	specifically,	the	aims	were	to:	1. Compare	the	inflammatory	environments	created	in	“control”	(irradiated)	and	“inflamed”	(poly	I:C	and	irradiated)	recipients.	2. Observe	the	behaviour	of	naïve	HSPCs	(cd41:GFP+)	in	the	transplant	recipient	to	assess	how	an	inflamed	environment	affects	the	early	behaviour	of	these	cells.	3. Determine	 if	 hematopoietic	 reconstitution	 and	 recipient	 survival	 are	 affected	 by	 the	 inflamed	environment	by	comparing	“control”	(irradiated),	“inflamed”	(poly	I:C	injected	and	irradiated)	and	“non-inflamed”	(c-myb	mutant;	no	poly	I:C	and	no	radiation)	recipients.		
5.3 Results	
5.3.1 Two	intra-peritoneal	injections	of	poly	I:C	cause	an	increase	in	inflammatory	cytokines	in	the	recipient		In	order	to	study	the	effect	of	an	inflamed	environment	on	HSCs,	it	was	first	necessary	to	establish	a	protocol	that	would	induce	systemic	inflammation	in	the	zebrafish	recipient.	As	in	the	previous	chapter,	poly	I:C	was	used	as	a	stimulus.	The	protocol	used	for	inducing	inflammation	in	donors	(Figure	4.3)	could	not	be	used	in	this	case	because	the	length	of	the	treatment	(23	days)	would	mean	that	the	recipients	would	be	too	large	for	acquisition	of	high	quality	images.	Instead,	a	protocol	from	Sato	et	al.	was	adapted	(412);	Recipients	were	injected	twice,	48	h	apart,	with	10	μg	of	poly	I:C	and	subsequently	irradiated	with	15	Gy	48	h	and	72	h	later	(equivalent	to	48	h	and	24	h	prior	to	transplant).	Since	it	is	necessary	to	irradiate	transplant	recipients	to	make	space	for	transplanted	cells	(121)	control	recipients	were	also	irradiated	48	h	and	24	h	prior	to	transplant	(Figure	5.1).	In	order	to	limit	inflammation	in	controls,	these	recipients	were	not	injected	prior	to	irradiation	as	the	intra-peritoneal	injection	
Post-transplant	behaviour	of	HSCs	in	recipients	with	systemic	inflammation	
	152
would	cause	significant	trauma.	Thus,	differences	between	controls	and	Poly	I:C	treated	recipients	may	not	be	poly	I:C	specific	and	could	be	due	to	inflammation	caused	by	the	procedure.		To	ensure	the	protocol	was	effectively	causing	inflammation,	3	recipients	were	selected	at	random	from	each	experimental	repeat	at	3	h	post	first	injection	“poly	I:C	10	μg”	and	at	3	h	post	second	injection,	“poly	I:C	2x	10	μg”.	Three	random	samples	were	also	taken	at	the	time	of	transplant	from	each	experimental	repeat,	from	inflamed	“poly	I:C	+	IR”	recipients	(after	2	poly	I:C	injections	and	2	doses	of	irradiation)	and	from	control	“IR”	recipients	(after	2	doses	of	irradiation;	Figure	5.1).	Non-irradiated,	non-injected	“No	IR,	No	poly	I:C”	siblings	were	taken	as	untreated	 negative	 controls	 for	measuring	mRNA	 cytokine	 levels.	 The	 results	 from	 irradiated	 “IR”	 and	 non-irradiated	 “non-IR”	 groups	 were	 presented	 previously	 in	 chapter	 3	 and	 are	 shown	 again	 here	 for	 ease	 of	comparison.	 Although	 previously	 il-1β,	 tnfα,	 il-6,	 infγ1.1,	 and	 cxcl-c1c	 mRNA	 transcripts	 were	 significantly	increased	in	control	“IR”	recipients	relative	to	untreated	samples	(Figure	3.5),	they	are	not	significantly	different	here	due	to	the	nature	of	the	statistical	test	(One-way	ANOVA).	As	I	mentioned	in	the	discussion	of	the	previous	chapter	 (4.4.2),	 this	 statistical	 test	 takes	 into	 consideration	 variation	 among	 the	 groups	 as	well	 as	 variation	within	 each	 group	 to	 determine	 statistical	 significance.	 This	 means	 that	 one-way	 ANOVA	 does	 not	 detect	statistically	significant	differences	between	“IR”,	“No	IR,	No	poly	I:C”	and	“poly	I:C	+	IR”	because	of	the	significant	variation	in	the	“poly	I:C	10	µg”	and	“poly	I:C	2x	10	µg”	groups.	Therefore,	in	this	chapter	I	present	the	one-way	ANOVA	analysis	of	all	the	groups,	but	one-way	ANOVA	analysis	of	just	the	“IR”,	“No	IR,	No	poly	I:C”	and	“poly	I:C	+	IR”	groups	can	be	found	in	the	appendix	(Supplementary	Figure	7.7),	and	will	be	discussed	at	the	end	of	the	chapter.		In	general,	cytokine	(il-1β,	tnfα,	il-6,	ifnφ,	infγ1.1,	ifnγ1.2	and	cxcl-c1c)	transcript	levels	were	significantly	higher	at	3	h	post	poly	I:C	injection	and	3h	post	2nd	poly	I:C	injection	than	at	the	time	of	transplant	in	either	inflammatory	“poly	I:C	+	IR”	recipients	or	control	“IR”	recipients.	For	instance,	mRNA	levels	of	il-1β	were	»25	fold	higher	than	untreated	(No	 IR,	no	Poly	 I:C)	samples	3h	after	 the	1st	poly	 I:C	 injection	and	»30	 fold	higher	3h	after	 the	2nd	injection	 (Figure	 5.2).	 However,	 in	 both	 control	 and	 poly	 I:C	 irradiated	 recipients,	 il-1β	 levels	 were	 not	significantly	higher	than	untreated	controls	(»3.5	and	»2	fold	respectively)	at	the	time	of	transplant.		Systemic	levels	of	tnfα,	il-6	and	cxcl-c1c	transcripts	followed	the	same	profile	as	il-1β.	Relative	Tnfα	transcript	levels	were	»10	and	»20	fold	higher	at	3	h	post	poly	I:C	injection	but	were	not	significantly	elevated	in	irradiated	control	recipients	(»4	fold	increase)	or	in	irradiated	Poly	I:C	treated	recipients	(»2	fold	increase)	at	the	time	of	transplant,	relative	to	untreated	controls	(Figure	5.2).	Likewise,	il-6	increased	»10	and	»15	fold	3h	after	poly	I:C	injections	but	were	at	basal	levels	in	both	recipient	groups	following	irradiation	(»2	fold	in	controls	and	»1.7	fold	in	Poly	 I:C	 treated	 recipients;	 Figure	5.2).	Again,	 il-6	 levels	 in	 control	 and	Poly	 I:C	 treated	 recipients	 are	not	significantly	different	to	untreated	samples.	Also,	cxcl-c1c	increased	by	»40	fold	3	h	after	poly	I:C	injection	but	irradiated	recipients	did	not	have	significant	levels	at	the	time	of	transplant	(»5.5	fold	in	control	“IR”	and	»3.5	fold	in	Poly	I:C	+	IR	recipients;	Figure	5.2).			
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Figure	5.1:	 Schematic	overview	of	 sampling	points	 for	measuring	gene	expression	 in	poly	 I:C	 stimulated	 recipients.	 Control	
recipients	were	irradiated	twice	with	15	Gy	(48	h	and	24	h	before	would-be	transplant).	Samples	were	collected	24	h	after	2	
doses	of	irradiation	(IR).	Poly	I:C	treated	recipient	TraNac	fish	were	injected	with	10	μg	poly	I:C	twice,	48	h	apart	(samples	were	
collected	3	h	after	the	1st	injection	of	10	μg	poly	I:C	(Poly	I:C	10	μg)	and	3	h	after	2	injections	of	10	μg	poly	I:C	(Poly	I:C	2x	10	μg).	
Injected	fish	were	then	irradiated	with	15	Gy	48	h	and	72	h	later	(48	h	and	24	h	before	would-be	transplant).	Samples	were	
collected	24	h	later	(Poly	I:C	+	IR).	mRNA	was	extracted	after	collected	samples	were	humanely	killed	and	decapitated.			As	described	in	chapter	4.1.3,	transcript	levels	of	type	I	and	II	IFNs	are	significantly	higher	after	poly	I:C	injection.	Thus,	unsurprisingly,	transcript	levels	of	ifnφ	rose	»30	fold	3	h	after	each	poly	I:C	injection	(Figure	5.2)	but	were	not	significantly	increased	in	irradiated	recipients	(control	and	poly	I:C	injected)	at	the	time	of	transplant.	Type	II	 IFNs	 infγ1.1	 and	 ifnγ1.2	were	 also	 increased	 after	 poly	 I:C	 stimulation,	 although	 the	 profiles	 of	 the	 two	transcripts	were	slightly	different.	Infγ1.1	increased	»10	fold	3	h	after	each	poly	I:C	injection	and	levels	were	»5.5	fold	in	irradiated	recipients	and	»4	fold	in	irradiated	Poly	I:C	treated	recipients	at	the	time	of	transplant	(Figure	5.2).	On	the	other	hand,	transcript	levels	of	orthologue	ifnγ1.2	almost	doubled	between	the	1st	and	2nd	poly	I:C	injection	(from	»17	to	»30	fold)	but	had	returned	to	basal	levels	in	recipients	at	the	time	of	transplant.			The	transcript	levels	of	HSC	chemokine	cxcl12a	were	not	affected	by	the	poly	I:C	injections	(Figure	5.2).	However,	while	transcript	levels	of	cxcl12a	doubled	in	irradiated	control	“IR”	recipients	relative	to	untreated	“No	IR,	No	Poly	I:C”	fish	(p<0.01;	Figure	3.5),	levels	of	cxcl12a	were	not	significantly	increased	in	inflamed	“poly	I:C	+	IR”	recipients	relative	to	untreated	“No	IR,	No	Poly	I:C”	fish.			
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Cumulatively,	these	results	show	that	there	are	high	levels	of	inflammatory	cytokine	transcripts	in	recipients	3	h	after	each	poly	I:C	injection.	They	also	indicate	that	the	inflammatory	profile	in	both	recipient	groups	(control	“IR”	and	inflamed	“Poly	I:C	+	IR”)	are	not	significantly	different	to	each	other	or	“No	IR,	No	poly	I:C”	samples	at	the	time	of	transplant.	From	these	measurements,	there	is	a	possibility	that	an	inflamed	recipient	was	not	created	and	this	is	addressed	in	the	discussion.	The	lower	than	expected	levels	of	cytokine	transcripts	in	Poly	I:C	treated	recipients	 (poly	 I:C	 +IR)	 might	 be	 explained	 by	 the	 greater	 loss	 of	 cytokine	 producing	 cells	 from	 ionising	irradiation,	due	to	the	proliferative	effect	of	poly	I:C,	compared	to	control	recipients.		In	chapter	3.3.1.1,	the	effect	of	irradiation	on	the	death	of	cells	of	the	WKM	was	assessed	using	flow	cytometry	and	the	qRT-PCR	data	had	supported	the	flow	cytometry	data.	Due	to	their	small	size,	 the	recipients	 in	these	experiments	were	too	difficult	to	dissect	therefore	qRT-PCR	was	used	to	assess	the	prevalence	of	blood	cells	from	the	mRNA	extracted	from	the	whole	body.			In	general,	the	results	show	that	blood-related	transcripts	increased	after	2	injections	of	poly	I:C	and	decrease	following	 irradiation	 (Figure	5.3).	However,	 radiation	did	not	have	a	different	effect	on	poly	 I:C	 injected	 fish	(“Poly	I:C	+IR”)	and	non-injected	fish	(“IR”).	It	is	not	surprising	that	a	single	poly	I:C	injection	would	not	cause	major	changes	to	blood	transcript	production	within	3	h.	However,	there	is	evidence	that	a	second	injection	of	poly	I:C,	and	51	h	after	the	1st	injection	of	poly	I:C,	there	has	been	a	major	shift	in	hematopoiesis.	Transcript	levels	of	 the	 erythroid-associated	 gene	 gata1	 were	 not	 affected	within	 3	 h	 of	 poly	 I:C	 injection	 but	 had	 increased	significantly	(»1.7	fold)	at	the	second	time	point	(51	h	after	the	1st	injection,	3	h	after	the	2nd	injection;	Figure	5.3).	 Transcript	 levels	 of	 gata1	 in	 both	 control	 (IR)	 and	 Poly	 I:C	 treated	 recipients	 (Poly	 I:C	 +	 IR)	 were	significantly	lower	than	poly	I:C	injected	fish	(p<0.001),	and	“No	IR,	No	poly	IC”	fish	(p<0.05).	However,	there	was	 no	 difference	 in	 gata1	 transcript	 levels	 between	 control	 and	 Poly	 I:C	 treated	 recipients	 at	 the	 time	 of	transplant.		
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Figure	 5.2:	 Two	 intra-peritoneal	 injections	 of	 poly	 I:C	 and	
irradiation	 causes	 inflammatory	 cytokine	 expression	 in	 the	
whole	body.	TraNac	fish	were	injected	with	10	μg	poly	I:C	twice,	
48	h	apart,	then	irradiated	with	15	Gy	48	h	and	72	h	later.	Fish	
were	 humanely	 killed	 and	 mRNA	 extracted	 from	 the	
decapitated	body	3	h	after	1st	(poly	I:C	10	μg)	and	3h	after	2nd	
injection	 (poly	 I:C	 2x	 10	 μg)	 and	 24	 h	 after	 the	 2	 doses	 of	
irradiation	 (Poly	 I:C	 +	 IR).	 Control	 recipients	 (IR)	 were	 not	
injected	 but	 were	 irradiated	 alongside	 inflamed	 recipients.	
Non-irradiated	or	injected	fish	(No	IR,	No	poly	I:C)	were	used	
as	 untreated	 controls.	 Transcript	 levels	 of	 il-1β,	 tnf⍺,	 il-6,	
ifnφ1,	ifnγ1.1,	ifnγ1.2,	cxcl-c1c	and	cxcl12a	in	the	decapitated	
fish.	 Relative	 transcript	 levels	 calculated	 using	 the	 DDCT	
method,	normalising	to	18S	expression.	Fold	change	relative	to	the	median	“untreated”	value.	The	experiment	was	repeated	3	
times	and	results	pooled,	n>8.	“No	IR	No	Poly	I:C”	and	“IR”	groups	previously	presented	in	chapter	3.3.1.3.	Statistical	significance	
using	One-way	ANOVA	and	Tukey	post-test.	*	p<0.05,	**	p<0.01,	***	p<0.001.			Like	 gata1,	 transcript	 levels	 of	 lymphoid-associated	 gene	 lck	 also	 increased	 after	 poly	 I:C	 treatment	 and	decreased	significantly	 following	 irradiation.	Levels	of	 lck	 transcript	were	doubled	3	h	after	 the	 first	poly	 I:C	injection.	The	levels	of	lck	almost	tripled	(p<0.05)	after	the	2nd	injection	(51	h	after	the	1st	injection,	3	h	after	the	
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2nd	 injection;	Figure	5.3).	Subsequent	 irradiation	caused	a	significant	decrease	 in	 lck	 transcript	 levels	 in	both	control	and	poly	I:C	injected	fish	relative	to	poly	I:C	injected	fish	(p<0.05)	but	not	significantly	different	relative	to	untreated	“No	IR,	No	poly	I:C”	fish	(»50	%	and	»25	%	respectively).		
	
Figure	5.3:	Two	intra-peritoneal	injections	of	poly	I:C	increase	blood	production	and	irradiation	decreases	blood	populations	in	
the	whole	body.	TraNac	fish	were	injected	with	10	μg	poly	I:C	twice,	48	h	apart,	then	irradiated	with	15	Gy	48	h	and	72	h	later.	
Fish	were	humanely	killed	and	mRNA	extracted	from	the	decapitated	body	3	h	after	1st	(poly	I:C	10	μg)	and		2nd	injection	(poly	
I:C	2x	10	μg)	and	24	h	after	the	2	doses	of	irradiation	(Poly	I:C	+	IR).	Control	recipients	(IR)	were	not	injected	but	were	irradiated	
alongside	inflamed	recipients.	Non-irradiated	or	injected	fish	(No	IR,	No	poly	I:C)	were	used	as	untreated	controls.	RTqPCR	was	
used	to	measure	relative	expression	of	gata1,	mpeg,	l-plastin,	lck,	lyz	and	mfap4,	normalised	to	18S,	using	the	DDCT	method.	
Repeated	three	times	and	experiments	pooled,	n>6.	“No	IR,	No	Poly	I:C”	and	“IR”	data	presented	in	in	chapter	3.3.1.3.	Statistical	
significance	using	One-way	ANOVA	and	Tukey	post-test.	*	p<0.05,	**	p<0.01,	***	p<0.001.		Similarly,	transcripts	of	myeloid	associated	genes	lyz	and	mfap4	(macrophage	transcript)	also	increased	after	2	poly	 I:C	 injections,	 relative	 to	untreated	 fish	 (p<0.01;	 Figure	5.3).	On	 the	other	hand,	 the	 transcript	 levels	of	immune	cell-associated	gene	l-plastin,	and	myeloid-specific	gene	mpeg	did	not	change	significantly,	relative	to	
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untreated	 fish.	 It	 is	 interesting	 to	 note	 that	 the	 myeloid-associated	 transcript	 mpeg	 did	 not	 change,	 but	macrophage	transcript	mfap4	increased	8	fold	after	2	injections	of	poly	I:C.	This	might	indicate	that	poly	I:C	could	stimulate	the	differentiation	of	the	mfap4+	subset	of	myeloid	cells,	or	perhaps	poly	I:C	might	somehow	intervene	in	the	degradation	of	mfap4	transcripts.	Again,	due	to	the	nature	of	the	one-way	ANOVA	statistical	test,	with	the	exception	of	gata1,	 there	were	no	significant	differences	 in	 transcript	 levels	of	cell-associated	genes	between	untreated	“No	IR,	No	poly	I:C”	and	irradiated	groups	(“IR”	or	“poly	I:C	+	IR”).			
5.3.2 A	transplant	of	200	cd41:GFP+	cells	from	Tg	(cd41:GFP;lyz:dsRed)	rescues	both	control	recipients	and	poly	
I:C	injected	recipients		The	 next	 step	 was	 to	 determine	 whether	 transplanted	 cd41:GFP+	 HSPCs	 behaved	 differently	 early	 post-transplant	 in	 a	moderately	 inflamed	environment,	 using	 the	 same	 imaging	 and	 counting	method	used	 in	 the	previous	results	chapters.		
	
Figure	5.4:	Schematic	overview	of	experiment	timeline.	Poly	I:C	TraNac	recipients	were	injected	twice	with	10	μg	poly	I:C,	48	h	
apart,	and	irradiated	twice	48	h	and	72	h	later	(48	h	and	24	h	before	transplant).	Control	recipients	were	not	injected	but	were	
irradiated	twice,	48	h	and	24	h	before	transplant.	Donor	Tg	(cd41:GFP;	lyz:dsRed)	fish	were	harvested	for	WKM	cells	which	were	
sorted	for	cd41:GFP+	cells.	Control	and	Poly	I:C	treated	recipients	received	a	transplant	of	200	cd41:GFP+	cells	and	105	WT	PB	
cells	from	the	same	donor	pool.	Non-transplanted	recipients	did	not	receive	105	WT	PB	cells.	All	recipients	were	imaged	4,	6	and	
8	dpt	and	survival	was	monitored	up	to	28	dpt.			Inflamed	recipients	were	prepared	in	the	same	way	as	before	(Figure	5.4);	recipients	were	injected	twice	with	10	μg	of	poly	 I:C	 (48	h	 apart)	 and	 irradiated	48	h	 and	24	h	before	 transplant.	 “Control”	 recipients	were	not	injected	but	were	irradiated	at	the	same	time	as	poly	I:C	injected	recipients,	48	h	and	24	h	before	transplant.	Naïve	 double	 transgenic	 Tg	 (cd41:GFP;lyz:dsRed)	 donors	 were	 humanely	 killed	 and	 cd41:GFP+	 cells	 were	selected	from	the	WKM.	Each	recipient	received	a	transplant	of	200	cd41:GFP+	cells	with	105	wild-type	PB	cells	delivered	retro-orbitally.	Since	both	groups	of	recipients	received	the	same	WKM	and	PB	mix,	transplants	were	delivered	alternatively	between	the	two	recipient	groups	every	3	fish.	This	ensured	that	the	time	delay	between	
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experimental	set-up	and	transplantation	was	evenly	distributed	across	both	groups.	Recipients	were	imaged	at	4,	6	and	8	dpt	and	the	number	of	cd41:GFP+	and	lyz:dsRed+	cells	were	counted	in	the	entire	recipient	and	in	the	WKM.	Survival	was	monitored	for	individual	fish	up	to	28	dpt,	at	which	point	the	recipients	were	humanely	killed	for	analysis	by	flow	cytometry.		
5.3.3 Early	post-transplant	behaviour	of	cd41:GFP+	cells	in	“control”	and	poly	I:C	treated	recipients		A	key	outcome	of	this	thesis	has	been	the	development	of	a	method	to	monitor	fluorescent	protein	expressing	donor	cells	in	the	transplant	recipient.	Observations	and	quantification	of	lyz:dsRed+	and	cd41:GFP+	cells	were	made	in	the	same	recipient	at	4,	6	and	8	dpt	(Figure	5.5).			
	 	
Figure	5.5:	Visualising	fluorescent	cells	in	the	mid	WKM	at	4,	6	or	8	dpt	in	control	and	poly	I:C	treated	recipients.	Poly	I:C	treated	
TraNac	recipients	were	injected	twice	with	10	μg	poly	I:C,	48	h	apart,	and	irradiated	twice	48	h	and	72	h	later	(48	h	and	24	h	
before	 transplant).	 Control	 recipients	 were	 irradiated	 twice,	 48	 h	 and	 24	 h	 before	 transplant.	 WKM	 was	 harvested	 from	
humanely	 killed	 donor	 Tg	 (cd41:GFP;	 lyz:dsRed)	 and	 sorted	 for	 cd41:GFP+	 cells.	 “Control”	 and	 poly	 I:C	 treated	 recipients	
received	a	transplant	of	200	cd41:GFP+	cells	and	105	WT	PB	cells	from	the	same	donor	pool	(non-transplanted	recipients	did	
not	 receive	 105	WT	 PB	 cells).	 The	 same	 recipient	was	 imaged	 4,	 6	 and	 8	 dpt	 using	 a	 Zeiss	 Axiovert	 200	 inverted	 confocal	
microscope	with	488	and	506	nm	lasers.	Representative	images	taken	from	a	control	(top)	and	a	poly	I:C	(bottom)	recipient	over	
time	(4,	6	and	8	dpt).	White	arrows	indicate	GFP+	cells,	black	arrows	indicate	dsRed+	cells.		The	 results	 show	 that	 the	 number	 of	 lyz:dsRed+	 cells	 increased	 significantly	 over	 time	 (p<0.0001)	 in	 both	recipient	groups,	although	the	rate	of	increase	was	not	consistent	across	fish,	even	in	the	same	recipient	group	(Figure	5.6A).	There	was	no	difference	between	poly	 I:C	and	control	 groups	and	no	 significant	 interaction,	 a	combination	of	recipient	effect	and	time	effect	(Figure	5.6A).	At	each	time	point,	the	number	of	lyz:dsRed+	in	the	WKM	of	recipients	was	not	significantly	different	between	groups	(Figure	5.6B).		
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Figure	5.6:	There	is	no	difference	in	the	accumulation	of	cd41:GFP+	and	lyz:dsRed+	donor	cells	in	poly	I:C	injected	recipient	
WKM	 and	 non-injected	 recipient	WKM.	 Poly	 I:C	 TraNac	 recipients	were	 injected	 twice	with	 10	 μg	 poly	 I:C,	 48	 h	 apart,	 and	
irradiated	twice	48	h	and	72	h	later	(48	h	and	24	h	before	transplant).	Control	recipients	were	not	injected	but	were	irradiated	
twice,	48	h	and	24	h	before	transplant.	Donor	Tg	(cd41:GFP;	lyz:dsRed)	fish	were	humanely	killed	and	WKM	cells	were	harvested	
and	sorted	for	cd41:GFP+	cells.	“Control”	and	poly	I:C	treated	recipients	received	a	transplant	of	200	cd41:GFP+	cells	(and	105	
WT	PB	cells;	non-transplanted	recipients	did	not	receive	105	WT	PB	cells)	from	the	same	donor	pool.	All	recipients	were	imaged	
using	Zeiss	axiovert	200	inverted	microscope	(wide	field)	and	fluorescent	cells	were	counted	in	the	WKM	at	4,	6,	and	8	dpt.	4	
experiments	pooled.	The	number	of	(A)	lyz:dsRed+	and	(C)	cd41:GFP+	cells	in	the	WKM	of	individual	recipients.	The	data	from	
the	same	 fish	 is	connected	by	a	 line	(Control	recipients	 in	blue,	n=	17;	Poly	 I:C	 treated	recipients	 in	plum,	n=	19).	Two	way	
repeated	measures	ANOVA.	Significance	demonstrated	with	L-shaped	arrows:	significance	over	time	indicated	by	the	horizontal	
arrow,	 significance	 between	 treatment	 groups	 indicated	 by	 vertical	 arrow.	 Interaction	 indicated	 in	 the	 angle	 between	 the	
arrows.	(B	and	D)	The	same	data	is	represented	as	in	A	and	C	to	show	data	spread.	Each	dot	represents	a	fish.	Student	test	at	
each	time	point.	
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Likewise,	the	number	of	cd41:GFP+	cells	in	the	WKM	significantly	increased	over	time	(p<0.0001)	but	there	was	no	significant	difference	in	the	number	of	cells	between	the	two	recipient	groups	at	any	of	the	time	points	groups	(Figure	5.6C,	D).	Again	there	was	no	cumulative	effect	(interaction)	between	time	and	recipient	treatment	(Figure	5.6C).	Together	these	results	indicate	that	transplanted	cells	behave	in	a	similar	way	in	both	recipient	groups.		
	
Figure	5.7:	There	is	no	correlation	between	the	number	of	observed	cd41:GFP+	cells	and	lyz:dsRed+	cells	in	the	WKM	at	8	dpt.	
Poly	I:C	TraNac	recipients	were	injected	twice	with	10	μg	poly	I:C,	48	h	apart,	and	irradiated	twice	48	h	and	72	h	later	(48	h	and	
24	h	before	transplant).	“Control”	recipients	were	not	injected	but	were	irradiated	twice,	48	h	and	24	h	before	transplant.	Donor	
Tg	(cd41:GFP;	lyz:dsRed)	fish	were	humanely	killed	and	harvested	for	WKM	cells	which	were	sorted	for	cd41:GFP+	cells.	“Control”	
and	poly	I:C	treated	recipients	received	a	transplant	of	200	cd41:GFP+	cells	(and	105	WT	PB	cells;	non-transplanted	recipients	
did	not	receive	105	WT	PB	cells)	from	the	same	donor	pool.	Recipients	were	imaged	8	dpt	using	Zeiss	axiovert	200	inverted	
microscope	(wide	field)	and	fluorescent	cells	were	counted	in	the	WKM.	Experiment	repeated	4	times	and	data	pooled;	the	same	
recipient	is	connected	by	a	line.	The	number	of	lyz:dsRed+	and	cd41:GFP+	cells	in	(A)	all	recipients	(“control”	recipients	in	blue,	
n=	17;	Poly	I:C	treated	recipients	in	plum,	n=	19)	and	(C)	recipients	that	survived	to	28	dpt	(“control”	recipients	in	blue,	n=	7;	
Poly	 I:C	 treated	recipients	 in	plum,	n=	8).	 (B	and	D)	Same	data	as	A	and	C	presented	as	X	and	Y	scatter	with	 line	of	best	 fit	
(Pearsons	correlation).		
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The	same	data	were	also	analysed	to	determine	if	a	relationship	exists	between	the	number	of	cd41:GFP+	and	lyz:dsRed+	cells	in	the	WKM	at	8	dpt	in	either	recipient	group.	In	general,	the	number	of	lyz:dsRed+	exceeded	the	number	of	cd41:GFP+	in	every	recipient	(Figure	5.7A).	In	fact,	this	trend	was	clear	in	fish	that	survived	to	28	dpt.	However,	interestingly,	2	Poly	I:C	treated	recipients	with	a	higher	number	of	cd41:GFP	than	lyz:dsRed+	also	survived	 to	 28	 dpt.	 The	 dependence	 of	 these	 two	 variables	 was	 tested	 using	 Pearson’s	 product-moment	correlation.	 There	 was	 no	 correlation	 between	 the	 number	 of	 cd41:GFP+	 and	 lyz:dsRed+	 in	 either	 set	 of	recipients	at	8	dpt	(control	recipients,	r=	-0.025,	p=0.922;	Poly	I:C	treated	recipients,	r	=0.4458,	p=	0.0558;	Figure	5.7B).	Although	the	data	from	the	poly	I:C	treated	recipient	group	indicates	a	trend	(p=	0.0558),	the	r	value	means	that	55	%	of	the	data	does	not	fit	the	line	and	thus	this	model	cannot	be	used	to	predict	cd41:GFP+	counts	from	lyz:dsRed	counts.	The	analysis	was	also	applied	to	the	recipients	that	survived	to	28	dpt.	These	results	showed	even	less	correlation	(control	recipients,	r=	-0.0203,	p=0.965;	Poly	I:C	treated	recipients,	r	=0.0382,	p=	0.929)	between	the	number	of	cd41:GFP+	and	lyz:dsRed+	(Figure	5.7D).		
5.3.4 Survival	of	poly	I:C	treated	recipients	is	not	affected	After	 imaging,	 individual	 recipients	were	 tracked	 for	28	days	 to	correlate	survival	with	early	post-transplant	imaging	data.	There	was	a	clear	difference	between	transplant	recipients	(both	“control”	and	poly	I:C	treated)	and	non-transplanted	but	irradiated	controls	and	poly	I:C	injected	and	irradiated	controls	(p<0.01).	“Control”	recipients	had	a	52	%	chance	of	surviving	to	28	dpt,	while	Poly	I:C	treated	recipients	had	a	slightly	lower	42	%	chance	 of	 surviving	 this	 long	 (Figure	 5.8).	 This	 difference	 was	 not	 significant,	 indicating	 that	 the	 inflamed	environment	does	not	affect	survival	to	28	dpt.	Interestingly,	in	chapter	4	many	of	the	recipients	did	not	have	cells	in	the	WKM	by	8	dpt	and	this	correlated	with	a	significantly	lower	survival.	However,	in	these	experiments,	only	2	transplanted	controls	did	not	have	cells	in	the	WKM	and	these	fish	died	by	6	dpt.	Likewise,	just	4	poly	I:C	transplant	recipients	did	not	have	cells	in	the	WKM	by	8	dpt	and	all	of	these	fish	died	by	9	dpt.	Thus,	again	the	presence	of	cells	 in	the	WKM	correlates	with	survival.	Fish	that	did	not	have	cells	 in	the	WKM	by	8	dpt	were	omitted	from	the	survival	analysis.		Overall,	there	was	no	difference	in	survival	between	non-transplanted	“control”	recipients	and	non-transplanted	Poly	I:C	treated	recipients	to	28	dpt	(Figure	5.8).	Although,	at	10	dpt,	the	non-transplanted	poly	I:C	group	had	better	survival	(»60	%)	than	non-transplanted	“control”	(»25	%).	This	shows	that	the	poly	I:C	injections	did	not	affect	survival	of	recipients,	independent	of	transplantation.			
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Figure	5.8:	Survival	of	“control”	and	poly	I:C	treated	recipients	post-transplant.	Poly	I:C	TraNac	recipients	were	injected	twice	
with	10	μg	poly	I:C,	48	h	apart,	and	irradiated	twice	48	h	and	72	h	later	(48	h	and	24	h	before	transplant).	“Control”	recipients	
did	not	get	an	I.P.	injection	but	were	irradiated	twice,	48	h	and	24	h	before	transplant.	Donor	Tg	(cd41:GFP;	lyz:dsRed)	fish	were	
humanely	killed	and	harvested	for	WKM	cells	which	were	sorted	for	cd41:GFP+	cells.	“Control”	and	poly	I:C	treated	recipients	
received	a	transplant	of	200	cd41:GFP+	cells	(and	105	WT	PB	cells)	from	the	same	donor	pool.	No	transplant	“control”	recipients	
did	not	 receive	105	WT	PB	cells.	All	 recipients	were	 imaged	and	 then	 tracked	 for	 survival	 to	28	dpt.	7	experiments	pooled;	
“Control”	recipients	n=	40,	data	previously	presented	in	Figure	4.9D;	Poly	I:C	treated	recipients	n=	32.	Mantel-cox	test	used	to	
compare	curves.	***	p<0.001,	**	p<0.01.		
5.3.5 A	 transplant	 of	 200	 cd41:GFP+	 cells	 from	 naïve	 Tg	 (cd41:GFP;lyz:dsRed)	 can	 reconstitute	 the	 WKM	 of	
“control”	and	poly	I:C	injected	recipients		In	order	to	determine	if	the	recipient	environment	affected	WKM	reconstitution,	recipients	were	harvested	at	28	dpt	 to	 be	 analysed	 by	 flow	 cytometry	 (Figure	 5.9).	 Firstly,	 there	 was	 no	 difference	 in	 the	 percentage	 of	erythrocyte,	 myelomonocyte,	 lymphocyte	 and	 precursor	 populations	 as	 determined	 using	 forward	 and	 side	scatter	 (Figure	5.10A).	Secondly,	 there	was	no	difference	 in	 the	percentage	of	 cd41:GFP+	between	recipients	groups	 (Figure	5.10B).	As	 the	 recipients	were	 individually	monitored,	 the	data	 can	be	paired	 for	 correlation	studies	(Figure	5.11A).	The	number	of	cd41:GFP+	cell	at	8	dpt	did	not	correlate	with	the	percentage	of	cd41:GFP+	cells	 determined	 by	 flow	 cytometry	 at	 28	 dpt	 (Pearson’s	 product-moment	 correlation;	 “control”	 recipients,	r2=0.0318,	p=0.7351;	poly	I:C	treated	recipients,	r2	=0.0902,	p=	0.6234;	Figure	5.11B).		There	was	large	variation	in	the	percentage	of	lyz:Red+	in	recipients	within	the	same	group	(Figure	5.10C,	D).	This	indicates	that	while	all	recipients	contained	donor	cells,	there	is	a	big	variation	in	donor	contribution	to	the	WKM	and	myeloid	population	at	28	dpt.	As	 lyz	 is	a	gene	expressed	by	57.4	±	3.5	%	of	myeloid	cells	(56),	 the	percentage	of	lyz:dsRed+	events	in	the	myeloid	gate	was	used	to	assess	donor	contribution.	In	some	cases,	the	poly	I:C	treated	recipients	had	more	donor	contribution	(average	27	%,	highest	87	%)	than	“control”	recipients	(average	9	%,	highest	55	%;	Figure	5.10D).	However,	the	difference	between	the	groups	was	not	significant.	Again	the	number	of	lyz:dsRed+	cell	at	8	dpt	was	compared	with	the	percentage	of	lyz:dsRed+	cells	determined	by	flow	
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cytometry	 at	 28	 dpt	 (Figure	 5.11C)	 but	 no	 correlation	 was	 found	 (Pearson’s	 product-moment	 correlation;	“control”	recipients,	r2=	0.04464,	p=	0.6878;	poly	I:C	treated	recipients,	r2=	0.198,	p=	0.4527;	Figure	5.11D).		
	 	
Figure	5.9:	 Flow	cytometry	 scatter	of	 a	 “control”	 and	a	poly	 I:C	 treated	 recipient	 at	28	dpt.	Poly	 I:C	TraNac	 recipients	were	
injected	twice	with	10	μg	poly	I:C,	48	h	apart,	and	irradiated	twice	48	h	and	72	h	later	(48	h	and	24	h	before	transplant).	“Control”	
recipients	were	irradiated	twice,	48	h	and	24	h	before	transplant.	Donor	Tg	(cd41:GFP;	lyz:dsRed)	were	humanely	killed	and	
WKM	were	harvested	and	sorted	 for	 cd41:GFP+	cells.	 “Control”	and	poly	 I:C	 treated	recipients	 received	a	 transplant	of	200	
cd41:GFP+	cells	and	105	PB	cells	from	the	same	donor	pool.	Recipients	were	harvested	at	28	dpt	for	flow	cytometry	analysis.	All	
cells	shown	in	first	panel:	SSC	indicates	side	scatter;	FSC	indicates	forward	scatter	(both	use	488	nm	laser,	488/10	filter).	Events	
after	debris	exclusion	shown	in	second	panel:	population	is	separated	into	dsRed+	(561	nm	laser,	610/20	filter)	and	GFP+	(488	
nm	laser,	530/30	filter)	events.	Third	panel	shows	GFP+	events	only:	SSC	indicates	side	scatter;	FSC	indicates	forward	scatter	
(both	use	488	nm	laser,	488/10	filter).		
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Figure	5.10:	Reconstitution	of	 the	WKM	in	“control”	and	poly	 I:C	 treated	recipients	28	days	post-transplant.	Poly	 I:C	 treated	
TraNac	recipients	were	injected	twice	with	10	μg	poly	I:C,	48	h	apart,	and	irradiated	twice	48	h	and	72	h	later	(48	h	and	24	h	
before	transplant).	Control	recipients	were	not	injected	but	were	irradiated	twice,	48	h	and	24	h	before	transplant.	Donor	Tg	
(cd41:GFP;	lyz:dsRed)	fish	were	humanely	killed	and	WKM	cells	were	harvested	and	sorted	for	cd41:GFP+	cells.	“Control”	and	
poly	I:C	treated	recipients	received	a	transplant	of	200	cd41:GFP+	cells	(and	105	WT	PB	cells;	non-transplanted	recipients	did	
not	receive	105	WT	PB	cells)	from	the	same	donor	pool.	Recipients	were	humanely	killed	at	28	dpt	for	flow	cytometry	analysis.	
(4	 experiments	 pooled;	 “control”	 recipients	 n=12,	 Poly	 I:C	 treated	 recipients	 n=6).	 Each	 dot	 represents	 a	 recipient.	 (A)	
Percentage	 of	myelomonocytes,	 lymphocytes,	 and	 precursors	 (Forward	 and	 by	 side	 scatter	 gating;	 Both	 use	 488	 nm	 lazer,	
488/10	filter).	(B)	Percentage	of	cd41:GFP+	(488	nm	laser,	530/30	filter).	(C)	Percentage	of	lyz:dsRed+	(561	nm	laser,	610/20	
filter)	in	the	WKM.	(D)	Percentage	of	myelomonocytes	dsRed+.	
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Figure	5.11:	There	is	no	correlation	between	the	number	of	fluorescent	cells	observed	at	8	dpt	and	the	percentage	of	fluorescent	
cells	at	28	dpt	in	the	WKM	of	“control”	or	poly	I:C	treated	recipients.	Poly	I:C	treated	TraNac	recipients	were	injected	twice	with	
10	μg	poly	I:C,	48	h	apart,	and	irradiated	twice	48	h	and	72	h	later	(48	h	and	24	h	before	transplant).	“Control”	recipients	did	not	
get	 an	 I.P.	 injection	 but	were	 irradiated	 twice,	 48	 h	 and	 24	 h	 before	 transplant.	 Donor	 Tg	 (cd41:GFP;	 lyz:dsRed)	 fish	were	
humanely	killed	and	WKM	cells	were	harvested	and	sorted	for	cd41:GFP+	cells.	“Control”	and	poly	I:C	treated	recipients	received	
a	transplant	of	200	cd41:GFP+	cells	(and	105	WT	PB	cells)	from	the	same	donor	pool.	Non-transplanted	recipients	did	not	receive	
105	WT	PB	cells.	All	recipients	were	imaged	8	dpt	and	humanely	killed	at	28	dpt	for	analysis	by	flow	cytometry.	(2	experiments	
pooled;	“control”	recipients	n=6,	Poly	I:C	treated	recipients	n=5).	(A)	The	number	of	cd41:GFP+	counted	in	the	WKM	at	8	dpt	
matched	with	the	percentage	of	cd41:GFP+	(488	nm	laser,	530/30	filter)	in	the	WKM	at	28	dpt.	Data	from	the	same	recipients	is	
connected	by	a	line.	(B)	The	same	data	as	A	is	presented	in	an	XY	scatter	with	a	line	of	best	fit.	(C)	The	number	of	lyz:dsRed	+	
counted	in	the	WKM	at	8	dpt	matched	with	the	percentage	of	lyz:dsRed+	(561	nm	laser,	610/20	filter)	in	the	WKM	at	28	dpt.	(D)	
The	same	data	as	C	is	presented	in	an	XY	scatter	with	a	line	of	best	fit.		
5.3.6 The	percentage	of	precursor	cells	is	lower	in	Poly	I:C	treated	recipient	WKM	than	“control”	recipient	WKM	
at	14	dpt			Altogether,	 the	 data	 indicates	 that	 there	 is	 no	 difference	 in	 reconstitution	 of	 “control”	 and	 poly	 I:C	 treated	recipients’	WKM	by	28	dpt.	In	order	to	determine	if	transplanted	cells	were	reconstituting	the	recipient	WKM	differently	before	this	stage,	recipients	were	humanely	killed	at	14	dpt	for	analysis	by	flow	cytometry.		
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Figure	5.12:	Flow	cytometry	scatter	of	“control”	and	poly	I:C	treated	recipients	at	14	dpt.	Poly	I:C	treated	TraNac	recipients	were	
injected	twice	with	10	μg	poly	I:C,	48	h	apart,	and	irradiated	twice	48	h	and	72	h	later	(48	h	and	24	h	before	transplant).	Control	
recipients	were	irradiated	twice,	48	h	and	24	h	before	transplant.	Donor	Tg	(cd41:GFP;	lyz:dsRed)	fish	were	humanely	killed	
and	the	WKM	was	harvested	and	sorted	for	cd41:GFP+	cells.	“Control”	and	poly	I:C	treated	recipients	received	a	transplant	of	
200	cd41:GFP+	cells	and	105	WT	PB	cells	from	the	same	donor	pool.	Non-transplanted	recipients	did	not	receive	105	WT	PB	cells.	
Recipients	were	humanely	killed	at	14	dpt	 for	analysis	by	 flow	cytometry.	 SSC	 indicates	 side	 scatter;	FSC	 indicates	 forward	
scatter	 (both	use	488	nm	 laser,	488/10	 filter).	The	debris	exclusion	gated	population	 is	 separated	by	dsRed	(561	nm	 laser,	
610/20	filter)	and	GFP	(488	nm	laser,	530/30	filter)	scatter	to	obtain	a	lyz-	population.		The	major	blood	lineages	were	determined	by	forward	and	side	scatter	gating	(Figure	5.12).	The	percentage	of	myelomonocytes	and	lymphocytes	in	the	WKM	did	not	differ	significantly	between	the	2	groups	(Figure	5.13A).	However,	 the	 percentage	 of	 erythrocytes	 was	 significantly	 higher,	 and	 the	 percentage	 of	 precursors	 was	significantly	lower,	in	the	poly	I:C	treated	recipient	group	compared	to	the	control	recipient	group.	This	might	indicate	 that	 “control”	 recipients	 have	 a	 greater	 population	 of	MPPs	 at	 this	 time,	 relative	 to	 poly	 I:C	 treated	recipients.			In	addition,	the	percentage	of	donor	derived	cells	(cd41:GFP	and	lyz:dsRed)	did	not	differ	significantly	between	the	groups	at	14	dpt.	These	data	support	earlier	observations	at	8	dpt	in	which	the	number	of	these	cells	observed	in	the	WKM	did	not	differ	significantly	between	the	2	recipient	groups	(Figure	5.6C,	D).		
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Figure	5.13:	 “Control”	 recipients	have	a	higher	percentage	of	precursors	 than	poly	 I:C	 injected	recipients	at	14	dpt.	Poly	 I:C	
treated	TraNac	recipients	were	injected	twice	with	10	μg	poly	I:C,	48	h	apart,	and	irradiated	twice	48	h	and	72	h	later	(48	h	and	
24	h	before	transplant).	“Control”	recipients	were	not	injected	but	were	irradiated	twice,	48	h	and	24	h	before	transplant.	Donor	
Tg	(cd41:GFP;	lyz:dsRed)	fish	were	humanely	killed	and	the	WKM	harvested	and	sorted	for	cd41:GFP+	cells.	“Control”	and	Poly	
I:C	treated	recipients	received	a	transplant	of	200	cd41:GFP+	cells	(and	105	WT	PB	cells)	from	the	same	donor	pool.	Recipients	
were	imaged	8	dpt	and	harvested	at	14	dpt	for	anaylsis	by	flow	cytometry.	(2	experiments	pooled;	“control”	recipients	n=8,	poly	
I:C	treated	recipients	n=4).	(A)	The	percentage	of	erythrocytes,	myelomonocytes,	lymphocytes,	and	precursors	(Forward	and	by	
side	scatter	gating;	Both	use	488	nm	lazer,	488/10	filter).	(B)	The	percentage	of	lyz:dsRed+	(561	nm	laser,	610/20	filter)	in	the	
WKM.	(C)	The	percentage	of	cd41:GFP+	(488	nm	laser,	530/30	filter).			
5.3.7 Using	c-myb	mutant	recipients	to	examine	a	non-inflamed	recipient	environment		In	order	to	study	hematopoietic	engraftment	in	a	non-inflamed	environment,	a	line	of	bloodless	mutants	with	the	c-mybt25127	mutation	(46)	was	used.	These	fish	were	transplanted	with	either	200	cd41:GFP+	cells	(in	order	to	compare	these	recipients	with	the	TraNac	“control”	and	poly	I:C	treated	recipients	described	previously	in	this	chapter	(Figure	5.8))	or	2,000	cd41:GFP+	cells	from	Tg	(cd41:GFP;lyz:dsRed)	donors,	together	with	105	WT	PB	cells.	 The	 survival	 of	mutants	 transplanted	with	 200	 cells	was	 very	 low	 (22	%	 to	 28	 dpt)	 compared	 to	 fish	receiving	2,000	cells	(p=	0.659;			Figure	5.14B).		
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Figure	 5.14:	 The	 non-inflamed	 recipient	 does	 not	 have	 a	
survival	 advantage	 over	 irradiated	 recipients.	 TraNac	
recipients	 were	 irradiated	 twice,	 48	 h	 and	 24	 h	 before	
transplant.	 C-myb	mutants	 were	 raised	 to	 6	 wpf.	 Donor	 Tg	
(cd41:GFP;	 lyz:dsRed)	 fish	 were	 harvested	 for	 WKM	 cells	
which	were	sorted	for	cd41:GFP+	cells	and	mixed	with	105	WT	
PB	cells.	Non-transplanted	recipients	did	not	receive	105	WT	
PB	 cells.	 (A)	 Protocol	 overview.	 (B)	 Survival	 curve	 of	 c-
mybt25127	transplanted	with	200	or	2,000	cd41:GFP+.	(Pooled	
separate	 experiments;	 2	 experiments	 with	 c-mybt25127	
transplanted	with	200	 cd41:GFP+	 (n=9)	with	3	experiments	
with	c-mybt25127	transplanted	with	2,000	cd41:GFP+	(n=20)).	
(C)	 Survival	 curve	 of	 irradiated	 TraNac	 recipients	 with	 c-
mybt25127	 recipients	 of	 200	 cd41:GFP+.	 (Pooled	 separate	
experiments;	3	experiments	c-mybt25127	transplanted	with	200	cd41:GFP+	(n=9),	7	experiments	with	TraNac	“control”	recipients	
(n=	40)	and	TraNac	Poly	I:C	treated	recipients	(n=	32);	data	previously	presented	in	Figure	4.9	and	Figure	5.8).	(D)	Survival	
curve	 of	 irradiated	TraNac	 recipients	 and	 c-mybt25127	 recipients	 of	 2,000	 cd41:GFP+.	 (3	 experiments;	 TraNac	 no	 transplant	
(n=15),	TraNac	transplanted	with	2,000	cd41:GFP+	(n=19),	c-mybt25127	no	transplant	(n=9),	c-mybt25127	transplanted	with	2,000	
cd41:GFP+	(n=20).)		Mantel-cox	test,	****	p<0.001.	
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	It	is	important	to	note	that	c-mybt25127	mutant	survival	was	determined	from	transplant	experiments	performed	independently	of	the	TraNac	transplants	and	therefore	these	experiments	warrant	repeating	with	all	the	groups	included	in	the	same	experiment.	However,	the	preliminary	data	here	suggests	that	survival	of	the	c-mybt25127	mutant	transplanted	with	200	cd41:GFP+	cells	is	lower	than	that	of	the	irradiated	TraNac	(“control”	or	poly	I:C	treated)	recipients	transplanted	with	200	cd41:GFP+	cells	(		Figure	 5.14C).	 The	 comparatively	 lower	 survival	 of	 the	 c-mybt25127	 recipients	 might	 indicate	 that	 the	inflammatory	environment	in	the	irradiated	TraNac	could	be	beneficial.	However,	I	do	not	think	this	is	likely.	It	is	more	likely	that	the	c-mybt25127	mutants	need	to	be	rescued	earlier	than	6	wpf,	and	it	also	indicates	that	a	dose	of	 200	 cells	 is	 very	 low.	 Furthermore,	 the	 sub-lethal	 irradiation	 of	 the	 TraNac	 does	 not	 deplete	 the	 HSPC	population	completely	and	the	remaining	cells	might	be	contributing	to	the	recipient	recovery.		
	Due	 to	 the	 low	 survival	 of	 the	 c-mybt25127	mutants	 transplanted	with	 200	 cd41:GFP+	 cells,	 the	 protocol	was	modified	to	a	transplant	of	2,000	cd41:GFP+	cells		Figure	5.14A).	The	survival	of	transplanted	c-mybt25127	recipients	was	not	significantly	different	to	survival	of	irradiated	TraNac,	also	transplanted	with	2,000	cd41:GFP+	cells	(independent	experiments;		Figure	 5.14D).	 However,	 survival	 of	 transplanted	 c-mybt25127	 mutants	 was	 significantly	 higher	 than	 non-transplanted	c-mybt25127	mutant	siblings	(p<0.0001;			Figure	5.14D).	Taken	together,	these	results	indicate	that	c-mybt25127	recipients	could	be	used	independently	of	TraNac	to	compare	an	inflammatory	and	non-inflamed	recipient	environment.		
5.4 Discussion		Studies	suggest	that	infection	and	inflammation	can	modulate	the	HSPC	compartment.	In	the	previous	chapter	it	was	 shown	 that	 inflammation	 pre-transplant	 can	modulate	 the	 behaviour	 of	 HSPCs	 in	 transplant	 recipients.	Indeed,	repeated	poly	I:C	treatment	of	zebrafish	causes	a	post-transplant	delay	in	the	migration	of	cd41:GFP+	cells	to	the	recipient	WKM	and	subsequent	proliferation	in	the	recipient	WKM.			In	 this	 chapter,	 HSPCs	 were	 transplanted	 into	 inflamed	 recipients.	 To	 understand	 the	 HSPC	 response,	independently	 of	 the	 differentiated	 hematopoietic	 cell	 response,	 cd41:GFP+	 cells	 from	 naïve	 donors	 were	transplanted	into	non-injected	irradiated	“control”	recipients	and	poly	I:C	injected	irradiated	recipients.		Unlike	in	the	previous	chapter,	cells	transplanted	into	both	recipient	groups	came	from	the	same	mix	of	sorted	cd41:GFP+	WKM	cells	and	WT	PB	cells	which	significantly	reduced	the	haemocytometer	counting	error	within	an	experiment.	In	each	experiment,	recipients	came	from	the	same	clutch	and	were	raised	together	before	being	randomly	 allocated	 to	 2	 groups.	 Both	 groups	were	 irradiated	 side	 by	 side	 in	 the	 same	 irradiation	 chamber.	Variation	 in	 individual	 response	 to	 the	 pre-transplant	 treatment	 protocol	 was	 reduced	 by	 repeating	 the	
Post-transplant	behaviour	of	HSCs	in	recipients	with	systemic	inflammation	
	170
experiment	with	n	>30	fish.	Donor	cells	were	transplanted	using	the	same	glass	needle	and	transplant	recipients	were	alternated	every	3	fish.		
5.4.1 Summary	of	results		The	findings	of	this	chapter	were:		 1. qPCR	data	indicated	that	after	poly	I:C	treatment	(10	µg)	there	was	a	significant	increase	in	transcript	levels	of	various	(il-1b,	il-6,	tnfa,	 ifnj,	 	 ifnγ1.1,	ifnγ1.2,	cxcl-c1c	and	cxcl8)	cytokines.	However,	the	high	level	of	cytokine	transcripts	expected	in	the	inflamed	recipient	“poly	I:C	+	IR”	fish	at	the	time	of	transplant,	relative	 to	 untreated	 “No	 IR,	 No	 poly	 I:C”	 or	 control	 “IR”	 recipient	 fish	 was	 not	 detected.	 The	 only	transcript	found	to	be	significantly	increased	in	irradiated	recipients	(“IR”	and	“poly	I:C	+	IR”)	was	cxcl12a.	There	is	a	strong	possibility	that	the	protocol	did	not	result	in	an	“inflamed”	recipient	and	this	is	likely	to	explain	the	rest	of	the	results.	2. Analysis	 of	 data	 obtained	 by	 live	 imaging	 of	 recipients	 revealed	 the	 number	 of	 fluorescent	 cells	(cd41:GFP+	or	lyz:dsRed+)	at	each	time	point	did	not	differ	significantly	between	recipient	groups.		3. Reconstitution	of	the	recipient	WKM	was	not	significantly	different	in	the	two	recipient	groups	at	28	dpt,	although	the	percentage	of	precursors	in	the	“control”	recipients	was	higher	than	the	percentage	in	poly	I:C	treated	recipients	at	14	dpt.	This	does	not	appear	to	have	significantly	affected	the	survival	of	poly	I:C	recipient	group.	4. Finally,	 the	 survival	 of	 “non-inflamed”	 c-mybt25127	 transplanted	with	 200	 cd41:GFP+	was	 lower	 than	irradiated	 TraNac	 transplanted	 with	 200	 cd41:GFP+	 cells.	 However,	 survival	 of	 “non-inflamed”	 c-mybt25127	transplanted	with	2,000	cd41:GFP+	was	the	same	as	irradiated	TraNac	transplanted	with	2,000	cd41:GFP+	cells.			
5.4.2 Creating	an	inflamed	recipient	environment		This	chapter	begins	by	establishing	a	protocol	for	inflamed	recipients.	The	protocol	was	adapted	from	a	paper	by	 Sato	et	 al.	which	used	poly	 I:C	 and	5-FU	as	 a	pre-conditioning	 regiment	 for	 transplantation	 (412).	As	 the	previous	chapters	used	irradiation	pre-treatment,	it	was	decided	that	this	work	would	continue	using	irradiation.	Poly	I:C	treated	recipients	were	injected	with	10	μg	of	poly	I:C	on	days	-6	and	-4,	then	irradiated	with	15	Gy	on	days	-2	and	-1.	“Control”	recipients	were	not	injected	days	-6	and	-4	but	were	irradiated	with	15	Gy	on	days	-2	and	 -1.	qRT-PCR	was	used	 to	measure	 systemic	mRNA	expression	 (whole	body	 samples),	normalised	 to	18S	expression.	Flow	cytometry	could	not	be	used	to	determine	the	populations	of	the	WKM	because	the	size	of	the	recipients	meant	they	could	not	be	dissected	with	precision.	However,	in	chapter	3.3.1.1,	qRT-PCR	had	supported	flow	cytometry	data,	indicating	it	is	a	reliable	alternative	to	flow	cytometry.			Importantly,	the	results	of	the	one-way	ANOVA	with	all	the	groups	present	in	the	analysis	(Figure	5.2)	concluded	that	there	was	no	significant	difference	in	transcript	levels	between	untreated	“No	IR,	No	poly	I:C”	and	irradiated	
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(“IR”	and	“poly	I:C	+	IR”)	recipients.	As	I	mentioned	earlier,	the	one-way	ANOVA	test	calculates	p-values	based	on	the	F-	statistic	(the	ratio	of	the	variance	among	the	means	to	the	variance	within	the	sample),	and	this	reduces	the	 statistical	 significance	 of	 the	 irradiated	 groups.	 Therefore,	 to	 understand	 if	 the	 protocol	 resulted	 in	 an	“inflamed”	recipient,	 the	recipient	groups	(“No	 IR,	No	poly	 I:C”,	 “IR”	and	“poly	 I:C	+	 IR”)	were	also	 tested	 for	statistical	 significance	 separately	 (Supplementary	 Figure	 7.7).	 Surprisingly,	 transcript	 levels	 for	 the	 tested	cytokines	(il-1b,	il-6,	tnfa,	ifnj,		ifnγ1.1,	ifnγ1.2	and	cxcl1)	were	not	significantly	different	between	“IR”	and	“poly	I:C	+IR”	recipients.	Indeed,	the	“poly	I:C	+	IR”	recipient	group	had	significantly	higher	levels	of	il-1b	(»2	fold)	and	
cxcl1	(»3.5	fold)	transcripts	relative	to	the	untreated	group,	and	not	significant	but	>	2.5	fold	higher	levels	of	
ifnγ1.1	(»4	fold).	The	“IR”	recipient	group	had	significantly	higher	levels	of	il-1b	(»3.5	fold),	il-6	(»2	fold),	tnfa	(»4.5	fold),	ifnγ1.1	(»6	fold)	and	cxcl1	(»6	fold)	transcripts,	relative	to	untreated	samples.	Additionally,	there	was	no	difference	in	transcript	levels	of	blood	cell-specific	genes	(Supplementary	Figure	7.8).	This	analysis	strongly	indicates	that	the	cytokine	milieu	of	the	“inflamed”	recipient	and	“control”	recipient	groups	were	not	significantly	different	and	an	“inflamed	recipient”	was	not	achieved	by	 the	protocol.	 I	would	suggest	not	using	“inflamed”	recipients	in	further	studies,	but	instead	focusing	on	“non-inflamed”	recipients	(such	as	the	cmyb	mutant,	if	this	can	be	shown).			Finally,	on	the	question	of	the	difference	between	“control”	and	“inflamed”	recipients,	the	chemokine	cxcl12a	was	significantly	upregulated	in	both	these	groups	relative	to	poly	IC	injected	and	the	non-injected,	non-irradiated	group	(Figure	5.2).	As	in	mice	and	humans	(424),	cxcl12a	is	a	chemoattractant	and	in	zebrafish	attracts	HSCs	to	the	spleen,	thymus	and	kidney	marrow.	Glass	et	al.	found	that	cxcl12a	is	upregulated	»3	fold	in	the	tubule	fraction	of	the	WKM	of	fish	irradiated	with	30	Gy	(307).	As	the	experiment	presented	here	took	the	whole	fish	for	analysis,	it	 is	 not	 clear	 whether	 the	 upregulation	 was	 specifically	 in	 the	 kidney	 or	 in	 other	 tissues	 such	 as	 non-hematopoietic	 tissues	 such	 as	 the	 skin	 and	 gills,	 also	 shown	 to	 express	 cxcl12a	 in	 the	 zebrafish	 (307).	 It	 is	interesting	that	the	increased	expression	is	not	as	pronounced	in	the	irradiated	Poly	I:C	treated	recipients	“Poly	I:C	+	IR”	as	it	was	anticipated	that	the	injury	caused	by	the	intra-peritoneal	injections	would	cause	up-regulation	of	 the	 chemokine	 to	 recruit	HSPCs	 to	 the	 injured	 site.	 The	 lower	 than	 expected	 level	 of	cxcl12a	might	 be	 an	indication	that	significant	damage	was	done	to	the	cells	which	would	normally	produce	this	chemokine.		
5.4.3 HSPCs	entering	an	inflammatory	environment	did	not	display	distinct	behaviours	As	in	the	previous	chapters,	recipients	were	imaged	4,	6	and	8	days	after	transplantation	with	200	cd41:GFP+	cells.	There	were	no	observable	differences	in	the	behaviour	of	cd41:GFP+	or	lyz:dsRed+	cells	in	the	WKM	at	any	of	 these	 time	points	 (Figure	5.6),	despite	 the	difference	 in	expression	of	cxcl12a.	 This	 could	 suggest	 that	 the	recipient	environments	of	the	two	groups	are	too	similar	to	observe	behavioural	changes	at	these	time	points.	Indeed,	 this	 is	 supported	 by	 the	 previously	 discussed	 qRT-PCR	 data	 which	 is	 remarkably	 similar	 between	“control”	and	poly	I:C	treated	recipients	at	the	time	of	transplant	(Figure	5.2;	Supplementary	Figure	7.7).	As	the	effects	 of	 radiation	 are	most	 extreme	 between	 4	 and	 8	 dpt	 (135),	 it	may	 be	 that	 the	 effects	 of	 the	 poly	 I:C	treatment	are	comparatively	unimportant.	This	idea	is	supported	by	the	fact	that	the	survival	curves	of	these	two	groups	overlap	closely	until	16	dpt	(Figure	5.8).		
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There	was	a	significant	survival	advantage	to	recipients	of	a	transplant,	whether	treated	with	poly	I:C	or	not.	The	survival	of	these	recipients	was	identical	for	the	first	16	days.	After	this	point,	the	probability	of	survival	of	poly	I:C	 treated	 recipients	 decreases	 slightly	 but	 not	 significantly.	 It	 would	 be	 interesting	 to	 see	 if	 this	 decrease	persists	in	the	longer	term.	Although,	previously	published	data	suggests	pre-conditioning	of	recipients	with	poly	I:C	improves	engraftment	and	recipient	survival	(412)	when	used	with	5-FU,	this	study	found	no	difference	in	the	survival	between	pre-conditioning	protocols	with	poly	I:C	and	irradiation	(Figure	5.8).		One	 of	 the	main	 questions	 of	 this	 thesis	was	 to	 determine	 if	 inflammation	 affected	 the	 behaviour	 of	HSPCs,	therefore	it	was	important	to	examine	a	non-irradiated	“non-inflamed”	c-mybt25127	mutant	recipient	control.	It	is	important	 to	 note	 that	 the	 inflammatory	 profile	 of	 the	 c-mybt25127	 mutant	 recipient	 was	 not	 assessed	 and	therefore	is	hypothetical.	The	survival	of	c-mybt25127	transplanted	with	200	cd41:GFP+	was	lower	than	irradiated	TraNac,	although	comparable	when	transplanted	with	2,000	cells	(		Figure	5.14C,	D).	The	comparison	with	irradiated	TraNac	is	not	the	most	suitable	as	the	organism	development	of	cmyb	mutants	would	have	been	affected	by	the	absence	of	a	hematopoietic	system.	Although	Hess	et	al.	argue	the	niche	is	not	affected	as	the	donor	HSPCs	are	able	to	rescue	the	hematopoietic	system	(46),	preservation	of	the	niche	signalling	has	not	been	demonstrated.	Therefore,	the	results	may	indicate	that	the	difference	in	survival	is	not	due	to	the	inflammatory	environment	but	rather	to	the	physiological	weakness	of	the	c-mybt25127	line.	The	survival	of	c-mybt25127	fish	improved	when	these	were	transplanted	with	2,000	cd41:GFP+	cells.	This	might	be	because	there	was	less	replicative	stress	on	HSPCs	when	a	larger	population	is	transplanted.			Altogether,	these	results	suggest	that	the	recipient	environment	has	a	less	significant	impact	on	the	behaviour	of	HSPCs	 than	 the	more	 chronic	 exposure	 to	 inflammation	 described	 in	 chapter	 4.	 This	 might	 be	 because	 the	exposure	is	more	transient,	or	it	may	be	that	the	HSPCs	have	been	affected	but	the	effect	on	replication	will	only	be	 determined	 by	 subsequent	 secondary	 transplants.	 Recently,	 Ishida	 et	 al.	 showed	 that	 the	 inflammatory	environment	 of	 the	 irradiated	 mouse	 recipient	 does	 impact	 transplanted	 HSPCs,	 but	 the	 effect	 of	 this	inflammation	was	only	observed	in	secondary	transplants	(410).		
5.4.4 Short	term	reconstitution	of	transplant	recipients		As	early	survival	and	the	behaviour	of	transplanted	cells	were	comparable	between	the	recipient	groups	in	the	first	2	wpt,	it	was	hypothesised	that	differences	might	manifest	just	before	the	difference	in	survival	is	noted.	Flow	cytometry	of	recipients	14	dpt	revealed	a	larger	precursor	population	in	“control”	recipients	than	poly	I:C	treated	 recipients.	 This	 might	 be	 the	 means	 by	 which	 survival	 in	 the	 “control”	 group	 is	 improved.	 The	environmental	components	which	support/inhibit	the	growth	of	this	population	need	further	study.			Flow	cytometry	of	recipients	at	28	dpt	shows	that	the	percentage	of	donor	contribution	to	the	recipient	WKM	was	not	significantly	different	between	control	and	poly	I:C	recipients.	This	is	contrary	to	the	report	published	by	Sato	et	al.	who	found	that	poly	I:C	and	5-FU	treatment	of	recipients	 lead	to	 increased	donor	chimerism	in	recipient	mice	compared	to	5-FU	treated	mice	(7.66	%	vs.	0.3	%),	2	months	post-transplant	(412).	It	is	likely	that	
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the	difference	in	our	conclusions	is	because	the	“inflamed”	recipient	in	this	work	is	not	significantly	different	to	the	 “control”	 recipient.	 It	 is	worth	noting	 that,	when	 comparing	pre-conditioning	 treatments,	 Sato	et	al.	 only	assessed	 DNA	 damage	 (gH2AX	 assay)	 and	 did	 not	 assess	 the	 inflammatory	 milieu.	 	 Thus,	 the	 difference	 in	interferon	 signalling	between	 irradiated,	poly	 I:C	 treated	and	5-FU	 treated	 recipients	was	not	determined.	 It	would	be	interesting	to	measure	this	component.	
	
5.5 Conclusion	and	future	work	In	conclusion,	 the	aim	of	 this	 thesis	 is	 to	assess	 the	response	of	HSCs	under	conditions	of	 inflammation.	This	chapter	 examined	 the	 acute	 effects	 of	 exposing	 naïve	 cd41:GFP+	 HSPCs	 to	 an	 inflammatory	 environment.	However,	it	is	not	clear	that	an	inflamed	recipient	was	created	because	the	cytokine	and	cellular	profiles	of	the	“control”	 and	 poly	 I:C	 treated	 recipients	 were	 not	 significantly	 different.	 This	 may	 explain	 why	 the	 initial	response	of	transplanted	cells	was	not	significantly	different	in	the	two	environments.	However,	Sato	et	al.	also	concluded	 that	 environmental	 interferons	 did	 not	 affect	 post-transplant	 reconstitution	 in	 mice	 (393).	 It	 is	important	to	remember	that	the	zebrafish	is	a	highly	regenerative	organism,	capable	of	reforming	amputated	fins	 or	 brain	 lesions,	 spinal	 cord	 and	 heart	 damage	 (425).	 Furthermore,	 they	 are	 very	 resilient	 to	 chronic	inflammation,	capable	of	healing	after	6	h	exposure,	3	days	a	week	over	6	weeks	(426).	This	may	have	had	an	important	role	in	the	physiology	of	the	zebrafish	WKM	as,	unlike	mammalian	BM,	the	endogenous	niche	cells	were	actively	regenerating.		Indeed,	there	is	an	indication	that	the	effects	of	the	environment	were	observed	a	little	later	at	14	dpt,	when	the	precursor	population	would	be	expanding	in	non-injected	irradiated	recipients.	In	poly	I:C	injected	recipients,	the	precursor	population	was	a	smaller	percentage	of	the	WKM,	and	this	could	be	an	indication	that	the	regeneration	of	HSPC	supportive	cells	was	affected	by	the	poly	I:C	treatment.	Furthermore,	a	reduced	precursor	population	at	14	dpt	may	be	the	cause	of	a	slightly	lower	survival	of	Poly	I:C	treated	recipients.			Based	on	these	findings,	it	would	be	interesting	to	examine	the	efficiency	of	WKM	regeneration	after	irradiation	(with	and	without	prior	poly	I:C	treatment).	For	instance,	Cre-recombinase	based	methods	or	photo-convertible	cells	are	used	for	lineage	tracing	experiments.	It	would	be	important	to	examine	the	cellular	composition	of	the	WKM	and	compare	 the	composition	at	various	 time	points	 to	establish	 the	regeneration	rate	 the	various	cell	types	as	this	will	have	an	important	impact	on	the	retention	of	HSPCs.	In	the	study	of	heart	regeneration,	reporter	lines	were	used	to	visualise	the	release	of	signals	that	facilitate	regeneration	over	time	(427).	However,	in	order	to	carry	out	 this	 study	 in	 the	zebrafish,	whole	 transcriptome	analysis	will	be	necessary	 to	 identify	candidate	genes	required	in	the	regeneration	of	the	WKM.			To	better	understand	inflammation	in	the	recipient,	future	work	could	examine	the	effect	of	poly	I:C	injection	in	recipients	 after	 the	 transplantation	 of	 naïve	 HSPCs.	 These	 recipients	 would	 be	 prepared	 by	 irradiation,	transplanted	 with	 200	 cd41:GFP+	 cells	 and	 then	 injected	 with	 poly	 I:C	 or	 saline	 at	 an	 appropriate	 interval	(perhaps	6	hpt).	This	might	be	able	to	cause	an	increased	inflammatory	milieu	in	poly	I:C	injected	recipients	that	would	be	significantly	different	from	the	protocol	described	in	this	chapter.			
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Mechanistically,	the	migration	of	transplanted	HSPCs	must	depend	on	signals.	It	was	not	possible	to	demonstrate	a	 change	 in	migration	 in	 the	 Poly	 I:C	 treated	 recipient,	 possibly	 because	 the	 signalling	was	 not	 significantly	different	 from	 irradiated	 controls.	 It	 would	 be	 interesting	 to	 test	 the	 involvement	 of	 specific	 inflammatory	molecules	 in	 the	 process	 of	 migration.	 For	 instance,	 a	 transgenic	 cxcl12a	 line	 exists	 and	 could	 be	 used	 in	conjunction	with	the	protocol	established	in	this	thesis	to	further	the	understanding	of	the	role	of	this	chemokine.		Furthermore,	the	effect	of	radiation	on	transplanted	cells	requires	further	investigation.	Radiation	damage	could	be	limited	using	ROS	reducing	agents	or	inflammation	reducing	agents.	In	fact,	a	single	dose	of	SCF,	TPO	and	IL-3	within	 2	 h	 of	 radiation	 significantly	 reduced	 cytopenia	 and	 improved	 hematopoietic	 recovery	 in	mice	 and	nonhuman	primates	(428).	This	suggests	that	a	greater	understanding	of	the	role	of	cytokines	could	potentially	lead	to	fewer	toxic	radiation	effects	and	greater	hematopoietic	recovery.		 	
Final	Discussion	
6 Final	Discussion		While	mouse	models	have	contributed	enormously	to	understanding	hematopoietic	regeneration,	it	has	not	been	possible	to	examine	HSPC	behaviour	in	vivo	without	terminal	anaesthesia.	The	zebrafish	has	been	a	central	model	for	the	understanding	of	early	hematopoiesis	and	human	hematopoietic	disorders	(150,	429-431).	Importantly,	immune	cell	types	and	inflammatory	molecular	pathways	are	conserved	between	zebrafish	and	mammals	(432-434).	This	thesis	has	demonstrated	that	live	imaging	of	young	adult	zebrafish	can	be	used	to	obtain	important	data	on	the	early-post-transplant	behaviour	of	transplanted	hematopoietic	cells	from	transgenic	donors.	Indeed,	the	regenerative	capacity	and	mobilisation	behaviour	of	transplanted	HSPCs	has	been	assessed,	in	the	context	of	inflammation	generated	by	a	viral	mimic.	There	are	many	exciting	directions	this	work	could	take	in	the	future	and	these	are	discussed	below.		
6.1 Significance	of	the	study	and	key	findings	Chapter	 3	 presents	 the	 refinements	 made	 to	 the	 HCT	 protocol	 in	 zebrafish	 in	 order	 to	 qualitatively	 and	quantitatively	analyse	the	behaviour	of	transplanted	cells.	This	meant	developing	a	method	to	deliver	the	cells	safely	and	without	causing	damage	into	small	(<1	cm)	optically	transparent	juveniles	to	provide	quality	images.	This	is	first	time	that	transplanted	cells	have	been	imaged	individually	in	the	WKM	of	the	adult	recipient	organism	and	the	method	is	central	to	answering	subsequent	questions	about	HSPC	post-transplant	behaviour	in	response	to	inflammation.	Data	correlating	cell	number	and	transplant	recipient	survival	was	presented.	It	revealed	that	post-transplant	deaths	that	occured	between	10	and	20	dpt	can	be	predicted	and	reduced	by	humanely	killing	fish	that	have	fewer	than	a	total	of	25	fluorescent	donor	cells	in	the	WKM	by	6	dpt.	If	this	protocol	is	applied,	the	number	of	animals	suffering	and	dying	because	of	 failed	HCT	would	be	reduced	by	50	%.	This	 information	is	important	 for	 improving	 animal	 welfare	 and	 reducing	 the	 severity	 of	 this	 protocol	 under	 UK	 Home	 Office	regulations.			In	 chapter	 4,	 the	 HCT	 donors	 were	 repeatedly	 stimulated	 with	 IFN	 inducer	 poly	 I:C	 prior	 to	 harvest	 and	transplant	 into	 irradiated	 recipients.	 Through	 the	 tracking	 of	 individuals	 over	 time,	 a	 statistically	 significant	interaction	was	found	between	the	treatment	and	time.	The	increase	in	the	number	of	HSPCs	in	the	recipient	WKM	 was	 greater	 when	 transplanted	 from	 poly	 I:C	 injected	 donors.	 This	 underscored	 a	 change	 in	 HSPC	(cd41:GFP+)	 behaviour	 in	 poly	 I:C	 treated	 cells	 that	 was	 not	 apparent	 by	 examining	 individual	 timepoints.	However,	 the	 survival	 of	 recipients	 of	HSPCs	 from	poly	 I:C	 injected	donors	was	not	 significantly	different	 to	recipients	of	HSPCs	from	saline	injected	donors	and	there	was	no	evidence	that	treatment	of	the	donor	affected	either	 early	 myeloid	 (lyz:dsRed+)	 output	 or	 long	 term	 (28	 dpt)	 hematopoiesis	 in	 recipients.	 Together,	 the	conclusion	is	that	poly	I:C	injected	donors	have	HSPCs	that	expand	rapidly	in	the	transplant	recipient	but	cope	equally	to	the	reconstitution	challenge	as	HSPCs	from	saline	injected	donors.		In	chapter	5,	the	HCT	recipients	were	stimulated	with	poly	I:C	prior	to	irradiation	and	receiving	HSPCs	from	naïve	donors.	 Essentially,	 the	 initial	 post-transplant	 behaviour	 of	 donor	 cells	 was	 not	 significantly	 different	 to	
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behaviour	in	“control”	(non-injected,	irradiated)	recipients.	Survival	was	not	significantly	different	either.	The	limitation	of	this	work	is	that	the	“inflamed”	recipient	was	not	demonstrably	different	to	the	“control”	recipient	at	the	time	of	transplant.	Preliminary	work	with	bloodless	mutants	(non-injected,	non-irradiated)	suggests	that	these	could	be	a	better	model	 to	examine	the	 	effect	of	 the	 inflammatory	environment	on	trasplanted	HSPCs.	Together,	 the	conclusion	 is	 that	 the	 inflammatory	environment	created	by	 this	protocol	did	not	differentially	affect	transplanted	HSPCs.	Some	suggestions	for	future	work	are	discussed	below.			In	conclusion,	this	thesis	has	demonstrated	the	first	use	of	in	vivo	imaging	to	quantify	early	post-transplant	events	in	the	adult	zebrafish.	The	results	indicate	that	the	recipient	environment	has	a	much	less	significant	impact	on	the	survival	of	transplant	recipients	than	the	state	of	the	donor	HSPC	prior	to	transplantation.		
6.2 Future	work	This	project	has	developed	the	HCT	method	in	a	manner	that	can	be	applied	to	many	questions.	In	the	immediate,	it	would	be	important	to	examine	the	competitiveness	of	the	pre-stimulated	HSPC	population	against	the	non-stimulated	HSPC	population	in	the	same	recipient.	An	experiment	design	was	outlined	in	Figure	4.14	in	which	donor	Tg	(runx1+23:GFP)	were	injected	with	either	saline	or	poly	I:C	before	harvesting	runx1:GFP+	HSPCs	from	their	WKMs.	 These	 HSPCs	 would	 then	 be	 transplanted	 into	 recipients	 along-side	 HSPCs	 from	 untreated	 Tg	(runx1+23:NLSmCherry)	 	 donors	 and	 PB	 from	 WT	 donors.	 Mobilisation,	 expansion	 and	 engraftment	 of	runx1:GFP+	cells	from	poly	I:C	injected	donors	would	be	measured	relative	to	the	runx:mCherry+	HSPCs	from	the	untreated	donors;	 likewise	 the	mobilisation,	 expansion	 and	 engraftment	 of	 runx1:GFP+	 cells	 from	 saline	injected	donors	would	be	measured	relative	to	the	same	population.	Thus	the	poly	I:C	and	saline	simulated	HSPCs	would	be	measured	relative	to	the	same	untreated	population	of	runx:mCherry+	HSPCs.			This	protocol	will	be	immensely	useful	for	all	kinds	of	work	requiring	the	in	vivo	readout	of	cell	potential	and	may	 even	 be	 applied	 to	 examining	HSC	behaviour	 in	 the	 absence/presence	 of	 specific	 niche	 components,	 as	mentioned	early	for	the	14	dpt	expansion	of	the	precursor	population.	For	instance,	Notch	has	an	important	role	in	the	emergence	of	HSCs,	partly	because	of	its	role	in	body	segmentation.	Using	this	protocol,	HSPC	behaviour	could	be	observed	in	a	heat	shock	induced	knockout	of	Notch.	This	protocol	could	also	be	applied	to	examining	leukemic	cell	behaviour	and	cells	of	xenogeneic	transplant	studies.		Another	immediate	question	that	could	be	answered	is	to	measure	the	cytokine	environment	of	the	bloodless	c-mybt25127	 mutant	 using	 qRT-PCR	 as	 this	 group	 of	 recipients	 were	 regarded	 as	 a	 non-inflamed	 control,	 but	cytokines	can	be	produced	by	various	cell	types.	In	addition,	the	niche	environment	of	the	the	c-mybt25127	mutant	should	be	examined	to	understand	if	it	has	been	affected	by	the	absence	of	hematopoiesis	during	development.	Further	experiments	can	take	advantage	of	these	mutants,	independently	of	TraNac	fish.	For	instance,	crossing	the	mutant	with	a	line	of	fish	in	which	inducible	promoters	(eg.	vascular	specific	gene	or	nephros	specific	gene)	could	drive	cytokine	 (il-1b,	 tnfa,	 il-6	etc.)	 expression	and	would	create	a	 cytokine	specific	 inflamed	recipient	niche	without	 the	use	 of	 poly	 I:C	 or	 irradiation.	 In	 this	way,	 the	 c-myb	mutant	 could	be	 compared	with	 and	
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without	cytokine	expression.	The	different	segments	of	 the	kidney	 tubules	express	different	 ion	 transporters	(311)	and	these	could	be	used	to	drive	the	cytokine	expression	in	distinct	sections	of	the	WKM.		Furthermore,	 the	 results	 of	 chapter	 5	 indicate	 that	 the	 environmental	 inflammation	 did	 not	 affect	 the	transplanted	HSPCs.	However,	previously	in	the	mouse,	Slayton	et	al.	have	found	that	HSCs	help	to	repair	the	endothelial	and	vascular	cells	of	the	irradiated	environment	(435).	Therefore,	it	might	be	of	interest	to	study	how	HSPCs	can	affect	environmental	inflammation.	Do	HSPCs	interact	and	repair	the	endothelial	and	vascular	cells	of	the	zebrafish?	Perhaps	the	imaging	techniques	described	for	HCT	could	be	used	to	examine	the	interaction	of	HSPCs	 and	 vascular	 cells	 and	 the	 molecules	 involved.	 With	 the	 progressing	 development	 of	 new	 imaging	techniques,	the	zebrafish	has	advantages	over	rodent	models	to	obtain	high-resolution	information	of	biological	processes.	 For	 instance,	 the	 Dallman	 lab	 has	 developed	 FRET	 (Förster	 Resonant	 Energy	 Transfer)-sensors	 of	Caspase	1	and	3	activation	(436).	Fluorescence-lifetime	imaging	and	optical	projection	tomography	of	these	fish	will	 facilitate	 the	dissection	of	molecular	 interactions	 in	 the	whole	organism	 in	 real	 time.	For	 instance,	 if	 the	promoter	driving	the	construct	were	chosen	from	candidate	genes	from	cells	in	the	WKM,	the	caspase	activity	in	those	cells	could	be	examined	following	irradiation	and	used	to	compare	death	in	the	non-injected	and	poly	I:C-injected	recipients	used	in	Chapter	5.			A	question	which	arose	in	this	thesis	was	the	cell-cycle	kinetics	of	zebrafish	HSPCs	(see	chapter	3.3.5).	The	BrdU	labelling	 experiments	 did	not	 reveal	 any	WKM	cells	with	 slow	 cycling	 activity.	 This	may	be	due	 to	 technical	obstacles	or	this	may	indeed	reflect	that	zebrafish	do	not	have	a	slow	cycling	population.	If	the	latter	is	the	case,	then	 the	 protections	 provided	 by	 the	 quiescent	 state	 (from	mutations	 for	 instance)	 of	 the	 LT-HSC	must	 be	compensated	for	by	other	mechanisms	(perhaps	cell-autonomous)	in	the	zebrafish.	Future	work	could	determine	if	the	hematopoietic	system	of	zebrafish	can	be	exhausted	as	this	would	reveal	if	there	is	a	limit	to	the	supply	of	the	most	 primitive	 population.	 Furthermore,	 the	 heterogeneity	 of	 the	 cd41:GFP+	 HSPC	 population	 could	 be	explored	 using	 single-cell	 lineage	 tracing	 experiments	 as	 recently	 published	 (55).	 With	 recent	 single-cell	transcriptome	data	analysis,	the	field	is	accepting	that	individual	cells	of	the	LT-HSC	population	have	significantly	different	transcriptomes	and	therefore	the	heterogeneity	of	this	population	must	be	taken	into	account	when	examining	its	behaviour	(79,	80).	With	the	recent	development	of	the	Zebrabrow	system	(55)	which	activates	a	unique	heritable	colour	in	each	cd41:GFP+	cell,	cells	of	the	same	clone	could	be	examined	for	post-transplant	behaviour,	differentiation	and	cell	cycle	kinetics.			Finally,	 the	 developed	method	 offers	 the	 possibility	 of	 integrated	multi-organ	 analysis	 of	 pathophysiological	responses,	which	will	undoubtedly	be	the	focus	of	future	research.	Indeed,	there	is	emerging	evidence	that	life-style	 choices	 such	as	diet	 and	 smoking	have	a	 significant	 impact	on	 the	 immune	system.	There	 is	 a	need	 for	systematic	reviews	and	meta-analysis	to	be	performed	to	get	an	understanding	of	how	these	factors,	as	well	as	gender	and	donor	age	can	affect	the	reconstitution	capacity	of	their	blood.	Indeed,	the	Dallman	lab	has	reported	inflammatory	responses	 to	both	acute	and	 long	term	exposure	 to	a	high	cholesterol	diet	 (HCD)	and	cigarette	smoke	(391,	392)	in	the	zebrafish	and	therefore	this	project	could	be	launched	relatively	quickly.	It	would	be	
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interesting	to	address	the	effect	of	chronic	inflammatory	responses	due	to	a	high	cholesterol	diet	or	cigarette	smoke	exposure	on	HSPC	behaviour,	both	of	which	are	of	clinical	interest	(325,	437-440).		
6.3 Implications	and	future	directions	Lastly,	the	differences	and	similarities	between	the	zebrafish,	mouse	and	human	HSPC	populations	are	difficult	to	 align.	 Therefore,	 to	 fully	 achieve	 the	 potential	 benefits	 of	 an	 immunological	 understanding	 for	 human	wellbeing,	 more	 emphasis	 needs	 to	 be	 placed	 on	 human	 studies	 as	 it	 is	 key	 to	 learning	 more	 about	 these	conditions	from	clinical	samples.	Studying	stem	cells	in	model	organisms	may	give	good	insights	but	it	is	difficult	to	draw	the	line	between	the	general	and	the	animal	specific	findings.	In	order	to	understand	more	about	human	HSPCs,	it	is	important	to	develop	humanised	animal	models	and	to	study	patient	samples.	
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Figure	7.1:	Cytospin	of	whole	kidney	marrow	cells	from	irradiated	and	non-irradiated	TraNac.	Adult	TraNac	fish	were	irradiated	
twice	with	15	Gy	(24h	apart)	and	their	WKM	harvested	5	days	later.	Live	WKM	cells	were	cytospun	onto	slides	and	stained	with	
Wright-Geimsa.	Representative	images	shown	here.	White	arrows	indicate	nucleated	cells	(myeloid	(M),	lymphoid	(L));	Black	
arrows	indicate	enucleate	cells.		
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Figure	7.2:	Irradiation	did	not	change	interferon	gene	expression	in	the	whole	kidney	marrow.	TraNac	fish	were	left	untreated	
(Non-IR)	or	irradiated	(IR)	with	2	doses	of	15	Gy,	24	h	apart,	and	the	WKM	was	harvested	1,	3,	8,	and	24	h	after	the	2nd	dose.	
RNA	was	extracted	and	qRT-PCR	was	performed	on	samples.	2	experiments	pooled.	Work	done	in	collaboration	with	D.	Polos.	
Expression	levels	of	ifnj	and	ifng1.2	were	normalised	to	18S	using	the	DDCT	method.	Fold	change	relative	to	the	median	control	
value.	2	experiments,	n=8.	Each	dot	represents	WKM	from	an	individual	fish.	Statistical	significance	using	one-way	ANOVA.		
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Figure	7.3:	Flow	cytometry	scatter	of	WKM	samples	from	transplant	recipients	and	non-transplanted	Tg	(ubi:GFP)	and	WT	fish.	
TraNac	or	WT	fish	were	irradiated	with	2	doses	of	15	Gy	and	retro-orbitally	transplanted	with	a	whole	Tg	(ubi:GFP)	donor	WKM	
(1:1),	105	WKM	cells	or	5	x	104	cells	from	a	Tg	(ubi:GFP)	donor.	(7	experiments	pooled;	3	(1:1)	transplants,	2	(105)	and	2	(5x	
104),	n>11.	Flow	cytometry	scatter	profile	of	Tg	(ubi:GFP)	donor,	WT,	transplant	recipient	TraNac	28	dpt	and	non-transplanted	
irradiated	TraNac	recipient.	SSC	indicates	side	scatter	(488	laser,	488/10	filter);	GFP	indicates	(488	laser,	530/30	filter).			
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Figure	7.4:	Both	cd41low	and	cd41high	contain	HSPCs	with	reconstitution	ability.	WKM	cells	 from	Tg	(cd41:GFP;lysC:dsRed)	
were	sorted	for	cd41high	or	cd41low	cells.	(A)	Procedure	overview.	(B)	Flow	cytometry	scatter	of	donor	WKM	cells	with	gating	
used	to	obtain	populations	from	donors	for	transplant.	(C)	Flow	cytometry	scatter	of	recipient	WKM,	28	dpt.	SSC	indicates	side	
scatter;	FSC	indicates	forward	scatter	(both	use	488	nm	laser,	488/10	filter),	GFP	(488	nm	laser,	530/30	filter),		dsRed	(561	nm	
laser,	610/20	filter		
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	Figure	7.5:	Eight	sequential	injections	of	poly	I:C	does	not	change	blood	populations	significantly	at	the	time	of	transplant.	Tg	
(cd41:GFP;lyz:dsRed)	 fish	were	 injected	 8	 times	with	 either	 saline	 or	 10	 μg	 poly	 I:C.	 One	week	 post	 injection,	WKMs	were	
harvested	to	measure	changes	in	blood	populations	by	qRT-PCR.	Expression	of	cxcl12a,	mpx,	lyz,	gata1,	c-myb	and	runx1	were	
normalised	to	18S,	using	DDCT	method.	Fold	change	normalised	to	the	median	“Saline”	control	value.	Two	experiments	pooled	
(n>5).	Statistical	significance	using	student	t-test.	*p<0.05.		 	
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Figure	7.6:	Pooled	survival.	Tg	(cd41:GFP;lyz:dsRed)	fish	were	injected	8	times	with	either	saline	or	10	μg	poly	I:C.	One	week	
post	 injection,	 donors	were	 harvested	 of	 their	WKM	and	 sorted	 for	 cd41:GFP+	 cells	 for	 transplant.	 TraNac	 recipients	were	
irradiated	with	 15	 Gy	 48	 and	 24	 h	 prior	 to	 RO	 injection	 of	 200	 cd41:GFP+	 cells	 from	 these	 donors	 (and	 105	WT	PB	 cells).	
Recipients	were	imaged	and	then	monitored	for	survival	to	28	dpt.	(6	experiments	pooled,	n>70).		 	
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Figure	7.7:	Cytokine	levels	in	recipients	after	irradiation.	Poly	I:C	treated	recipient	(Poly	I:C	+	IR)	TraNac	fish	were	injected	with	
10	μg	poly	I:C	twice,	48	h	apart,	then	irradiated	with	15	Gy	48	h	and	72	h	later.	“Control”	recipients	(IR)	were	not	injected	but	
were	 irradiated	 alongside	 inflamed	 recipients.	 Non-irradiated	 or	 injected	 fish	 (No	 IR,	 No	 poly	 I:C)	were	 used	 as	 untreated	
controls.	Fish	were	humanely	killed	and	the	decapitated	body	harvested	 for	analysis.	RTqPCR	was	used	to	measure	relative	
expression	of	il-1β,	tnf⍺,	il-6,	ifnφ1,	ifnγ1.1,	ifnγ1.2,	and	cxcl-c1c,	normalised	to	18S,	using	the	DDCT	method.	Three	experiments	
pooled,	n>8.	“No	IR	No	Poly	I:C”	and	“IR”	data	presented	in	in	chapter	3.3.1.3.	Statistical	significance	using	One-way	ANOVA	and	
Tukey	post-test.	*	p<0.05,	**	p<0.01,	***	p<0.001.			
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Figure	7.8:	Relative	transcript	levels	of	specific	blood	genes	in	recipients	after	irradiation.	Poly	I:C	treated	recipient	(Poly	I:C	+	
IR)	TraNac	fish	were	injected	with	10	μg	poly	I:C	twice,	48	h	apart,	then	irradiated	with	15	Gy	48	h	and	72	h	later.	“Control”	
recipients	(IR)	were	not	injected	but	were	irradiated	alongside	inflamed	recipients.	Non-irradiated	or	injected	fish	(No	IR,	No	
poly	I:C)	were	used	as	untreated	controls.	Fish	were	humanely	killed	and	the	decapitated	body	harvested	for	analysis.		RTqPCR	
was	used	to	measure	relative	expression	of	gata1,	lck,	lyz,	mpeg,	mfap4	and	l-plastin,	normalised	to	18S,	using	the	DDCT	method.	
Three	experiments	pooled,	n>6.	“No	IR	No	Poly	I:C”	and	“IR”	data	presented	in	chapter	3.3.1.3.	Statistical	significance	using	One-
way	ANOVA	and	Tukey	post-test.	*	p<0.05,	**	p<0.01,	***	p<0.001.		
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